{"date": "2024-12-31", "symbol": "ABBV", "type": "income_statement_annual", "result": {"date": "2024-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-02-14", "acceptedDate": "2025-02-14 13:17:23", "fiscalYear": "2024", "period": "FY", "revenue": 56334000000, "costOfRevenue": 16904000000, "grossProfit": 39430000000, "researchAndDevelopmentExpenses": 12791000000, "generalAndAdministrativeExpenses": 11089000000, "sellingAndMarketingExpenses": 2100000000, "sellingGeneralAndAdministrativeExpenses": 13189000000, "otherExpenses": 4313000000, "operatingExpenses": 30293000000, "costAndExpenses": 47197000000, "netInterestIncome": -2160000000, "interestIncome": 648000000, "interestExpense": 2808000000, "depreciationAndAmortization": 8386000000, "ebitda": 14910000000, "ebit": 6524000000, "nonOperatingIncomeExcludingInterest": 2613000000, "operatingIncome": 9137000000, "totalOtherIncomeExpensesNet": -5421000000, "incomeBeforeTax": 3716000000, "incomeTaxExpense": -570000000, "netIncomeFromContinuingOperations": 4286000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4278000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4238000000, "eps": 2.4, "epsDiluted": 2.39, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1773000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "income_statement_annual", "result": {"date": "2023-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-02-20", "acceptedDate": "2024-02-20 12:45:17", "fiscalYear": "2023", "period": "FY", "revenue": 54318000000, "costOfRevenue": 20415000000, "grossProfit": 33903000000, "researchAndDevelopmentExpenses": 7675000000, "generalAndAdministrativeExpenses": 10704000000, "sellingAndMarketingExpenses": 2200000000, "sellingGeneralAndAdministrativeExpenses": 12872000000, "otherExpenses": 599000000, "operatingExpenses": 21146000000, "costAndExpenses": 41561000000, "netInterestIncome": -1684000000, "interestIncome": 540000000, "interestExpense": 2224000000, "depreciationAndAmortization": 8698000000, "ebitda": 17172000000, "ebit": 8474000000, "nonOperatingIncomeExcludingInterest": 4283000000, "operatingIncome": 12757000000, "totalOtherIncomeExpensesNet": -6507000000, "incomeBeforeTax": 6250000000, "incomeTaxExpense": 1377000000, "netIncomeFromContinuingOperations": 4873000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4863000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4820000000, "eps": 2.73, "epsDiluted": 2.72, "weightedAverageShsOut": 1768000000, "weightedAverageShsOutDil": 1773000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "income_statement_annual", "result": {"date": "2022-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-02-17", "acceptedDate": "2023-02-17 12:54:29", "fiscalYear": "2022", "period": "FY", "revenue": 58054000000, "costOfRevenue": 17414000000, "grossProfit": 40640000000, "researchAndDevelopmentExpenses": 6510000000, "generalAndAdministrativeExpenses": 13260000000, "sellingAndMarketingExpenses": 2000000000, "sellingGeneralAndAdministrativeExpenses": 15260000000, "otherExpenses": 753000000, "operatingExpenses": 22523000000, "costAndExpenses": 39937000000, "netInterestIncome": -2044000000, "interestIncome": 186000000, "interestExpense": 2230000000, "depreciationAndAmortization": 8467000000, "ebitda": 24174000000, "ebit": 15707000000, "nonOperatingIncomeExcludingInterest": 2410000000, "operatingIncome": 18117000000, "totalOtherIncomeExpensesNet": -4640000000, "incomeBeforeTax": 13477000000, "incomeTaxExpense": 1632000000, "netIncomeFromContinuingOperations": 11845000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 11836000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 11782000000, "eps": 6.65, "epsDiluted": 6.63, "weightedAverageShsOut": 1771000000, "weightedAverageShsOutDil": 1778000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "income_statement_annual", "result": {"date": "2021-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-02-18", "acceptedDate": "2022-02-18 12:41:31", "fiscalYear": "2021", "period": "FY", "revenue": 56197000000, "costOfRevenue": 17446000000, "grossProfit": 38751000000, "researchAndDevelopmentExpenses": 8046000000, "generalAndAdministrativeExpenses": 10249000000, "sellingAndMarketingExpenses": 2100000000, "sellingGeneralAndAdministrativeExpenses": 12349000000, "otherExpenses": 432000000, "operatingExpenses": 20827000000, "costAndExpenses": 38273000000, "netInterestIncome": -2384000000, "interestIncome": 39000000, "interestExpense": 2423000000, "depreciationAndAmortization": 8521000000, "ebitda": 23933000000, "ebit": 15412000000, "nonOperatingIncomeExcludingInterest": 2512000000, "operatingIncome": 17924000000, "totalOtherIncomeExpensesNet": -4935000000, "incomeBeforeTax": 12989000000, "incomeTaxExpense": 1440000000, "netIncomeFromContinuingOperations": 11549000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 11542000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 11468000000, "eps": 6.48, "epsDiluted": 6.45, "weightedAverageShsOut": 1770000000, "weightedAverageShsOutDil": 1777000000}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2025-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-11-04", "acceptedDate": "2025-11-04 14:05:49", "fiscalYear": "2025", "period": "Q3", "revenue": 15776000000, "costOfRevenue": 3390000000, "grossProfit": 12386000000, "researchAndDevelopmentExpenses": 2244000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3380000000, "otherExpenses": 1871000000, "operatingExpenses": 7495000000, "costAndExpenses": 10885000000, "netInterestIncome": -709000000, "interestIncome": 72000000, "interestExpense": 781000000, "depreciationAndAmortization": 2063000000, "ebitda": 3444000000, "ebit": 1381000000, "nonOperatingIncomeExcludingInterest": 3510000000, "operatingIncome": 4891000000, "totalOtherIncomeExpensesNet": -4177000000, "incomeBeforeTax": 714000000, "incomeTaxExpense": 526000000, "netIncomeFromContinuingOperations": 188000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 186000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 186000000, "eps": 0.1, "epsDiluted": 0.1, "weightedAverageShsOut": 1772000000, "weightedAverageShsOutDil": 1772000000}}
{"date": "2025-06-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2025-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-08-04", "acceptedDate": "2025-08-04 15:17:04", "fiscalYear": "2025", "period": "Q2", "revenue": 15423000000, "costOfRevenue": 2403000000, "grossProfit": 13020000000, "researchAndDevelopmentExpenses": 2100000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3218000000, "otherExpenses": 1840000000, "operatingExpenses": 7158000000, "costAndExpenses": 9561000000, "netInterestIncome": -678000000, "interestIncome": 62000000, "interestExpense": 740000000, "depreciationAndAmortization": 2050000000, "ebitda": 4344000000, "ebit": 2294000000, "nonOperatingIncomeExcludingInterest": 3568000000, "operatingIncome": 5862000000, "totalOtherIncomeExpensesNet": -4308000000, "incomeBeforeTax": 1554000000, "incomeTaxExpense": 613000000, "netIncomeFromContinuingOperations": 941000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 6000000, "netIncome": 944000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 938000000, "eps": 0.53, "epsDiluted": 0.53, "weightedAverageShsOut": 1772000000, "weightedAverageShsOutDil": 1772000000}}
{"date": "2025-03-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2025-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-05-09", "acceptedDate": "2025-05-09 13:24:59", "fiscalYear": "2025", "period": "Q1", "revenue": 13343000000, "costOfRevenue": 4002000000, "grossProfit": 9341000000, "researchAndDevelopmentExpenses": 2067000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3293000000, "otherExpenses": 248000000, "operatingExpenses": 5608000000, "costAndExpenses": 9610000000, "netInterestIncome": -627000000, "interestIncome": 73000000, "interestExpense": 700000000, "depreciationAndAmortization": 2039000000, "ebitda": 4400000000, "ebit": 2361000000, "nonOperatingIncomeExcludingInterest": 1372000000, "operatingIncome": 3733000000, "totalOtherIncomeExpensesNet": -2072000000, "incomeBeforeTax": 1661000000, "incomeTaxExpense": 372000000, "netIncomeFromContinuingOperations": 1289000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1286000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1276000000, "eps": 0.72, "epsDiluted": 0.72, "weightedAverageShsOut": 1768000000, "weightedAverageShsOutDil": 1772000000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2024-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-02-14", "acceptedDate": "2025-02-14 13:17:23", "fiscalYear": "2024", "period": "Q4", "revenue": 15102000000, "costOfRevenue": 4396000000, "grossProfit": 10706000000, "researchAndDevelopmentExpenses": 6774000000, "generalAndAdministrativeExpenses": 779000000, "sellingAndMarketingExpenses": 2100000000, "sellingGeneralAndAdministrativeExpenses": 2879000000, "otherExpenses": 2543000000, "operatingExpenses": 12196000000, "costAndExpenses": 16592000000, "netInterestIncome": -610000000, "interestIncome": 92000000, "interestExpense": 702000000, "depreciationAndAmortization": 2102000000, "ebitda": 535000000, "ebit": -1567000000, "nonOperatingIncomeExcludingInterest": 77000000, "operatingIncome": -1490000000, "totalOtherIncomeExpensesNet": -779000000, "incomeBeforeTax": -2269000000, "incomeTaxExpense": -2246000000, "netIncomeFromContinuingOperations": -23000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": -22000000, "netIncomeDeductions": 0, "bottomLineNetIncome": -32000000, "eps": -0.0181, "epsDiluted": -0.0181, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1773000000}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2024-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-11-04", "acceptedDate": "2024-11-04 14:19:33", "fiscalYear": "2024", "period": "Q3", "revenue": 14460000000, "costOfRevenue": 4212000000, "grossProfit": 10248000000, "researchAndDevelopmentExpenses": 2130000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 4205000000, "otherExpenses": 82000000, "operatingExpenses": 6417000000, "costAndExpenses": 10629000000, "netInterestIncome": -591000000, "interestIncome": 129000000, "interestExpense": 720000000, "depreciationAndAmortization": 2079000000, "ebitda": 4883000000, "ebit": 2804000000, "nonOperatingIncomeExcludingInterest": 1027000000, "operatingIncome": 3831000000, "totalOtherIncomeExpensesNet": -1747000000, "incomeBeforeTax": 2084000000, "incomeTaxExpense": 520000000, "netIncomeFromContinuingOperations": 1564000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1561000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1551000000, "eps": 0.88, "epsDiluted": 0.88, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1772000000}}
{"date": "2024-06-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2024-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-08-07", "acceptedDate": "2024-08-07 15:00:51", "fiscalYear": "2024", "period": "Q2", "revenue": 14462000000, "costOfRevenue": 4202000000, "grossProfit": 10260000000, "researchAndDevelopmentExpenses": 1948000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3377000000, "otherExpenses": 937000000, "operatingExpenses": 6262000000, "costAndExpenses": 10464000000, "netInterestIncome": -506000000, "interestIncome": 220000000, "interestExpense": 726000000, "depreciationAndAmortization": 2131000000, "ebitda": 5003000000, "ebit": 2872000000, "nonOperatingIncomeExcludingInterest": 1126000000, "operatingIncome": 3998000000, "totalOtherIncomeExpensesNet": -1852000000, "incomeBeforeTax": 2146000000, "incomeTaxExpense": 773000000, "netIncomeFromContinuingOperations": 1373000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1370000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1360000000, "eps": 0.77, "epsDiluted": 0.77, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1771000000}}
{"date": "2024-03-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2024-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-05-03", "acceptedDate": "2024-05-03 11:04:11", "fiscalYear": "2024", "period": "Q1", "revenue": 12310000000, "costOfRevenue": 4094000000, "grossProfit": 8216000000, "researchAndDevelopmentExpenses": 1939000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3315000000, "otherExpenses": 164000000, "operatingExpenses": 5418000000, "costAndExpenses": 9512000000, "netInterestIncome": -453000000, "interestIncome": 207000000, "interestExpense": 660000000, "depreciationAndAmortization": 2074000000, "ebitda": 4489000000, "ebit": 2415000000, "nonOperatingIncomeExcludingInterest": 383000000, "operatingIncome": 2798000000, "totalOtherIncomeExpensesNet": -1043000000, "incomeBeforeTax": 1755000000, "incomeTaxExpense": 383000000, "netIncomeFromContinuingOperations": 1372000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1369000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1359000000, "eps": 0.77, "epsDiluted": 0.77, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1773000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2023-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-02-20", "acceptedDate": "2024-02-20 12:45:17", "fiscalYear": "2023", "period": "Q4", "revenue": 14301000000, "costOfRevenue": 5704000000, "grossProfit": 8597000000, "researchAndDevelopmentExpenses": 2209000000, "generalAndAdministrativeExpenses": 1355000000, "sellingAndMarketingExpenses": 1838000000, "sellingGeneralAndAdministrativeExpenses": 3193000000, "otherExpenses": 0, "operatingExpenses": 5402000000, "costAndExpenses": 11106000000, "netInterestIncome": -378000000, "interestIncome": 186000000, "interestExpense": 564000000, "depreciationAndAmortization": 2076000000, "ebitda": 3852000000, "ebit": 1776000000, "nonOperatingIncomeExcludingInterest": 1419000000, "operatingIncome": 3195000000, "totalOtherIncomeExpensesNet": -1983000000, "incomeBeforeTax": 1212000000, "incomeTaxExpense": 388000000, "netIncomeFromContinuingOperations": 824000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 822000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 811000000, "eps": 0.46, "epsDiluted": 0.46, "weightedAverageShsOut": 1765940733, "weightedAverageShsOutDil": 1772000000}}
{"date": "2023-09-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2023-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-11-06", "acceptedDate": "2023-11-06 13:01:04", "fiscalYear": "2023", "period": "Q3", "revenue": 13927000000, "costOfRevenue": 6485000000, "grossProfit": 7442000000, "researchAndDevelopmentExpenses": 1723000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3372000000, "otherExpenses": 66000000, "operatingExpenses": 5161000000, "costAndExpenses": 11646000000, "netInterestIncome": -398000000, "interestIncome": 157000000, "interestExpense": 555000000, "depreciationAndAmortization": 2235000000, "ebitda": 4743000000, "ebit": 2508000000, "nonOperatingIncomeExcludingInterest": -227000000, "operatingIncome": 2281000000, "totalOtherIncomeExpensesNet": -328000000, "incomeBeforeTax": 1953000000, "incomeTaxExpense": 172000000, "netIncomeFromContinuingOperations": 1781000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1778000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1767000000, "eps": 1, "epsDiluted": 1, "weightedAverageShsOut": 1767000000, "weightedAverageShsOutDil": 1771000000}}
{"date": "2023-06-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2023-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-08-07", "acceptedDate": "2023-08-07 13:10:46", "fiscalYear": "2023", "period": "Q2", "revenue": 13865000000, "costOfRevenue": 4240000000, "grossProfit": 9625000000, "researchAndDevelopmentExpenses": 1733000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3268000000, "otherExpenses": 111000000, "operatingExpenses": 5112000000, "costAndExpenses": 9352000000, "netInterestIncome": -454000000, "interestIncome": 98000000, "interestExpense": 552000000, "depreciationAndAmortization": 2260000000, "ebitda": 5422000000, "ebit": 3162000000, "nonOperatingIncomeExcludingInterest": 1351000000, "operatingIncome": 4513000000, "totalOtherIncomeExpensesNet": -1903000000, "incomeBeforeTax": 2610000000, "incomeTaxExpense": 583000000, "netIncomeFromContinuingOperations": 2027000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2024000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2013000000, "eps": 1.14, "epsDiluted": 1.14, "weightedAverageShsOut": 1767000000, "weightedAverageShsOutDil": 1771000000}}
{"date": "2023-03-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2023-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-05-05", "acceptedDate": "2023-05-05 12:54:58", "fiscalYear": "2023", "period": "Q1", "revenue": 12225000000, "costOfRevenue": 3986000000, "grossProfit": 8239000000, "researchAndDevelopmentExpenses": 2292000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3039000000, "otherExpenses": 140000000, "operatingExpenses": 5471000000, "costAndExpenses": 9457000000, "netInterestIncome": -454000000, "interestIncome": 99000000, "interestExpense": 553000000, "depreciationAndAmortization": 2127000000, "ebitda": 3155000000, "ebit": 1028000000, "nonOperatingIncomeExcludingInterest": 1740000000, "operatingIncome": 2768000000, "totalOtherIncomeExpensesNet": -2293000000, "incomeBeforeTax": 475000000, "incomeTaxExpense": 234000000, "netIncomeFromContinuingOperations": 241000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 239000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 228000000, "eps": 0.13, "epsDiluted": 0.13, "weightedAverageShsOut": 1770000000, "weightedAverageShsOutDil": 1776000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2022-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-02-17", "acceptedDate": "2023-02-17 12:54:29", "fiscalYear": "2022", "period": "Q4", "revenue": 15121000000, "costOfRevenue": 4170000000, "grossProfit": 10951000000, "researchAndDevelopmentExpenses": 2033000000, "generalAndAdministrativeExpenses": 1417000000, "sellingAndMarketingExpenses": 2000000000, "sellingGeneralAndAdministrativeExpenses": 3417000000, "otherExpenses": -1000000, "operatingExpenses": 5449000000, "costAndExpenses": 9619000000, "netInterestIncome": -476000000, "interestIncome": 90000000, "interestExpense": 566000000, "depreciationAndAmortization": 2157000000, "ebitda": 5688000000, "ebit": 3531000000, "nonOperatingIncomeExcludingInterest": 1971000000, "operatingIncome": 5502000000, "totalOtherIncomeExpensesNet": -2537000000, "incomeBeforeTax": 2965000000, "incomeTaxExpense": 493000000, "netIncomeFromContinuingOperations": 2472000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2473000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2462000000, "eps": 1.4, "epsDiluted": 1.39, "weightedAverageShsOut": 1769181000, "weightedAverageShsOutDil": 1778000000}}
{"date": "2022-09-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2022-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-11-04", "acceptedDate": "2022-11-04 13:07:23", "fiscalYear": "2022", "period": "Q3", "revenue": 14812000000, "costOfRevenue": 5022000000, "grossProfit": 9790000000, "researchAndDevelopmentExpenses": 1614000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3304000000, "otherExpenses": 229000000, "operatingExpenses": 5147000000, "costAndExpenses": 10209000000, "netInterestIncome": -497000000, "interestIncome": 63000000, "interestExpense": 560000000, "depreciationAndAmortization": 2205000000, "ebitda": 7165000000, "ebit": 4960000000, "nonOperatingIncomeExcludingInterest": -357000000, "operatingIncome": 4603000000, "totalOtherIncomeExpensesNet": -203000000, "incomeBeforeTax": 4400000000, "incomeTaxExpense": 448000000, "netIncomeFromContinuingOperations": 3952000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3949000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3931000000, "eps": 2.23, "epsDiluted": 2.22, "weightedAverageShsOut": 1771000000, "weightedAverageShsOutDil": 1776000000}}
{"date": "2022-06-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2022-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-08-04", "acceptedDate": "2022-08-04 15:57:33", "fiscalYear": "2022", "period": "Q2", "revenue": 14583000000, "costOfRevenue": 4170000000, "grossProfit": 10413000000, "researchAndDevelopmentExpenses": 1878000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5412000000, "otherExpenses": -172000000, "operatingExpenses": 7118000000, "costAndExpenses": 11288000000, "netInterestIncome": -532000000, "interestIncome": 24000000, "interestExpense": 556000000, "depreciationAndAmortization": 2052000000, "ebitda": 3791000000, "ebit": 1739000000, "nonOperatingIncomeExcludingInterest": 1556000000, "operatingIncome": 3295000000, "totalOtherIncomeExpensesNet": -2112000000, "incomeBeforeTax": 1183000000, "incomeTaxExpense": 255000000, "netIncomeFromContinuingOperations": 928000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 924000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 913000000, "eps": 0.52, "epsDiluted": 0.51, "weightedAverageShsOut": 1770000000, "weightedAverageShsOutDil": 1776000000}}
{"date": "2022-03-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2022-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-05-06", "acceptedDate": "2022-05-06 12:51:05", "fiscalYear": "2022", "period": "Q1", "revenue": 13538000000, "costOfRevenue": 4052000000, "grossProfit": 9486000000, "researchAndDevelopmentExpenses": 1642000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3127000000, "otherExpenses": 0, "operatingExpenses": 4769000000, "costAndExpenses": 8821000000, "netInterestIncome": -539000000, "interestIncome": 9000000, "interestExpense": 548000000, "depreciationAndAmortization": 2053000000, "ebitda": 7530000000, "ebit": 5477000000, "nonOperatingIncomeExcludingInterest": -760000000, "operatingIncome": 4717000000, "totalOtherIncomeExpensesNet": 212000000, "incomeBeforeTax": 4929000000, "incomeTaxExpense": 436000000, "netIncomeFromContinuingOperations": 4493000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4490000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4475000000, "eps": 2.54, "epsDiluted": 2.53, "weightedAverageShsOut": 1771000000, "weightedAverageShsOutDil": 1778000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2021-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-02-18", "acceptedDate": "2022-02-18 12:41:31", "fiscalYear": "2021", "period": "Q4", "revenue": 14886000000, "costOfRevenue": 4320000000, "grossProfit": 10566000000, "researchAndDevelopmentExpenses": 2232000000, "generalAndAdministrativeExpenses": 1160000000, "sellingAndMarketingExpenses": 2100000000, "sellingGeneralAndAdministrativeExpenses": 3260000000, "otherExpenses": 0, "operatingExpenses": 5492000000, "costAndExpenses": 9812000000, "netInterestIncome": -571000000, "interestIncome": 9000000, "interestExpense": 580000000, "depreciationAndAmortization": 1979000000, "ebitda": 6830000000, "ebit": 4851000000, "nonOperatingIncomeExcludingInterest": 223000000, "operatingIncome": 5074000000, "totalOtherIncomeExpensesNet": -803000000, "incomeBeforeTax": 4271000000, "incomeTaxExpense": 226000000, "netIncomeFromContinuingOperations": 4045000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4044000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4023000000, "eps": 2.29, "epsDiluted": 2.26, "weightedAverageShsOut": 1768338000, "weightedAverageShsOutDil": 1778000000}}
{"date": "2021-09-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2021-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-11-02", "acceptedDate": "2021-11-02 12:52:31", "fiscalYear": "2021", "period": "Q3", "revenue": 14342000000, "costOfRevenue": 4390000000, "grossProfit": 9952000000, "researchAndDevelopmentExpenses": 2063000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3083000000, "otherExpenses": 500000000, "operatingExpenses": 5646000000, "costAndExpenses": 10036000000, "netInterestIncome": -585000000, "interestIncome": 11000000, "interestExpense": 596000000, "depreciationAndAmortization": 2127000000, "ebitda": 6411000000, "ebit": 4284000000, "nonOperatingIncomeExcludingInterest": 22000000, "operatingIncome": 4306000000, "totalOtherIncomeExpensesNet": -618000000, "incomeBeforeTax": 3688000000, "incomeTaxExpense": 508000000, "netIncomeFromContinuingOperations": 3180000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3179000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3158000000, "eps": 1.78, "epsDiluted": 1.78, "weightedAverageShsOut": 1770000000, "weightedAverageShsOutDil": 1777000000}}
{"date": "2021-06-30", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2021-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-08-02", "acceptedDate": "2021-08-02 13:28:20", "fiscalYear": "2021", "period": "Q2", "revenue": 13959000000, "costOfRevenue": 4523000000, "grossProfit": 9436000000, "researchAndDevelopmentExpenses": 1899000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 3072000000, "otherExpenses": 0, "operatingExpenses": 4995000000, "costAndExpenses": 9518000000, "netInterestIncome": -606000000, "interestIncome": 9000000, "interestExpense": 615000000, "depreciationAndAmortization": 2200000000, "ebitda": 3978000000, "ebit": 1778000000, "nonOperatingIncomeExcludingInterest": 2663000000, "operatingIncome": 4441000000, "totalOtherIncomeExpensesNet": -3278000000, "incomeBeforeTax": 1163000000, "incomeTaxExpense": 394000000, "netIncomeFromContinuingOperations": 769000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 766000000, "netIncomeDeductions": 2000000, "bottomLineNetIncome": 749000000, "eps": 0.42, "epsDiluted": 0.42, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1776000000}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "income_statement_quarter", "result": {"date": "2021-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-05-07", "acceptedDate": "2021-05-07 10:14:00", "fiscalYear": "2021", "period": "Q1", "revenue": 13010000000, "costOfRevenue": 4213000000, "grossProfit": 8797000000, "researchAndDevelopmentExpenses": 1852000000, "generalAndAdministrativeExpenses": 0, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2842000000, "otherExpenses": 0, "operatingExpenses": 4694000000, "costAndExpenses": 8907000000, "netInterestIncome": -622000000, "interestIncome": 10000000, "interestExpense": 632000000, "depreciationAndAmortization": 2215000000, "ebitda": 6714000000, "ebit": 4499000000, "nonOperatingIncomeExcludingInterest": -396000000, "operatingIncome": 4103000000, "totalOtherIncomeExpensesNet": -236000000, "incomeBeforeTax": 3867000000, "incomeTaxExpense": 312000000, "netIncomeFromContinuingOperations": 3555000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3553000000, "netIncomeDeductions": 7000000, "bottomLineNetIncome": 3529000000, "eps": 2, "epsDiluted": 1.99, "weightedAverageShsOut": 1769000000, "weightedAverageShsOutDil": 1775000000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "balance_sheet_annual", "result": {"date": "2024-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-02-14", "acceptedDate": "2025-02-14 13:17:23", "fiscalYear": "2024", "period": "FY", "cashAndCashEquivalents": 5524000000, "shortTermInvestments": 31000000, "cashAndShortTermInvestments": 5555000000, "netReceivables": 10919000000, "accountsReceivables": 10919000000, "otherReceivables": 0, "inventory": 4181000000, "prepaids": 0, "otherCurrentAssets": 4927000000, "totalCurrentAssets": 25582000000, "propertyPlantEquipmentNet": 5134000000, "goodwill": 34956000000, "intangibleAssets": 60068000000, "goodwillAndIntangibleAssets": 95024000000, "longTermInvestments": 279000000, "taxAssets": 0, "otherNonCurrentAssets": 9142000000, "totalNonCurrentAssets": 109579000000, "otherAssets": 0, "totalAssets": 135161000000, "totalPayables": 2945000000, "accountPayables": 2945000000, "otherPayables": 0, "accruedExpenses": 1986000000, "shortTermDebt": 6804000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 27014000000, "totalCurrentLiabilities": 38749000000, "longTermDebt": 60340000000, "capitalLeaseObligationsNonCurrent": 720000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 7628000000, "otherNonCurrentLiabilities": 24383000000, "totalNonCurrentLiabilities": 93048000000, "otherLiabilities": 0, "capitalLeaseObligations": 915000000, "totalLiabilities": 131797000000, "treasuryStock": -8201000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -7900000000, "additionalPaidInCapital": 21333000000, "accumulatedOtherComprehensiveIncomeLoss": -1925000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 3325000000, "totalEquity": 3364000000, "minorityInterest": 39000000, "totalLiabilitiesAndTotalEquity": 135161000000, "totalInvestments": 310000000, "totalDebt": 67841000000, "netDebt": 62317000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "balance_sheet_annual", "result": {"date": "2023-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-02-20", "acceptedDate": "2024-02-20 12:45:17", "fiscalYear": "2023", "period": "FY", "cashAndCashEquivalents": 12814000000, "shortTermInvestments": 2000000, "cashAndShortTermInvestments": 12816000000, "netReceivables": 11155000000, "accountsReceivables": 11155000000, "otherReceivables": 0, "inventory": 4099000000, "prepaids": 0, "otherCurrentAssets": 4932000000, "totalCurrentAssets": 33002000000, "propertyPlantEquipmentNet": 4989000000, "goodwill": 32293000000, "intangibleAssets": 55610000000, "goodwillAndIntangibleAssets": 87903000000, "longTermInvestments": 304000000, "taxAssets": 0, "otherNonCurrentAssets": 8513000000, "totalNonCurrentAssets": 101709000000, "otherAssets": 0, "totalAssets": 134711000000, "totalPayables": 3688000000, "accountPayables": 3688000000, "otherPayables": 0, "accruedExpenses": 1802000000, "shortTermDebt": 7191000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 25160000000, "totalCurrentLiabilities": 37841000000, "longTermDebt": 52167000000, "capitalLeaseObligationsNonCurrent": 762000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 8633000000, "otherNonCurrentLiabilities": 24911000000, "totalNonCurrentLiabilities": 86473000000, "otherLiabilities": 0, "capitalLeaseObligations": 762000000, "totalLiabilities": 124314000000, "treasuryStock": -6533000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -1000000000, "additionalPaidInCapital": 20180000000, "accumulatedOtherComprehensiveIncomeLoss": -2305000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 10360000000, "totalEquity": 10397000000, "minorityInterest": 37000000, "totalLiabilitiesAndTotalEquity": 134711000000, "totalInvestments": 306000000, "totalDebt": 60120000000, "netDebt": 47306000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "balance_sheet_annual", "result": {"date": "2022-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-02-17", "acceptedDate": "2023-02-17 12:54:29", "fiscalYear": "2022", "period": "FY", "cashAndCashEquivalents": 9201000000, "shortTermInvestments": 28000000, "cashAndShortTermInvestments": 9229000000, "netReceivables": 11254000000, "accountsReceivables": 11254000000, "otherReceivables": 0, "inventory": 3579000000, "prepaids": 0, "otherCurrentAssets": 4401000000, "totalCurrentAssets": 28463000000, "propertyPlantEquipmentNet": 4935000000, "goodwill": 32156000000, "intangibleAssets": 67439000000, "goodwillAndIntangibleAssets": 99595000000, "longTermInvestments": 241000000, "taxAssets": 0, "otherNonCurrentAssets": 5571000000, "totalNonCurrentAssets": 110342000000, "otherAssets": 0, "totalAssets": 138805000000, "totalPayables": 2934000000, "accountPayables": 2934000000, "otherPayables": 0, "accruedExpenses": 1371000000, "shortTermDebt": 4302000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 20931000000, "totalCurrentLiabilities": 29538000000, "longTermDebt": 59118000000, "capitalLeaseObligationsNonCurrent": 771000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 8692000000, "otherNonCurrentLiabilities": 23399000000, "totalNonCurrentLiabilities": 91980000000, "otherLiabilities": 0, "capitalLeaseObligations": 771000000, "totalLiabilities": 121518000000, "treasuryStock": -4594000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 4784000000, "additionalPaidInCapital": 19245000000, "accumulatedOtherComprehensiveIncomeLoss": -2199000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 17254000000, "totalEquity": 17287000000, "minorityInterest": 33000000, "totalLiabilitiesAndTotalEquity": 138805000000, "totalInvestments": 269000000, "totalDebt": 64191000000, "netDebt": 54990000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "balance_sheet_annual", "result": {"date": "2021-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-02-18", "acceptedDate": "2022-02-18 12:41:31", "fiscalYear": "2021", "period": "FY", "cashAndCashEquivalents": 9746000000, "shortTermInvestments": 84000000, "cashAndShortTermInvestments": 9830000000, "netReceivables": 9977000000, "accountsReceivables": 9977000000, "otherReceivables": 0, "inventory": 3128000000, "prepaids": 4993000000, "otherCurrentAssets": 0, "totalCurrentAssets": 27928000000, "propertyPlantEquipmentNet": 5110000000, "goodwill": 32379000000, "intangibleAssets": 75951000000, "goodwillAndIntangibleAssets": 108330000000, "longTermInvestments": 277000000, "taxAssets": 0, "otherNonCurrentAssets": 4884000000, "totalNonCurrentAssets": 118601000000, "otherAssets": 0, "totalAssets": 146529000000, "totalPayables": 2882000000, "accountPayables": 2882000000, "otherPayables": 0, "accruedExpenses": 1785000000, "shortTermDebt": 12673000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 17854000000, "totalCurrentLiabilities": 35194000000, "longTermDebt": 64164000000, "capitalLeaseObligationsNonCurrent": 738000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 8979000000, "otherNonCurrentLiabilities": 22018000000, "totalNonCurrentLiabilities": 95899000000, "otherLiabilities": 0, "capitalLeaseObligations": 738000000, "totalLiabilities": 131093000000, "treasuryStock": -3143000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 3127000000, "additionalPaidInCapital": 18305000000, "accumulatedOtherComprehensiveIncomeLoss": -2899000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 15408000000, "totalEquity": 15436000000, "minorityInterest": 28000000, "totalLiabilitiesAndTotalEquity": 146529000000, "totalInvestments": 361000000, "totalDebt": 77575000000, "netDebt": 67829000000}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2025-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-11-04", "acceptedDate": "2025-11-04 14:05:49", "fiscalYear": "2025", "period": "Q3", "cashAndCashEquivalents": 5629000000, "shortTermInvestments": 42000000, "cashAndShortTermInvestments": 5671000000, "netReceivables": 12769000000, "accountsReceivables": 12769000000, "otherReceivables": 0, "inventory": 4938000000, "prepaids": 0, "otherCurrentAssets": 5161000000, "totalCurrentAssets": 28539000000, "propertyPlantEquipmentNet": 5483000000, "goodwill": 35626000000, "intangibleAssets": 54315000000, "goodwillAndIntangibleAssets": 89941000000, "longTermInvestments": 291000000, "taxAssets": 0, "otherNonCurrentAssets": 9644000000, "totalNonCurrentAssets": 105359000000, "otherAssets": 0, "totalAssets": 133898000000, "totalPayables": 33362000000, "accountPayables": 33362000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 5772000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 257000000, "totalCurrentLiabilities": 39391000000, "longTermDebt": 62971000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2480000000, "otherNonCurrentLiabilities": 31655000000, "totalNonCurrentLiabilities": 97106000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 136497000000, "treasuryStock": -9143000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -14234000000, "additionalPaidInCapital": 22291000000, "accumulatedOtherComprehensiveIncomeLoss": -1574000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": -2642000000, "totalEquity": -2599000000, "minorityInterest": 43000000, "totalLiabilitiesAndTotalEquity": 133898000000, "totalInvestments": 333000000, "totalDebt": 68743000000, "netDebt": 63114000000}}
{"date": "2025-06-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2025-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-08-04", "acceptedDate": "2025-08-04 15:17:04", "fiscalYear": "2025", "period": "Q2", "cashAndCashEquivalents": 6467000000, "shortTermInvestments": 0, "cashAndShortTermInvestments": 6467000000, "netReceivables": 12637000000, "accountsReceivables": 12637000000, "otherReceivables": 0, "inventory": 4960000000, "prepaids": 0, "otherCurrentAssets": 5197000000, "totalCurrentAssets": 29261000000, "propertyPlantEquipmentNet": 5283000000, "goodwill": 35638000000, "intangibleAssets": 57031000000, "goodwillAndIntangibleAssets": 92669000000, "longTermInvestments": 310000000, "taxAssets": 0, "otherNonCurrentAssets": 9659000000, "totalNonCurrentAssets": 107921000000, "otherAssets": 0, "totalAssets": 137182000000, "totalPayables": 31832000000, "accountPayables": 31832000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 7522000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 413000000, "totalCurrentLiabilities": 39767000000, "longTermDebt": 62959000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2554000000, "otherNonCurrentLiabilities": 32040000000, "totalNonCurrentLiabilities": 97553000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 137320000000, "treasuryStock": -9147000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -11503000000, "additionalPaidInCapital": 21987000000, "accumulatedOtherComprehensiveIncomeLoss": -1538000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": -183000000, "totalEquity": -138000000, "minorityInterest": 45000000, "totalLiabilitiesAndTotalEquity": 137182000000, "totalInvestments": 310000000, "totalDebt": 70481000000, "netDebt": 64014000000}}
{"date": "2025-03-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2025-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-05-09", "acceptedDate": "2025-05-09 13:24:59", "fiscalYear": "2025", "period": "Q1", "cashAndCashEquivalents": 5175000000, "shortTermInvestments": 1000000, "cashAndShortTermInvestments": 5176000000, "netReceivables": 12477000000, "accountsReceivables": 12477000000, "otherReceivables": 0, "inventory": 4526000000, "prepaids": 0, "otherCurrentAssets": 5496000000, "totalCurrentAssets": 27675000000, "propertyPlantEquipmentNet": 5237000000, "goodwill": 35285000000, "intangibleAssets": 58489000000, "goodwillAndIntangibleAssets": 93774000000, "longTermInvestments": 287000000, "taxAssets": 0, "otherNonCurrentAssets": 9192000000, "totalNonCurrentAssets": 108490000000, "otherAssets": 0, "totalAssets": 136165000000, "totalPayables": 30959000000, "accountPayables": 30959000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 5362000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 82000000, "totalCurrentLiabilities": 36403000000, "longTermDebt": 64527000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2582000000, "otherNonCurrentLiabilities": 31191000000, "totalNonCurrentLiabilities": 98300000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 134703000000, "treasuryStock": -9137000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -9527000000, "additionalPaidInCapital": 21808000000, "accumulatedOtherComprehensiveIncomeLoss": -1742000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 1420000000, "totalEquity": 1462000000, "minorityInterest": 42000000, "totalLiabilitiesAndTotalEquity": 136165000000, "totalInvestments": 288000000, "totalDebt": 69889000000, "netDebt": 64714000000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2024-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-02-14", "acceptedDate": "2025-02-14 13:17:23", "fiscalYear": "2024", "period": "Q4", "cashAndCashEquivalents": 5524000000, "shortTermInvestments": 31000000, "cashAndShortTermInvestments": 5555000000, "netReceivables": 10919000000, "accountsReceivables": 10919000000, "otherReceivables": 0, "inventory": 4181000000, "prepaids": 0, "otherCurrentAssets": 4927000000, "totalCurrentAssets": 25582000000, "propertyPlantEquipmentNet": 5134000000, "goodwill": 34956000000, "intangibleAssets": 60068000000, "goodwillAndIntangibleAssets": 95024000000, "longTermInvestments": 279000000, "taxAssets": 0, "otherNonCurrentAssets": 9142000000, "totalNonCurrentAssets": 109579000000, "otherAssets": 0, "totalAssets": 135161000000, "totalPayables": 31910000000, "accountPayables": 31910000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 6804000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 35000000, "totalCurrentLiabilities": 38749000000, "longTermDebt": 60340000000, "capitalLeaseObligationsNonCurrent": 720000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 7628000000, "otherNonCurrentLiabilities": 24383000000, "totalNonCurrentLiabilities": 93048000000, "otherLiabilities": 0, "capitalLeaseObligations": 915000000, "totalLiabilities": 131797000000, "treasuryStock": -8201000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -7900000000, "additionalPaidInCapital": 21333000000, "accumulatedOtherComprehensiveIncomeLoss": -1925000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 3325000000, "totalEquity": 3364000000, "minorityInterest": 39000000, "totalLiabilitiesAndTotalEquity": 135161000000, "totalInvestments": 310000000, "totalDebt": 67841000000, "netDebt": 62317000000}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2024-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-11-04", "acceptedDate": "2024-11-04 14:19:33", "fiscalYear": "2024", "period": "Q3", "cashAndCashEquivalents": 7257000000, "shortTermInvestments": 28000000, "cashAndShortTermInvestments": 7285000000, "netReceivables": 11472000000, "accountsReceivables": 11472000000, "otherReceivables": 0, "inventory": 4450000000, "prepaids": 0, "otherCurrentAssets": 4578000000, "totalCurrentAssets": 27785000000, "propertyPlantEquipmentNet": 5141000000, "goodwill": 35295000000, "intangibleAssets": 66646000000, "goodwillAndIntangibleAssets": 101941000000, "longTermInvestments": 267000000, "taxAssets": 0, "otherNonCurrentAssets": 8288000000, "totalNonCurrentAssets": 115637000000, "otherAssets": 0, "totalAssets": 143422000000, "totalPayables": 30398000000, "accountPayables": 30398000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 12570000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 94000000, "totalCurrentLiabilities": 43062000000, "longTermDebt": 58509000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2749000000, "otherNonCurrentLiabilities": 33031000000, "totalNonCurrentLiabilities": 94289000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 137351000000, "treasuryStock": -7848000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -4964000000, "additionalPaidInCapital": 21160000000, "accumulatedOtherComprehensiveIncomeLoss": -2334000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 6032000000, "totalEquity": 6071000000, "minorityInterest": 39000000, "totalLiabilitiesAndTotalEquity": 143422000000, "totalInvestments": 295000000, "totalDebt": 71079000000, "netDebt": 63822000000}}
{"date": "2024-06-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2024-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-08-07", "acceptedDate": "2024-08-07 15:00:51", "fiscalYear": "2024", "period": "Q2", "cashAndCashEquivalents": 13130000000, "shortTermInvestments": 27000000, "cashAndShortTermInvestments": 13157000000, "netReceivables": 11724000000, "accountsReceivables": 11724000000, "otherReceivables": 0, "inventory": 4218000000, "prepaids": 0, "otherCurrentAssets": 4717000000, "totalCurrentAssets": 33816000000, "propertyPlantEquipmentNet": 5023000000, "goodwill": 33386000000, "intangibleAssets": 60243000000, "goodwillAndIntangibleAssets": 93629000000, "longTermInvestments": 272000000, "taxAssets": 0, "otherNonCurrentAssets": 9197000000, "totalNonCurrentAssets": 108121000000, "otherAssets": 0, "totalAssets": 141937000000, "totalPayables": 29296000000, "accountPayables": 29296000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 12586000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 33000000, "totalCurrentLiabilities": 41915000000, "longTermDebt": 58048000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2726000000, "otherNonCurrentLiabilities": 32427000000, "totalNonCurrentLiabilities": 93201000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 135116000000, "treasuryStock": -7838000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -3768000000, "additionalPaidInCapital": 20879000000, "accumulatedOtherComprehensiveIncomeLoss": -2513000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 6778000000, "totalEquity": 6821000000, "minorityInterest": 43000000, "totalLiabilitiesAndTotalEquity": 141937000000, "totalInvestments": 299000000, "totalDebt": 70634000000, "netDebt": 57504000000}}
{"date": "2024-03-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2024-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-05-03", "acceptedDate": "2024-05-03 11:04:11", "fiscalYear": "2024", "period": "Q1", "cashAndCashEquivalents": 18067000000, "shortTermInvestments": 2000000, "cashAndShortTermInvestments": 18069000000, "netReceivables": 11949000000, "accountsReceivables": 11949000000, "otherReceivables": 0, "inventory": 4245000000, "prepaids": 0, "otherCurrentAssets": 4608000000, "totalCurrentAssets": 38871000000, "propertyPlantEquipmentNet": 4980000000, "goodwill": 33426000000, "intangibleAssets": 62225000000, "goodwillAndIntangibleAssets": 95651000000, "longTermInvestments": 305000000, "taxAssets": 0, "otherNonCurrentAssets": 9067000000, "totalNonCurrentAssets": 110003000000, "otherAssets": 0, "totalAssets": 148874000000, "totalPayables": 31258000000, "accountPayables": 31258000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 10196000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 68000000, "totalCurrentLiabilities": 41522000000, "longTermDebt": 63805000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2722000000, "otherNonCurrentLiabilities": 32778000000, "totalNonCurrentLiabilities": 99305000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 140827000000, "treasuryStock": -7829000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -2384000000, "additionalPaidInCapital": 20656000000, "accumulatedOtherComprehensiveIncomeLoss": -2454000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 8007000000, "totalEquity": 8047000000, "minorityInterest": 40000000, "totalLiabilitiesAndTotalEquity": 148874000000, "totalInvestments": 307000000, "totalDebt": 74001000000, "netDebt": 55934000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2023-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-02-20", "acceptedDate": "2024-02-20 12:45:17", "fiscalYear": "2023", "period": "Q4", "cashAndCashEquivalents": 12814000000, "shortTermInvestments": 2000000, "cashAndShortTermInvestments": 12816000000, "netReceivables": 11155000000, "accountsReceivables": 11155000000, "otherReceivables": 0, "inventory": 4099000000, "prepaids": 0, "otherCurrentAssets": 4932000000, "totalCurrentAssets": 33002000000, "propertyPlantEquipmentNet": 4989000000, "goodwill": 32293000000, "intangibleAssets": 55610000000, "goodwillAndIntangibleAssets": 87903000000, "longTermInvestments": 304000000, "taxAssets": 0, "otherNonCurrentAssets": 8513000000, "totalNonCurrentAssets": 101709000000, "otherAssets": 0, "totalAssets": 134711000000, "totalPayables": 6471000000, "accountPayables": 3688000000, "otherPayables": 2783000000, "accruedExpenses": 24179000000, "shortTermDebt": 7191000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 0, "totalCurrentLiabilities": 37841000000, "longTermDebt": 52167000000, "capitalLeaseObligationsNonCurrent": 762000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 8633000000, "otherNonCurrentLiabilities": 24911000000, "totalNonCurrentLiabilities": 86473000000, "otherLiabilities": 0, "capitalLeaseObligations": 762000000, "totalLiabilities": 124314000000, "treasuryStock": -6533000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": -1000000000, "additionalPaidInCapital": 20180000000, "accumulatedOtherComprehensiveIncomeLoss": -2305000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 10360000000, "totalEquity": 10397000000, "minorityInterest": 37000000, "totalLiabilitiesAndTotalEquity": 134711000000, "totalInvestments": 306000000, "totalDebt": 60120000000, "netDebt": 47306000000}}
{"date": "2023-09-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2023-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-11-06", "acceptedDate": "2023-11-06 13:01:04", "fiscalYear": "2023", "period": "Q3", "cashAndCashEquivalents": 13287000000, "shortTermInvestments": 3000000, "cashAndShortTermInvestments": 13290000000, "netReceivables": 11412000000, "accountsReceivables": 11412000000, "otherReceivables": 0, "inventory": 3981000000, "prepaids": 0, "otherCurrentAssets": 4541000000, "totalCurrentAssets": 33224000000, "propertyPlantEquipmentNet": 4934000000, "goodwill": 32091000000, "intangibleAssets": 58603000000, "goodwillAndIntangibleAssets": 90694000000, "longTermInvestments": 275000000, "taxAssets": 0, "otherNonCurrentAssets": 7094000000, "totalNonCurrentAssets": 102997000000, "otherAssets": 0, "totalAssets": 136221000000, "totalPayables": 29570000000, "accountPayables": 29570000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 5115000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 88000000, "totalCurrentLiabilities": 34773000000, "longTermDebt": 55631000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2044000000, "otherNonCurrentLiabilities": 31644000000, "totalNonCurrentLiabilities": 89319000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 124092000000, "treasuryStock": -6525000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 933000000, "additionalPaidInCapital": 20021000000, "accumulatedOtherComprehensiveIncomeLoss": -2353000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 12094000000, "totalEquity": 12129000000, "minorityInterest": 35000000, "totalLiabilitiesAndTotalEquity": 136221000000, "totalInvestments": 278000000, "totalDebt": 60746000000, "netDebt": 47459000000}}
{"date": "2023-06-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2023-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-08-07", "acceptedDate": "2023-08-07 13:10:46", "fiscalYear": "2023", "period": "Q2", "cashAndCashEquivalents": 8759000000, "shortTermInvestments": 7000000, "cashAndShortTermInvestments": 8766000000, "netReceivables": 11491000000, "accountsReceivables": 11491000000, "otherReceivables": 0, "inventory": 4055000000, "prepaids": 0, "otherCurrentAssets": 4540000000, "totalCurrentAssets": 28852000000, "propertyPlantEquipmentNet": 4943000000, "goodwill": 32224000000, "intangibleAssets": 62862000000, "goodwillAndIntangibleAssets": 95086000000, "longTermInvestments": 288000000, "taxAssets": 0, "otherNonCurrentAssets": 6198000000, "totalNonCurrentAssets": 106515000000, "otherAssets": 0, "totalAssets": 135367000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 5203000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 27036000000, "totalCurrentLiabilities": 32239000000, "longTermDebt": 55812000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2124000000, "otherNonCurrentLiabilities": 32294000000, "totalNonCurrentLiabilities": 90230000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 122469000000, "treasuryStock": -6528000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 1789000000, "additionalPaidInCapital": 19839000000, "accumulatedOtherComprehensiveIncomeLoss": -2252000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 12866000000, "totalEquity": 12898000000, "minorityInterest": 32000000, "totalLiabilitiesAndTotalEquity": 135367000000, "totalInvestments": 295000000, "totalDebt": 61015000000, "netDebt": 52256000000}}
{"date": "2023-03-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2023-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-05-05", "acceptedDate": "2023-05-05 12:54:58", "fiscalYear": "2023", "period": "Q1", "cashAndCashEquivalents": 6711000000, "shortTermInvestments": 11000000, "cashAndShortTermInvestments": 6722000000, "netReceivables": 11473000000, "accountsReceivables": 11473000000, "otherReceivables": 0, "inventory": 3833000000, "prepaids": 0, "otherCurrentAssets": 4460000000, "totalCurrentAssets": 26488000000, "propertyPlantEquipmentNet": 4931000000, "goodwill": 32220000000, "intangibleAssets": 64848000000, "goodwillAndIntangibleAssets": 97068000000, "longTermInvestments": 257000000, "taxAssets": 0, "otherNonCurrentAssets": 5800000000, "totalNonCurrentAssets": 108056000000, "otherAssets": 0, "totalAssets": 134544000000, "totalPayables": 24654000000, "accountPayables": 24654000000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 2801000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 135000000, "totalCurrentLiabilities": 27590000000, "longTermDebt": 59292000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2110000000, "otherNonCurrentLiabilities": 32249000000, "totalNonCurrentLiabilities": 93651000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 121241000000, "treasuryStock": -6524000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 2393000000, "additionalPaidInCapital": 19619000000, "accumulatedOtherComprehensiveIncomeLoss": -2232000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 13274000000, "totalEquity": 13303000000, "minorityInterest": 29000000, "totalLiabilitiesAndTotalEquity": 134544000000, "totalInvestments": 268000000, "totalDebt": 62093000000, "netDebt": 55382000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2022-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-02-17", "acceptedDate": "2023-02-17 12:54:29", "fiscalYear": "2022", "period": "Q4", "cashAndCashEquivalents": 9201000000, "shortTermInvestments": 28000000, "cashAndShortTermInvestments": 9229000000, "netReceivables": 11254000000, "accountsReceivables": 11254000000, "otherReceivables": 0, "inventory": 3579000000, "prepaids": 0, "otherCurrentAssets": 4401000000, "totalCurrentAssets": 28463000000, "propertyPlantEquipmentNet": 4935000000, "goodwill": 32156000000, "intangibleAssets": 67439000000, "goodwillAndIntangibleAssets": 99595000000, "longTermInvestments": 241000000, "taxAssets": 0, "otherNonCurrentAssets": 5571000000, "totalNonCurrentAssets": 110342000000, "otherAssets": 0, "totalAssets": 138805000000, "totalPayables": 2934000000, "accountPayables": 2934000000, "otherPayables": 0, "accruedExpenses": 1371000000, "shortTermDebt": 4302000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 20931000000, "totalCurrentLiabilities": 29538000000, "longTermDebt": 59118000000, "capitalLeaseObligationsNonCurrent": 771000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 8692000000, "otherNonCurrentLiabilities": 23399000000, "totalNonCurrentLiabilities": 91980000000, "otherLiabilities": 0, "capitalLeaseObligations": 771000000, "totalLiabilities": 121518000000, "treasuryStock": -4594000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 4784000000, "additionalPaidInCapital": 19245000000, "accumulatedOtherComprehensiveIncomeLoss": -2199000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 17254000000, "totalEquity": 17287000000, "minorityInterest": 33000000, "totalLiabilitiesAndTotalEquity": 138805000000, "totalInvestments": 269000000, "totalDebt": 64191000000, "netDebt": 54990000000}}
{"date": "2022-09-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2022-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-11-04", "acceptedDate": "2022-11-04 13:07:23", "fiscalYear": "2022", "period": "Q3", "cashAndCashEquivalents": 11832000000, "shortTermInvestments": 47000000, "cashAndShortTermInvestments": 11879000000, "netReceivables": 10743000000, "accountsReceivables": 10743000000, "otherReceivables": 0, "inventory": 3172000000, "prepaids": 4570000000, "otherCurrentAssets": 0, "totalCurrentAssets": 30364000000, "propertyPlantEquipmentNet": 4893000000, "goodwill": 31726000000, "intangibleAssets": 68725000000, "goodwillAndIntangibleAssets": 100451000000, "longTermInvestments": 235000000, "taxAssets": 0, "otherNonCurrentAssets": 5382000000, "totalNonCurrentAssets": 110961000000, "otherAssets": 0, "totalAssets": 141325000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 9207000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 23505000000, "totalCurrentLiabilities": 32712000000, "longTermDebt": 60399000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1972000000, "otherNonCurrentLiabilities": 30215000000, "totalNonCurrentLiabilities": 92586000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 125298000000, "treasuryStock": -4590000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 4953000000, "additionalPaidInCapital": 19056000000, "accumulatedOtherComprehensiveIncomeLoss": -3443000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 15994000000, "totalEquity": 16027000000, "minorityInterest": 33000000, "totalLiabilitiesAndTotalEquity": 141325000000, "totalInvestments": 282000000, "totalDebt": 69606000000, "netDebt": 57774000000}}
{"date": "2022-06-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2022-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-08-04", "acceptedDate": "2022-08-04 15:57:33", "fiscalYear": "2022", "period": "Q2", "cashAndCashEquivalents": 8521000000, "shortTermInvestments": 1440000000, "cashAndShortTermInvestments": 9961000000, "netReceivables": 11237000000, "accountsReceivables": 11237000000, "otherReceivables": 0, "inventory": 3396000000, "prepaids": 4506000000, "otherCurrentAssets": 0, "totalCurrentAssets": 29100000000, "propertyPlantEquipmentNet": 4958000000, "goodwill": 32028000000, "intangibleAssets": 71823000000, "goodwillAndIntangibleAssets": 103851000000, "longTermInvestments": 244000000, "taxAssets": 0, "otherNonCurrentAssets": 5033000000, "totalNonCurrentAssets": 114086000000, "otherAssets": 0, "totalAssets": 143186000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 11930000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 22543000000, "totalCurrentLiabilities": 34473000000, "longTermDebt": 61002000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2255000000, "otherNonCurrentLiabilities": 30768000000, "totalNonCurrentLiabilities": 94025000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 128498000000, "treasuryStock": -4591000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 3516000000, "additionalPaidInCapital": 18906000000, "accumulatedOtherComprehensiveIncomeLoss": -3196000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 14653000000, "totalEquity": 14688000000, "minorityInterest": 35000000, "totalLiabilitiesAndTotalEquity": 143186000000, "totalInvestments": 1684000000, "totalDebt": 72932000000, "netDebt": 64411000000}}
{"date": "2022-03-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2022-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-05-06", "acceptedDate": "2022-05-06 12:51:05", "fiscalYear": "2022", "period": "Q1", "cashAndCashEquivalents": 6098000000, "shortTermInvestments": 1474000000, "cashAndShortTermInvestments": 7572000000, "netReceivables": 10733000000, "accountsReceivables": 10733000000, "otherReceivables": 0, "inventory": 3483000000, "prepaids": 4721000000, "otherCurrentAssets": 0, "totalCurrentAssets": 26509000000, "propertyPlantEquipmentNet": 5075000000, "goodwill": 32298000000, "intangibleAssets": 73986000000, "goodwillAndIntangibleAssets": 106284000000, "longTermInvestments": 260000000, "taxAssets": 0, "otherNonCurrentAssets": 5083000000, "totalNonCurrentAssets": 116702000000, "otherAssets": 0, "totalAssets": 143211000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 9952000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 22569000000, "totalCurrentLiabilities": 32521000000, "longTermDebt": 63522000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2831000000, "otherNonCurrentLiabilities": 28023000000, "totalNonCurrentLiabilities": 94376000000, "otherLiabilities": 0, "capitalLeaseObligations": 73462000000, "totalLiabilities": 126897000000, "treasuryStock": -4585000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 5103000000, "additionalPaidInCapital": 18731000000, "accumulatedOtherComprehensiveIncomeLoss": -2984000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 16283000000, "totalEquity": 16314000000, "minorityInterest": 31000000, "totalLiabilitiesAndTotalEquity": 143211000000, "totalInvestments": 1734000000, "totalDebt": 73474000000, "netDebt": 67376000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2021-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-02-18", "acceptedDate": "2022-02-18 12:41:31", "fiscalYear": "2021", "period": "Q4", "cashAndCashEquivalents": 9746000000, "shortTermInvestments": 84000000, "cashAndShortTermInvestments": 9830000000, "netReceivables": 9977000000, "accountsReceivables": 9977000000, "otherReceivables": 0, "inventory": 3128000000, "prepaids": 4993000000, "otherCurrentAssets": 0, "totalCurrentAssets": 27928000000, "propertyPlantEquipmentNet": 5110000000, "goodwill": 32379000000, "intangibleAssets": 75951000000, "goodwillAndIntangibleAssets": 108330000000, "longTermInvestments": 277000000, "taxAssets": 0, "otherNonCurrentAssets": 4884000000, "totalNonCurrentAssets": 118601000000, "otherAssets": 0, "totalAssets": 146529000000, "totalPayables": 2882000000, "accountPayables": 2882000000, "otherPayables": 0, "accruedExpenses": 1785000000, "shortTermDebt": 12673000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 17854000000, "totalCurrentLiabilities": 35194000000, "longTermDebt": 64164000000, "capitalLeaseObligationsNonCurrent": 738000000, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 8979000000, "otherNonCurrentLiabilities": 22018000000, "totalNonCurrentLiabilities": 95899000000, "otherLiabilities": 0, "capitalLeaseObligations": 738000000, "totalLiabilities": 131093000000, "treasuryStock": -3143000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 3127000000, "additionalPaidInCapital": 18305000000, "accumulatedOtherComprehensiveIncomeLoss": -2899000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 15408000000, "totalEquity": 15436000000, "minorityInterest": 28000000, "totalLiabilitiesAndTotalEquity": 146529000000, "totalInvestments": 361000000, "totalDebt": 77575000000, "netDebt": 67829000000}}
{"date": "2021-09-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2021-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-11-02", "acceptedDate": "2021-11-02 12:52:31", "fiscalYear": "2021", "period": "Q3", "cashAndCashEquivalents": 12182000000, "shortTermInvestments": 67000000, "cashAndShortTermInvestments": 12249000000, "netReceivables": 9281000000, "accountsReceivables": 9281000000, "otherReceivables": 0, "inventory": 3094000000, "prepaids": 4333000000, "otherCurrentAssets": 0, "totalCurrentAssets": 28957000000, "propertyPlantEquipmentNet": 5130000000, "goodwill": 32296000000, "intangibleAssets": 77456000000, "goodwillAndIntangibleAssets": 109752000000, "longTermInvestments": 272000000, "taxAssets": 0, "otherNonCurrentAssets": 4747000000, "totalNonCurrentAssets": 119901000000, "otherAssets": 0, "totalAssets": 148858000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 6672000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 21861000000, "totalCurrentLiabilities": 28533000000, "longTermDebt": 74049000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3602000000, "otherNonCurrentLiabilities": 29097000000, "totalNonCurrentLiabilities": 106748000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 135281000000, "treasuryStock": -3020000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 1600000000, "additionalPaidInCapital": 18108000000, "accumulatedOtherComprehensiveIncomeLoss": -3156000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 13550000000, "totalEquity": 13577000000, "minorityInterest": 27000000, "totalLiabilitiesAndTotalEquity": 148858000000, "totalInvestments": 339000000, "totalDebt": 80721000000, "netDebt": 68539000000}}
{"date": "2021-06-30", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2021-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-08-02", "acceptedDate": "2021-08-02 13:28:20", "fiscalYear": "2021", "period": "Q2", "cashAndCashEquivalents": 8546000000, "shortTermInvestments": 54000000, "cashAndShortTermInvestments": 8600000000, "netReceivables": 9914000000, "accountsReceivables": 9914000000, "otherReceivables": 0, "inventory": 3386000000, "prepaids": 4099000000, "otherCurrentAssets": 0, "totalCurrentAssets": 25999000000, "propertyPlantEquipmentNet": 5161000000, "goodwill": 32398000000, "intangibleAssets": 79340000000, "goodwillAndIntangibleAssets": 111738000000, "longTermInvestments": 266000000, "taxAssets": 0, "otherNonCurrentAssets": 4808000000, "totalNonCurrentAssets": 121973000000, "otherAssets": 0, "totalAssets": 147972000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 7901000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 20783000000, "totalCurrentLiabilities": 28684000000, "longTermDebt": 74237000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3661000000, "otherNonCurrentLiabilities": 28796000000, "totalNonCurrentLiabilities": 106694000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 135378000000, "treasuryStock": -3022000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 740000000, "additionalPaidInCapital": 17936000000, "accumulatedOtherComprehensiveIncomeLoss": -3103000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 12569000000, "totalEquity": 12594000000, "minorityInterest": 25000000, "totalLiabilitiesAndTotalEquity": 147972000000, "totalInvestments": 320000000, "totalDebt": 82138000000, "netDebt": 73592000000}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "balance_sheet_quarter", "result": {"date": "2021-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-05-07", "acceptedDate": "2021-05-07 10:14:00", "fiscalYear": "2021", "period": "Q1", "cashAndCashEquivalents": 9755000000, "shortTermInvestments": 22000000, "cashAndShortTermInvestments": 9777000000, "netReceivables": 9588000000, "accountsReceivables": 9588000000, "otherReceivables": 0, "inventory": 3272000000, "prepaids": 3932000000, "otherCurrentAssets": 0, "totalCurrentAssets": 26569000000, "propertyPlantEquipmentNet": 5193000000, "goodwill": 32349000000, "intangibleAssets": 81293000000, "goodwillAndIntangibleAssets": 113642000000, "longTermInvestments": 305000000, "taxAssets": 0, "otherNonCurrentAssets": 4792000000, "totalNonCurrentAssets": 123932000000, "otherAssets": 0, "totalAssets": 150501000000, "totalPayables": 0, "accountPayables": 0, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 11347000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 20604000000, "totalCurrentLiabilities": 31951000000, "longTermDebt": 74183000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3768000000, "otherNonCurrentLiabilities": 26866000000, "totalNonCurrentLiabilities": 104817000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 136768000000, "treasuryStock": -3017000000, "preferredStock": 0, "commonStock": 18000000, "retainedEarnings": 2292000000, "additionalPaidInCapital": 17712000000, "accumulatedOtherComprehensiveIncomeLoss": -3295000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 13710000000, "totalEquity": 13733000000, "minorityInterest": 23000000, "totalLiabilitiesAndTotalEquity": 150501000000, "totalInvestments": 327000000, "totalDebt": 85530000000, "netDebt": 75775000000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "cash_flow_annual", "result": {"date": "2024-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-02-14", "acceptedDate": "2025-02-14 13:17:23", "fiscalYear": "2024", "period": "FY", "netIncome": 4286000000, "depreciationAndAmortization": 8386000000, "deferredIncomeTax": -1449000000, "stockBasedCompensation": 911000000, "changeInWorkingCapital": -2782000000, "accountsReceivables": 207000000, "inventory": -319000000, "accountsPayables": 177000000, "otherWorkingCapital": -2847000000, "otherNonCashItems": 9454000000, "netCashProvidedByOperatingActivities": 18806000000, "investmentsInPropertyPlantAndEquipment": -974000000, "acquisitionsNet": -17493000000, "purchasesOfInvestments": -73000000, "salesMaturitiesOfInvestments": 555000000, "otherInvestingActivities": -2835000000, "netCashProvidedByInvestingActivities": -20820000000, "netDebtIssuance": 7350000000, "longTermNetDebtIssuance": 7350000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1708000000, "netCommonStockIssuance": -1708000000, "commonStockIssuance": 0, "commonStockRepurchased": -1708000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -11025000000, "commonDividendsPaid": -11025000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 172000000, "netCashProvidedByFinancingActivities": -5211000000, "effectOfForexChangesOnCash": -65000000, "netChangeInCash": -7290000000, "cashAtEndOfPeriod": 5524000000, "cashAtBeginningOfPeriod": 12814000000, "operatingCashFlow": 18806000000, "capitalExpenditure": -974000000, "freeCashFlow": 17832000000, "incomeTaxesPaid": 4064000000, "interestPaid": 2811000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "cash_flow_annual", "result": {"date": "2023-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-02-20", "acceptedDate": "2024-02-20 12:45:17", "fiscalYear": "2023", "period": "FY", "netIncome": 4820000000, "depreciationAndAmortization": 8698000000, "deferredIncomeTax": -2889000000, "stockBasedCompensation": 747000000, "changeInWorkingCapital": 2813000000, "accountsReceivables": 66000000, "inventory": -417000000, "accountsPayables": 3840000000, "otherWorkingCapital": -676000000, "otherNonCashItems": 8650000000, "netCashProvidedByOperatingActivities": 22839000000, "investmentsInPropertyPlantAndEquipment": -777000000, "acquisitionsNet": -1223000000, "purchasesOfInvestments": -77000000, "salesMaturitiesOfInvestments": 55000000, "otherInvestingActivities": 13000000, "netCashProvidedByInvestingActivities": -2009000000, "netDebtIssuance": -4149000000, "longTermNetDebtIssuance": -4149000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1972000000, "netCommonStockIssuance": -1972000000, "commonStockIssuance": 0, "commonStockRepurchased": -1972000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -10539000000, "commonDividendsPaid": -10539000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -562000000, "netCashProvidedByFinancingActivities": -17222000000, "effectOfForexChangesOnCash": 5000000, "netChangeInCash": 3613000000, "cashAtEndOfPeriod": 12814000000, "cashAtBeginningOfPeriod": 9201000000, "operatingCashFlow": 22839000000, "capitalExpenditure": -777000000, "freeCashFlow": 22062000000, "incomeTaxesPaid": 4702000000, "interestPaid": 2469000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "cash_flow_annual", "result": {"date": "2022-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-02-17", "acceptedDate": "2023-02-17 12:54:29", "fiscalYear": "2022", "period": "FY", "netIncome": 11845000000, "depreciationAndAmortization": 8467000000, "deferredIncomeTax": -1931000000, "stockBasedCompensation": 671000000, "changeInWorkingCapital": -258000000, "accountsReceivables": -1455000000, "inventory": -686000000, "accountsPayables": 1605000000, "otherWorkingCapital": 278000000, "otherNonCashItems": 6149000000, "netCashProvidedByOperatingActivities": 24943000000, "investmentsInPropertyPlantAndEquipment": -695000000, "acquisitionsNet": -794000000, "purchasesOfInvestments": -1438000000, "salesMaturitiesOfInvestments": 1530000000, "otherInvestingActivities": 774000000, "netCashProvidedByInvestingActivities": -623000000, "netDebtIssuance": -12433000000, "longTermNetDebtIssuance": -12433000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1487000000, "netCommonStockIssuance": -1487000000, "commonStockIssuance": 0, "commonStockRepurchased": -1487000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -10043000000, "commonDividendsPaid": -10043000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -840000000, "netCashProvidedByFinancingActivities": -24803000000, "effectOfForexChangesOnCash": -62000000, "netChangeInCash": -545000000, "cashAtEndOfPeriod": 9201000000, "cashAtBeginningOfPeriod": 9746000000, "operatingCashFlow": 24943000000, "capitalExpenditure": -695000000, "freeCashFlow": 24248000000, "incomeTaxesPaid": 2988000000, "interestPaid": 2546000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "cash_flow_annual", "result": {"date": "2021-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-02-18", "acceptedDate": "2022-02-18 12:41:31", "fiscalYear": "2021", "period": "FY", "netIncome": 11549000000, "depreciationAndAmortization": 8521000000, "deferredIncomeTax": -898000000, "stockBasedCompensation": 692000000, "changeInWorkingCapital": -1322000000, "accountsReceivables": -1321000000, "inventory": -142000000, "accountsPayables": 1628000000, "otherWorkingCapital": -1487000000, "otherNonCashItems": 4235000000, "netCashProvidedByOperatingActivities": 22777000000, "investmentsInPropertyPlantAndEquipment": -787000000, "acquisitionsNet": -1902000000, "purchasesOfInvestments": -119000000, "salesMaturitiesOfInvestments": 98000000, "otherInvestingActivities": 366000000, "netCashProvidedByInvestingActivities": -2344000000, "netDebtIssuance": -8414000000, "longTermNetDebtIssuance": -8414000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -934000000, "netCommonStockIssuance": -934000000, "commonStockIssuance": 0, "commonStockRepurchased": -934000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -9261000000, "commonDividendsPaid": -9261000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -430000000, "netCashProvidedByFinancingActivities": -19039000000, "effectOfForexChangesOnCash": -97000000, "netChangeInCash": 1297000000, "cashAtEndOfPeriod": 9746000000, "cashAtBeginningOfPeriod": 8449000000, "operatingCashFlow": 22777000000, "capitalExpenditure": -787000000, "freeCashFlow": 21990000000, "incomeTaxesPaid": 3648000000, "interestPaid": 2712000000}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2025-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-11-04", "acceptedDate": "2025-11-04 14:05:49", "fiscalYear": "2025", "period": "Q3", "netIncome": 188000000, "depreciationAndAmortization": 2063000000, "deferredIncomeTax": 193000000, "stockBasedCompensation": 209000000, "changeInWorkingCapital": 3142000000, "accountsReceivables": -156000000, "inventory": 2000000, "accountsPayables": 1730000000, "otherWorkingCapital": 1566000000, "otherNonCashItems": 1229000000, "netCashProvidedByOperatingActivities": 7024000000, "investmentsInPropertyPlantAndEquipment": 504000000, "acquisitionsNet": 1274000000, "purchasesOfInvestments": -7000000, "salesMaturitiesOfInvestments": 3000000, "otherInvestingActivities": -5038000000, "netCashProvidedByInvestingActivities": -3264000000, "netDebtIssuance": -1775000000, "longTermNetDebtIssuance": -9000000, "shortTermNetDebtIssuance": -1766000000, "netStockIssuance": -973000000, "netCommonStockIssuance": -973000000, "commonStockIssuance": -977000000, "commonStockRepurchased": 4000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2911000000, "commonDividendsPaid": -2911000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1069000000, "netCashProvidedByFinancingActivities": -4590000000, "effectOfForexChangesOnCash": -8000000, "netChangeInCash": -838000000, "cashAtEndOfPeriod": 5629000000, "cashAtBeginningOfPeriod": 6467000000, "operatingCashFlow": 7024000000, "capitalExpenditure": 504000000, "freeCashFlow": 7528000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-06-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2025-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-08-04", "acceptedDate": "2025-08-04 15:17:04", "fiscalYear": "2025", "period": "Q2", "netIncome": 941000000, "depreciationAndAmortization": 2050000000, "deferredIncomeTax": -272000000, "stockBasedCompensation": 179000000, "changeInWorkingCapital": -562000000, "accountsReceivables": -17000000, "inventory": -56000000, "accountsPayables": 515000000, "otherWorkingCapital": -1004000000, "otherNonCashItems": 2817000000, "netCashProvidedByOperatingActivities": 5153000000, "investmentsInPropertyPlantAndEquipment": -269000000, "acquisitionsNet": -940000000, "purchasesOfInvestments": -12000000, "salesMaturitiesOfInvestments": 7000000, "otherInvestingActivities": 33000000, "netCashProvidedByInvestingActivities": -1181000000, "netDebtIssuance": 209000000, "longTermNetDebtIssuance": -3754000000, "shortTermNetDebtIssuance": 3963000000, "netStockIssuance": -12000000, "netCommonStockIssuance": -12000000, "commonStockIssuance": 0, "commonStockRepurchased": -12000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2910000000, "commonDividendsPaid": -2910000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 3000000, "netCashProvidedByFinancingActivities": -2710000000, "effectOfForexChangesOnCash": 30000000, "netChangeInCash": 1292000000, "cashAtEndOfPeriod": 6467000000, "cashAtBeginningOfPeriod": 5175000000, "operatingCashFlow": 5153000000, "capitalExpenditure": -269000000, "freeCashFlow": 4884000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-03-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2025-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-05-09", "acceptedDate": "2025-05-09 13:24:59", "fiscalYear": "2025", "period": "Q1", "netIncome": 1289000000, "depreciationAndAmortization": 2039000000, "deferredIncomeTax": -28000000, "stockBasedCompensation": 410000000, "changeInWorkingCapital": -2580000000, "accountsReceivables": -1479000000, "inventory": -155000000, "accountsPayables": -696000000, "otherWorkingCapital": -250000000, "otherNonCashItems": 505000000, "netCashProvidedByOperatingActivities": 1635000000, "investmentsInPropertyPlantAndEquipment": -235000000, "acquisitionsNet": -538000000, "purchasesOfInvestments": -10000000, "salesMaturitiesOfInvestments": 32000000, "otherInvestingActivities": 16000000, "netCashProvidedByInvestingActivities": -735000000, "netDebtIssuance": 2561000000, "longTermNetDebtIssuance": 968000000, "shortTermNetDebtIssuance": 1593000000, "netStockIssuance": -961000000, "netCommonStockIssuance": -961000000, "commonStockIssuance": 0, "commonStockRepurchased": -961000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2925000000, "commonDividendsPaid": -2925000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 67000000, "netCashProvidedByFinancingActivities": -1258000000, "effectOfForexChangesOnCash": 9000000, "netChangeInCash": -349000000, "cashAtEndOfPeriod": 5175000000, "cashAtBeginningOfPeriod": 5524000000, "operatingCashFlow": 1635000000, "capitalExpenditure": -235000000, "freeCashFlow": 1400000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2024-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2025-02-14", "acceptedDate": "2025-02-14 13:17:23", "fiscalYear": "2024", "period": "Q4", "netIncome": 4286000000, "depreciationAndAmortization": 2102000000, "deferredIncomeTax": -767000000, "stockBasedCompensation": 674000000, "changeInWorkingCapital": -397000000, "accountsReceivables": 387000000, "inventory": -128000000, "accountsPayables": 1247000000, "otherWorkingCapital": -1903000000, "otherNonCashItems": 1150000000, "netCashProvidedByOperatingActivities": 7048000000, "investmentsInPropertyPlantAndEquipment": -291000000, "acquisitionsNet": -1792000000, "purchasesOfInvestments": -27000000, "salesMaturitiesOfInvestments": 39000000, "otherInvestingActivities": 197000000, "netCashProvidedByInvestingActivities": -1874000000, "netDebtIssuance": -3762000000, "longTermNetDebtIssuance": -3762000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -358000000, "netCommonStockIssuance": -358000000, "commonStockIssuance": 0, "commonStockRepurchased": -358000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2752000000, "commonDividendsPaid": -2752000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 11000000, "netCashProvidedByFinancingActivities": -6861000000, "effectOfForexChangesOnCash": -46000000, "netChangeInCash": -1733000000, "cashAtEndOfPeriod": 5524000000, "cashAtBeginningOfPeriod": 7257000000, "operatingCashFlow": 7048000000, "capitalExpenditure": -291000000, "freeCashFlow": 6757000000, "incomeTaxesPaid": 0, "interestPaid": 705000000}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2024-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-11-04", "acceptedDate": "2024-11-04 14:19:33", "fiscalYear": "2024", "period": "Q3", "netIncome": 1590000000, "depreciationAndAmortization": 2079000000, "deferredIncomeTax": -277000000, "stockBasedCompensation": 181000000, "changeInWorkingCapital": 750000000, "accountsReceivables": 344000000, "inventory": -64000000, "accountsPayables": 267000000, "otherWorkingCapital": 203000000, "otherNonCashItems": 1124000000, "netCashProvidedByOperatingActivities": 5447000000, "investmentsInPropertyPlantAndEquipment": -249000000, "acquisitionsNet": -8294000000, "purchasesOfInvestments": -24000000, "salesMaturitiesOfInvestments": 507000000, "otherInvestingActivities": -196000000, "netCashProvidedByInvestingActivities": -8256000000, "netDebtIssuance": -403000000, "longTermNetDebtIssuance": -403000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -17000000, "netCommonStockIssuance": -17000000, "commonStockIssuance": 0, "commonStockRepurchased": -17000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2751000000, "commonDividendsPaid": -2751000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 99000000, "netCashProvidedByFinancingActivities": -3072000000, "effectOfForexChangesOnCash": 8000000, "netChangeInCash": -5873000000, "cashAtEndOfPeriod": 7257000000, "cashAtBeginningOfPeriod": 13130000000, "operatingCashFlow": 5447000000, "capitalExpenditure": -249000000, "freeCashFlow": 5198000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-06-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2024-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-08-07", "acceptedDate": "2024-08-07 15:00:51", "fiscalYear": "2024", "period": "Q2", "netIncome": 1373000000, "depreciationAndAmortization": 2131000000, "deferredIncomeTax": -16000000, "stockBasedCompensation": 218000000, "changeInWorkingCapital": -3382000000, "accountsReceivables": 178000000, "inventory": -52000000, "accountsPayables": -1699000000, "otherWorkingCapital": -1809000000, "otherNonCashItems": 1947000000, "netCashProvidedByOperatingActivities": 2271000000, "investmentsInPropertyPlantAndEquipment": -241000000, "acquisitionsNet": -843000000, "purchasesOfInvestments": -16000000, "salesMaturitiesOfInvestments": 3000000, "otherInvestingActivities": -5000000, "netCashProvidedByInvestingActivities": -1102000000, "netDebtIssuance": -3348000000, "longTermNetDebtIssuance": -3345000000, "shortTermNetDebtIssuance": -3000000, "netStockIssuance": -9000000, "netCommonStockIssuance": -9000000, "commonStockIssuance": 0, "commonStockRepurchased": -9000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2750000000, "commonDividendsPaid": -2750000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 10000000, "netCashProvidedByFinancingActivities": -6097000000, "effectOfForexChangesOnCash": -9000000, "netChangeInCash": -4937000000, "cashAtEndOfPeriod": 13130000000, "cashAtBeginningOfPeriod": 18067000000, "operatingCashFlow": 2271000000, "capitalExpenditure": -241000000, "freeCashFlow": 2030000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-03-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2024-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-05-03", "acceptedDate": "2024-05-03 11:04:11", "fiscalYear": "2024", "period": "Q1", "netIncome": 1359000000, "depreciationAndAmortization": 2074000000, "deferredIncomeTax": -389000000, "stockBasedCompensation": 348000000, "changeInWorkingCapital": 247000000, "accountsReceivables": -702000000, "inventory": -75000000, "accountsPayables": 362000000, "otherWorkingCapital": 662000000, "otherNonCashItems": 401000000, "netCashProvidedByOperatingActivities": 4040000000, "investmentsInPropertyPlantAndEquipment": -193000000, "acquisitionsNet": -9389000000, "purchasesOfInvestments": -6000000, "salesMaturitiesOfInvestments": 6000000, "otherInvestingActivities": -6000000, "netCashProvidedByInvestingActivities": -9588000000, "netDebtIssuance": 14863000000, "longTermNetDebtIssuance": 14860000000, "shortTermNetDebtIssuance": 3000000, "netStockIssuance": -1324000000, "netCommonStockIssuance": -1324000000, "commonStockIssuance": 0, "commonStockRepurchased": -1324000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2772000000, "commonDividendsPaid": -2772000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 52000000, "netCashProvidedByFinancingActivities": 10819000000, "effectOfForexChangesOnCash": -18000000, "netChangeInCash": 5253000000, "cashAtEndOfPeriod": 18067000000, "cashAtBeginningOfPeriod": 12814000000, "operatingCashFlow": 4040000000, "capitalExpenditure": -193000000, "freeCashFlow": 3847000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2023-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2024-02-20", "acceptedDate": "2024-02-20 12:45:17", "fiscalYear": "2023", "period": "Q4", "netIncome": 826000000, "depreciationAndAmortization": 2076000000, "deferredIncomeTax": -1391000000, "stockBasedCompensation": 125000000, "changeInWorkingCapital": 443000000, "accountsReceivables": 339000000, "inventory": 96000000, "accountsPayables": 179000000, "otherWorkingCapital": -171000000, "otherNonCashItems": 2674000000, "netCashProvidedByOperatingActivities": 4753000000, "investmentsInPropertyPlantAndEquipment": -205000000, "acquisitionsNet": -553000000, "purchasesOfInvestments": -34000000, "salesMaturitiesOfInvestments": 14000000, "otherInvestingActivities": -22000000, "netCashProvidedByInvestingActivities": -800000000, "netDebtIssuance": -1794000000, "longTermNetDebtIssuance": -1794000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -3000000, "netCommonStockIssuance": -3000000, "commonStockIssuance": 0, "commonStockRepurchased": -3000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2626000000, "commonDividendsPaid": -2626000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -26000000, "netCashProvidedByFinancingActivities": -4449000000, "effectOfForexChangesOnCash": 23000000, "netChangeInCash": -473000000, "cashAtEndOfPeriod": 12814000000, "cashAtBeginningOfPeriod": 13287000000, "operatingCashFlow": 4753000000, "capitalExpenditure": -205000000, "freeCashFlow": 4548000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-09-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2023-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-11-06", "acceptedDate": "2023-11-06 13:01:04", "fiscalYear": "2023", "period": "Q3", "netIncome": 1781000000, "depreciationAndAmortization": 2235000000, "deferredIncomeTax": -863000000, "stockBasedCompensation": 130000000, "changeInWorkingCapital": 2643000000, "accountsReceivables": 2000000, "inventory": -55000000, "accountsPayables": 2554000000, "otherWorkingCapital": 142000000, "otherNonCashItems": 1648000000, "netCashProvidedByOperatingActivities": 7574000000, "investmentsInPropertyPlantAndEquipment": -219000000, "acquisitionsNet": -157000000, "purchasesOfInvestments": -8000000, "salesMaturitiesOfInvestments": 5000000, "otherInvestingActivities": 10000000, "netCashProvidedByInvestingActivities": -369000000, "netDebtIssuance": -2000000, "longTermNetDebtIssuance": -2000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -4000000, "netCommonStockIssuance": -4000000, "commonStockIssuance": 0, "commonStockRepurchased": -4000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2627000000, "commonDividendsPaid": -2627000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -28000000, "netCashProvidedByFinancingActivities": -2661000000, "effectOfForexChangesOnCash": -16000000, "netChangeInCash": 4528000000, "cashAtEndOfPeriod": 13287000000, "cashAtBeginningOfPeriod": 8759000000, "operatingCashFlow": 7574000000, "capitalExpenditure": -219000000, "freeCashFlow": 7355000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-06-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2023-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-08-07", "acceptedDate": "2023-08-07 13:10:46", "fiscalYear": "2023", "period": "Q2", "netIncome": 2027000000, "depreciationAndAmortization": 2260000000, "deferredIncomeTax": -368000000, "stockBasedCompensation": 179000000, "changeInWorkingCapital": 554000000, "accountsReceivables": -80000000, "inventory": -273000000, "accountsPayables": 1572000000, "otherWorkingCapital": -667000000, "otherNonCashItems": 1669000000, "netCashProvidedByOperatingActivities": 6319000000, "investmentsInPropertyPlantAndEquipment": -178000000, "acquisitionsNet": -160000000, "purchasesOfInvestments": -16000000, "salesMaturitiesOfInvestments": 14000000, "otherInvestingActivities": -1000000, "netCashProvidedByInvestingActivities": -341000000, "netDebtIssuance": -1002000000, "longTermNetDebtIssuance": -1002000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -10000000, "netCommonStockIssuance": -10000000, "commonStockIssuance": 0, "commonStockRepurchased": -10000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2625000000, "commonDividendsPaid": -2625000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -283000000, "netCashProvidedByFinancingActivities": -3920000000, "effectOfForexChangesOnCash": -10000000, "netChangeInCash": 2048000000, "cashAtEndOfPeriod": 8759000000, "cashAtBeginningOfPeriod": 6711000000, "operatingCashFlow": 6319000000, "capitalExpenditure": -178000000, "freeCashFlow": 6141000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-03-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2023-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-05-05", "acceptedDate": "2023-05-05 12:54:58", "fiscalYear": "2023", "period": "Q1", "netIncome": 241000000, "depreciationAndAmortization": 2127000000, "deferredIncomeTax": -267000000, "stockBasedCompensation": 313000000, "changeInWorkingCapital": -825000000, "accountsReceivables": -195000000, "inventory": -185000000, "accountsPayables": -465000000, "otherWorkingCapital": 20000000, "otherNonCashItems": 2604000000, "netCashProvidedByOperatingActivities": 4193000000, "investmentsInPropertyPlantAndEquipment": -175000000, "acquisitionsNet": -353000000, "purchasesOfInvestments": -19000000, "salesMaturitiesOfInvestments": 22000000, "otherInvestingActivities": 26000000, "netCashProvidedByInvestingActivities": -499000000, "netDebtIssuance": -1351000000, "longTermNetDebtIssuance": -1351000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1955000000, "netCommonStockIssuance": -1955000000, "commonStockIssuance": 0, "commonStockRepurchased": -1955000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2661000000, "commonDividendsPaid": -2661000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -225000000, "netCashProvidedByFinancingActivities": -6192000000, "effectOfForexChangesOnCash": 8000000, "netChangeInCash": -2490000000, "cashAtEndOfPeriod": 6711000000, "cashAtBeginningOfPeriod": 9201000000, "operatingCashFlow": 4193000000, "capitalExpenditure": -175000000, "freeCashFlow": 4018000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2022-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2023-02-17", "acceptedDate": "2023-02-17 12:54:29", "fiscalYear": "2022", "period": "Q4", "netIncome": 2472000000, "depreciationAndAmortization": 2157000000, "deferredIncomeTax": -516000000, "stockBasedCompensation": 132000000, "changeInWorkingCapital": 843000000, "accountsReceivables": -416000000, "inventory": -170000000, "accountsPayables": 1275000000, "otherWorkingCapital": 154000000, "otherNonCashItems": 2340000000, "netCashProvidedByOperatingActivities": 7428000000, "investmentsInPropertyPlantAndEquipment": -213000000, "acquisitionsNet": -300000000, "purchasesOfInvestments": -10000000, "salesMaturitiesOfInvestments": 70000000, "otherInvestingActivities": 5000000, "netCashProvidedByInvestingActivities": -448000000, "netDebtIssuance": -6851000000, "longTermNetDebtIssuance": -6851000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -4000000, "netCommonStockIssuance": -4000000, "commonStockIssuance": 0, "commonStockRepurchased": -4000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2506000000, "commonDividendsPaid": -2506000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -273000000, "netCashProvidedByFinancingActivities": -9634000000, "effectOfForexChangesOnCash": 23000000, "netChangeInCash": -2631000000, "cashAtEndOfPeriod": 9201000000, "cashAtBeginningOfPeriod": 11832000000, "operatingCashFlow": 7428000000, "capitalExpenditure": -213000000, "freeCashFlow": 7215000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-09-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2022-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-11-04", "acceptedDate": "2022-11-04 13:07:23", "fiscalYear": "2022", "period": "Q3", "netIncome": 3952000000, "depreciationAndAmortization": 2205000000, "deferredIncomeTax": -621000000, "stockBasedCompensation": 126000000, "changeInWorkingCapital": 1338000000, "accountsReceivables": 357000000, "inventory": -17000000, "accountsPayables": 778000000, "otherWorkingCapital": 220000000, "otherNonCashItems": 602000000, "netCashProvidedByOperatingActivities": 7602000000, "investmentsInPropertyPlantAndEquipment": -177000000, "acquisitionsNet": -100000000, "purchasesOfInvestments": -17000000, "salesMaturitiesOfInvestments": 1410000000, "otherInvestingActivities": 170000000, "netCashProvidedByInvestingActivities": 1286000000, "netDebtIssuance": -2701000000, "longTermNetDebtIssuance": -2701000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -4000000, "netCommonStockIssuance": -4000000, "commonStockIssuance": 0, "commonStockRepurchased": -4000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2504000000, "commonDividendsPaid": -2504000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -309000000, "netCashProvidedByFinancingActivities": -5518000000, "effectOfForexChangesOnCash": -59000000, "netChangeInCash": 3311000000, "cashAtEndOfPeriod": 11832000000, "cashAtBeginningOfPeriod": 8521000000, "operatingCashFlow": 7602000000, "capitalExpenditure": -177000000, "freeCashFlow": 7425000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-06-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2022-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-08-04", "acceptedDate": "2022-08-04 15:57:33", "fiscalYear": "2022", "period": "Q2", "netIncome": 928000000, "depreciationAndAmortization": 2052000000, "deferredIncomeTax": -600000000, "stockBasedCompensation": 107000000, "changeInWorkingCapital": -1164000000, "accountsReceivables": -611000000, "inventory": -114000000, "accountsPayables": -190000000, "otherWorkingCapital": -249000000, "otherNonCashItems": 3682000000, "netCashProvidedByOperatingActivities": 5005000000, "investmentsInPropertyPlantAndEquipment": -143000000, "acquisitionsNet": -209000000, "purchasesOfInvestments": -5000000, "salesMaturitiesOfInvestments": 42000000, "otherInvestingActivities": 445000000, "netCashProvidedByInvestingActivities": 130000000, "netDebtIssuance": -2000000, "longTermNetDebtIssuance": -2000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -9000000, "netCommonStockIssuance": -9000000, "commonStockIssuance": 0, "commonStockRepurchased": -9000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2507000000, "commonDividendsPaid": -2507000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -161000000, "netCashProvidedByFinancingActivities": -2679000000, "effectOfForexChangesOnCash": -33000000, "netChangeInCash": 2423000000, "cashAtEndOfPeriod": 8521000000, "cashAtBeginningOfPeriod": 6098000000, "operatingCashFlow": 5005000000, "capitalExpenditure": -143000000, "freeCashFlow": 4862000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-03-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2022-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-05-06", "acceptedDate": "2022-05-06 12:51:05", "fiscalYear": "2022", "period": "Q1", "netIncome": 4493000000, "depreciationAndAmortization": 2053000000, "deferredIncomeTax": -194000000, "stockBasedCompensation": 306000000, "changeInWorkingCapital": -1275000000, "accountsReceivables": -785000000, "inventory": -385000000, "accountsPayables": -258000000, "otherWorkingCapital": 153000000, "otherNonCashItems": -475000000, "netCashProvidedByOperatingActivities": 4908000000, "investmentsInPropertyPlantAndEquipment": -162000000, "acquisitionsNet": -185000000, "purchasesOfInvestments": -1406000000, "salesMaturitiesOfInvestments": 8000000, "otherInvestingActivities": 154000000, "netCashProvidedByInvestingActivities": -1591000000, "netDebtIssuance": -2879000000, "longTermNetDebtIssuance": -2879000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -1470000000, "netCommonStockIssuance": -1470000000, "commonStockIssuance": 0, "commonStockRepurchased": -1470000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2526000000, "commonDividendsPaid": -2526000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -97000000, "netCashProvidedByFinancingActivities": -6972000000, "effectOfForexChangesOnCash": 7000000, "netChangeInCash": -3648000000, "cashAtEndOfPeriod": 6098000000, "cashAtBeginningOfPeriod": 9746000000, "operatingCashFlow": 4908000000, "capitalExpenditure": -162000000, "freeCashFlow": 4746000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2021-12-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2022-02-18", "acceptedDate": "2022-02-18 12:41:31", "fiscalYear": "2021", "period": "Q4", "netIncome": 4045000000, "depreciationAndAmortization": 1979000000, "deferredIncomeTax": -745000000, "stockBasedCompensation": 129000000, "changeInWorkingCapital": -1084000000, "accountsReceivables": -749000000, "inventory": -112000000, "accountsPayables": 174000000, "otherWorkingCapital": -397000000, "otherNonCashItems": 751000000, "netCashProvidedByOperatingActivities": 5075000000, "investmentsInPropertyPlantAndEquipment": -187000000, "acquisitionsNet": -1065000000, "purchasesOfInvestments": -46000000, "salesMaturitiesOfInvestments": 10000000, "otherInvestingActivities": 143000000, "netCashProvidedByInvestingActivities": -1145000000, "netDebtIssuance": -3752000000, "longTermNetDebtIssuance": -3752000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -131000000, "netCommonStockIssuance": -131000000, "commonStockIssuance": 0, "commonStockRepurchased": -131000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2314000000, "commonDividendsPaid": -2314000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -141000000, "netCashProvidedByFinancingActivities": -6338000000, "effectOfForexChangesOnCash": -28000000, "netChangeInCash": -2436000000, "cashAtEndOfPeriod": 9746000000, "cashAtBeginningOfPeriod": 12182000000, "operatingCashFlow": 5075000000, "capitalExpenditure": -187000000, "freeCashFlow": 4888000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-09-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2021-09-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-11-02", "acceptedDate": "2021-11-02 12:52:31", "fiscalYear": "2021", "period": "Q3", "netIncome": 3180000000, "depreciationAndAmortization": 2127000000, "deferredIncomeTax": -34000000, "stockBasedCompensation": 135000000, "changeInWorkingCapital": 1708000000, "accountsReceivables": 590000000, "inventory": 219000000, "accountsPayables": 1146000000, "otherWorkingCapital": -247000000, "otherNonCashItems": 819000000, "netCashProvidedByOperatingActivities": 7935000000, "investmentsInPropertyPlantAndEquipment": -217000000, "acquisitionsNet": -492000000, "purchasesOfInvestments": -17000000, "salesMaturitiesOfInvestments": 23000000, "otherInvestingActivities": 88000000, "netCashProvidedByInvestingActivities": -615000000, "netDebtIssuance": -1201000000, "longTermNetDebtIssuance": -1201000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -6000000, "netCommonStockIssuance": -6000000, "commonStockIssuance": 0, "commonStockRepurchased": -6000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2315000000, "commonDividendsPaid": -2315000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -121000000, "netCashProvidedByFinancingActivities": -3643000000, "effectOfForexChangesOnCash": -41000000, "netChangeInCash": 3636000000, "cashAtEndOfPeriod": 12182000000, "cashAtBeginningOfPeriod": 8546000000, "operatingCashFlow": 7935000000, "capitalExpenditure": -217000000, "freeCashFlow": 7718000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-06-30", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2021-06-30", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-08-02", "acceptedDate": "2021-08-02 13:28:20", "fiscalYear": "2021", "period": "Q2", "netIncome": 769000000, "depreciationAndAmortization": 2200000000, "deferredIncomeTax": -91000000, "stockBasedCompensation": 159000000, "changeInWorkingCapital": -990000000, "accountsReceivables": -296000000, "inventory": -62000000, "accountsPayables": 72000000, "otherWorkingCapital": -704000000, "otherNonCashItems": 2843000000, "netCashProvidedByOperatingActivities": 4890000000, "investmentsInPropertyPlantAndEquipment": -195000000, "acquisitionsNet": -147000000, "purchasesOfInvestments": -40000000, "salesMaturitiesOfInvestments": 54000000, "otherInvestingActivities": 86000000, "netCashProvidedByInvestingActivities": -242000000, "netDebtIssuance": -3461000000, "longTermNetDebtIssuance": -3461000000, "shortTermNetDebtIssuance": 0, "netStockIssuance": -10000000, "netCommonStockIssuance": -10000000, "commonStockIssuance": 0, "commonStockRepurchased": -10000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2310000000, "commonDividendsPaid": -2310000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -103000000, "netCashProvidedByFinancingActivities": -5884000000, "effectOfForexChangesOnCash": 27000000, "netChangeInCash": -1209000000, "cashAtEndOfPeriod": 8546000000, "cashAtBeginningOfPeriod": 9755000000, "operatingCashFlow": 4890000000, "capitalExpenditure": -195000000, "freeCashFlow": 4695000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "cash_flow_quarter", "result": {"date": "2021-03-31", "symbol": "ABBV", "reportedCurrency": "USD", "cik": "0001551152", "filingDate": "2021-05-07", "acceptedDate": "2021-05-07 10:14:00", "fiscalYear": "2021", "period": "Q1", "netIncome": 3555000000, "depreciationAndAmortization": 2215000000, "deferredIncomeTax": -28000000, "stockBasedCompensation": 269000000, "changeInWorkingCapital": -956000000, "accountsReceivables": -866000000, "inventory": -187000000, "accountsPayables": 236000000, "otherWorkingCapital": -139000000, "otherNonCashItems": -178000000, "netCashProvidedByOperatingActivities": 4877000000, "investmentsInPropertyPlantAndEquipment": -188000000, "acquisitionsNet": -198000000, "purchasesOfInvestments": -16000000, "salesMaturitiesOfInvestments": 11000000, "otherInvestingActivities": 49000000, "netCashProvidedByInvestingActivities": -342000000, "netDebtIssuance": 0, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 0, "netStockIssuance": -787000000, "netCommonStockIssuance": -787000000, "commonStockIssuance": 0, "commonStockRepurchased": -787000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2322000000, "commonDividendsPaid": -2322000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -65000000, "netCashProvidedByFinancingActivities": -3174000000, "effectOfForexChangesOnCash": -55000000, "netChangeInCash": 1306000000, "cashAtEndOfPeriod": 9755000000, "cashAtBeginningOfPeriod": 8449000000, "operatingCashFlow": 4877000000, "capitalExpenditure": -188000000, "freeCashFlow": 4689000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2025-09-30", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7851166328600405, "ebitMargin": 0.08753803245436105, "ebitdaMargin": 0.21830628803245436, "operatingProfitMargin": 0.31002789046653145, "pretaxProfitMargin": 0.04525862068965517, "continuousOperationsProfitMargin": 0.01191683569979716, "netProfitMargin": 0.011790060851926978, "bottomLineProfitMargin": 0.011790060851926978, "receivablesTurnover": 1.2354922076905004, "payablesTurnover": 0.10161261315268869, "inventoryTurnover": 0.6865127582017011, "fixedAssetTurnover": 2.87725697610797, "assetTurnover": 0.11782102794664595, "currentRatio": 0.7245055977253687, "quickRatio": 0.5991470132771445, "solvencyRatio": 0.016476552598225603, "cashRatio": 0.1429006625879008, "priceToEarningsRatio": 551.4635483870967, "priceToEarningsGrowthRatio": -6.797108852213052, "forwardPriceToEarningsGrowthRatio": -6.797108852213052, "priceToBookRatio": -155.2948069644209, "priceToSalesRatio": 26.007155172413793, "priceToFreeCashFlowRatio": 54.50171094580234, "priceToOperatingCashFlowRatio": 58.41242596810934, "debtToAssetsRatio": 0.5133982583757786, "debtToEquityRatio": -26.019303557910675, "debtToCapitalRatio": 1.0399691381370932, "longTermDebtToCapitalRatio": 1.0437932006166188, "financialLeverageRatio": -50.68054504163513, "workingCapitalTurnoverRatio": -1.4772918812622904, "operatingCashFlowRatio": 0.17831484349216825, "operatingCashFlowSalesRatio": 0.44523326572008115, "freeCashFlowOperatingCashFlowRatio": 1.071753986332574, "debtServiceCoverageRatio": 0.4531759589998447, "interestCoverageRatio": 7.332833583208396, "shortTermOperatingCashFlowCoverageRatio": 1.2169092169092168, "operatingCashFlowCoverageRatio": 0.1021776762724932, "capitalExpenditureCoverageRatio": 13.936507936507937, "dividendPaidAndCapexCoverageRatio": 2.0568081991215226, "dividendPayoutRatio": 15.650537634408602, "dividendYield": 0.007095000966148534, "dividendYieldPercentage": 0.7095000966148535, "revenuePerShare": 8.90293453724605, "netIncomePerShare": 0.10496613995485328, "interestDebtPerShare": 39.17042889390519, "cashPerShare": 3.200338600451467, "bookValuePerShare": -1.466704288939052, "tangibleBookValuePerShare": -52.223476297968396, "shareholdersEquityPerShare": -1.4909706546275394, "operatingCashFlowPerShare": 3.963882618510158, "capexPerShare": 0.28442437923250563, "freeCashFlowPerShare": 4.248306997742664, "netIncomePerEBT": 0.2605042016806723, "ebtPerEbit": 0.14598241668370476, "priceToFairValue": -155.2948069644209, "debtToMarketCap": 0.1675478019292163, "effectiveTaxRate": 0.7366946778711485, "enterpriseValueMultiple": 137.45728222996516, "dividendPerShare": 1.6427765237020315}}
{"date": "2025-06-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2025-06-30", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.8441937366271154, "ebitMargin": 0.1487388964533489, "ebitdaMargin": 0.2816572651235168, "operatingProfitMargin": 0.3800816961680607, "pretaxProfitMargin": 0.10075860727484925, "continuousOperationsProfitMargin": 0.06101277313103806, "netProfitMargin": 0.06120728781689684, "bottomLineProfitMargin": 0.060818258445179275, "receivablesTurnover": 1.2204637176545066, "payablesTurnover": 0.07549007288263383, "inventoryTurnover": 0.4844758064516129, "fixedAssetTurnover": 2.9193639977285635, "assetTurnover": 0.11242728637867942, "currentRatio": 0.7358110996554933, "quickRatio": 0.6110845676063067, "solvencyRatio": 0.02180308767841538, "cashRatio": 0.1626222747504212, "priceToEarningsRatio": 87.1076906779661, "priceToEarningsGrowthRatio": -3.3009230151650315, "forwardPriceToEarningsGrowthRatio": -3.3009230151650315, "priceToBookRatio": -1797.3696174863387, "priceToSalesRatio": 21.32650197756597, "priceToFreeCashFlowRatio": 67.34615888615889, "priceToOperatingCashFlowRatio": 63.83051426353581, "debtToAssetsRatio": 0.5137773177238997, "debtToEquityRatio": -385.14207650273227, "debtToCapitalRatio": 1.0026032035050785, "longTermDebtToCapitalRatio": 1.002915126800051, "financialLeverageRatio": -749.6284153005464, "workingCapitalTurnoverRatio": -1.603722574607466, "operatingCashFlowRatio": 0.12957980234868108, "operatingCashFlowSalesRatio": 0.3341113920767685, "freeCashFlowOperatingCashFlowRatio": 0.9477973995730642, "debtServiceCoverageRatio": 0.45158557250060516, "interestCoverageRatio": 7.921621621621622, "shortTermOperatingCashFlowCoverageRatio": 0.6850571656474342, "operatingCashFlowCoverageRatio": 0.07311190249854571, "capitalExpenditureCoverageRatio": 19.156133828996282, "dividendPaidAndCapexCoverageRatio": 1.6209499842717836, "dividendPayoutRatio": 3.082627118644068, "dividendYield": 0.008847172662516178, "dividendYieldPercentage": 0.8847172662516177, "revenuePerShare": 8.70372460496614, "netIncomePerShare": 0.5327313769751693, "interestDebtPerShare": 40.192437923250566, "cashPerShare": 3.649548532731377, "bookValuePerShare": -0.07787810383747178, "tangibleBookValuePerShare": -52.37415349887133, "shareholdersEquityPerShare": -0.10327313769751693, "operatingCashFlowPerShare": 2.9080135440180586, "capexPerShare": 0.1518058690744921, "freeCashFlowPerShare": 2.7562076749435667, "netIncomePerEBT": 0.6074646074646075, "ebtPerEbit": 0.26509723643807576, "priceToFairValue": -1797.3696174863387, "debtToMarketCap": 0.21428095409855763, "effectiveTaxRate": 0.3944658944658945, "enterpriseValueMultiple": 90.45410681399632, "dividendPerShare": 1.642212189616253}}
{"date": "2025-03-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2025-03-31", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.700067451097954, "ebitMargin": 0.17694671363261635, "ebitdaMargin": 0.3297609233305853, "operatingProfitMargin": 0.27977216518024434, "pretaxProfitMargin": 0.12448474855729597, "continuousOperationsProfitMargin": 0.09660496140298283, "netProfitMargin": 0.0963801244098029, "bottomLineProfitMargin": 0.09563066776586975, "receivablesTurnover": 1.0694077101867436, "payablesTurnover": 0.12926774120611131, "inventoryTurnover": 0.8842244807777286, "fixedAssetTurnover": 2.5478327286614473, "assetTurnover": 0.09799140748356773, "currentRatio": 0.7602395406971952, "quickRatio": 0.6359091283685411, "solvencyRatio": 0.024683934285056754, "cashRatio": 0.14215861330110155, "priceToEarningsRatio": 72.01231726283049, "priceToEarningsGrowthRatio": -0.017659164645132532, "forwardPriceToEarningsGrowthRatio": -0.017659164645132532, "priceToBookRatio": 260.86715492957745, "priceToSalesRatio": 27.762224387319193, "priceToFreeCashFlowRatio": 264.59382857142856, "priceToOperatingCashFlowRatio": 226.56352293577982, "debtToAssetsRatio": 0.5132669922520472, "debtToEquityRatio": 49.21760563380282, "debtToCapitalRatio": 0.9800866650773394, "longTermDebtToCapitalRatio": 0.9784675572808468, "financialLeverageRatio": 95.89084507042253, "workingCapitalTurnoverRatio": -1.2188170815254624, "operatingCashFlowRatio": 0.044913880724116145, "operatingCashFlowSalesRatio": 0.12253616128306978, "freeCashFlowOperatingCashFlowRatio": 0.8562691131498471, "debtServiceCoverageRatio": 0.6644671725503134, "interestCoverageRatio": 5.332857142857143, "shortTermOperatingCashFlowCoverageRatio": 0.3049235359940321, "operatingCashFlowCoverageRatio": 0.023394239436821247, "capitalExpenditureCoverageRatio": 6.957446808510638, "dividendPaidAndCapexCoverageRatio": 0.5174050632911392, "dividendPayoutRatio": 2.274494556765163, "dividendYield": 0.007896199717000202, "dividendYieldPercentage": 0.7896199717000202, "revenuePerShare": 7.546945701357466, "netIncomePerShare": 0.7273755656108597, "interestDebtPerShare": 39.925904977375566, "cashPerShare": 2.927601809954751, "bookValuePerShare": 0.8269230769230769, "tangibleBookValuePerShare": -52.21266968325792, "shareholdersEquityPerShare": 0.8031674208144797, "operatingCashFlowPerShare": 0.9247737556561086, "capexPerShare": 0.1329185520361991, "freeCashFlowPerShare": 0.7918552036199095, "netIncomePerEBT": 0.7742323901264299, "ebtPerEbit": 0.44495044200375033, "priceToFairValue": 260.86715492957745, "debtToMarketCap": 0.18866923146031697, "effectiveTaxRate": 0.22396146899458158, "enterpriseValueMultiple": 98.89667272727273, "dividendPerShare": 1.6544117647058822}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7089127267911535, "ebitMargin": -0.10376109124619255, "ebitdaMargin": 0.03542577142100384, "operatingProfitMargin": -0.09866242881737518, "pretaxProfitMargin": -0.15024500066216395, "continuousOperationsProfitMargin": -0.0015229770891272679, "netProfitMargin": -0.0014567606939478214, "bottomLineProfitMargin": -0.002118924645742286, "receivablesTurnover": 1.3830936898983424, "payablesTurnover": 0.13776245691005953, "inventoryTurnover": 1.0514231045204496, "fixedAssetTurnover": 2.941566030385664, "assetTurnover": 0.11173341422451742, "currentRatio": 0.6601976825208392, "quickRatio": 0.5522981238225503, "solvencyRatio": 0.015781846324271417, "cashRatio": 0.14255851763916488, "priceToEarningsRatio": -3572.1738636363634, "priceToEarningsGrowthRatio": 35.00181494265672, "forwardPriceToEarningsGrowthRatio": 35.00181494265672, "priceToBookRatio": 94.54174436090226, "priceToSalesRatio": 20.81520990597272, "priceToFreeCashFlowRatio": 46.52231759656652, "priceToOperatingCashFlowRatio": 44.60148978433598, "debtToAssetsRatio": 0.5019273311088258, "debtToEquityRatio": 20.403308270676693, "debtToCapitalRatio": 0.9532782508501251, "longTermDebtToCapitalRatio": 0.9477735019241341, "financialLeverageRatio": 40.64992481203007, "workingCapitalTurnoverRatio": -1.0618759668119815, "operatingCashFlowRatio": 0.1818885648661901, "operatingCashFlowSalesRatio": 0.4666931532247384, "freeCashFlowOperatingCashFlowRatio": 0.9587116912599319, "debtServiceCoverageRatio": 0.37050359712230213, "interestCoverageRatio": -2.1225071225071224, "shortTermOperatingCashFlowCoverageRatio": 1.0358612580834803, "operatingCashFlowCoverageRatio": 0.10388997803688035, "capitalExpenditureCoverageRatio": 24.219931271477662, "dividendPaidAndCapexCoverageRatio": 2.316135392704568, "dividendPayoutRatio": -125.0909090909091, "dividendYield": 0.00875453672372279, "dividendYieldPercentage": 0.875453672372279, "revenuePerShare": 8.537026568682872, "netIncomePerShare": -0.01243640474844545, "interestDebtPerShare": 38.746749576031654, "cashPerShare": 3.140192198982476, "bookValuePerShare": 1.901639344262295, "tangibleBookValuePerShare": -51.81458451102318, "shareholdersEquityPerShare": 1.8795929903900508, "operatingCashFlowPerShare": 3.9841718485019784, "capexPerShare": 0.16449971735443752, "freeCashFlowPerShare": 3.819672131147541, "netIncomePerEBT": 0.009695901278096077, "ebtPerEbit": 1.5228187919463088, "priceToFairValue": 94.54174436090226, "debtToMarketCap": 0.2135954265180389, "effectiveTaxRate": 0.989863375936536, "enterpriseValueMultiple": 704.0528971962617, "dividendPerShare": 1.5556811758055398}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2024-09-30", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7087136929460581, "ebitMargin": 0.19391424619640388, "ebitdaMargin": 0.3376901798063624, "operatingProfitMargin": 0.2649377593360996, "pretaxProfitMargin": 0.1441217150760719, "continuousOperationsProfitMargin": 0.10816044260027663, "netProfitMargin": 0.10795297372060858, "bottomLineProfitMargin": 0.10726141078838174, "receivablesTurnover": 1.2604602510460252, "payablesTurnover": 0.13856174748338707, "inventoryTurnover": 0.9465168539325842, "fixedAssetTurnover": 2.8126823575179927, "assetTurnover": 0.10082135237271828, "currentRatio": 0.6452324555292369, "quickRatio": 0.5418930843899493, "solvencyRatio": 0.02650144520243755, "cashRatio": 0.16852445311411454, "priceToEarningsRatio": 55.94844971172325, "priceToEarningsGrowthRatio": 3.9163914798206294, "forwardPriceToEarningsGrowthRatio": 3.9163914798206294, "priceToBookRatio": 57.91480769230769, "priceToSalesRatio": 24.159206085753805, "priceToFreeCashFlowRatio": 67.20702577914582, "priceToOperatingCashFlowRatio": 64.1347751055627, "debtToAssetsRatio": 0.49559342360307346, "debtToEquityRatio": 11.783653846153847, "debtToCapitalRatio": 0.9217751034223393, "longTermDebtToCapitalRatio": 0.9065400288188903, "financialLeverageRatio": 23.77685676392573, "workingCapitalTurnoverRatio": -1.2371663244353184, "operatingCashFlowRatio": 0.12649203474060658, "operatingCashFlowSalesRatio": 0.37669432918395573, "freeCashFlowOperatingCashFlowRatio": 0.9542867633559757, "debtServiceCoverageRatio": 0.32829194883370955, "interestCoverageRatio": 5.320833333333334, "shortTermOperatingCashFlowCoverageRatio": 0.43333333333333335, "operatingCashFlowCoverageRatio": 0.07663304210807693, "capitalExpenditureCoverageRatio": 21.87550200803213, "dividendPaidAndCapexCoverageRatio": 1.8156666666666668, "dividendPayoutRatio": 1.7623318385650224, "dividendYield": 0.007874801927691973, "dividendYieldPercentage": 0.7874801927691972, "revenuePerShare": 8.174109666478236, "netIncomePerShare": 0.8824194460146976, "interestDebtPerShare": 40.58733747880158, "cashPerShare": 4.118145845110232, "bookValuePerShare": 3.4318824194460147, "tangibleBookValuePerShare": -54.19446014697569, "shareholdersEquityPerShare": 3.4098360655737703, "operatingCashFlowPerShare": 3.0791407574901073, "capexPerShare": 0.14075749010740532, "freeCashFlowPerShare": 2.938383267382702, "netIncomePerEBT": 0.7490403071017274, "ebtPerEbit": 0.5439832941790655, "priceToFairValue": 57.91480769230769, "debtToMarketCap": 0.20346530215136954, "effectiveTaxRate": 0.2495201535508637, "enterpriseValueMultiple": 84.6127626459144, "dividendPerShare": 1.5551158846806106}}
{"date": "2024-06-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7094454432305352, "ebitMargin": 0.1985894067210621, "ebitdaMargin": 0.34594108698658554, "operatingProfitMargin": 0.27644862398008574, "pretaxProfitMargin": 0.14838888120591895, "continuousOperationsProfitMargin": 0.09493845941086987, "netProfitMargin": 0.09473101922279076, "bottomLineProfitMargin": 0.09403955192919375, "receivablesTurnover": 1.2335380416240191, "payablesTurnover": 0.14343255051884216, "inventoryTurnover": 0.9962067330488383, "fixedAssetTurnover": 2.879155882938483, "assetTurnover": 0.10189027526296879, "currentRatio": 0.8067756173207682, "quickRatio": 0.7061433854228797, "solvencyRatio": 0.025911069007371442, "cashRatio": 0.3132530120481928, "priceToEarningsRatio": 54.99717700729927, "priceToEarningsGrowthRatio": 0, "forwardPriceToEarningsGrowthRatio": 0, "priceToBookRatio": 44.46511212747123, "priceToSalesRatio": 20.839754529110774, "priceToFreeCashFlowRatio": 148.46528571428573, "priceToOperatingCashFlowRatio": 132.71005284015854, "debtToAssetsRatio": 0.497643320628166, "debtToEquityRatio": 10.421068161699617, "debtToCapitalRatio": 0.9124425153722937, "longTermDebtToCapitalRatio": 0.8954431863758369, "financialLeverageRatio": 20.940838005311303, "workingCapitalTurnoverRatio": -2.690604651162791, "operatingCashFlowRatio": 0.05418108075867828, "operatingCashFlowSalesRatio": 0.15703222237588163, "freeCashFlowOperatingCashFlowRatio": 0.8938793483047116, "debtServiceCoverageRatio": 0.31775841346153844, "interestCoverageRatio": 5.506887052341598, "shortTermOperatingCashFlowCoverageRatio": 0.18043858255204195, "operatingCashFlowCoverageRatio": 0.03215165501033496, "capitalExpenditureCoverageRatio": 9.423236514522822, "dividendPaidAndCapexCoverageRatio": 0.7592778335005015, "dividendPayoutRatio": 2.0072992700729926, "dividendYield": 0.009124555928600581, "dividendYieldPercentage": 0.9124555928600583, "revenuePerShare": 8.175240248728095, "netIncomePerShare": 0.7744488411531939, "interestDebtPerShare": 40.339174674957604, "cashPerShare": 7.437535330695308, "bookValuePerShare": 3.8558507631430188, "tangibleBookValuePerShare": -49.07179197286602, "shareholdersEquityPerShare": 3.831543244771057, "operatingCashFlowPerShare": 1.283776144714528, "capexPerShare": 0.1362351611079706, "freeCashFlowPerShare": 1.1475409836065573, "netIncomePerEBT": 0.6383970177073626, "ebtPerEbit": 0.536768384192096, "priceToFairValue": 44.46511212747123, "debtToMarketCap": 0.23436504853119036, "effectiveTaxRate": 0.36020503261882575, "enterpriseValueMultiple": 71.73466520087948, "dividendPerShare": 1.5545505935556811}}
{"date": "2024-03-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6674248578391552, "ebitMargin": 0.19618196588139725, "ebitdaMargin": 0.36466287571080425, "operatingProfitMargin": 0.2272948822095857, "pretaxProfitMargin": 0.14256701868399674, "continuousOperationsProfitMargin": 0.11145410235580828, "netProfitMargin": 0.11121039805036556, "bottomLineProfitMargin": 0.11039805036555646, "receivablesTurnover": 1.030211733199431, "payablesTurnover": 0.1309744705355429, "inventoryTurnover": 0.9644287396937573, "fixedAssetTurnover": 2.4718875502008033, "assetTurnover": 0.08268737321493343, "currentRatio": 0.9361543278262127, "quickRatio": 0.8339193680458552, "solvencyRatio": 0.02444843673443303, "cashRatio": 0.4351187322383315, "priceToEarningsRatio": 58.39379839298758, "priceToEarningsGrowthRatio": 0.8664886213152996, "forwardPriceToEarningsGrowthRatio": 0.8664886213152996, "priceToBookRatio": 39.93561134007743, "priceToSalesRatio": 25.97599025182778, "priceToFreeCashFlowRatio": 83.12046789706265, "priceToOperatingCashFlowRatio": 79.14961386138613, "debtToAssetsRatio": 0.49707134892593735, "debtToEquityRatio": 9.242038216560509, "debtToCapitalRatio": 0.902363184079602, "longTermDebtToCapitalRatio": 0.888500529159472, "financialLeverageRatio": 18.592981141501188, "workingCapitalTurnoverRatio": -3.287049399198932, "operatingCashFlowRatio": 0.09729781802417996, "operatingCashFlowSalesRatio": 0.3281884646628757, "freeCashFlowOperatingCashFlowRatio": 0.9522277227722772, "debtServiceCoverageRatio": 0.37822402358142965, "interestCoverageRatio": 4.239393939393939, "shortTermOperatingCashFlowCoverageRatio": 0.3962338171832091, "operatingCashFlowCoverageRatio": 0.054593856839772435, "capitalExpenditureCoverageRatio": 20.932642487046632, "dividendPaidAndCapexCoverageRatio": 1.3625632377740304, "dividendPayoutRatio": 2.024835646457268, "dividendYield": 0.008668881380306078, "dividendYieldPercentage": 0.8668881380306078, "revenuePerShare": 6.958733747880158, "netIncomePerShare": 0.7738835500282646, "interestDebtPerShare": 42.20520067834935, "cashPerShare": 10.214245336348219, "bookValuePerShare": 4.548897682306388, "tangibleBookValuePerShare": -49.52176370830978, "shareholdersEquityPerShare": 4.526286037309214, "operatingCashFlowPerShare": 2.283776144714528, "capexPerShare": 0.10910118711136235, "freeCashFlowPerShare": 2.1746749576031656, "netIncomePerEBT": 0.7800569800569801, "ebtPerEbit": 0.6272337383845604, "priceToFairValue": 39.93561134007743, "debtToMarketCap": 0.23142348161040047, "effectiveTaxRate": 0.21823361823361823, "enterpriseValueMultiple": 83.69312541768768, "dividendPerShare": 1.5669869983041267}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.6011467729529404, "ebitMargin": 0.12418711978183344, "ebitdaMargin": 0.26935179358086847, "operatingProfitMargin": 0.223410950283197, "pretaxProfitMargin": 0.08474931822949444, "continuousOperationsProfitMargin": 0.057618348367247045, "netProfitMargin": 0.05747849800713237, "bottomLineProfitMargin": 0.05670932102650164, "receivablesTurnover": 1.282025997310623, "payablesTurnover": 1.5466377440347072, "inventoryTurnover": 1.3915589168089777, "fixedAssetTurnover": 2.866506313890559, "assetTurnover": 0.10616059564549295, "currentRatio": 0.8721228297349436, "quickRatio": 0.7638011680452419, "solvencyRatio": 0.023311935904242482, "cashRatio": 0.3386274147089136, "priceToEarningsRatio": 83.23231003437044, "priceToEarningsGrowthRatio": -1.5413390747105638, "forwardPriceToEarningsGrowthRatio": -1.5413390747105638, "priceToBookRatio": 26.415814227124518, "priceToSalesRatio": 19.13627266575834, "priceToFreeCashFlowRatio": 60.1732267794657, "priceToOperatingCashFlowRatio": 57.57791613570587, "debtToAssetsRatio": 0.4462887217821856, "debtToEquityRatio": 5.803088803088803, "debtToCapitalRatio": 0.8530079455164585, "longTermDebtToCapitalRatio": 0.8343115773985639, "financialLeverageRatio": 13.002992277992279, "workingCapitalTurnoverRatio": -4.477457733249843, "operatingCashFlowRatio": 0.1256045030522449, "operatingCashFlowSalesRatio": 0.3323543808125306, "freeCashFlowOperatingCashFlowRatio": 0.9568693456764149, "debtServiceCoverageRatio": 0.4466795615731786, "interestCoverageRatio": 5.664893617021277, "shortTermOperatingCashFlowCoverageRatio": 0.6609650952579613, "operatingCashFlowCoverageRatio": 0.0790585495675316, "capitalExpenditureCoverageRatio": 23.185365853658535, "dividendPaidAndCapexCoverageRatio": 1.6789120452137054, "dividendPayoutRatio": 3.1946472019464722, "dividendYield": 0.009595574124481393, "dividendYieldPercentage": 0.9595574124481393, "revenuePerShare": 8.098233271795765, "netIncomePerShare": 0.46547428497420584, "interestDebtPerShare": 34.363554147657794, "cashPerShare": 7.2573216985759395, "bookValuePerShare": 5.887513553378125, "tangibleBookValuePerShare": -43.889355147458396, "shareholdersEquityPerShare": 5.866561547850089, "operatingCashFlowPerShare": 2.691483304723115, "capexPerShare": 0.11608543603371314, "freeCashFlowPerShare": 2.575397868689402, "netIncomePerEBT": 0.6782178217821783, "ebtPerEbit": 0.37934272300469485, "priceToFairValue": 26.415814227124518, "debtToMarketCap": 0.21689797748703982, "effectiveTaxRate": 0.3201320132013201, "enterpriseValueMultiple": 83.32654086007528, "dividendPerShare": 1.4870261220708816}}
{"date": "2023-09-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2023-09-30", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.5343577224097078, "ebitMargin": 0.1800818553888131, "ebitdaMargin": 0.34056149924606877, "operatingProfitMargin": 0.1637825805988368, "pretaxProfitMargin": 0.14023120557191068, "continuousOperationsProfitMargin": 0.12788109427730307, "netProfitMargin": 0.12766568535937386, "bottomLineProfitMargin": 0.12687585266030013, "receivablesTurnover": 1.2203820539782686, "payablesTurnover": 0.21931011159959418, "inventoryTurnover": 1.6289876915347903, "fixedAssetTurnover": 2.822659100121605, "assetTurnover": 0.10223827456853202, "currentRatio": 0.955453944152072, "quickRatio": 0.8409685675667903, "solvencyRatio": 0.032338909841085645, "cashRatio": 0.38210680700543526, "priceToEarningsRatio": 37.034451631046124, "priceToEarningsGrowthRatio": -3.0156624899566147, "forwardPriceToEarningsGrowthRatio": -3.0156624899566147, "priceToBookRatio": 21.77848685298495, "priceToSalesRatio": 18.91211459754434, "priceToFreeCashFlowRatio": 35.81087967369137, "priceToOperatingCashFlowRatio": 34.775418537100606, "debtToAssetsRatio": 0.44593711689093457, "debtToEquityRatio": 5.022821233669588, "debtToCapitalRatio": 0.8339648544755629, "longTermDebtToCapitalRatio": 0.8214248800295312, "financialLeverageRatio": 11.263519100380353, "workingCapitalTurnoverRatio": -5.643030794165316, "operatingCashFlowRatio": 0.21781267075029476, "operatingCashFlowSalesRatio": 0.5438357147985926, "freeCashFlowOperatingCashFlowRatio": 0.9710852917876948, "debtServiceCoverageRatio": 0.8061728395061728, "interestCoverageRatio": 4.10990990990991, "shortTermOperatingCashFlowCoverageRatio": 1.4807429130009775, "operatingCashFlowCoverageRatio": 0.12468310670661442, "capitalExpenditureCoverageRatio": 34.58447488584475, "dividendPaidAndCapexCoverageRatio": 2.6612789880534082, "dividendPayoutRatio": 1.4775028121484814, "dividendYield": 0.009973840215510881, "dividendYieldPercentage": 0.9973840215510881, "revenuePerShare": 7.881720430107527, "netIncomePerShare": 1.0062252405206564, "interestDebtPerShare": 34.69213355970572, "cashPerShare": 7.5212224108658745, "bookValuePerShare": 6.864176570458404, "tangibleBookValuePerShare": -44.46236559139785, "shareholdersEquityPerShare": 6.844368986983588, "operatingCashFlowPerShare": 4.286361063950198, "capexPerShare": 0.12393887945670629, "freeCashFlowPerShare": 4.162422184493492, "netIncomePerEBT": 0.910394265232975, "ebtPerEbit": 0.8562034195528277, "priceToFairValue": 21.77848685298495, "debtToMarketCap": 0.2306322412376947, "effectiveTaxRate": 0.08806963645673323, "enterpriseValueMultiple": 65.53827113641155, "dividendPerShare": 1.486700622524052}}
{"date": "2023-06-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2023-06-30", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.6941940137035701, "ebitMargin": 0.22805625676163, "ebitdaMargin": 0.39105661738189684, "operatingProfitMargin": 0.3254958528669311, "pretaxProfitMargin": 0.18824377930039668, "continuousOperationsProfitMargin": 0.14619545618463758, "netProfitMargin": 0.14597908402452217, "bottomLineProfitMargin": 0.1451857194374324, "receivablesTurnover": 1.2065964668001044, "payablesTurnover": 0, "inventoryTurnover": 1.0456226880394575, "fixedAssetTurnover": 2.8049767347764516, "assetTurnover": 0.1024252587410521, "currentRatio": 0.894940910077856, "quickRatio": 0.7691615744905239, "solvencyRatio": 0.03498028072410161, "cashRatio": 0.2716895685350042, "priceToEarningsRatio": 29.405621294466403, "priceToEarningsGrowthRatio": 0.03784881948792706, "forwardPriceToEarningsGrowthRatio": 0.03784881948792706, "priceToBookRatio": 18.50364604383647, "priceToSalesRatio": 17.170422646952755, "priceToFreeCashFlowRatio": 38.76696140693698, "priceToOperatingCashFlowRatio": 37.67493432505143, "debtToAssetsRatio": 0.45073762438408177, "debtToEquityRatio": 4.742344162909995, "debtToCapitalRatio": 0.8258550912954616, "longTermDebtToCapitalRatio": 0.8126619878272519, "financialLeverageRatio": 10.521296440230063, "workingCapitalTurnoverRatio": -6.177322343506349, "operatingCashFlowRatio": 0.19600483885976613, "operatingCashFlowSalesRatio": 0.45575189325640103, "freeCashFlowOperatingCashFlowRatio": 0.971830985915493, "debtServiceCoverageRatio": 0.8408340573414422, "interestCoverageRatio": 8.17572463768116, "shortTermOperatingCashFlowCoverageRatio": 1.2144916394387852, "operatingCashFlowCoverageRatio": 0.10356469720560518, "capitalExpenditureCoverageRatio": 35.5, "dividendPaidAndCapexCoverageRatio": 2.2543703175169463, "dividendPayoutRatio": 1.2969367588932805, "dividendYield": 0.011026265572709904, "dividendYieldPercentage": 1.1026265572709906, "revenuePerShare": 7.846632710809281, "netIncomePerShare": 1.1454442558007922, "interestDebtPerShare": 34.84267119411432, "cashPerShare": 4.960950764006792, "bookValuePerShare": 7.299377475947934, "tangibleBookValuePerShare": -46.512733446519526, "shareholdersEquityPerShare": 7.281267685342388, "operatingCashFlowPerShare": 3.576117713638936, "capexPerShare": 0.1007357102433503, "freeCashFlowPerShare": 3.475382003395586, "netIncomePerEBT": 0.7754789272030651, "ebtPerEbit": 0.5783292709949036, "priceToFairValue": 18.50364604383647, "debtToMarketCap": 0.2562924167310076, "effectiveTaxRate": 0.22337164750957855, "enterpriseValueMultiple": 53.545538546661746, "dividendPerShare": 1.4855687606112054}}
{"date": "2023-03-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2023-03-31", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6739468302658487, "ebitMargin": 0.08408997955010225, "ebitdaMargin": 0.25807770961145193, "operatingProfitMargin": 0.22642126789366054, "pretaxProfitMargin": 0.03885480572597137, "continuousOperationsProfitMargin": 0.01971370143149284, "netProfitMargin": 0.019550102249488752, "bottomLineProfitMargin": 0.018650306748466256, "receivablesTurnover": 1.0655451930619715, "payablesTurnover": 0.16167761823639165, "inventoryTurnover": 1.03991651447952, "fixedAssetTurnover": 2.479213141350639, "assetTurnover": 0.09086246878344631, "currentRatio": 0.9600579920260964, "quickRatio": 0.8211308445088801, "solvencyRatio": 0.019514850586847682, "cashRatio": 0.24324030445813702, "priceToEarningsRatio": 295.0678870292887, "priceToEarningsGrowthRatio": -3.252716864889797, "forwardPriceToEarningsGrowthRatio": -3.252716864889797, "priceToBookRatio": 21.250934156998646, "priceToSalesRatio": 23.07442944785276, "priceToFreeCashFlowRatio": 70.20530114484818, "priceToOperatingCashFlowRatio": 67.27519675649893, "debtToAssetsRatio": 0.46150701629206803, "debtToEquityRatio": 4.677791170709658, "debtToCapitalRatio": 0.8238751708307349, "longTermDebtToCapitalRatio": 0.8170768679546895, "financialLeverageRatio": 10.135904776254332, "workingCapitalTurnoverRatio": -11.231051906293064, "operatingCashFlowRatio": 0.15197535338890902, "operatingCashFlowSalesRatio": 0.3429856850715746, "freeCashFlowOperatingCashFlowRatio": 0.9582637729549248, "debtServiceCoverageRatio": 0.8709004174120453, "interestCoverageRatio": 5.005424954792043, "shortTermOperatingCashFlowCoverageRatio": 1.4969653695108889, "operatingCashFlowCoverageRatio": 0.06752774064709388, "capitalExpenditureCoverageRatio": 23.96, "dividendPaidAndCapexCoverageRatio": 1.478490832157969, "dividendPayoutRatio": 11.133891213389122, "dividendYield": 0.009433330178254843, "dividendYieldPercentage": 0.9433330178254844, "revenuePerShare": 6.906779661016949, "netIncomePerShare": 0.13502824858757062, "interestDebtPerShare": 35.39322033898305, "cashPerShare": 3.7977401129943504, "bookValuePerShare": 7.515819209039548, "tangibleBookValuePerShare": -47.324858757062145, "shareholdersEquityPerShare": 7.4994350282485875, "operatingCashFlowPerShare": 2.3689265536723165, "capexPerShare": 0.09887005649717515, "freeCashFlowPerShare": 2.2700564971751414, "netIncomePerEBT": 0.5031578947368421, "ebtPerEbit": 0.17160404624277456, "priceToFairValue": 21.250934156998646, "debtToMarketCap": 0.22012167258864265, "effectiveTaxRate": 0.4926315789473684, "enterpriseValueMultiple": 106.9625673534073, "dividendPerShare": 1.5033898305084745}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7242245883208782, "ebitMargin": 0.23351630183188943, "ebitdaMargin": 0.37616559751339196, "operatingProfitMargin": 0.36386482375504264, "pretaxProfitMargin": 0.19608491501884795, "continuousOperationsProfitMargin": 0.16348125123999735, "netProfitMargin": 0.16354738443224653, "bottomLineProfitMargin": 0.16281991931750545, "receivablesTurnover": 1.343611160476275, "payablesTurnover": 1.4212678936605316, "inventoryTurnover": 1.165129924559933, "fixedAssetTurnover": 3.06403242147923, "assetTurnover": 0.10893699794675984, "currentRatio": 0.9636062021802424, "quickRatio": 0.8424402464621843, "solvencyRatio": 0.03810135124014549, "cashRatio": 0.31149705464147875, "priceToEarningsRatio": 28.903896220177923, "priceToEarningsGrowthRatio": -0.7765745610963465, "forwardPriceToEarningsGrowthRatio": -0.7765745610963465, "priceToBookRatio": 16.571075774313204, "priceToSalesRatio": 18.908626506844787, "priceToFreeCashFlowRatio": 39.62818314760915, "priceToOperatingCashFlowRatio": 38.491833792407114, "debtToAssetsRatio": 0.46245452253160907, "debtToEquityRatio": 3.720354700359337, "debtToCapitalRatio": 0.788151513291178, "longTermDebtToCapitalRatio": 0.7740795055779605, "financialLeverageRatio": 8.044801205517562, "workingCapitalTurnoverRatio": -8.834940111013731, "operatingCashFlowRatio": 0.25147267926061345, "operatingCashFlowSalesRatio": 0.4912373520269823, "freeCashFlowOperatingCashFlowRatio": 0.971324717285945, "debtServiceCoverageRatio": 1.0671733771569434, "interestCoverageRatio": 9.720848056537102, "shortTermOperatingCashFlowCoverageRatio": 1.7266387726638772, "operatingCashFlowCoverageRatio": 0.11571715661073982, "capitalExpenditureCoverageRatio": 34.87323943661972, "dividendPaidAndCapexCoverageRatio": 2.7318867230599486, "dividendPayoutRatio": 1.0133441164577437, "dividendYield": 0.008764770921699512, "dividendYieldPercentage": 0.8764770921699512, "revenuePerShare": 8.54689260171797, "netIncomePerShare": 1.3978219300342927, "interestDebtPerShare": 36.60281226171884, "cashPerShare": 5.216538047831172, "bookValuePerShare": 9.771187911242547, "tangibleBookValuePerShare": -46.52322176193391, "shareholdersEquityPerShare": 9.75253521262098, "operatingCashFlowPerShare": 4.198552889726941, "capexPerShare": 0.12039469110283232, "freeCashFlowPerShare": 4.078158198624109, "netIncomePerEBT": 0.8340640809443508, "ebtPerEbit": 0.5388949472918939, "priceToFairValue": 16.571075774313204, "debtToMarketCap": 0.22181235907988153, "effectiveTaxRate": 0.16627318718381112, "enterpriseValueMultiple": 59.93448337025316, "dividendPerShare": 1.4164746286558583}}
{"date": "2022-09-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2022-09-30", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.660950580610316, "ebitMargin": 0.33486362408857684, "ebitdaMargin": 0.48372940858763164, "operatingProfitMargin": 0.31076154469349176, "pretaxProfitMargin": 0.2970564407237375, "continuousOperationsProfitMargin": 0.2668106940318661, "netProfitMargin": 0.2666081555495544, "bottomLineProfitMargin": 0.2653929246556846, "receivablesTurnover": 1.378758261193335, "payablesTurnover": 0, "inventoryTurnover": 1.5832282471626733, "fixedAssetTurnover": 3.027181688125894, "assetTurnover": 0.10480806651335574, "currentRatio": 0.9282220591831744, "quickRatio": 0.8312545854732208, "solvencyRatio": 0.049114910054430236, "cashRatio": 0.3617021276595745, "priceToEarningsRatio": 15.047221448467969, "priceToEarningsGrowthRatio": 0.04575763247487336, "forwardPriceToEarningsGrowthRatio": 0.04575763247487336, "priceToBookRatio": 14.860942228335627, "priceToSalesRatio": 16.046847826086957, "priceToFreeCashFlowRatio": 32.01157037037037, "priceToOperatingCashFlowRatio": 31.266233885819524, "debtToAssetsRatio": 0.49252432336812313, "debtToEquityRatio": 4.352007002625985, "debtToCapitalRatio": 0.8131542056074766, "longTermDebtToCapitalRatio": 0.7906352676292331, "financialLeverageRatio": 8.836126047267726, "workingCapitalTurnoverRatio": -3.8368087035358114, "operatingCashFlowRatio": 0.23239178283198828, "operatingCashFlowSalesRatio": 0.5132325141776938, "freeCashFlowOperatingCashFlowRatio": 0.9767166535122336, "debtServiceCoverageRatio": 0.6877239684652401, "interestCoverageRatio": 8.219642857142857, "shortTermOperatingCashFlowCoverageRatio": 0.8256761159986966, "operatingCashFlowCoverageRatio": 0.10921472286871821, "capitalExpenditureCoverageRatio": 42.94915254237288, "dividendPaidAndCapexCoverageRatio": 2.835509138381201, "dividendPayoutRatio": 0.634084578374272, "dividendYield": 0.01053491138789001, "dividendYieldPercentage": 1.053491138789001, "revenuePerShare": 8.363636363636363, "netIncomePerShare": 2.229813664596273, "interestDebtPerShare": 39.61942405420666, "cashPerShare": 6.707509881422925, "bookValuePerShare": 9.049689440993788, "tangibleBookValuePerShare": -47.670242800677585, "shareholdersEquityPerShare": 9.031055900621118, "operatingCashFlowPerShare": 4.292490118577075, "capexPerShare": 0.09994353472614342, "freeCashFlowPerShare": 4.192546583850931, "netIncomePerEBT": 0.8975, "ebtPerEbit": 0.9558983271779274, "priceToFairValue": 14.860942228335627, "debtToMarketCap": 0.2928486589718339, "effectiveTaxRate": 0.10181818181818182, "enterpriseValueMultiple": 41.23655408234473, "dividendPerShare": 1.4138904573687183}}
{"date": "2022-06-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2022-06-30", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7140506068710142, "ebitMargin": 0.11924843996434205, "ebitdaMargin": 0.25996022766234655, "operatingProfitMargin": 0.22594802166906672, "pretaxProfitMargin": 0.0811218542138106, "continuousOperationsProfitMargin": 0.06363574024549133, "netProfitMargin": 0.06336144826167456, "bottomLineProfitMargin": 0.06260714530617843, "receivablesTurnover": 1.2977663077333808, "payablesTurnover": 0, "inventoryTurnover": 1.2279151943462898, "fixedAssetTurnover": 2.9413069786204113, "assetTurnover": 0.10184654924364114, "currentRatio": 0.8441388913062396, "quickRatio": 0.7456270124445218, "solvencyRatio": 0.023159893539199054, "cashRatio": 0.24717895164331505, "priceToEarningsRatio": 73.34772727272727, "priceToEarningsGrowthRatio": -0.9222932043204319, "forwardPriceToEarningsGrowthRatio": -0.9222932043204319, "priceToBookRatio": 18.5008667167133, "priceToSalesRatio": 18.589672906809298, "priceToFreeCashFlowRatio": 55.75754833401892, "priceToOperatingCashFlowRatio": 54.16447552447553, "debtToAssetsRatio": 0.5093514729093627, "debtToEquityRatio": 4.977274278304784, "debtToCapitalRatio": 0.8326996631843352, "longTermDebtToCapitalRatio": 0.8063181547815742, "financialLeverageRatio": 9.771787347300894, "workingCapitalTurnoverRatio": -2.561791831357049, "operatingCashFlowRatio": 0.14518608766280858, "operatingCashFlowSalesRatio": 0.3432078447507372, "freeCashFlowOperatingCashFlowRatio": 0.9714285714285714, "debtServiceCoverageRatio": 0.28319718084254364, "interestCoverageRatio": 5.926258992805756, "shortTermOperatingCashFlowCoverageRatio": 0.4195305951383068, "operatingCashFlowCoverageRatio": 0.06862556902319969, "capitalExpenditureCoverageRatio": 35, "dividendPaidAndCapexCoverageRatio": 1.8886792452830188, "dividendPayoutRatio": 2.713203463203463, "dividendYield": 0.009247742104929228, "dividendYieldPercentage": 0.9247742104929229, "revenuePerShare": 8.238983050847457, "netIncomePerShare": 0.5220338983050847, "interestDebtPerShare": 41.51864406779661, "cashPerShare": 5.627683615819209, "bookValuePerShare": 8.298305084745763, "tangibleBookValuePerShare": -50.37457627118644, "shareholdersEquityPerShare": 8.278531073446327, "operatingCashFlowPerShare": 2.827683615819209, "capexPerShare": 0.0807909604519774, "freeCashFlowPerShare": 2.7468926553672315, "netIncomePerEBT": 0.7810650887573964, "ebtPerEbit": 0.3590288315629742, "priceToFairValue": 18.5008667167133, "debtToMarketCap": 0.2690292489815311, "effectiveTaxRate": 0.21555367709213863, "enterpriseValueMultiple": 88.50018464785018, "dividendPerShare": 1.4163841807909605}}
{"date": "2022-03-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2022-03-31", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.7006943418525632, "ebitMargin": 0.4045649283498301, "ebitdaMargin": 0.5562121435958044, "operatingProfitMargin": 0.3484266509085537, "pretaxProfitMargin": 0.3640862756684887, "continuousOperationsProfitMargin": 0.3318806322942828, "netProfitMargin": 0.3316590338306988, "bottomLineProfitMargin": 0.33055104151277886, "receivablesTurnover": 1.2613435199850926, "payablesTurnover": 0, "inventoryTurnover": 1.1633649153028998, "fixedAssetTurnover": 2.667586206896552, "assetTurnover": 0.09453184462087409, "currentRatio": 0.815134835952154, "quickRatio": 0.7080348082777282, "solvencyRatio": 0.051561502635996126, "cashRatio": 0.1875096091756096, "priceToEarningsRatio": 15.985345768374165, "priceToEarningsGrowthRatio": 1.4642576723830745, "forwardPriceToEarningsGrowthRatio": 1.4642576723830745, "priceToBookRatio": 17.63169010624578, "priceToSalesRatio": 21.2067373319545, "priceToFreeCashFlowRatio": 60.49237463126844, "priceToOperatingCashFlowRatio": 58.495682559087214, "debtToAssetsRatio": 0.5130471821298643, "debtToEquityRatio": 4.512313455751397, "debtToCapitalRatio": 0.8185879652840446, "longTermDebtToCapitalRatio": 0.7959651650899067, "financialLeverageRatio": 8.795123748694959, "workingCapitalTurnoverRatio": -2.039162524476578, "operatingCashFlowRatio": 0.15091786845422958, "operatingCashFlowSalesRatio": 0.3625350864234008, "freeCashFlowOperatingCashFlowRatio": 0.9669926650366748, "debtServiceCoverageRatio": 0.6756190476190476, "interestCoverageRatio": 8.607664233576642, "shortTermOperatingCashFlowCoverageRatio": 0.49316720257234725, "operatingCashFlowCoverageRatio": 0.06679913983177722, "capitalExpenditureCoverageRatio": 30.296296296296298, "dividendPaidAndCapexCoverageRatio": 1.8258928571428572, "dividendPayoutRatio": 0.5625835189309577, "dividendYield": 0.00879842586896037, "dividendYieldPercentage": 0.879842586896037, "revenuePerShare": 7.644268774703558, "netIncomePerShare": 2.5352907961603615, "interestDebtPerShare": 41.79672501411632, "cashPerShare": 4.275550536420102, "bookValuePerShare": 9.211744776962169, "tangibleBookValuePerShare": -50.80180688876341, "shareholdersEquityPerShare": 9.194240542066629, "operatingCashFlowPerShare": 2.771315640880858, "capexPerShare": 0.09147374364765669, "freeCashFlowPerShare": 2.6798418972332017, "netIncomePerEBT": 0.9109352809900588, "ebtPerEbit": 1.0449438202247192, "priceToFairValue": 17.63169010624578, "debtToMarketCap": 0.25592064223911093, "effectiveTaxRate": 0.08845607628322175, "enterpriseValueMultiple": 47.074742363877824, "dividendPerShare": 1.4263128176171656}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7097944377267231, "ebitMargin": 0.3258766626360339, "ebitdaMargin": 0.4588203681311299, "operatingProfitMargin": 0.340857181244122, "pretaxProfitMargin": 0.28691387881230684, "continuousOperationsProfitMargin": 0.27173182856375117, "netProfitMargin": 0.27166465135026197, "bottomLineProfitMargin": 0.2702539298669891, "receivablesTurnover": 1.4920316728475493, "payablesTurnover": 1.4989590562109647, "inventoryTurnover": 1.381074168797954, "fixedAssetTurnover": 2.9131115459882584, "assetTurnover": 0.10159081137522265, "currentRatio": 0.7935443541512758, "quickRatio": 0.7046655679945445, "solvencyRatio": 0.045944482161518925, "cashRatio": 0.2769222026481787, "priceToEarningsRatio": 14.801741172106825, "priceToEarningsGrowthRatio": 0.5166097899284344, "forwardPriceToEarningsGrowthRatio": 0.5166097899284344, "priceToBookRatio": 15.539522663551404, "priceToSalesRatio": 16.084439419588875, "priceToFreeCashFlowRatio": 48.98383085106383, "priceToOperatingCashFlowRatio": 47.17890939901478, "debtToAssetsRatio": 0.5294173849545141, "debtToEquityRatio": 5.034722222222222, "debtToCapitalRatio": 0.8342922899884925, "longTermDebtToCapitalRatio": 0.806364047654954, "financialLeverageRatio": 9.509929906542055, "workingCapitalTurnoverRatio": -4.351359251680795, "operatingCashFlowRatio": 0.14420071603114168, "operatingCashFlowSalesRatio": 0.34092435845761115, "freeCashFlowOperatingCashFlowRatio": 0.963152709359606, "debtServiceCoverageRatio": 0.49830227118388287, "interestCoverageRatio": 8.748275862068965, "shortTermOperatingCashFlowCoverageRatio": 0.40045766590389015, "operatingCashFlowCoverageRatio": 0.06542056074766354, "capitalExpenditureCoverageRatio": 27.13903743315508, "dividendPaidAndCapexCoverageRatio": 2.029188324670132, "dividendPayoutRatio": 0.5722057368941642, "dividendYield": 0.009664500450333144, "dividendYieldPercentage": 0.9664500450333143, "revenuePerShare": 8.418073920257326, "netIncomePerShare": 2.2868931165874398, "interestDebtPerShare": 44.19686734097215, "cashPerShare": 5.558892021774118, "bookValuePerShare": 8.729100432157201, "tangibleBookValuePerShare": -52.53181235713987, "shareholdersEquityPerShare": 8.713266355187752, "operatingCashFlowPerShare": 2.869926450712477, "capexPerShare": 0.10574901404595728, "freeCashFlowPerShare": 2.7641774366665195, "netIncomePerEBT": 0.9468508546007961, "ebtPerEbit": 0.8417422152148206, "priceToFairValue": 15.539522663551404, "debtToMarketCap": 0.3209123686699429, "effectiveTaxRate": 0.05291500819480215, "enterpriseValueMultiple": 44.98711057101025, "dividendPerShare": 1.3085733609751078}}
{"date": "2021-09-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2021-09-30", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.6939060103193418, "ebitMargin": 0.29870310974759445, "ebitdaMargin": 0.4470087853855808, "operatingProfitMargin": 0.3002370659601171, "pretaxProfitMargin": 0.25714684144470784, "continuousOperationsProfitMargin": 0.22172639799191188, "netProfitMargin": 0.22165667270952447, "bottomLineProfitMargin": 0.2201924417793892, "receivablesTurnover": 1.5453076177136085, "payablesTurnover": 0, "inventoryTurnover": 1.4188752424046542, "fixedAssetTurnover": 2.795711500974659, "assetTurnover": 0.09634685404882505, "currentRatio": 1.0148599866820873, "quickRatio": 0.9064241404689307, "solvencyRatio": 0.03922206370443743, "cashRatio": 0.4269442400028038, "priceToEarningsRatio": 15.014933941491035, "priceToEarningsGrowthRatio": 0.04636964893695761, "forwardPriceToEarningsGrowthRatio": 0.04636964893695761, "priceToBookRatio": 14.090767527675277, "priceToSalesRatio": 13.312641193696834, "priceToFreeCashFlowRatio": 24.738261207566726, "priceToOperatingCashFlowRatio": 24.061739130434784, "debtToAssetsRatio": 0.5422684706230099, "debtToEquityRatio": 5.957269372693727, "debtToCapitalRatio": 0.8562654474865017, "longTermDebtToCapitalRatio": 0.8453178689254444, "financialLeverageRatio": 10.985830258302583, "workingCapitalTurnoverRatio": -12.68642193719593, "operatingCashFlowRatio": 0.2780990432131216, "operatingCashFlowSalesRatio": 0.5532701157439688, "freeCashFlowOperatingCashFlowRatio": 0.9726528040327662, "debtServiceCoverageRatio": 0.812190423775454, "interestCoverageRatio": 7.224832214765101, "shortTermOperatingCashFlowCoverageRatio": 1.1892985611510791, "operatingCashFlowCoverageRatio": 0.09830155721559446, "capitalExpenditureCoverageRatio": 36.566820276497694, "dividendPaidAndCapexCoverageRatio": 3.1338862559241707, "dividendPayoutRatio": 0.7282164202579428, "dividendYield": 0.012124868865484138, "dividendYieldPercentage": 1.212486886548414, "revenuePerShare": 8.102824858757062, "netIncomePerShare": 1.796045197740113, "interestDebtPerShare": 45.94180790960452, "cashPerShare": 6.920338983050847, "bookValuePerShare": 7.670621468926553, "tangibleBookValuePerShare": -54.336158192090394, "shareholdersEquityPerShare": 7.655367231638418, "operatingCashFlowPerShare": 4.483050847457627, "capexPerShare": 0.12259887005649718, "freeCashFlowPerShare": 4.36045197740113, "netIncomePerEBT": 0.8619848156182213, "ebtPerEbit": 0.8564793311658151, "priceToFairValue": 14.090767527675277, "debtToMarketCap": 0.4227782028901707, "effectiveTaxRate": 0.13774403470715835, "enterpriseValueMultiple": 40.47245359538294, "dividendPerShare": 1.307909604519774}}
{"date": "2021-06-30", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2021-06-30", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.675979654703059, "ebitMargin": 0.12737302099004227, "ebitdaMargin": 0.28497743391360414, "operatingProfitMargin": 0.3181459989970628, "pretaxProfitMargin": 0.08331542374095566, "continuousOperationsProfitMargin": 0.05508990615373594, "netProfitMargin": 0.05487499104520381, "bottomLineProfitMargin": 0.05365713876352174, "receivablesTurnover": 1.4080088763364937, "payablesTurnover": 0, "inventoryTurnover": 1.3357944477259303, "fixedAssetTurnover": 2.704708389846929, "assetTurnover": 0.09433541480820695, "currentRatio": 0.906393808394924, "quickRatio": 0.7883489053130666, "solvencyRatio": 0.02190902510009012, "cashRatio": 0.29793613164133315, "priceToEarningsRatio": 65.03268929503916, "priceToEarningsGrowthRatio": -0.8231985986713818, "forwardPriceToEarningsGrowthRatio": -0.8231985986713818, "priceToBookRatio": 15.853302569814623, "priceToSalesRatio": 14.274672970843184, "priceToFreeCashFlowRatio": 42.44092864749734, "priceToOperatingCashFlowRatio": 40.74849897750511, "debtToAssetsRatio": 0.5550915037980159, "debtToEquityRatio": 6.534966982257936, "debtToCapitalRatio": 0.8672854171286177, "longTermDebtToCapitalRatio": 0.8552058613459899, "financialLeverageRatio": 11.772774285941603, "workingCapitalTurnoverRatio": -3.4607660840461136, "operatingCashFlowRatio": 0.1704783154371775, "operatingCashFlowSalesRatio": 0.3503116269073716, "freeCashFlowOperatingCashFlowRatio": 0.9601226993865031, "debtServiceCoverageRatio": 0.4208548614372945, "interestCoverageRatio": 7.221138211382113, "shortTermOperatingCashFlowCoverageRatio": 0.6189089988609037, "operatingCashFlowCoverageRatio": 0.05953395505125521, "capitalExpenditureCoverageRatio": 25.076923076923077, "dividendPaidAndCapexCoverageRatio": 1.9520958083832336, "dividendPayoutRatio": 3.0156657963446474, "dividendYield": 0.011592884397964952, "dividendYieldPercentage": 1.159288439796495, "revenuePerShare": 7.890898812888637, "netIncomePerShare": 0.43301300169587337, "interestDebtPerShare": 46.77953646127756, "cashPerShare": 4.861503674392312, "bookValuePerShare": 7.119276427360091, "tangibleBookValuePerShare": -56.04522328999435, "shareholdersEquityPerShare": 7.105144149236857, "operatingCashFlowPerShare": 2.764273600904466, "capexPerShare": 0.11023176936122103, "freeCashFlowPerShare": 2.654041831543245, "netIncomePerEBT": 0.6586414445399829, "ebtPerEbit": 0.26187795541544695, "priceToFairValue": 15.853302569814623, "debtToMarketCap": 0.41221486522945683, "effectiveTaxRate": 0.33877901977644026, "enterpriseValueMultiple": 68.59028657616894, "dividendPerShare": 1.3058224985867721}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "ratios_quarter", "result": {"symbol": "ABBV", "date": "2021-03-31", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6761721752498079, "ebitMargin": 0.3458109146810146, "ebitdaMargin": 0.516064565718678, "operatingProfitMargin": 0.3153727901614143, "pretaxProfitMargin": 0.2972328977709454, "continuousOperationsProfitMargin": 0.2732513451191391, "netProfitMargin": 0.27309761721752496, "bottomLineProfitMargin": 0.27125288239815526, "receivablesTurnover": 1.3569044639132248, "payablesTurnover": 0, "inventoryTurnover": 1.287591687041565, "fixedAssetTurnover": 2.5052955902176004, "assetTurnover": 0.08644460834147281, "currentRatio": 0.8315545679321461, "quickRatio": 0.7291477575036776, "solvencyRatio": 0.04217360786148807, "cashRatio": 0.30531125786360364, "priceToEarningsRatio": 13.470389811426964, "priceToEarningsGrowthRatio": 0.0007654015430639346, "forwardPriceToEarningsGrowthRatio": 0.0007654015430639346, "priceToBookRatio": 13.963616338439095, "priceToSalesRatio": 14.714925441967717, "priceToFreeCashFlowRatio": 40.827720196203884, "priceToOperatingCashFlowRatio": 39.25388148451917, "debtToAssetsRatio": 0.5683018717483604, "debtToEquityRatio": 6.238512035010941, "debtToCapitalRatio": 0.8618500604594922, "longTermDebtToCapitalRatio": 0.8440148817311959, "financialLeverageRatio": 10.97746170678337, "workingCapitalTurnoverRatio": -2.636271529888551, "operatingCashFlowRatio": 0.15263997996932804, "operatingCashFlowSalesRatio": 0.3748654880860876, "freeCashFlowOperatingCashFlowRatio": 0.9614517121181054, "debtServiceCoverageRatio": 0.5344352617079889, "interestCoverageRatio": 6.492088607594937, "shortTermOperatingCashFlowCoverageRatio": 0.42980523486384065, "operatingCashFlowCoverageRatio": 0.0570209283292412, "capitalExpenditureCoverageRatio": 25.94148936170213, "dividendPaidAndCapexCoverageRatio": 1.943027888446215, "dividendPayoutRatio": 0.6535322262876443, "dividendYield": 0.012129051858121645, "dividendYieldPercentage": 1.2129051858121644, "revenuePerShare": 7.354437535330695, "netIncomePerShare": 2.00847936687394, "interestDebtPerShare": 48.70661390616167, "cashPerShare": 5.526851328434144, "bookValuePerShare": 7.763143018654607, "tangibleBookValuePerShare": -56.477671000565294, "shareholdersEquityPerShare": 7.750141322781232, "operatingCashFlowPerShare": 2.7569248162803843, "capexPerShare": 0.10627473148671567, "freeCashFlowPerShare": 2.6506500847936687, "netIncomePerEBT": 0.9188001034393587, "ebtPerEbit": 0.9424811113819157, "priceToFairValue": 13.963616338439095, "debtToMarketCap": 0.44676908071711635, "effectiveTaxRate": 0.08068269976726145, "enterpriseValueMultiple": 39.799848078641645, "dividendPerShare": 1.3126059920859243}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "ratios_annual", "result": {"symbol": "ABBV", "date": "2024-12-31", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.6999325451769801, "ebitMargin": 0.115809280363546, "ebitdaMargin": 0.2646714240068165, "operatingProfitMargin": 0.16219334682429792, "pretaxProfitMargin": 0.065963716405723, "continuousOperationsProfitMargin": 0.07608193985869989, "netProfitMargin": 0.0759399297049739, "bottomLineProfitMargin": 0.07522987893634395, "receivablesTurnover": 5.159263668834142, "payablesTurnover": 5.739898132427844, "inventoryTurnover": 4.043051901458981, "fixedAssetTurnover": 10.972730814179977, "assetTurnover": 0.4167918260444951, "currentRatio": 0.6601976825208392, "quickRatio": 0.5522981238225503, "solvencyRatio": 0.09608716435123713, "cashRatio": 0.14255851763916488, "priceToEarningsRatio": 73.48090229079008, "priceToEarningsGrowthRatio": -6.0788746440562695, "forwardPriceToEarningsGrowthRatio": -6.0788746440562695, "priceToBookRatio": 94.54174436090226, "priceToSalesRatio": 5.580134554620655, "priceToFreeCashFlowRatio": 17.628493719156573, "priceToOperatingCashFlowRatio": 16.715479102414122, "debtToAssetsRatio": 0.5019273311088258, "debtToEquityRatio": 20.403308270676693, "debtToCapitalRatio": 0.9532782508501251, "longTermDebtToCapitalRatio": 0.9477735019241341, "financialLeverageRatio": 40.64992481203007, "workingCapitalTurnoverRatio": -6.257247584138621, "operatingCashFlowRatio": 0.48532865364267463, "operatingCashFlowSalesRatio": 0.3338303688713743, "freeCashFlowOperatingCashFlowRatio": 0.9482080187174307, "debtServiceCoverageRatio": 1.6104868913857677, "interestCoverageRatio": 3.2539173789173788, "shortTermOperatingCashFlowCoverageRatio": 2.7639623750734863, "operatingCashFlowCoverageRatio": 0.27720699871758964, "capitalExpenditureCoverageRatio": 19.308008213552363, "dividendPaidAndCapexCoverageRatio": 1.5672972747728977, "dividendPayoutRatio": 2.5771388499298737, "dividendYield": 0.03507222651854788, "dividendYieldPercentage": 3.5072226518547884, "revenuePerShare": 31.84511023176936, "netIncomePerShare": 2.4183154324477107, "interestDebtPerShare": 39.93725268513284, "cashPerShare": 3.140192198982476, "bookValuePerShare": 1.901639344262295, "tangibleBookValuePerShare": -51.81458451102318, "shareholdersEquityPerShare": 1.8795929903900508, "operatingCashFlowPerShare": 10.630864895421142, "capexPerShare": 0.5505935556811759, "freeCashFlowPerShare": 10.080271339739966, "netIncomePerEBT": 1.151237890204521, "ebtPerEbit": 0.40669804093247236, "priceToFairValue": 94.54174436090226, "debtToMarketCap": 0.2135954265180389, "effectiveTaxRate": -0.1533907427341227, "enterpriseValueMultiple": 25.262796780684106, "dividendPerShare": 6.232334652345958}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "ratios_annual", "result": {"symbol": "ABBV", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.6241577377664862, "ebitMargin": 0.1560072167605582, "ebitdaMargin": 0.31613829669722743, "operatingProfitMargin": 0.23485768990021724, "pretaxProfitMargin": 0.1150631466548842, "continuousOperationsProfitMargin": 0.08971243418388011, "netProfitMargin": 0.0895283331492323, "bottomLineProfitMargin": 0.0887366987002467, "receivablesTurnover": 4.869385925593904, "payablesTurnover": 5.535520607375271, "inventoryTurnover": 4.980483044645036, "fixedAssetTurnover": 10.887552615754661, "assetTurnover": 0.40321874234472316, "currentRatio": 0.8721228297349436, "quickRatio": 0.7638011680452419, "solvencyRatio": 0.10908666763196422, "cashRatio": 0.3386274147089136, "priceToEarningsRatio": 56.34113921447666, "priceToEarningsGrowthRatio": -0.955787183102729, "forwardPriceToEarningsGrowthRatio": -0.955787183102729, "priceToBookRatio": 26.446617760617762, "priceToSalesRatio": 5.044128281600942, "priceToFreeCashFlowRatio": 12.418953857311214, "priceToOperatingCashFlowRatio": 11.996451683523796, "debtToAssetsRatio": 0.4462887217821856, "debtToEquityRatio": 5.803088803088803, "debtToCapitalRatio": 0.8530079455164585, "longTermDebtToCapitalRatio": 0.8343115773985639, "financialLeverageRatio": 13.002992277992279, "workingCapitalTurnoverRatio": -18.369293202570173, "operatingCashFlowRatio": 0.6035517031790915, "operatingCashFlowSalesRatio": 0.420468353032144, "freeCashFlowOperatingCashFlowRatio": 0.9659792460265335, "debtServiceCoverageRatio": 1.6776420605416889, "interestCoverageRatio": 5.736061151079137, "shortTermOperatingCashFlowCoverageRatio": 3.1760534000834375, "operatingCashFlowCoverageRatio": 0.37989021956087826, "capitalExpenditureCoverageRatio": 29.393822393822393, "dividendPaidAndCapexCoverageRatio": 2.018292682926829, "dividendPayoutRatio": 2.1671807526218383, "dividendYield": 0.0384653342626233, "dividendYieldPercentage": 3.84653342626233, "revenuePerShare": 30.72285067873303, "netIncomePerShare": 2.7505656108597285, "interestDebtPerShare": 35.262443438914026, "cashPerShare": 7.248868778280543, "bookValuePerShare": 5.880656108597285, "tangibleBookValuePerShare": -43.838235294117645, "shareholdersEquityPerShare": 5.85972850678733, "operatingCashFlowPerShare": 12.917986425339366, "capexPerShare": 0.43947963800904977, "freeCashFlowPerShare": 12.478506787330316, "netIncomePerEBT": 0.77808, "ebtPerEbit": 0.4899270988476915, "priceToFairValue": 26.446617760617762, "debtToMarketCap": 0.21664534691724016, "effectiveTaxRate": 0.22032, "enterpriseValueMultiple": 18.710281854181225, "dividendPerShare": 5.960972850678733}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "ratios_annual", "result": {"symbol": "ABBV", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7000378957522306, "ebitMargin": 0.27055844558514486, "ebitdaMargin": 0.4164054156475006, "operatingProfitMargin": 0.31207151961966445, "pretaxProfitMargin": 0.23214593309677198, "continuousOperationsProfitMargin": 0.20403417507837532, "netProfitMargin": 0.20387914700106796, "bottomLineProfitMargin": 0.20294897853722396, "receivablesTurnover": 5.158521414608139, "payablesTurnover": 5.935241990456714, "inventoryTurnover": 4.865604917574742, "fixedAssetTurnover": 11.763728470111449, "assetTurnover": 0.4182414178163611, "currentRatio": 0.9636062021802424, "quickRatio": 0.8424402464621843, "solvencyRatio": 0.16707812834312613, "cashRatio": 0.31149705464147875, "priceToEarningsRatio": 24.181421933085506, "priceToEarningsGrowthRatio": 9.217389066258473, "forwardPriceToEarningsGrowthRatio": 9.217389066258473, "priceToBookRatio": 16.58811348093196, "priceToSalesRatio": 4.9300876769903885, "priceToFreeCashFlowRatio": 11.803501732101617, "priceToOperatingCashFlowRatio": 11.474614521108126, "debtToAssetsRatio": 0.46245452253160907, "debtToEquityRatio": 3.720354700359337, "debtToCapitalRatio": 0.788151513291178, "longTermDebtToCapitalRatio": 0.7740795055779605, "financialLeverageRatio": 8.044801205517562, "workingCapitalTurnoverRatio": -13.920153458817888, "operatingCashFlowRatio": 0.8444376735053152, "operatingCashFlowSalesRatio": 0.4296517035863162, "freeCashFlowOperatingCashFlowRatio": 0.9721364711542316, "debtServiceCoverageRatio": 3.4510104102878136, "interestCoverageRatio": 8.124215246636771, "shortTermOperatingCashFlowCoverageRatio": 5.798000929800093, "operatingCashFlowCoverageRatio": 0.38857472231309687, "capitalExpenditureCoverageRatio": 35.889208633093524, "dividendPaidAndCapexCoverageRatio": 2.322872043211026, "dividendPayoutRatio": 0.8485130111524164, "dividendYield": 0.03508945890363312, "dividendYieldPercentage": 3.508945890363312, "revenuePerShare": 32.78035008469791, "netIncomePerShare": 6.683229813664596, "interestDebtPerShare": 37.50479954827781, "cashPerShare": 5.211180124223603, "bookValuePerShare": 9.761151891586675, "tangibleBookValuePerShare": -46.475437605872386, "shareholdersEquityPerShare": 9.742518351214004, "operatingCashFlowPerShare": 14.084133258046302, "capexPerShare": 0.3924336533032185, "freeCashFlowPerShare": 13.691699604743082, "netIncomePerEBT": 0.878236996364176, "ebtPerEbit": 0.7438869570017111, "priceToFairValue": 16.58811348093196, "debtToMarketCap": 0.22158453486691354, "effectiveTaxRate": 0.12109519922831491, "enterpriseValueMultiple": 14.1143919086622, "dividendPerShare": 5.670807453416149}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "ratios_annual", "result": {"symbol": "ABBV", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.6895563820132747, "ebitMargin": 0.27424951509867074, "ebitdaMargin": 0.42587682616509775, "operatingProfitMargin": 0.31894941011086003, "pretaxProfitMargin": 0.23113333451963627, "continuousOperationsProfitMargin": 0.20550919088207556, "netProfitMargin": 0.2053846290727263, "bottomLineProfitMargin": 0.20406783280246277, "receivablesTurnover": 5.632655106745514, "payablesTurnover": 6.0534351145038165, "inventoryTurnover": 5.577365728900256, "fixedAssetTurnover": 10.997455968688845, "assetTurnover": 0.3835213507223826, "currentRatio": 0.7935443541512758, "quickRatio": 0.7046655679945445, "solvencyRatio": 0.15304402218272525, "cashRatio": 0.2769222026481787, "priceToEarningsRatio": 20.76399237567146, "priceToEarningsGrowthRatio": 0.15116186449488822, "forwardPriceToEarningsGrowthRatio": 0.15116186449488822, "priceToBookRatio": 15.554127725856699, "priceToSalesRatio": 4.2646048721462, "priceToFreeCashFlowRatio": 10.89849931787176, "priceToOperatingCashFlowRatio": 10.521930017122536, "debtToAssetsRatio": 0.5294173849545141, "debtToEquityRatio": 5.034722222222222, "debtToCapitalRatio": 0.8342922899884925, "longTermDebtToCapitalRatio": 0.806364047654954, "financialLeverageRatio": 9.509929906542055, "workingCapitalTurnoverRatio": -9.562191594350859, "operatingCashFlowRatio": 0.6471841791214411, "operatingCashFlowSalesRatio": 0.4053063330782782, "freeCashFlowOperatingCashFlowRatio": 0.9654476006497783, "debtServiceCoverageRatio": 1.4899973502914678, "interestCoverageRatio": 7.397441188609162, "shortTermOperatingCashFlowCoverageRatio": 1.7972855677424446, "operatingCashFlowCoverageRatio": 0.29361263293586853, "capitalExpenditureCoverageRatio": 28.941550190597205, "dividendPaidAndCapexCoverageRatio": 2.2668192675159236, "dividendPayoutRatio": 0.8023739386588113, "dividendYield": 0.038642565656059884, "dividendYieldPercentage": 3.8642565656059884, "revenuePerShare": 31.749717514124296, "netIncomePerShare": 6.52090395480226, "interestDebtPerShare": 45.19661016949153, "cashPerShare": 5.553672316384181, "bookValuePerShare": 8.72090395480226, "tangibleBookValuePerShare": -52.48248587570622, "shareholdersEquityPerShare": 8.705084745762711, "operatingCashFlowPerShare": 12.868361581920905, "capexPerShare": 0.44463276836158194, "freeCashFlowPerShare": 12.423728813559322, "netIncomePerEBT": 0.8885980444991917, "ebtPerEbit": 0.7246708324034814, "priceToFairValue": 15.554127725856699, "debtToMarketCap": 0.3206110373949545, "effectiveTaxRate": 0.11086303795519285, "enterpriseValueMultiple": 12.847825178623658, "dividendPerShare": 5.2322033898305085}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2025-09-30", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "marketCap": 410288880000, "enterpriseValue": 473402880000, "evToSales": 30.007789046653144, "evToOperatingCashFlow": 67.39790432801823, "evToFreeCashFlow": 62.885611052072264, "evToEBITDA": 137.45728222996516, "netDebtToEBITDA": 18.325783972125436, "currentRatio": 0.7245055977253687, "incomeQuality": 37.361702127659576, "grahamNumber": null, "grahamNetNet": -67.03174379232506, "taxBurden": 0.2605042016806723, "interestBurden": 0.5170166545981173, "workingCapital": -10852000000, "investedCapital": 84572000000, "returnOnAssets": 0.0013891170891275448, "operatingReturnOnAssets": 0.03608528847572672, "returnOnTangibleAssets": 0.004231407966876721, "returnOnEquity": -0.07040121120363362, "returnOnInvestedCapital": 0.012842432917482351, "returnOnCapitalEmployed": 0.051752780217338396, "earningsYield": 0.00045333912047531004, "freeCashFlowYield": 0.018348047843753407, "capexToOperatingCashFlow": 0.07175398633257403, "capexToDepreciation": 0.2443044110518662, "capexToRevenue": 0.03194726166328601, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.14224137931034483, "stockBasedCompensationToRevenue": 0.013247971602434077, "intangiblesToTotalAssets": 0.6717127963076371, "averageReceivables": 12703000000, "averagePayables": 32597000000, "averageInventory": 4949000000, "daysOfSalesOutstanding": 72.84546146044624, "daysOfPayablesOutstanding": 885.7168141592921, "daysOfInventoryOutstanding": 131.09734513274338, "operatingCycle": 203.94280659318963, "cashConversionCycle": -681.7740075661025, "freeCashFlowToEquity": -55586000000, "freeCashFlowToFirm": 3276624649.859944, "tangibleAssetValue": -92540000000, "netCurrentAssetValue": -107958000000}}
{"date": "2025-06-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2025-06-30", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "marketCap": 328918640000, "enterpriseValue": 392932640000, "evToSales": 25.47705634442067, "evToOperatingCashFlow": 76.25318067145352, "evToFreeCashFlow": 80.45303849303849, "evToEBITDA": 90.45410681399632, "netDebtToEBITDA": 14.736187845303867, "currentRatio": 0.7358110996554933, "incomeQuality": 5.476089266737513, "grahamNumber": null, "grahamNetNet": -67.09664221218962, "taxBurden": 0.6074646074646075, "interestBurden": 0.6774193548387096, "workingCapital": -10506000000, "investedCapital": 87446000000, "returnOnAssets": 0.006881369275852517, "operatingReturnOnAssets": 0.04289053839990927, "returnOnTangibleAssets": 0.021207287758632308, "returnOnEquity": -5.158469945355192, "returnOnInvestedCapital": 0.03382639990318883, "returnOnCapitalEmployed": 0.06017553764820613, "earningsYield": 0.0028700106506581685, "freeCashFlowYield": 0.014848656798532306, "capexToOperatingCashFlow": 0.052202600426935766, "capexToDepreciation": 0.13121951219512196, "capexToRevenue": 0.017441483498670817, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.13616028010114764, "stockBasedCompensationToRevenue": 0.011606042922907346, "intangiblesToTotalAssets": 0.675518654050823, "averageReceivables": 12557000000, "averagePayables": 31395500000, "averageInventory": 4743000000, "daysOfSalesOutstanding": 73.74246255592297, "daysOfPayablesOutstanding": 1192.2097378277153, "daysOfInventoryOutstanding": 185.7677902621723, "operatingCycle": 259.5102528180953, "cashConversionCycle": -932.69948500962, "freeCashFlowToEquity": -59130000000, "freeCashFlowToFirm": 4948095238.095238, "tangibleAssetValue": -92807000000, "netCurrentAssetValue": -108059000000}}
{"date": "2025-03-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2025-03-31", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "marketCap": 370431360000, "enterpriseValue": 435145360000, "evToSales": 32.61225811286817, "evToOperatingCashFlow": 266.1439510703364, "evToFreeCashFlow": 310.8181142857143, "evToEBITDA": 98.89667272727273, "netDebtToEBITDA": 14.707727272727272, "currentRatio": 0.7602395406971952, "incomeQuality": 1.2684251357641583, "grahamNumber": 3.625547963052043, "grahamNetNet": -66.68905542986425, "taxBurden": 0.7742323901264299, "interestBurden": 0.7035154595510377, "workingCapital": -8728000000, "investedCapital": 90283000000, "returnOnAssets": 0.009444424044357948, "operatingReturnOnAssets": 0.02751671421094919, "returnOnTangibleAssets": 0.030336628057842468, "returnOnEquity": 0.9056338028169014, "returnOnInvestedCapital": 0.027557473424177418, "returnOnCapitalEmployed": 0.03741905735650849, "earningsYield": 0.003471628320021285, "freeCashFlowYield": 0.003779377642324883, "capexToOperatingCashFlow": 0.1437308868501529, "capexToDepreciation": 0.11525257479156449, "capexToRevenue": 0.01761223113242899, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.1549126883009818, "stockBasedCompensationToRevenue": 0.030727722401259087, "intangiblesToTotalAssets": 0.6886791759997062, "averageReceivables": 11698000000, "averagePayables": 31434500000, "averageInventory": 4353500000, "daysOfSalesOutstanding": 84.15873491718504, "daysOfPayablesOutstanding": 696.2293853073463, "daysOfInventoryOutstanding": 101.78410794602699, "operatingCycle": 185.94284286321204, "cashConversionCycle": -510.2865424441343, "freeCashFlowToEquity": -63314000000, "freeCashFlowToFirm": -802773028.2962074, "tangibleAssetValue": -92312000000, "netCurrentAssetValue": -107028000000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "marketCap": 314351300000, "enterpriseValue": 376668300000, "evToSales": 24.941617004370283, "evToOperatingCashFlow": 53.44328887627696, "evToFreeCashFlow": 55.74490158354299, "evToEBITDA": 704.0528971962617, "netDebtToEBITDA": 116.48037383177571, "currentRatio": 0.6601976825208392, "incomeQuality": 1.6444237050863275, "grahamNumber": null, "grahamNetNet": -65.55243075183719, "taxBurden": 0.009695901278096077, "interestBurden": 1.4479897894065092, "workingCapital": -13167000000, "investedCapital": 86991000000, "returnOnAssets": -0.0001627688460428674, "operatingReturnOnAssets": -0.010696991560863369, "returnOnTangibleAssets": -0.000548122679821611, "returnOnEquity": -0.006616541353383459, "returnOnInvestedCapital": -0.00014632973429082153, "returnOnCapitalEmployed": -0.015454507737626022, "earningsYield": -6.998539532045836e-05, "freeCashFlowYield": 0.02149505982637896, "capexToOperatingCashFlow": 0.04128830874006811, "capexToDepreciation": 0.1384395813510942, "capexToRevenue": 0.01926897099721891, "salesGeneralAndAdministrativeToRevenue": 0.05158257184478877, "researchAndDevelopementToRevenue": 0.44854986094557014, "stockBasedCompensationToRevenue": 0.044629850350946895, "intangiblesToTotalAssets": 0.7030430375626106, "averageReceivables": 11195500000, "averagePayables": 31154000000, "averageInventory": 4315500000, "daysOfSalesOutstanding": 65.07151370679381, "daysOfPayablesOutstanding": 653.2984531392174, "daysOfInventoryOutstanding": 85.598271155596, "operatingCycle": 150.6697848623898, "cashConversionCycle": -502.62866827682757, "freeCashFlowToEquity": -55560000000, "freeCashFlowToFirm": -314884089.9074483, "tangibleAssetValue": -91660000000, "netCurrentAssetValue": -106215000000}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2024-09-30", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "marketCap": 349342120000, "enterpriseValue": 413164120000, "evToSales": 28.572899031811893, "evToOperatingCashFlow": 75.85168349550212, "evToFreeCashFlow": 79.48520969603693, "evToEBITDA": 84.6127626459144, "netDebtToEBITDA": 13.070243702641818, "currentRatio": 0.6452324555292369, "incomeQuality": 3.4257861635220124, "grahamNumber": 8.22802389214155, "grahamNetNet": -67.40361786319954, "taxBurden": 0.7490403071017274, "interestBurden": 0.7432239657631954, "workingCapital": -15277000000, "investedCapital": 91805000000, "returnOnAssets": 0.010883964803168273, "operatingReturnOnAssets": 0.026850388458047582, "returnOnTangibleAssets": 0.037631686796364604, "returnOnEquity": 0.2587864721485411, "returnOnInvestedCapital": 0.025459030299713456, "returnOnCapitalEmployed": 0.038172578716620165, "earningsYield": 0.004468399058206895, "freeCashFlowYield": 0.014879396735784393, "capexToOperatingCashFlow": 0.045713236644024234, "capexToDepreciation": 0.11976911976911978, "capexToRevenue": 0.017219917012448134, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.14730290456431536, "stockBasedCompensationToRevenue": 0.012517289073305671, "intangiblesToTotalAssets": 0.7107765893656482, "averageReceivables": 11598000000, "averagePayables": 29847000000, "averageInventory": 4334000000, "daysOfSalesOutstanding": 71.40248962655602, "daysOfPayablesOutstanding": 649.5299145299145, "daysOfInventoryOutstanding": 95.08547008547009, "operatingCycle": 166.4879597120261, "cashConversionCycle": -483.04195481788844, "freeCashFlowToEquity": -58624000000, "freeCashFlowToFirm": 11112345489.443378, "tangibleAssetValue": -95870000000, "netCurrentAssetValue": -109566000000}}
{"date": "2024-06-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "marketCap": 301384530000, "enterpriseValue": 358888530000, "evToSales": 24.815968054211037, "evToOperatingCashFlow": 158.0310568031704, "evToFreeCashFlow": 176.79237931034484, "evToEBITDA": 71.73466520087948, "netDebtToEBITDA": 11.493903657805317, "currentRatio": 0.8067756173207682, "incomeQuality": 1.6540422432629278, "grahamNumber": 8.170986481397403, "grahamNetNet": -62.77953646127756, "taxBurden": 0.6383970177073626, "interestBurden": 0.7472144846796658, "workingCapital": -8099000000, "investedCapital": 90553000000, "returnOnAssets": 0.009652169624551737, "operatingReturnOnAssets": 0.027495521146036428, "returnOnTangibleAssets": 0.028359691976484226, "returnOnEquity": 0.20212452050752433, "returnOnInvestedCapital": 0.022715084892635823, "returnOnCapitalEmployed": 0.039971206334606386, "earningsYield": 0.004545687862611926, "freeCashFlowYield": 0.006735581285476066, "capexToOperatingCashFlow": 0.10612065169528842, "capexToDepreciation": 0.11309244486156735, "capexToRevenue": 0.01666436177568801, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.1346978287926981, "stockBasedCompensationToRevenue": 0.01507398700041488, "intangiblesToTotalAssets": 0.6596518173555873, "averageReceivables": 11836500000, "averagePayables": 30277000000, "averageInventory": 4231500000, "daysOfSalesOutstanding": 72.9608629511824, "daysOfPayablesOutstanding": 627.472632079962, "daysOfInventoryOutstanding": 90.3426939552594, "operatingCycle": 163.30355690644183, "cashConversionCycle": -464.1690751735201, "freeCashFlowToEquity": -55474000000, "freeCashFlowToFirm": 9175491146.318733, "tangibleAssetValue": -86808000000, "netCurrentAssetValue": -101300000000}}
{"date": "2024-03-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "marketCap": 319764440000, "enterpriseValue": 375698440000, "evToSales": 30.519775792038992, "evToOperatingCashFlow": 92.99466336633664, "evToFreeCashFlow": 97.66010917598129, "evToEBITDA": 83.69312541768768, "netDebtToEBITDA": 12.46023613276899, "currentRatio": 0.9361543278262127, "incomeQuality": 2.972774098601913, "grahamNumber": 8.877691811919073, "grahamNetNet": -63.12817976257773, "taxBurden": 0.7800569800569801, "interestBurden": 0.7267080745341615, "workingCapital": -2651000000, "investedCapital": 97980000000, "returnOnAssets": 0.009195695688971882, "operatingReturnOnAssets": 0.0197330606343777, "returnOnTangibleAssets": 0.025721962309527835, "returnOnEquity": 0.17097539652803798, "returnOnInvestedCapital": 0.01860841814562848, "returnOnCapitalEmployed": 0.02606379014829719, "earningsYield": 0.004281276554703832, "freeCashFlowYield": 0.012030731121947143, "capexToOperatingCashFlow": 0.04777227722772277, "capexToDepreciation": 0.09305689488910318, "capexToRevenue": 0.015678310316815595, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.15751421608448415, "stockBasedCompensationToRevenue": 0.02826969943135662, "intangiblesToTotalAssets": 0.6424963391861575, "averageReceivables": 11552000000, "averagePayables": 17473000000, "averageInventory": 4172000000, "daysOfSalesOutstanding": 87.36068237205524, "daysOfPayablesOutstanding": 687.1568148510015, "daysOfInventoryOutstanding": 93.31949193942354, "operatingCycle": 180.68017431147877, "cashConversionCycle": -506.47664053952275, "freeCashFlowToEquity": -52087000000, "freeCashFlowToFirm": 1580965811.9658117, "tangibleAssetValue": -87604000000, "netCurrentAssetValue": -101956000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "marketCap": 273667835393.01, "enterpriseValue": 320973835393.01, "evToSales": 22.4441532335508, "evToOperatingCashFlow": 67.53078800610352, "evToFreeCashFlow": 70.57472194217459, "evToEBITDA": 83.32654086007528, "netDebtToEBITDA": 12.280893042575286, "currentRatio": 0.8721228297349436, "incomeQuality": 5.754237288135593, "grahamNumber": 7.8384631586306845, "grahamNetNet": -57.239888129360004, "taxBurden": 0.6782178217821783, "interestBurden": 0.6824324324324325, "workingCapital": -4839000000, "investedCapital": 88053000000, "returnOnAssets": 0.0061019515852454515, "operatingReturnOnAssets": 0.02358525386443831, "returnOnTangibleAssets": 0.017561100666552726, "returnOnEquity": 0.07934362934362935, "returnOnInvestedCapital": 0.020874085563484707, "returnOnCapitalEmployed": 0.03298234747599876, "earningsYield": 0.003003641252979324, "freeCashFlowYield": 0.016618686640571735, "capexToOperatingCashFlow": 0.04313065432358511, "capexToDepreciation": 0.098747591522158, "capexToRevenue": 0.014334661911754422, "salesGeneralAndAdministrativeToRevenue": 0.09474861897769386, "researchAndDevelopementToRevenue": 0.15446472274666107, "stockBasedCompensationToRevenue": 0.008740647507167331, "intangiblesToTotalAssets": 0.6525302313842225, "averageReceivables": 11283500000, "averagePayables": 16629000000, "averageInventory": 4040000000, "daysOfSalesOutstanding": 70.20138451856513, "daysOfPayablesOutstanding": 58.19074333800842, "daysOfInventoryOutstanding": 64.67566619915848, "operatingCycle": 134.87705071772362, "cashConversionCycle": 76.6863073797152, "freeCashFlowToEquity": -42758000000, "freeCashFlowToFirm": 6368445544.554456, "tangibleAssetValue": -77506000000, "netCurrentAssetValue": -91312000000}}
{"date": "2023-09-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2023-09-30", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "marketCap": 263389020000, "enterpriseValue": 310848020000, "evToSales": 22.319811876211674, "evToOperatingCashFlow": 41.041460258780035, "evToFreeCashFlow": 42.26349694085656, "evToEBITDA": 65.53827113641155, "netDebtToEBITDA": 10.006114273666455, "currentRatio": 0.955453944152072, "incomeQuality": 4.252667040988209, "grahamNumber": 12.448171700219389, "grahamNetNet": -56.735993208828525, "taxBurden": 0.910394265232975, "interestBurden": 0.7787081339712919, "workingCapital": -1549000000, "investedCapital": 94079000000, "returnOnAssets": 0.013052319392751486, "operatingReturnOnAssets": 0.01679750209876725, "returnOnTangibleAssets": 0.03905374832516968, "returnOnEquity": 0.14701504878452126, "returnOnInvestedCapital": 0.019520031898897283, "returnOnCapitalEmployed": 0.022484425518492234, "earningsYield": 0.006750471223136029, "freeCashFlowYield": 0.02792447460414257, "capexToOperatingCashFlow": 0.028914708212305254, "capexToDepreciation": 0.09798657718120805, "capexToRevenue": 0.015724851008831767, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.12371652186400517, "stockBasedCompensationToRevenue": 0.009334386443598765, "intangiblesToTotalAssets": 0.6657857452228364, "averageReceivables": 11451500000, "averagePayables": 14785000000, "averageInventory": 4018000000, "daysOfSalesOutstanding": 73.74739714224168, "daysOfPayablesOutstanding": 410.37779491133387, "daysOfInventoryOutstanding": 55.24903623747109, "operatingCycle": 128.99643337971276, "cashConversionCycle": -281.3813615316211, "freeCashFlowToEquity": -40104000000, "freeCashFlowToFirm": 2465121351.766513, "tangibleAssetValue": -78565000000, "netCurrentAssetValue": -90868000000}}
{"date": "2023-06-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2023-06-30", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "marketCap": 238067909999.99997, "enterpriseValue": 290323910000, "evToSales": 20.939337179949515, "evToOperatingCashFlow": 45.944597246399745, "evToFreeCashFlow": 47.27632470281713, "evToEBITDA": 53.545538546661746, "netDebtToEBITDA": 9.637772039837698, "currentRatio": 0.894940910077856, "incomeQuality": 3.1174148988653183, "grahamNumber": 13.698775146533203, "grahamNetNet": -58.32328805885682, "taxBurden": 0.7754789272030651, "interestBurden": 0.825426944971537, "workingCapital": -3387000000, "investedCapital": 96642000000, "returnOnAssets": 0.01495194545199347, "operatingReturnOnAssets": 0.03344065265958038, "returnOnTangibleAssets": 0.05024701472158089, "returnOnEquity": 0.157313850458573, "returnOnInvestedCapital": 0.03235383920382228, "returnOnCapitalEmployed": 0.04376115119075324, "earningsYield": 0.008501775816824703, "freeCashFlowYield": 0.025795160716956773, "capexToOperatingCashFlow": 0.028169014084507043, "capexToDepreciation": 0.07876106194690266, "capexToRevenue": 0.01283808150018031, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.12499098449332853, "stockBasedCompensationToRevenue": 0.01291020555355211, "intangiblesToTotalAssets": 0.7024311686009146, "averageReceivables": 11482000000, "averagePayables": 12327000000, "averageInventory": 3944000000, "daysOfSalesOutstanding": 74.58997475658133, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 86.07311320754717, "operatingCycle": 160.6630879641285, "cashConversionCycle": 160.6630879641285, "freeCashFlowToEquity": -46115000000, "freeCashFlowToFirm": 6822698850.574713, "tangibleAssetValue": -82188000000, "netCurrentAssetValue": -93617000000}}
{"date": "2023-03-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2023-03-31", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "marketCap": 282084900000, "enterpriseValue": 337466900000, "evToSales": 27.604654396728016, "evToOperatingCashFlow": 80.48340090627237, "evToFreeCashFlow": 83.98877551020408, "evToEBITDA": 106.9625673534073, "netDebtToEBITDA": 17.553724247226626, "currentRatio": 0.9600579920260964, "incomeQuality": 17.398340248962654, "grahamNumber": 4.773290320980426, "grahamNetNet": -58.755790960451975, "taxBurden": 0.5031578947368421, "interestBurden": 0.46206225680933855, "workingCapital": -1102000000, "investedCapital": 100897000000, "returnOnAssets": 0.0017763705553573551, "operatingReturnOnAssets": 0.020252497722691505, "returnOnTangibleAssets": 0.006377414878855801, "returnOnEquity": 0.018005122796444176, "returnOnInvestedCapital": 0.012795734039211738, "returnOnCapitalEmployed": 0.02588028498232885, "earningsYield": 0.0008472626503581014, "freeCashFlowYield": 0.01424393861564373, "capexToOperatingCashFlow": 0.041736227045075125, "capexToDepreciation": 0.08227550540667607, "capexToRevenue": 0.014314928425357873, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.1874846625766871, "stockBasedCompensationToRevenue": 0.025603271983640083, "intangiblesToTotalAssets": 0.7214591509097396, "averageReceivables": 11363500000, "averagePayables": 13794000000, "averageInventory": 3706000000, "daysOfSalesOutstanding": 84.46380368098158, "daysOfPayablesOutstanding": 556.66332162569, "daysOfInventoryOutstanding": 86.54540893125942, "operatingCycle": 171.00921261224101, "cashConversionCycle": -385.65410901344893, "freeCashFlowToEquity": -51364000000, "freeCashFlowToFirm": 2500574736.8421054, "tangibleAssetValue": -83765000000, "netCurrentAssetValue": -94753000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "marketCap": 285917341410, "enterpriseValue": 340907341410, "evToSales": 22.545290748627735, "evToOperatingCashFlow": 45.89490325928917, "evToFreeCashFlow": 47.24980476923077, "evToEBITDA": 59.93448337025316, "netDebtToEBITDA": 9.667721518987342, "currentRatio": 0.9636062021802424, "incomeQuality": 3.004854368932039, "grahamNumber": 17.513621009281557, "grahamNetNet": -57.68714450358669, "taxBurden": 0.8340640809443508, "interestBurden": 0.8397054658736902, "workingCapital": -1075000000, "investedCapital": 103455000000, "returnOnAssets": 0.017816361082093585, "operatingReturnOnAssets": 0.0392817620390533, "returnOnTangibleAssets": 0.06307064524356032, "returnOnEquity": 0.14332908311116263, "returnOnInvestedCapital": 0.040390995114112746, "returnOnCapitalEmployed": 0.05035372070249938, "earningsYield": 0.008649352948668353, "freeCashFlowYield": 0.025234565921812443, "capexToOperatingCashFlow": 0.028675282714054926, "capexToDepreciation": 0.09874826147426982, "capexToRevenue": 0.014086369949077441, "salesGeneralAndAdministrativeToRevenue": 0.09371073341710204, "researchAndDevelopementToRevenue": 0.134448779842603, "stockBasedCompensationToRevenue": 0.008729581376893062, "intangiblesToTotalAssets": 0.7175173804978207, "averageReceivables": 10998500000, "averagePayables": 1467000000, "averageInventory": 3375500000, "daysOfSalesOutstanding": 66.98366510151445, "daysOfPayablesOutstanding": 63.32374100719424, "daysOfInventoryOutstanding": 77.24460431654676, "operatingCycle": 144.2282694180612, "cashConversionCycle": 80.90452841086694, "freeCashFlowToEquity": -47775000000, "freeCashFlowToFirm": 3614889376.0539627, "tangibleAssetValue": -82308000000, "netCurrentAssetValue": -93055000000}}
{"date": "2022-09-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2022-09-30", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "marketCap": 237685910000, "enterpriseValue": 295459910000, "evToSales": 19.947333918444503, "evToOperatingCashFlow": 38.86607603262299, "evToFreeCashFlow": 39.79258047138047, "evToEBITDA": 41.23655408234473, "netDebtToEBITDA": 8.063363572923937, "currentRatio": 0.9282220591831744, "incomeQuality": 1.923582995951417, "grahamNumber": 21.28603689490131, "grahamNetNet": -58.597261434217955, "taxBurden": 0.8975, "interestBurden": 0.8870967741935484, "workingCapital": -2348000000, "investedCapital": 102996000000, "returnOnAssets": 0.027942685299840793, "operatingReturnOnAssets": 0.0323572726537814, "returnOnTangibleAssets": 0.0966139844399863, "returnOnEquity": 0.2469050894085282, "returnOnInvestedCapital": 0.035090230089041836, "returnOnCapitalEmployed": 0.04237982561940099, "earningsYield": 0.01661436304743516, "freeCashFlowYield": 0.031238704894202607, "capexToOperatingCashFlow": 0.023283346487766376, "capexToDepreciation": 0.08027210884353742, "capexToRevenue": 0.011949770456386713, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.1089657034836619, "stockBasedCompensationToRevenue": 0.008506616257088847, "intangiblesToTotalAssets": 0.710780116752167, "averageReceivables": 10990000000, "averagePayables": 0, "averageInventory": 3284000000, "daysOfSalesOutstanding": 65.27612746421819, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 56.84587813620072, "operatingCycle": 122.1220056004189, "cashConversionCycle": 122.1220056004189, "freeCashFlowToEquity": -50349000000, "freeCashFlowToFirm": 3457981818.181818, "tangibleAssetValue": -84424000000, "netCurrentAssetValue": -94934000000}}
{"date": "2022-06-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2022-06-30", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "marketCap": 271093200000, "enterpriseValue": 335504200000, "evToSales": 23.00652814921484, "evToOperatingCashFlow": 67.0338061938062, "evToFreeCashFlow": 69.00538872891813, "evToEBITDA": 88.50018464785018, "netDebtToEBITDA": 16.990503824848325, "currentRatio": 0.8441388913062396, "incomeQuality": 5.393318965517241, "grahamNumber": 9.860915859670271, "grahamNetNet": -61.24929378531073, "taxBurden": 0.7810650887573964, "interestBurden": 0.6802760207015526, "workingCapital": -5373000000, "investedCapital": 103436000000, "returnOnAssets": 0.006453144860531058, "operatingReturnOnAssets": 0.02301001756303313, "returnOnTangibleAssets": 0.023490530062285495, "returnOnEquity": 0.06305875929843718, "returnOnInvestedCapital": 0.02142478746368544, "returnOnCapitalEmployed": 0.03030916265763984, "earningsYield": 0.0034084219006599945, "freeCashFlowYield": 0.017934791429663303, "capexToOperatingCashFlow": 0.02857142857142857, "capexToDepreciation": 0.06968810916179337, "capexToRevenue": 0.009805938421449632, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.1287800864019749, "stockBasedCompensationToRevenue": 0.007337310567098677, "intangiblesToTotalAssets": 0.7252873884318299, "averageReceivables": 10985000000, "averagePayables": 0, "averageInventory": 3439500000, "daysOfSalesOutstanding": 69.34992799835425, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 73.29496402877697, "operatingCycle": 142.64489202713122, "cashConversionCycle": 142.64489202713122, "freeCashFlowToEquity": -59549000000, "freeCashFlowToFirm": 2634152155.536771, "tangibleAssetValue": -89163000000, "netCurrentAssetValue": -99398000000}}
{"date": "2022-03-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2022-03-31", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "marketCap": 287096810000, "enterpriseValue": 354472810000, "evToSales": 26.183543359432708, "evToOperatingCashFlow": 72.2234739201304, "evToFreeCashFlow": 74.68875052675938, "evToEBITDA": 47.074742363877824, "netDebtToEBITDA": 8.947675962815405, "currentRatio": 0.815134835952154, "incomeQuality": 1.0923659025150234, "grahamNumber": 22.901455238470863, "grahamNetNet": -61.84853190287973, "taxBurden": 0.9109352809900588, "interestBurden": 0.899945225488406, "workingCapital": -6012000000, "investedCapital": 105347000000, "returnOnAssets": 0.03135234025319284, "operatingReturnOnAssets": 0.03256022640988472, "returnOnTangibleAssets": 0.12159124759660953, "returnOnEquity": 0.27574771233802126, "returnOnInvestedCapital": 0.03564059521702262, "returnOnCapitalEmployed": 0.04261450898906857, "earningsYield": 0.01563932389217421, "freeCashFlowYield": 0.01653100917422245, "capexToOperatingCashFlow": 0.03300733496332518, "capexToDepreciation": 0.07890891378470531, "capexToRevenue": 0.011966317033535234, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.12128822573496824, "stockBasedCompensationToRevenue": 0.022603043285566553, "intangiblesToTotalAssets": 0.7421496952049773, "averageReceivables": 10355000000, "averagePayables": 1441000000, "averageInventory": 3305500000, "daysOfSalesOutstanding": 71.3524892894076, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 77.36179664363277, "operatingCycle": 148.71428593304037, "cashConversionCycle": 148.71428593304037, "freeCashFlowToEquity": -62630000000, "freeCashFlowToFirm": 5629526070.1967945, "tangibleAssetValue": -89970000000, "netCurrentAssetValue": -100388000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "marketCap": 239432965200, "enterpriseValue": 307261965200, "evToSales": 20.64100263334677, "evToOperatingCashFlow": 60.54422959605911, "evToFreeCashFlow": 62.86046751227496, "evToEBITDA": 44.98711057101025, "netDebtToEBITDA": 9.93103953147877, "currentRatio": 0.7935443541512758, "incomeQuality": 1.2546353522867737, "grahamNumber": 21.17408673686106, "grahamNetNet": -63.458597847244135, "taxBurden": 0.9468508546007961, "interestBurden": 0.8804370232941662, "workingCapital": -7266000000, "investedCapital": 106174000000, "returnOnAssets": 0.027598632352640092, "operatingReturnOnAssets": 0.03435493098883837, "returnOnTangibleAssets": 0.10586664572371005, "returnOnEquity": 0.26246105919003115, "returnOnInvestedCapital": 0.038751606738432795, "returnOnCapitalEmployed": 0.04557416805137648, "earningsYield": 0.016889904849242538, "freeCashFlowYield": 0.020414899827670013, "capexToOperatingCashFlow": 0.03684729064039409, "capexToDepreciation": 0.0944921677614957, "capexToRevenue": 0.012562138922477496, "salesGeneralAndAdministrativeToRevenue": 0.07792556764745398, "researchAndDevelopementToRevenue": 0.14993954050785974, "stockBasedCompensationToRevenue": 0.008665860540104797, "intangiblesToTotalAssets": 0.7393075773396393, "averageReceivables": 9629000000, "averagePayables": 1441000000, "averageInventory": 3111000000, "daysOfSalesOutstanding": 60.32043530834341, "daysOfPayablesOutstanding": 60.041666666666664, "daysOfInventoryOutstanding": 65.16666666666667, "operatingCycle": 125.48710197501009, "cashConversionCycle": 65.44543530834343, "freeCashFlowToEquity": -62941000000, "freeCashFlowToFirm": 14076309295.247015, "tangibleAssetValue": -92894000000, "netCurrentAssetValue": -103165000000}}
{"date": "2021-09-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2021-09-30", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "marketCap": 190929900000, "enterpriseValue": 259468900000, "evToSales": 18.091542323246408, "evToOperatingCashFlow": 32.699294265910524, "evToFreeCashFlow": 33.61867064006219, "evToEBITDA": 40.47245359538294, "netDebtToEBITDA": 10.690843862111995, "currentRatio": 1.0148599866820873, "incomeQuality": 2.4952830188679247, "grahamNumber": 17.588666093531003, "grahamNetNet": -64.70296610169491, "taxBurden": 0.8619848156182213, "interestBurden": 0.8608776844070962, "workingCapital": 424000000, "investedCapital": 115306000000, "returnOnAssets": 0.02135592309449274, "operatingReturnOnAssets": 0.029013239901627193, "returnOnTangibleAssets": 0.08129187336981537, "returnOnEquity": 0.23461254612546126, "returnOnInvestedCapital": 0.029235920427655583, "returnOnCapitalEmployed": 0.035786411801371286, "earningsYield": 0.016650089902105432, "freeCashFlowYield": 0.04042321291741105, "capexToOperatingCashFlow": 0.027347195967233773, "capexToDepreciation": 0.10202162670427832, "capexToRevenue": 0.015130386278064427, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.14384325756519314, "stockBasedCompensationToRevenue": 0.009412913122298146, "intangiblesToTotalAssets": 0.7372932593478349, "averageReceivables": 9597500000, "averagePayables": 0, "averageInventory": 3240000000, "daysOfSalesOutstanding": 58.24083112536606, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 63.430523917995444, "operatingCycle": 121.6713550433615, "cashConversionCycle": 121.6713550433615, "freeCashFlowToEquity": -60821000000, "freeCashFlowToFirm": 2494904555.314533, "tangibleAssetValue": -96175000000, "netCurrentAssetValue": -106324000000}}
{"date": "2021-06-30", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2021-06-30", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "marketCap": 199260160000, "enterpriseValue": 272852160000, "evToSales": 19.546683859875348, "evToOperatingCashFlow": 55.79798773006135, "evToFreeCashFlow": 58.115476038338656, "evToEBITDA": 68.59028657616894, "netDebtToEBITDA": 18.499748617395674, "currentRatio": 0.906393808394924, "incomeQuality": 6.35890767230169, "grahamNumber": 8.320092872060732, "grahamNetNet": -66.50621820237423, "taxBurden": 0.6586414445399829, "interestBurden": 0.6541057367829022, "workingCapital": -2685000000, "investedCapital": 114214000000, "returnOnAssets": 0.005176655042845943, "operatingReturnOnAssets": 0.029758135576752335, "returnOnTangibleAssets": 0.021140365402660486, "returnOnEquity": 0.06094359137560665, "returnOnInvestedCapital": 0.02308754981305639, "returnOnCapitalEmployed": 0.037229226745355774, "earningsYield": 0.0038442205406238757, "freeCashFlowYield": 0.02356216114651318, "capexToOperatingCashFlow": 0.03987730061349693, "capexToDepreciation": 0.08863636363636364, "capexToRevenue": 0.013969482054588438, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.13604126370083816, "stockBasedCompensationToRevenue": 0.01139050075220288, "intangiblesToTotalAssets": 0.7551293487957181, "averageReceivables": 9751000000, "averagePayables": 0, "averageInventory": 3329000000, "daysOfSalesOutstanding": 63.92005157962605, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 67.37563564006192, "operatingCycle": 131.29568721968798, "cashConversionCycle": 131.29568721968798, "freeCashFlowToEquity": -68897000000, "freeCashFlowToFirm": 483650902.8374891, "tangibleAssetValue": -99144000000, "netCurrentAssetValue": -109379000000}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "key_metrics_quarter", "result": {"symbol": "ABBV", "date": "2021-03-31", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "marketCap": 191441180000, "enterpriseValue": 267216180000, "evToSales": 20.53929131437356, "evToOperatingCashFlow": 54.79109698585196, "evToFreeCashFlow": 56.98788227767115, "evToEBITDA": 39.799848078641645, "netDebtToEBITDA": 11.28611855823652, "currentRatio": 0.8315545679321461, "incomeQuality": 1.3718706047819973, "grahamNumber": 18.71456588024879, "grahamNetNet": -66.79706048615037, "taxBurden": 0.9188001034393587, "interestBurden": 0.8595243387419427, "workingCapital": -5382000000, "investedCapital": 113453000000, "returnOnAssets": 0.02360781655935841, "operatingReturnOnAssets": 0.027256481967409138, "returnOnTangibleAssets": 0.09639436772565724, "returnOnEquity": 0.2591539022611233, "returnOnInvestedCapital": 0.0290380754201785, "returnOnCapitalEmployed": 0.034609869253479544, "earningsYield": 0.018559225345351506, "freeCashFlowYield": 0.02449316286078053, "capexToOperatingCashFlow": 0.038548287881894606, "capexToDepreciation": 0.08487584650112867, "capexToRevenue": 0.014450422751729438, "salesGeneralAndAdministrativeToRevenue": 0, "researchAndDevelopementToRevenue": 0.1423520368946964, "stockBasedCompensationToRevenue": 0.02067640276710223, "intangiblesToTotalAssets": 0.7550913282968219, "averageReceivables": 9205000000, "averagePayables": 9922000000, "averageInventory": 3291000000, "daysOfSalesOutstanding": 66.32744043043813, "daysOfPayablesOutstanding": 0, "daysOfInventoryOutstanding": 69.89793496320911, "operatingCycle": 136.22537539364725, "cashConversionCycle": 136.22537539364725, "freeCashFlowToEquity": -71086000000, "freeCashFlowToFirm": 7057008533.747091, "tangibleAssetValue": -99909000000, "netCurrentAssetValue": -110199000000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "key_metrics_annual", "result": {"symbol": "ABBV", "date": "2024-12-31", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "marketCap": 314351300000, "enterpriseValue": 376668300000, "evToSales": 6.686340398338481, "evToOperatingCashFlow": 20.029155588641924, "evToFreeCashFlow": 21.123166218034992, "evToEBITDA": 25.262796780684106, "netDebtToEBITDA": 4.179543930248156, "currentRatio": 0.6601976825208392, "incomeQuality": 4.387774148390108, "grahamNumber": 10.112991473647549, "grahamNetNet": -65.55243075183719, "taxBurden": 1.151237890204521, "interestBurden": 0.5695892090741876, "workingCapital": -13167000000, "investedCapital": 86991000000, "returnOnAssets": 0.03165114197142667, "operatingReturnOnAssets": 0.06771358273551906, "returnOnTangibleAssets": 0.10658494655803871, "returnOnEquity": 1.2866165413533834, "returnOnInvestedCapital": 0.10210172082198185, "returnOnCapitalEmployed": 0.09477036053603285, "earningsYield": 0.013608978235496403, "freeCashFlowYield": 0.056726344061564245, "capexToOperatingCashFlow": 0.05179198128256939, "capexToDepreciation": 0.11614595754829478, "capexToRevenue": 0.017289736216139454, "salesGeneralAndAdministrativeToRevenue": 0.19684382433343983, "researchAndDevelopementToRevenue": 0.22705648453864452, "stockBasedCompensationToRevenue": 0.01617140625554727, "intangiblesToTotalAssets": 0.7030430375626106, "averageReceivables": 11037000000, "averagePayables": 3316500000, "averageInventory": 4140000000, "daysOfSalesOutstanding": 70.74652962686831, "daysOfPayablesOutstanding": 63.589978703265494, "daysOfInventoryOutstanding": 90.2783364884051, "operatingCycle": 161.02486611527343, "cashConversionCycle": 97.43488741200792, "freeCashFlowToEquity": -44485000000, "freeCashFlowToFirm": 23264721205.597416, "tangibleAssetValue": -91660000000, "netCurrentAssetValue": -106215000000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "key_metrics_annual", "result": {"symbol": "ABBV", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "marketCap": 273986960000, "enterpriseValue": 321292960000, "evToSales": 5.915036636105895, "evToOperatingCashFlow": 14.067733263277727, "evToFreeCashFlow": 14.563183754872632, "evToEBITDA": 18.710281854181225, "netDebtToEBITDA": 2.7548334498020033, "currentRatio": 0.8721228297349436, "incomeQuality": 4.738381742738589, "grahamNumber": 19.043247456624417, "grahamNetNet": -57.17321832579186, "taxBurden": 0.77808, "interestBurden": 0.737550153410432, "workingCapital": -4839000000, "investedCapital": 88053000000, "returnOnAssets": 0.036099501896652834, "operatingReturnOnAssets": 0.0932815630529841, "returnOnTangibleAssets": 0.10389249700905828, "returnOnEquity": 0.4694015444015444, "returnOnInvestedCapital": 0.09558218506452947, "returnOnCapitalEmployed": 0.13169195829462166, "earningsYield": 0.01774901988036219, "freeCashFlowYield": 0.08052208032090287, "capexToOperatingCashFlow": 0.03402075397346644, "capexToDepreciation": 0.0893308806622212, "capexToRevenue": 0.014304650392135203, "salesGeneralAndAdministrativeToRevenue": 0.19706174748702088, "researchAndDevelopementToRevenue": 0.1412975440921978, "stockBasedCompensationToRevenue": 0.01375234728819176, "intangiblesToTotalAssets": 0.6525302313842225, "averageReceivables": 11204500000, "averagePayables": 3311000000, "averageInventory": 3839000000, "daysOfSalesOutstanding": 74.95811701461761, "daysOfPayablesOutstanding": 65.93779084006857, "daysOfInventoryOutstanding": 73.28606416850354, "operatingCycle": 148.24418118312116, "cashConversionCycle": 82.30639034305258, "freeCashFlowToEquity": -25244000000, "freeCashFlowToFirm": 18292008320, "tangibleAssetValue": -77506000000, "netCurrentAssetValue": -91312000000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "key_metrics_annual", "result": {"symbol": "ABBV", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "marketCap": 286211310000, "enterpriseValue": 341201310000, "evToSales": 5.877309229338202, "evToOperatingCashFlow": 13.679241069638776, "evToFreeCashFlow": 14.071317634444078, "evToEBITDA": 14.1143919086622, "netDebtToEBITDA": 2.2747580044676097, "currentRatio": 0.9636062021802424, "incomeQuality": 2.1057830308146896, "grahamNumber": 38.27542951898355, "grahamNetNet": -57.62789384528515, "taxBurden": 0.878236996364176, "interestBurden": 0.858025084357293, "workingCapital": -1075000000, "investedCapital": 103455000000, "returnOnAssets": 0.08527070350491697, "operatingReturnOnAssets": 0.12698802105602558, "returnOnTangibleAssets": 0.3018617699566437, "returnOnEquity": 0.6859858583516866, "returnOnInvestedCapital": 0.14020655527107412, "returnOnCapitalEmployed": 0.16580486331646335, "earningsYield": 0.041354061095628954, "freeCashFlowYield": 0.08472062127803405, "capexToOperatingCashFlow": 0.027863528845768353, "capexToDepreciation": 0.08208338254399433, "capexToRevenue": 0.011971612636510835, "salesGeneralAndAdministrativeToRevenue": 0.2284080338994729, "researchAndDevelopementToRevenue": 0.112136975918972, "stockBasedCompensationToRevenue": 0.011558204430357943, "intangiblesToTotalAssets": 0.7175173804978207, "averageReceivables": 10615500000, "averagePayables": 2908000000, "averageInventory": 3353500000, "daysOfSalesOutstanding": 70.75670927067902, "daysOfPayablesOutstanding": 61.497071321924885, "daysOfInventoryOutstanding": 75.01636614218445, "operatingCycle": 145.77307541286348, "cashConversionCycle": 84.27600409093859, "freeCashFlowToEquity": -30742000000, "freeCashFlowToFirm": 15385957705.720856, "tangibleAssetValue": -82308000000, "netCurrentAssetValue": -93055000000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "key_metrics_annual", "result": {"symbol": "ABBV", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "marketCap": 239658000000, "enterpriseValue": 307487000000, "evToSales": 5.471591010196274, "evToOperatingCashFlow": 13.499890240154542, "evToFreeCashFlow": 13.983037744429286, "evToEBITDA": 12.847825178623658, "netDebtToEBITDA": 2.834120252371203, "currentRatio": 0.7935443541512758, "incomeQuality": 1.9722053857476838, "grahamNumber": 35.73811669316795, "grahamNetNet": -63.39901129943503, "taxBurden": 0.8885980444991917, "interestBurden": 0.8427848429794965, "workingCapital": -7266000000, "investedCapital": 106174000000, "returnOnAssets": 0.07876939035958752, "operatingReturnOnAssets": 0.12066214733384047, "returnOnTangibleAssets": 0.30215450666247806, "returnOnEquity": 0.7490913811007269, "returnOnInvestedCapital": 0.1285150224799297, "returnOnCapitalEmployed": 0.16099160192212691, "earningsYield": 0.04816029508716588, "freeCashFlowYield": 0.0917557519465238, "capexToOperatingCashFlow": 0.03455239935022172, "capexToDepreciation": 0.09236005163713179, "capexToRevenue": 0.014004306279694645, "salesGeneralAndAdministrativeToRevenue": 0.1823762834314999, "researchAndDevelopementToRevenue": 0.14317490257487053, "stockBasedCompensationToRevenue": 0.012313824581383349, "intangiblesToTotalAssets": 0.7393075773396393, "averageReceivables": 9399500000, "averagePayables": 2579000000, "averageInventory": 3219000000, "daysOfSalesOutstanding": 64.8007011050412, "daysOfPayablesOutstanding": 60.296343001261036, "daysOfInventoryOutstanding": 65.44308150865528, "operatingCycle": 130.24378261369648, "cashConversionCycle": 69.94743961243545, "freeCashFlowToEquity": -45839000000, "freeCashFlowToFirm": 24215378859.03457, "tangibleAssetValue": -92894000000, "netCurrentAssetValue": -103165000000}}
{"date": "2025-12-23", "symbol": "ABBV", "type": "ratios_ttm", "result": [{"symbol": "ABBV", "grossProfitMarginTTM": 0.7620716249748508, "ebitMarginTTM": 0.07492790557306686, "ebitdaMarginTTM": 0.21331567299309234, "operatingProfitMarginTTM": 0.2178928307960566, "pretaxProfitMarginTTM": 0.027831802025350412, "continuousOperationsProfitMarginTTM": 0.04015491918717725, "netProfitMarginTTM": 0.04013815304137885, "bottomLineProfitMarginTTM": 0.03970223325062035, "receivablesTurnoverTTM": 4.671000078314668, "payablesTurnoverTTM": 0.42536418679935256, "inventoryTurnoverTTM": 2.8738355609558526, "fixedAssetTurnoverTTM": 10.877986503738828, "assetTurnoverTTM": 0.4454435465802327, "currentRatioTTM": 0.7245055977253687, "quickRatioTTM": 0.5991470132771445, "solvencyRatioTTM": 0.07800904049173242, "cashRatioTTM": 0.1429006625879008, "priceToEarningsRatioTTM": 167.86998329156222, "priceToEarningsGrowthRatioTTM": -4.541098265964056, "forwardPriceToEarningsGrowthRatioTTM": 4.879116913731652, "priceToBookRatioTTM": -152.11231642694926, "priceToSalesRatioTTM": 6.71980461406009, "priceToFreeCashFlowRatioTTM": 19.485440536778647, "priceToOperatingCashFlowRatioTTM": 19.265615532118886, "debtToAssetsRatioTTM": 0.5133982583757786, "debtToEquityRatioTTM": -26.019303557910675, "debtToCapitalRatioTTM": 1.0399691381370932, "longTermDebtToCapitalRatioTTM": 1.0437932006166188, "financialLeverageRatioTTM": -50.68054504163513, "workingCapitalTurnoverRatioTTM": -5.585167150482255, "operatingCashFlowRatioTTM": 0.5295625904394404, "operatingCashFlowSalesRatioTTM": 0.34974180135470456, "freeCashFlowOperatingCashFlowRatioTTM": 0.9860498561840844, "debtServiceCoverageRatioTTM": 1.5683486773103368, "interestCoverageRatioTTM": 4.626557493770025, "shortTermOperatingCashFlowCoverageRatioTTM": 3.613998613998614, "operatingCashFlowCoverageRatioTTM": 0.30344907845162417, "capitalExpenditureCoverageRatioTTM": 71.68384879725086, "dividendPaidAndCapexCoverageRatioTTM": 1.7694460938162695, "dividendPayoutRatioTTM": 4.802840434419382, "dividendYieldTTM": 0.0289248, "enterpriseValueTTM": 463910026401, "revenuePerShareTTM": 33.659142212189614, "netIncomePerShareTTM": 1.3510158013544018, "interestDebtPerShareTTM": 40.379232505643344, "cashPerShareTTM": 3.200338600451467, "bookValuePerShareTTM": -1.466704288939052, "tangibleBookValuePerShareTTM": -52.223476297968396, "shareholdersEquityPerShareTTM": -1.4909706546275394, "operatingCashFlowPerShareTTM": 11.772009029345373, "capexPerShareTTM": 0.16422121896162528, "freeCashFlowPerShareTTM": 11.607787810383748, "netIncomePerEBTTTM": 1.4421686746987952, "ebtPerEbitTTM": 0.12773160972606956, "priceToFairValueTTM": -152.11231642694926, "debtToMarketCapTTM": 0.17151617149822243, "effectiveTaxRateTTM": -0.4427710843373494, "enterpriseValueMultipleTTM": 36.462314422777645, "dividendPerShareTTM": 6.56}]}
{"date": "2025-12-23", "symbol": "ABBV", "type": "key_metrics_ttm", "result": [{"symbol": "ABBV", "marketCap": 400796026401, "enterpriseValueTTM": 463910026401, "evToSalesTTM": 7.7779831399805515, "evToOperatingCashFlowTTM": 22.239215071955893, "evToFreeCashFlowTTM": 22.553844445573436, "evToEBITDATTM": 36.462314422777645, "netDebtToEBITDATTM": 4.960622494694648, "currentRatioTTM": 0.7245055977253687, "incomeQualityTTM": 3.1115751789976134, "grahamNumberTTM": null, "grahamNetNetTTM": -67.03174379232506, "taxBurdenTTM": 1.4421686746987952, "interestBurdenTTM": 0.3714477511747595, "workingCapitalTTM": -10852000000, "investedCapitalTTM": 84572000000, "returnOnAssetsTTM": 0.017879281243931948, "operatingReturnOnAssetsTTM": 0.09588313413014608, "returnOnTangibleAssetsTTM": 0.05446231544463908, "returnOnEquityTTM": 4.9875, "returnOnInvestedCapitalTTM": 0.1869808535391078, "returnOnCapitalEmployedTTM": 0.13751362332948883, "earningsYieldTTM": 0.005956991121296333, "freeCashFlowYieldTTM": 0.051320369078261596, "capexToOperatingCashFlowTTM": 0.013950143815915628, "capexToDepreciationTTM": 0.03525563363217834, "capexToRevenueTTM": 0.004878948427335524, "salesGeneralAndAdministrativeToRevenueTTM": 0.01306082757695661, "researchAndDevelopementToRevenueTTM": 0.22106163235195495, "stockBasedCompensationToRevenueTTM": 0.024679766615250485, "intangiblesToTotalAssetsTTM": 0.6717127963076371, "averageReceivablesTTM": 12703000000, "averagePayablesTTM": 32597000000, "averageInventoryTTM": 4949000000, "daysOfSalesOutstandingTTM": 78.14172423043391, "daysOfPayablesOutstandingTTM": 858.0882249312945, "daysOfInventoryOutstandingTTM": 127.0079627933197, "operatingCycleTTM": 205.14968702375361, "cashConversionCycleTTM": -652.9385379075409, "freeCashFlowToEquityTTM": -42545000000, "freeCashFlowToFirmTTM": 14756743975.903614, "tangibleAssetValueTTM": -92540000000, "netCurrentAssetValueTTM": -107958000000}]}
{"date": "2025-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2025-09-30", "stockPrice": 231.54, "numberOfShares": 1772000000, "marketCapitalization": 410288880000, "minusCashAndCashEquivalents": 5629000000, "addTotalDebt": 68743000000, "enterpriseValue": 473402880000}}
{"date": "2025-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2025-06-30", "stockPrice": 185.62, "numberOfShares": 1772000000, "marketCapitalization": 328918640000, "minusCashAndCashEquivalents": 6467000000, "addTotalDebt": 70481000000, "enterpriseValue": 392932640000}}
{"date": "2025-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2025-03-31", "stockPrice": 209.52, "numberOfShares": 1768000000, "marketCapitalization": 370431360000, "minusCashAndCashEquivalents": 5175000000, "addTotalDebt": 69889000000, "enterpriseValue": 435145360000}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2024-12-31", "stockPrice": 177.7, "numberOfShares": 1769000000, "marketCapitalization": 314351300000, "minusCashAndCashEquivalents": 5524000000, "addTotalDebt": 67841000000, "enterpriseValue": 376668300000}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2024-09-30", "stockPrice": 197.48, "numberOfShares": 1769000000, "marketCapitalization": 349342120000, "minusCashAndCashEquivalents": 7257000000, "addTotalDebt": 71079000000, "enterpriseValue": 413164120000}}
{"date": "2024-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2024-06-30", "stockPrice": 170.37, "numberOfShares": 1769000000, "marketCapitalization": 301384530000, "minusCashAndCashEquivalents": 13130000000, "addTotalDebt": 70634000000, "enterpriseValue": 358888530000}}
{"date": "2024-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2024-03-31", "stockPrice": 180.76, "numberOfShares": 1769000000, "marketCapitalization": 319764440000, "minusCashAndCashEquivalents": 18067000000, "addTotalDebt": 74001000000, "enterpriseValue": 375698440000}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2023-12-31", "stockPrice": 154.97, "numberOfShares": 1765940733, "marketCapitalization": 273667835393, "minusCashAndCashEquivalents": 12814000000, "addTotalDebt": 60120000000, "enterpriseValue": 320973835393}}
{"date": "2023-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2023-09-30", "stockPrice": 149.06, "numberOfShares": 1767000000, "marketCapitalization": 263389020000, "minusCashAndCashEquivalents": 13287000000, "addTotalDebt": 60746000000, "enterpriseValue": 310848020000}}
{"date": "2023-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2023-06-30", "stockPrice": 134.73, "numberOfShares": 1767000000, "marketCapitalization": 238067909999, "minusCashAndCashEquivalents": 8759000000, "addTotalDebt": 61015000000, "enterpriseValue": 290323909999}}
{"date": "2023-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2023-03-31", "stockPrice": 159.37, "numberOfShares": 1770000000, "marketCapitalization": 282084900000, "minusCashAndCashEquivalents": 6711000000, "addTotalDebt": 62093000000, "enterpriseValue": 337466900000}}
{"date": "2022-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2022-12-31", "stockPrice": 161.61, "numberOfShares": 1769181000, "marketCapitalization": 285917341410, "minusCashAndCashEquivalents": 9201000000, "addTotalDebt": 64191000000, "enterpriseValue": 340907341410}}
{"date": "2022-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2022-09-30", "stockPrice": 134.21, "numberOfShares": 1771000000, "marketCapitalization": 237685910000, "minusCashAndCashEquivalents": 11832000000, "addTotalDebt": 69606000000, "enterpriseValue": 295459910000}}
{"date": "2022-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2022-06-30", "stockPrice": 153.16, "numberOfShares": 1770000000, "marketCapitalization": 271093200000, "minusCashAndCashEquivalents": 8521000000, "addTotalDebt": 72932000000, "enterpriseValue": 335504200000}}
{"date": "2022-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2022-03-31", "stockPrice": 162.11, "numberOfShares": 1771000000, "marketCapitalization": 287096810000, "minusCashAndCashEquivalents": 6098000000, "addTotalDebt": 73474000000, "enterpriseValue": 354472810000}}
{"date": "2021-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2021-12-31", "stockPrice": 135.4, "numberOfShares": 1768338000, "marketCapitalization": 239432965200, "minusCashAndCashEquivalents": 9746000000, "addTotalDebt": 77575000000, "enterpriseValue": 307261965200}}
{"date": "2021-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2021-09-30", "stockPrice": 107.87, "numberOfShares": 1770000000, "marketCapitalization": 190929900000, "minusCashAndCashEquivalents": 12182000000, "addTotalDebt": 80721000000, "enterpriseValue": 259468900000}}
{"date": "2021-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2021-06-30", "stockPrice": 112.64, "numberOfShares": 1769000000, "marketCapitalization": 199260160000, "minusCashAndCashEquivalents": 8546000000, "addTotalDebt": 82138000000, "enterpriseValue": 272852160000}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2021-03-31", "stockPrice": 108.22, "numberOfShares": 1769000000, "marketCapitalization": 191441180000, "minusCashAndCashEquivalents": 9755000000, "addTotalDebt": 85530000000, "enterpriseValue": 267216180000}}
{"date": "2020-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2020-12-31", "stockPrice": 107.15, "numberOfShares": 1769000000, "marketCapitalization": 189548350000, "minusCashAndCashEquivalents": 8449000000, "addTotalDebt": 87063000000, "enterpriseValue": 268162350000}}
{"date": "2020-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2020-09-30", "stockPrice": 87.59, "numberOfShares": 1769000000, "marketCapitalization": 154946710000, "minusCashAndCashEquivalents": 7890000000, "addTotalDebt": 87059000000, "enterpriseValue": 234115710000}}
{"date": "2020-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2020-06-30", "stockPrice": 98.18, "numberOfShares": 1647000000, "marketCapitalization": 161702460000, "minusCashAndCashEquivalents": 6017000000, "addTotalDebt": 87432000000, "enterpriseValue": 243117460000}}
{"date": "2020-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2020-03-31", "stockPrice": 76.19, "numberOfShares": 1481000000, "marketCapitalization": 112837390000, "minusCashAndCashEquivalents": 41142000000, "addTotalDebt": 67046000000, "enterpriseValue": 138741390000}}
{"date": "2019-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2019-12-31", "stockPrice": 88.54, "numberOfShares": 1478911462, "marketCapitalization": 130942820845, "minusCashAndCashEquivalents": 39924000000, "addTotalDebt": 67088000000, "enterpriseValue": 158106820845}}
{"date": "2019-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2019-09-30", "stockPrice": 75.72, "numberOfShares": 1481000000, "marketCapitalization": 112141320000, "minusCashAndCashEquivalents": 10648000000, "addTotalDebt": 38777000000, "enterpriseValue": 140270320000}}
{"date": "2019-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2019-06-30", "stockPrice": 73.4, "numberOfShares": 1480000000, "marketCapitalization": 108632000000, "minusCashAndCashEquivalents": 5172000000, "addTotalDebt": 37661000000, "enterpriseValue": 141121000000}}
{"date": "2019-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2019-03-31", "stockPrice": 80.78, "numberOfShares": 1480000000, "marketCapitalization": 119554400000, "minusCashAndCashEquivalents": 4897000000, "addTotalDebt": 37561000000, "enterpriseValue": 152218400000}}
{"date": "2018-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2018-12-31", "stockPrice": 92.19, "numberOfShares": 1481301000, "marketCapitalization": 136561139190, "minusCashAndCashEquivalents": 7289000000, "addTotalDebt": 40310000000, "enterpriseValue": 169582139190}}
{"date": "2018-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2018-09-30", "stockPrice": 95, "numberOfShares": 1511000000, "marketCapitalization": 143545000000, "minusCashAndCashEquivalents": 8015000000, "addTotalDebt": 40508000000, "enterpriseValue": 176038000000}}
{"date": "2018-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2018-06-30", "stockPrice": 92.65, "numberOfShares": 1568000000, "marketCapitalization": 145275200000, "minusCashAndCashEquivalents": 3547000000, "addTotalDebt": 37109000000, "enterpriseValue": 178837200000}}
{"date": "2018-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2018-03-31", "stockPrice": 94.65, "numberOfShares": 1591000000, "marketCapitalization": 150588150000, "minusCashAndCashEquivalents": 9007000000, "addTotalDebt": 37287000000, "enterpriseValue": 178868150000}}
{"date": "2017-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2017-12-31", "stockPrice": 96.71, "numberOfShares": 1592131025, "marketCapitalization": 153974991427, "minusCashAndCashEquivalents": 9303000000, "addTotalDebt": 37368000000, "enterpriseValue": 182039991427}}
{"date": "2017-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2017-09-30", "stockPrice": 88.86, "numberOfShares": 1597000000, "marketCapitalization": 141909420000, "minusCashAndCashEquivalents": 8446000000, "addTotalDebt": 37795000000, "enterpriseValue": 171258420000}}
{"date": "2017-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2017-06-30", "stockPrice": 72.51, "numberOfShares": 1595000000, "marketCapitalization": 115653450000, "minusCashAndCashEquivalents": 6088000000, "addTotalDebt": 37237000000, "enterpriseValue": 146802450000}}
{"date": "2017-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2017-03-31", "stockPrice": 65.16, "numberOfShares": 1597000000, "marketCapitalization": 104060520000, "minusCashAndCashEquivalents": 4740000000, "addTotalDebt": 36951000000, "enterpriseValue": 136271520000}}
{"date": "2016-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2016-12-31", "stockPrice": 62.62, "numberOfShares": 1592512724, "marketCapitalization": 99723146776, "minusCashAndCashEquivalents": 5100000000, "addTotalDebt": 36842000000, "enterpriseValue": 131465146776}}
{"date": "2016-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2016-09-30", "stockPrice": 63.07, "numberOfShares": 1632000000, "marketCapitalization": 102930240000, "minusCashAndCashEquivalents": 6218000000, "addTotalDebt": 37310000000, "enterpriseValue": 134022240000}}
{"date": "2016-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2016-06-30", "stockPrice": 61.91, "numberOfShares": 1624000000, "marketCapitalization": 100541840000, "minusCashAndCashEquivalents": 6327000000, "addTotalDebt": 37845000000, "enterpriseValue": 132059840000}}
{"date": "2016-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2016-03-31", "stockPrice": 57.12, "numberOfShares": 1616000000, "marketCapitalization": 92305920000, "minusCashAndCashEquivalents": 7556000000, "addTotalDebt": 31913000000, "enterpriseValue": 116662920000}}
{"date": "2015-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2015-12-31", "stockPrice": 59.24, "numberOfShares": 1609892935, "marketCapitalization": 95370057469, "minusCashAndCashEquivalents": 8399000000, "addTotalDebt": 31671000000, "enterpriseValue": 118642057469}}
{"date": "2015-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2015-09-30", "stockPrice": 54.41, "numberOfShares": 1652000000, "marketCapitalization": 89885320000, "minusCashAndCashEquivalents": 9223000000, "addTotalDebt": 32127000000, "enterpriseValue": 112789320000}}
{"date": "2015-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2015-06-30", "stockPrice": 67.19, "numberOfShares": 1620000000, "marketCapitalization": 108847800000, "minusCashAndCashEquivalents": 7400000000, "addTotalDebt": 31123000000, "enterpriseValue": 132570800000}}
{"date": "2015-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2015-03-31", "stockPrice": 58.54, "numberOfShares": 1595000000, "marketCapitalization": 93371300000, "minusCashAndCashEquivalents": 7906000000, "addTotalDebt": 15273000000, "enterpriseValue": 100738300000}}
{"date": "2014-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2014-12-31", "stockPrice": 65.44, "numberOfShares": 1591389331, "marketCapitalization": 104140517820, "minusCashAndCashEquivalents": 8348000000, "addTotalDebt": 14977000000, "enterpriseValue": 110769517820}}
{"date": "2014-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2014-09-30", "stockPrice": 57.76, "numberOfShares": 1595000000, "marketCapitalization": 92127200000, "minusCashAndCashEquivalents": 7719000000, "addTotalDebt": 14792000000, "enterpriseValue": 99200200000}}
{"date": "2014-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2014-06-30", "stockPrice": 56.44, "numberOfShares": 1594000000, "marketCapitalization": 89965360000, "minusCashAndCashEquivalents": 9086000000, "addTotalDebt": 14741000000, "enterpriseValue": 95620360000}}
{"date": "2014-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2014-03-31", "stockPrice": 51.4, "numberOfShares": 1595000000, "marketCapitalization": 81983000000, "minusCashAndCashEquivalents": 8140000000, "addTotalDebt": 14406000000, "enterpriseValue": 88249000000}}
{"date": "2013-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2013-12-31", "stockPrice": 52.81, "numberOfShares": 1587360562, "marketCapitalization": 83828511279, "minusCashAndCashEquivalents": 9595000000, "addTotalDebt": 14723000000, "enterpriseValue": 88956511279}}
{"date": "2013-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2013-09-30", "stockPrice": 44.73, "numberOfShares": 1590000000, "marketCapitalization": 71120700000, "minusCashAndCashEquivalents": 8975000000, "addTotalDebt": 14809000000, "enterpriseValue": 76954700000}}
{"date": "2013-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2013-06-30", "stockPrice": 41.61, "numberOfShares": 1589000000, "marketCapitalization": 66118290000, "minusCashAndCashEquivalents": 8743000000, "addTotalDebt": 14758000000, "enterpriseValue": 72133290000}}
{"date": "2013-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2013-03-31", "stockPrice": 41.12, "numberOfShares": 1588000000, "marketCapitalization": 65298559999, "minusCashAndCashEquivalents": 6979000000, "addTotalDebt": 15037000000, "enterpriseValue": 73356559999}}
{"date": "2012-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2012-12-31", "stockPrice": 34.16, "numberOfShares": 1583729114, "marketCapitalization": 54100186534, "minusCashAndCashEquivalents": 5901000000, "addTotalDebt": 15672000000, "enterpriseValue": 63871186534}}
{"date": "2012-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2012-09-30", "stockPrice": 35, "numberOfShares": 1577001448, "marketCapitalization": 55195050680, "minusCashAndCashEquivalents": 2760988000, "addTotalDebt": 0, "enterpriseValue": 52434062680}}
{"date": "2012-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2012-06-30", "stockPrice": 35, "numberOfShares": 1616000000, "marketCapitalization": 56560000000, "minusCashAndCashEquivalents": 74537000, "addTotalDebt": 0, "enterpriseValue": 56485463000}}
{"date": "2012-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2012-03-31", "stockPrice": 35, "numberOfShares": 1616000000, "marketCapitalization": 56560000000, "minusCashAndCashEquivalents": 40999000, "addTotalDebt": 0, "enterpriseValue": 56519001000}}
{"date": "2011-12-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2011-12-31", "stockPrice": 35, "numberOfShares": 1580000000, "marketCapitalization": 55300000000, "minusCashAndCashEquivalents": 27000000, "addTotalDebt": 48000000, "enterpriseValue": 55321000000}}
{"date": "2011-09-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2011-09-30", "stockPrice": 35, "numberOfShares": 1580000000, "marketCapitalization": 55300000000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 55300000000}}
{"date": "2011-06-30", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2011-06-30", "stockPrice": 35, "numberOfShares": 1580000000, "marketCapitalization": 55300000000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 55300000000}}
{"date": "2011-03-31", "symbol": "ABBV", "type": "enterprise_values", "result": {"symbol": "ABBV", "date": "2011-03-31", "stockPrice": 35, "numberOfShares": 1616000000, "marketCapitalization": 56560000000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 56560000000}}
{"date": "2029-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2029-12-31", "revenueLow": 79410431182, "revenueHigh": 81931921807, "revenueAvg": 80447540964, "ebitdaLow": 26874548248, "ebitdaHigh": 27727886033, "ebitdaAvg": 27225533080, "ebitLow": 14998823471, "ebitHigh": 15475075674, "ebitAvg": 15194709909, "netIncomeLow": 33005476548, "netIncomeHigh": 34373239669, "netIncomeAvg": 33568049448, "sgaExpenseLow": 18568028972, "sgaExpenseHigh": 19157612862, "sgaExpenseAvg": 18810529663, "epsAvg": 18.93291, "epsHigh": 19.38705, "epsLow": 18.61561, "numAnalystsRevenue": 23, "numAnalystsEps": 8}}
{"date": "2028-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2028-12-31", "revenueLow": 75807458025, "revenueHigh": 78214544751, "revenueAvg": 76797512545, "ebitdaLow": 25655208742, "ebitdaHigh": 26469829282, "ebitdaAvg": 25990268854, "ebitLow": 14318303827, "ebitHigh": 14772947736, "ebitAvg": 14505302597, "netIncomeLow": 30721231997, "netIncomeHigh": 31994334648, "netIncomeAvg": 31244869817, "sgaExpenseLow": 17725568995, "sgaExpenseHigh": 18288402560, "sgaExpenseAvg": 17957067059, "epsAvg": 17.6226, "epsHigh": 18.04531, "epsLow": 17.32726, "numAnalystsRevenue": 11, "numAnalystsEps": 7}}
{"date": "2027-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2027-12-31", "revenueLow": 71772852348, "revenueHigh": 71808445916, "revenueAvg": 71790649132, "ebitdaLow": 24289793603, "ebitdaHigh": 24301839389, "ebitdaAvg": 24295816496, "ebitLow": 13556258622, "ebitHigh": 13562981437, "ebitAvg": 13559620029, "netIncomeLow": 21364366332, "netIncomeHigh": 31549471217, "netIncomeAvg": 26456918774.5, "sgaExpenseLow": 16782183171, "sgaExpenseHigh": 16790505785, "sgaExpenseAvg": 16786344478, "epsAvg": 15.87617, "epsHigh": 17.7944, "epsLow": 12.04984, "numAnalystsRevenue": 24, "numAnalystsEps": 14}}
{"date": "2026-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2026-12-31", "revenueLow": 66024206816, "revenueHigh": 67674066568, "revenueAvg": 66719930808, "ebitdaLow": 22344302949, "ebitdaHigh": 22902658253, "ebitdaAvg": 22579753981, "ebitLow": 12470470291, "ebitHigh": 12782091255, "ebitAvg": 12601876722, "netIncomeLow": 24466424863, "netIncomeHigh": 26505286214, "netIncomeAvg": 25485855538.5, "sgaExpenseLow": 15438014461, "sgaExpenseHigh": 15823790527, "sgaExpenseAvg": 15600691116, "epsAvg": 14.29512, "epsHigh": 14.9494, "epsLow": 13.79945, "numAnalystsRevenue": 21, "numAnalystsEps": 18}}
{"date": "2025-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2025-12-31", "revenueLow": 60864310246, "revenueHigh": 61084361984, "revenueAvg": 60944329060, "ebitdaLow": 20598060204, "ebitdaHigh": 20672531416, "ebitdaAvg": 20625140644, "ebitLow": 11495883242, "ebitHigh": 11537446008, "ebitAvg": 11510996975, "netIncomeLow": 18609142060, "netIncomeHigh": 19140829300, "netIncomeAvg": 18874985680, "sgaExpenseLow": 14231509125, "sgaExpenseHigh": 14282962404, "sgaExpenseAvg": 14250219408, "epsAvg": 10.63579, "epsHigh": 10.79573, "epsLow": 10.49585, "numAnalystsRevenue": 21, "numAnalystsEps": 17}}
{"date": "2024-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2024-12-31", "revenueLow": 55941604799, "revenueHigh": 56191344106, "revenueAvg": 56041500522, "ebitdaLow": 18932089083, "ebitdaHigh": 19016607338, "ebitdaAvg": 18965896385, "ebitLow": 10566096199, "ebitHigh": 10613266271, "ebitAvg": 10584964228, "netIncomeLow": 17805831220, "netIncomeHigh": 18071852140, "netIncomeAvg": 17938841680, "sgaExpenseLow": 13080464659, "sgaExpenseHigh": 13138859590, "sgaExpenseAvg": 13103822631, "epsAvg": 10.08278, "epsHigh": 10.19281, "epsLow": 10.04277, "numAnalystsRevenue": 17, "numAnalystsEps": 18}}
{"date": "2023-12-31", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2023-12-31", "revenueLow": 53007047102, "revenueHigh": 54779213486, "revenueAvg": 54049737112, "ebitdaLow": 22992569250, "ebitdaHigh": 34488853878, "ebitdaAvg": 28740711564, "ebitLow": 17330998617, "ebitHigh": 25996497925, "ebitAvg": 21663748271, "netIncomeLow": 4238399999, "netIncomeHigh": 6357600000, "netIncomeAvg": 5298000000, "sgaExpenseLow": 11815875757, "sgaExpenseHigh": 17723813638, "sgaExpenseAvg": 14769844698, "epsAvg": 11.13146, "epsHigh": 11.39847, "epsLow": 10.9449, "numAnalystsRevenue": 25, "numAnalystsEps": 26}}
{"date": "2022-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2022-12-30", "revenueLow": 57520648052, "revenueHigh": 59347080332, "revenueAvg": 58271874634, "ebitdaLow": 20902335683, "ebitdaHigh": 31353503526, "ebitdaAvg": 26127919605, "ebitLow": 15755453289, "ebitHigh": 23633179934, "ebitAvg": 19694316612, "netIncomeLow": 10482240007, "netIncomeHigh": 15723360012, "netIncomeAvg": 13102800010, "sgaExpenseLow": 10741705235, "sgaExpenseHigh": 16112557854, "sgaExpenseAvg": 13427131545, "epsAvg": 13.7644, "epsHigh": 14.09457, "epsLow": 13.53372, "numAnalystsRevenue": 14, "numAnalystsEps": 8}}
{"date": "2021-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2021-12-30", "revenueLow": 55509070429, "revenueHigh": 57271629814, "revenueAvg": 56234025565, "ebitdaLow": 18704722712, "ebitdaHigh": 28057084070, "ebitdaAvg": 23380903391, "ebitLow": 14057661469, "ebitHigh": 21086492204, "ebitAvg": 17572076837, "netIncomeLow": 9006527830, "netIncomeHigh": 13509791748, "netIncomeAvg": 11258159789, "sgaExpenseLow": 9682682927, "sgaExpenseHigh": 14524024392, "sgaExpenseAvg": 12103353660, "epsAvg": 12.67965, "epsHigh": 12.9838, "epsLow": 12.46715, "numAnalystsRevenue": 15, "numAnalystsEps": 15}}
{"date": "2020-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2020-12-30", "revenueLow": 45047072998, "revenueHigh": 46477436372, "revenueAvg": 45635393190, "ebitdaLow": 9399453831, "ebitdaHigh": 14099180748, "ebitdaAvg": 11749317290, "ebitLow": 8701265695, "ebitHigh": 13051898544, "ebitAvg": 10876582120, "netIncomeLow": 3235618164, "netIncomeHigh": 5540879301, "netIncomeAvg": 4388248733, "sgaExpenseLow": 8630683108, "sgaExpenseHigh": 12946024663, "sgaExpenseAvg": 10788353886, "epsAvg": 10.47864, "epsHigh": 10.72999, "epsLow": 10.30303, "numAnalystsRevenue": 15, "numAnalystsEps": 11}}
{"date": "2019-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2019-12-30", "revenueLow": 32825669784, "revenueHigh": 33867971374, "revenueAvg": 33254376980, "ebitdaLow": 9569420693, "ebitdaHigh": 14354131042, "ebitdaAvg": 11961775868, "ebitLow": 10162934353, "ebitHigh": 15244401532, "ebitAvg": 12703667943, "netIncomeLow": 6165805664, "netIncomeHigh": 9248708496, "netIncomeAvg": 7707257080, "sgaExpenseLow": 5433114152, "sgaExpenseHigh": 8149671228, "sgaExpenseAvg": 6791392691, "epsAvg": 8.92432, "epsHigh": 9.13839, "epsLow": 8.77475, "numAnalystsRevenue": 14, "numAnalystsEps": 8}}
{"date": "2018-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2018-12-30", "revenueLow": 32394497302, "revenueHigh": 33423108028, "revenueAvg": 32817573333, "ebitdaLow": 5660454507, "ebitdaHigh": 10073661142, "ebitdaAvg": 7867057825, "ebitLow": 3782030285, "ebitHigh": 8164375324, "ebitAvg": 5973202805, "netIncomeLow": 3519807836, "netIncomeHigh": 7143361240, "netIncomeAvg": 5331584538, "sgaExpenseLow": 5774341176, "sgaExpenseHigh": 8661511766, "sgaExpenseAvg": 7217926471, "epsAvg": 7.96039, "epsHigh": 8.15134, "epsLow": 7.82698, "numAnalystsRevenue": 11, "numAnalystsEps": 10}}
{"date": "2017-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2017-12-30", "revenueLow": 27641800641, "revenueHigh": 28519500713, "revenueAvg": 28002805882, "ebitdaLow": 8159220750, "ebitdaHigh": 12238831125, "ebitdaAvg": 10199025938, "ebitLow": 7541319181, "ebitHigh": 11311978773, "ebitAvg": 9426648977, "netIncomeLow": 4183657643, "netIncomeHigh": 6275486465, "netIncomeAvg": 5229572054, "sgaExpenseLow": 4925370773, "sgaExpenseHigh": 7388056161, "sgaExpenseAvg": 6156713467, "epsAvg": 5.5604, "epsHigh": 5.69378, "epsLow": 5.46721, "numAnalystsRevenue": 11, "numAnalystsEps": 10}}
{"date": "2016-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2016-12-30", "revenueLow": 25370584888, "revenueHigh": 26176167870, "revenueAvg": 25701927778, "ebitdaLow": 7941554159, "ebitdaHigh": 11912331238, "ebitdaAvg": 9926942699, "ebitLow": 7363725132, "ebitHigh": 11045587699, "ebitAvg": 9204656416, "netIncomeLow": 4668174984, "netIncomeHigh": 7002262477, "netIncomeAvg": 5835218731, "sgaExpenseLow": 4596967492, "sgaExpenseHigh": 6895451238, "sgaExpenseAvg": 5746209365, "epsAvg": 4.82408, "epsHigh": 4.9398, "epsLow": 4.74323, "numAnalystsRevenue": 10, "numAnalystsEps": 11}}
{"date": "2015-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2015-12-30", "revenueLow": 22565241893, "revenueHigh": 23281747837, "revenueAvg": 22859946667, "ebitdaLow": 6292226496, "ebitdaHigh": 9438339745, "ebitdaAvg": 7865283121, "ebitLow": 5773838786, "ebitHigh": 8660758179, "ebitAvg": 7217298483, "netIncomeLow": 3951287116, "netIncomeHigh": 5926930674, "netIncomeAvg": 4939108895, "sgaExpenseLow": 4892122838, "sgaExpenseHigh": 7338184257, "sgaExpenseAvg": 6115153548, "epsAvg": 4.28931, "epsHigh": 4.3922, "epsLow": 4.21742, "numAnalystsRevenue": 11, "numAnalystsEps": 10}}
{"date": "2014-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2014-12-30", "revenueLow": 14837011020, "revenueHigh": 22255516529, "revenueAvg": 18546263775, "ebitdaLow": 2324714031, "ebitdaHigh": 4167478024, "ebitdaAvg": 3246096028, "ebitLow": 2317117218, "ebitHigh": 3876199082, "ebitAvg": 3096658150, "netIncomeLow": 962085657, "netIncomeHigh": 2224872674, "netIncomeAvg": 1593479166, "sgaExpenseLow": 5748358897, "sgaExpenseHigh": 8622538346, "sgaExpenseAvg": 7185448622, "epsAvg": 2.83, "epsHigh": 3.4, "epsLow": 2.26, "numAnalystsRevenue": 20, "numAnalystsEps": 20}}
{"date": "2013-12-30", "symbol": "ABBV", "type": "analyst_estimates_annual", "result": {"symbol": "ABBV", "date": "2013-12-30", "revenueLow": 14661968148, "revenueHigh": 21992952223, "revenueAvg": 18327460186, "ebitdaLow": 5088270808, "ebitdaHigh": 7632406213, "ebitdaAvg": 6360338511, "ebitLow": 4415229983, "ebitHigh": 6622844975, "ebitAvg": 5519037479, "netIncomeLow": 3218847503, "netIncomeHigh": 4828271254, "netIncomeAvg": 4023559379, "sgaExpenseLow": 4172382590, "sgaExpenseHigh": 6258573889, "sgaExpenseAvg": 5215478240, "epsAvg": 2.98, "epsHigh": 3.57, "epsLow": 2.39, "numAnalystsRevenue": 11, "numAnalystsEps": 11}}
{"date": "2025-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-11-04 00:00:00", "acceptedDate": "2025-11-04 14:05:49", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/0001551152-25-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/abbv-20250930.htm"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-10-31 00:00:00", "acceptedDate": "2025-10-31 07:51:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000047/0001551152-25-000047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000047/abbv-20251031.htm"}}
{"date": "2025-10-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-10-03 00:00:00", "acceptedDate": "2025-10-03 16:09:03", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000043/0001551152-25-000043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000043/abbv-20251003.htm"}}
{"date": "2025-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 17:00:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000199750525000005/0001997505-25-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000199750525000005/xslF345X05/form4-10022025_051001.xml"}}
{"date": "2025-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 17:00:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000144807425000012/0001448074-25-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000144807425000012/xslF345X05/form4-10022025_051004.xml"}}
{"date": "2025-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117178025000004/0001171780-25-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000117178025000004/xslF345X05/form4-10022025_051003.xml"}}
{"date": "2025-09-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-09-11 00:00:00", "acceptedDate": "2025-09-11 07:30:54", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925089245/0001104659-25-089245-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925089245/tm2525781d1_8k.htm"}}
{"date": "2025-08-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-08-14 00:00:00", "acceptedDate": "2025-08-14 17:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925021944/0001415889-25-021944-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925021944/xslF345X05/form4-08142025_050801.xml"}}
{"date": "2025-08-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-08-07 00:00:00", "acceptedDate": "2025-08-07 17:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925021280/0001415889-25-021280-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925021280/xslF345X05/form4-08072025_050802.xml"}}
{"date": "2025-08-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-08-04 00:00:00", "acceptedDate": "2025-08-04 15:17:04", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/0001551152-25-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/abbv-20250630.htm"}}
{"date": "2025-07-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-31 00:00:00", "acceptedDate": "2025-07-31 07:48:24", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000036/0001551152-25-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000036/abbv-20250630xexhibit991.htm"}}
{"date": "2025-07-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-30 00:00:00", "acceptedDate": "2025-07-30 17:00:26", "formType": "3/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925072217/0001104659-25-072217-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925072217/xslF345X02/tm2522008-1_3aseq1.xml"}}
{"date": "2025-07-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-11 00:00:00", "acceptedDate": "2025-07-11 18:20:44", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925067472/0001104659-25-067472-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925067472/xslF345X02/tm2520705-1_3seq1.xml"}}
{"date": "2025-07-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-07 00:00:00", "acceptedDate": "2025-07-07 13:20:09", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000093247125000695/0000932471-25-000695-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000093247125000695/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-07-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-03 00:00:00", "acceptedDate": "2025-07-03 13:07:55", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000034/0001551152-25-000034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000034/abbv-20250630nonxgaapxex991.htm"}}
{"date": "2025-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-02 00:00:00", "acceptedDate": "2025-07-02 17:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925019106/0001415889-25-019106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588925019106/xslF345X05/form4-07022025_050704.xml"}}
{"date": "2025-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-02 00:00:00", "acceptedDate": "2025-07-02 17:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925019107/0001415889-25-019107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588925019107/xslF345X05/form4-07022025_050706.xml"}}
{"date": "2025-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-07-02 00:00:00", "acceptedDate": "2025-07-02 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925019105/0001415889-25-019105-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925019105/xslF345X05/form4-07022025_050701.xml"}}
{"date": "2025-06-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-06-13 00:00:00", "acceptedDate": "2025-06-13 16:15:15", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925059360/0001104659-25-059360-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925059360/tm2517646d1_11k.htm"}}
{"date": "2025-05-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-30 00:00:00", "acceptedDate": "2025-05-30 16:05:32", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925054864/0001104659-25-054864-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925054864/tm2515986d1_sd.htm"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012804/0001415889-25-012804-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1222890/000141588925012804/xslF345X05/form4-05132025_050526.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012803/0001415889-25-012803-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1194624/000141588925012803/xslF345X05/form4-05132025_050524.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012802/0001415889-25-012802-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239126/000141588925012802/xslF345X05/form4-05132025_050522.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012801/0001415889-25-012801-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1223690/000141588925012801/xslF345X05/form4-05132025_050520.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012800/0001415889-25-012800-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1355580/000141588925012800/xslF345X05/form4-05132025_050518.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012799/0001415889-25-012799-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012799/xslF345X05/form4-05132025_050515.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012798/0001415889-25-012798-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012798/xslF345X05/form4-05132025_050513.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012797/0001415889-25-012797-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1466338/000141588925012797/xslF345X05/form4-05132025_050511.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012796/0001415889-25-012796-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012796/xslF345X05/form4-05132025_050509.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012795/0001415889-25-012795-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012795/xslF345X05/form4-05132025_050507.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012794/0001415889-25-012794-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1061632/000141588925012794/xslF345X05/form4-05132025_050505.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012793/0001415889-25-012793-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588925012793/xslF345X05/form4-05132025_050503.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:05:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012792/0001415889-25-012792-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588925012792/xslF345X05/form4-05132025_050501.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-13 17:04:57", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925012791/0001415889-25-012791-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1222890/000141588925012791/xslF345X02/form3-05132025_090553.xml"}}
{"date": "2025-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-13 00:00:00", "acceptedDate": "2025-05-12 17:58:55", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/tm2513856d1_8k.htm"}}
{"date": "2025-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-05-09 00:00:00", "acceptedDate": "2025-05-09 13:24:59", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/0001551152-25-000029-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/abbv-20250331.htm"}}
{"date": "2025-04-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-25 00:00:00", "acceptedDate": "2025-04-25 07:48:22", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000026/0001551152-25-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000026/abbv-20250331xexhibit991.htm"}}
{"date": "2025-04-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-03 00:00:00", "acceptedDate": "2025-04-03 16:13:07", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000023/0001551152-25-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000023/abbv-20250331nonxgaapxex991.htm"}}
{"date": "2025-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 17:00:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009691/0001415889-25-009691-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588925009691/xslF345X05/form4-04022025_050412.xml"}}
{"date": "2025-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 17:00:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009688/0001415889-25-009688-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588925009688/xslF345X05/form4-04022025_050404.xml"}}
{"date": "2025-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 17:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009690/0001415889-25-009690-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588925009690/xslF345X05/form4-04022025_050409.xml"}}
{"date": "2025-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 17:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009689/0001415889-25-009689-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009689/xslF345X05/form4-04022025_050407.xml"}}
{"date": "2025-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-04-02 00:00:00", "acceptedDate": "2025-04-02 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009687/0001415889-25-009687-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925009687/xslF345X05/form4-04022025_050401.xml"}}
{"date": "2025-03-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-25 00:00:00", "acceptedDate": "2025-03-24 19:40:26", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925027375/0001104659-25-027375-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925027375/tm252086d2_ars.pdf"}}
{"date": "2025-03-24", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-24 00:00:00", "acceptedDate": "2025-03-24 16:28:59", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837025003538/0001558370-25-003538-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837025003538/tmb-20250324xdefa14a.htm"}}
{"date": "2025-03-24", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-24 00:00:00", "acceptedDate": "2025-03-24 16:28:10", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837025003537/0001558370-25-003537-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837025003537/abbv-20250509xdef14a.htm"}}
{"date": "2025-03-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-18 00:00:00", "acceptedDate": "2025-03-18 17:00:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925008437/0001415889-25-008437-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925008437/xslF345X05/form4-03182025_050302.xml"}}
{"date": "2025-03-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-10 00:00:00", "acceptedDate": "2025-03-10 17:05:17", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837025002603/0001558370-25-002603-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837025002603/abbv-20250509xpre14a.htm"}}
{"date": "2025-03-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-10 00:00:00", "acceptedDate": "2025-03-10 16:28:43", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925007518/0001415889-25-007518-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925007518/xslF345X02/form3-03102025_080337.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006586/0001415889-25-006586-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006586/xslF345X05/form4-03042025_050321.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006587/0001415889-25-006587-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006587/xslF345X05/form4-03042025_050323.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006585/0001415889-25-006585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006585/xslF345X05/form4-03042025_050318.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006579/0001415889-25-006579-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588925006579/xslF345X05/form4-03042025_050304.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006584/0001415889-25-006584-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006584/xslF345X05/form4-03042025_050316.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006583/0001415889-25-006583-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006583/xslF345X05/form4-03042025_050314.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/0001415889-25-006578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006578/xslF345X05/form4-03042025_050301.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006581/0001415889-25-006581-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006581/xslF345X05/form4-03042025_050309.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006582/0001415889-25-006582-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006582/xslF345X05/form4-03042025_050312.xml"}}
{"date": "2025-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 17:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006580/0001415889-25-006580-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006580/xslF345X05/form4-03042025_050307.xml"}}
{"date": "2025-02-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-28 00:00:00", "acceptedDate": "2025-02-28 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006025/0001415889-25-006025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006025/xslF345X05/form4-02282025_050204.xml"}}
{"date": "2025-02-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-28 00:00:00", "acceptedDate": "2025-02-28 17:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/0001415889-25-006024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925006024/xslF345X05/form4-02282025_050201.xml"}}
{"date": "2025-02-26", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-26 00:00:00", "acceptedDate": "2025-02-26 17:04:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/0001104659-25-017490-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/tm255723d7_ex4-2.htm"}}
{"date": "2025-02-24", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-24 00:00:00", "acceptedDate": "2025-02-24 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925005291/0001415889-25-005291-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925005291/xslF345X05/form4-02242025_050201.xml"}}
{"date": "2025-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-20 00:00:00", "acceptedDate": "2025-02-20 17:00:33", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925015715/0001104659-25-015715-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925015715/tm255723-6_424b5.htm"}}
{"date": "2025-02-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 09:22:24", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/0001104659-25-015015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/tm255723d4_ex1-1.htm"}}
{"date": "2025-02-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-18 21:25:54", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014903/0001104659-25-014903-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014903/tm255723d5_fwp.htm"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004464/0001415889-25-004464-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004464/xslF345X05/form4-02182025_050220.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004463/0001415889-25-004463-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004463/xslF345X05/form4-02182025_050218.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/0001415889-25-004462-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/xslF345X05/form4-02182025_050216.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/0001415889-25-004461-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004461/xslF345X05/form4-02182025_050214.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004460/0001415889-25-004460-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004460/xslF345X05/form4-02182025_050212.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/0001415889-25-004459-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004459/xslF345X05/form4-02182025_050209.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004457/0001415889-25-004457-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004457/xslF345X05/form4-02182025_050205.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004458/0001415889-25-004458-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004458/xslF345X05/form4-02182025_050207.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004456/0001415889-25-004456-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004456/xslF345X05/form4-02182025_050203.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925004455/0001415889-25-004455-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588925004455/xslF345X05/form4-02182025_050201.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 16:15:26", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014772/0001104659-25-014772-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014772/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 08:41:04", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014554/0001104659-25-014554-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014554/tm255723-3_424b5.htm"}}
{"date": "2025-02-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-14 00:00:00", "acceptedDate": "2025-02-14 16:31:51", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014191/0001104659-25-014191-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925014191/tm255723-1_s3asr.htm"}}
{"date": "2025-02-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-14 00:00:00", "acceptedDate": "2025-02-14 13:17:23", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm"}}
{"date": "2025-02-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-14 00:00:00", "acceptedDate": "2025-02-14 07:30:58", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/tm256372d1_ex99-1.htm"}}
{"date": "2025-02-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-07 00:00:00", "acceptedDate": "2025-02-07 16:00:13", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925003337/0001415889-25-003337-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925003337/xslF345X05/form4a-02072025_040201.xml"}}
{"date": "2025-02-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-02-05 00:00:00", "acceptedDate": "2025-02-05 16:15:17", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925009673/0001104659-25-009673-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925009673/0001104659-25-009673.txt"}}
{"date": "2025-01-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-01-31 00:00:00", "acceptedDate": "2025-01-31 07:42:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000011/0001551152-25-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000011/abbv-20241231xexhibit991.htm"}}
{"date": "2025-01-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-01-10 00:00:00", "acceptedDate": "2025-01-10 08:31:46", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000006/0001551152-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000006/0001551152-25-000006.txt"}}
{"date": "2025-01-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-01-06 00:00:00", "acceptedDate": "2025-01-06 16:02:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000002/0001551152-25-000002-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000002/abbv-20241231nonxgaapxex991.htm"}}
{"date": "2025-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925000521/0001415889-25-000521-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588925000521/xslF345X05/form4-01032025_050107.xml"}}
{"date": "2025-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925000519/0001415889-25-000519-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925000519/xslF345X05/form4-01032025_050103.xml"}}
{"date": "2025-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2025-01-03 00:00:00", "acceptedDate": "2025-01-03 17:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588925000520/0001415889-25-000520-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588925000520/xslF345X05/form4-01032025_050105.xml"}}
{"date": "2024-12-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-12-18 00:00:00", "acceptedDate": "2024-12-18 17:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924029754/0001415889-24-029754-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924029754/xslF345X05/form4-12182024_051202.xml"}}
{"date": "2024-12-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-12-13 00:00:00", "acceptedDate": "2024-12-13 16:05:18", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924128413/0001104659-24-128413-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924128413/0001104659-24-128413.txt"}}
{"date": "2024-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-11-04 00:00:00", "acceptedDate": "2024-11-04 16:16:46", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924113907/0001104659-24-113907-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924113907/tm2427253d2_s8.htm"}}
{"date": "2024-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-11-04 00:00:00", "acceptedDate": "2024-11-04 16:15:57", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924113897/0001104659-24-113897-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924113897/tm2427253d1_s8.htm"}}
{"date": "2024-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-11-04 00:00:00", "acceptedDate": "2024-11-04 14:19:33", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/0001551152-24-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/abbv-20240930.htm"}}
{"date": "2024-10-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-10-30 00:00:00", "acceptedDate": "2024-10-30 07:43:14", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000036/0001551152-24-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000036/abbv-20240930xexhibit991.htm"}}
{"date": "2024-10-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-10-03 00:00:00", "acceptedDate": "2024-10-03 16:07:32", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000033/0001551152-24-000033-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000033/abbv-20240930nonxgaapxex991.htm"}}
{"date": "2024-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-10-02 00:00:00", "acceptedDate": "2024-10-02 17:00:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024453/0001415889-24-024453-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588924024453/xslF345X05/form4-10022024_051010.xml"}}
{"date": "2024-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-10-02 00:00:00", "acceptedDate": "2024-10-02 17:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024451/0001415889-24-024451-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588924024451/xslF345X05/form4-10022024_051005.xml"}}
{"date": "2024-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-10-02 00:00:00", "acceptedDate": "2024-10-02 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024452/0001415889-24-024452-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588924024452/xslF345X05/form4-10022024_051007.xml"}}
{"date": "2024-10-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-10-02 00:00:00", "acceptedDate": "2024-10-02 17:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024450/0001415889-24-024450-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024450/xslF345X05/form4-10022024_051002.xml"}}
{"date": "2024-09-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-09-30 00:00:00", "acceptedDate": "2024-09-30 17:06:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024096/0001415889-24-024096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924024096/xslF345X05/form4-09302024_090946.xml"}}
{"date": "2024-09-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-09-10 00:00:00", "acceptedDate": "2024-09-10 15:30:45", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/0001104659-24-098564-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/tm2423380d1_ex3-1.htm"}}
{"date": "2024-08-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-08-14 00:00:00", "acceptedDate": "2024-08-14 16:09:27", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924089617/0001104659-24-089617-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924089617/tm2420586d1_s8.htm"}}
{"date": "2024-08-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-08-07 00:00:00", "acceptedDate": "2024-08-07 17:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924020926/0001415889-24-020926-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588924020926/xslF345X05/form4-08072024_050802.xml"}}
{"date": "2024-08-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-08-07 00:00:00", "acceptedDate": "2024-08-07 15:00:51", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/0001551152-24-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/abbv-20240630.htm"}}
{"date": "2024-07-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-25 00:00:00", "acceptedDate": "2024-07-25 07:41:17", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000026/0001551152-24-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000026/abbv-20240630xexhibit991.htm"}}
{"date": "2024-07-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-19 00:00:00", "acceptedDate": "2024-07-19 16:40:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000089706924001526/0000897069-24-001526-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000089706924001526/xslF345X05/form4.xml"}}
{"date": "2024-07-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-03 00:00:00", "acceptedDate": "2024-07-03 14:07:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000024/0001551152-24-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000024/abbv-20240630nonxgaapxex991.htm"}}
{"date": "2024-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 16:20:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000089706924001475/0000897069-24-001475-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000089706924001475/xslF345X05/form4.xml"}}
{"date": "2024-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 16:20:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000089706924001473/0000897069-24-001473-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000089706924001473/xslF345X05/form4.xml"}}
{"date": "2024-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 16:18:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000089706924001471/0000897069-24-001471-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000089706924001471/xslF345X05/form4.xml"}}
{"date": "2024-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 16:16:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000089706924001469/0000897069-24-001469-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000089706924001469/xslF345X05/form4.xml"}}
{"date": "2024-06-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-06-27 00:00:00", "acceptedDate": "2024-06-27 17:00:18", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924075726/0001104659-24-075726-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924075726/tm2418364d1_11k.htm"}}
{"date": "2024-06-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-06-03 00:00:00", "acceptedDate": "2024-06-03 11:28:55", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000087666124000445/0000876661-24-000445-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/876661/000087666124000445/xslF25X02/primary_doc.xml"}}
{"date": "2024-05-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-31 00:00:00", "acceptedDate": "2024-05-31 16:05:10", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924067135/0001104659-24-067135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924067135/tm2415825d1_sd.htm"}}
{"date": "2024-05-17", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-17 00:00:00", "acceptedDate": "2024-05-17 09:03:24", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000087666124000360/0000876661-24-000360-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/876661/000087666124000360/xslF25X02/primary_doc.xml"}}
{"date": "2024-05-08", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-08 00:00:00", "acceptedDate": "2024-05-08 17:00:46", "formType": "8-K/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/0001104659-24-058808-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/tm2413796d1_8ka.htm"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 20:16:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012558/0001415889-24-012558-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012558/xslF345X05/form4-05082024_120518.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:31:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012530/0001415889-24-012530-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012530/xslF345X05/form4-05072024_100540.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012528/0001415889-24-012528-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588924012528/xslF345X05/form4-05072024_100531.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012527/0001415889-24-012527-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588924012527/xslF345X05/form4-05072024_060528.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012524/0001415889-24-012524-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239126/000141588924012524/xslF345X05/form4-05072024_060515.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012523/0001415889-24-012523-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1466338/000141588924012523/xslF345X05/form4-05072024_060513.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012526/0001415889-24-012526-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1061632/000141588924012526/xslF345X05/form4-05072024_060519.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012522/0001415889-24-012522-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012522/xslF345X05/form4-05072024_060511.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012521/0001415889-24-012521-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1355580/000141588924012521/xslF345X05/form4-05072024_060509.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012525/0001415889-24-012525-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012525/xslF345X05/form4-05072024_060517.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012520/0001415889-24-012520-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1194624/000141588924012520/xslF345X05/form4-05072024_060507.xml"}}
{"date": "2024-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-07 00:00:00", "acceptedDate": "2024-05-07 18:30:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924012519/0001415889-24-012519-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1223690/000141588924012519/xslF345X05/form4-05072024_060504.xml"}}
{"date": "2024-05-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-05-03 00:00:00", "acceptedDate": "2024-05-03 11:04:11", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/0001551152-24-000020-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/abbv-20240331.htm"}}
{"date": "2024-04-26", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-04-26 00:00:00", "acceptedDate": "2024-04-26 07:43:16", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000016/0001551152-24-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000016/abbv-20240331xexhibit991.htm"}}
{"date": "2024-04-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-04-03 00:00:00", "acceptedDate": "2024-04-03 16:06:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000013/0001551152-24-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000013/abbv-20240331nonxgaapxex991.htm"}}
{"date": "2024-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-04-02 00:00:00", "acceptedDate": "2024-04-02 17:00:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924009800/0001415889-24-009800-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924009800/xslF345X05/form4-04022024_050401.xml"}}
{"date": "2024-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-04-02 00:00:00", "acceptedDate": "2024-04-02 17:00:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924009802/0001415889-24-009802-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588924009802/xslF345X05/form4-04022024_050408.xml"}}
{"date": "2024-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-04-02 00:00:00", "acceptedDate": "2024-04-02 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924009801/0001415889-24-009801-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588924009801/xslF345X05/form4-04022024_050405.xml"}}
{"date": "2024-04-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-04-02 00:00:00", "acceptedDate": "2024-04-01 17:44:53", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465924005805/0001214659-24-005805-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465924005805/p41245px14a6g.htm"}}
{"date": "2024-03-26", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-26 00:00:00", "acceptedDate": "2024-03-26 14:31:47", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465924005132/0001214659-24-005132-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465924005132/b326242px14a6g.htm"}}
{"date": "2024-03-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-22 00:00:00", "acceptedDate": "2024-03-22 17:00:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924008970/0001415889-24-008970-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924008970/xslF345X05/form4-03222024_050301.xml"}}
{"date": "2024-03-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-20 00:00:00", "acceptedDate": "2024-03-20 17:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/0001415889-24-008760-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/xslF345X05/form4-03202024_050301.xml"}}
{"date": "2024-03-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-18 00:00:00", "acceptedDate": "2024-03-18 16:27:23", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924035573/0001104659-24-035573-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924035573/tm244274d2_ars.pdf"}}
{"date": "2024-03-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-18 00:00:00", "acceptedDate": "2024-03-18 16:17:24", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837024003498/0001558370-24-003498-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837024003498/tmb-20240318xdefa14a.htm"}}
{"date": "2024-03-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-18 00:00:00", "acceptedDate": "2024-03-18 16:15:49", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837024003496/0001558370-24-003496-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837024003496/abbv-20240503xdef14a.htm"}}
{"date": "2024-03-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-05 00:00:00", "acceptedDate": "2024-03-05 17:30:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/0001415889-24-006792-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006792/xslF345X05/form4-03052024_100336.xml"}}
{"date": "2024-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-04 00:00:00", "acceptedDate": "2024-03-04 17:18:50", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837024002359/0001558370-24-002359-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837024002359/abbv-20240503xpre14a.htm"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006165/0001415889-24-006165-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006165/xslF345X05/form4-03012024_050325.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006164/0001415889-24-006164-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006164/xslF345X05/form4-03012024_050323.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006163/0001415889-24-006163-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006163/xslF345X05/form4-03012024_050320.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006162/0001415889-24-006162-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006162/xslF345X05/form4-03012024_050317.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006161/0001415889-24-006161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006161/xslF345X05/form4-03012024_050315.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006160/0001415889-24-006160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006160/xslF345X05/form4-03012024_050313.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006159/0001415889-24-006159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006159/xslF345X05/form4-03012024_050311.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006158/0001415889-24-006158-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006158/xslF345X05/form4-03012024_050307.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006157/0001415889-24-006157-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006157/xslF345X05/form4-03012024_050305.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006156/0001415889-24-006156-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006156/xslF345X05/form4-03012024_050303.xml"}}
{"date": "2024-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-03-01 00:00:00", "acceptedDate": "2024-03-01 17:50:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924006155/0001415889-24-006155-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588924006155/xslF345X05/form4-03012024_050301.xml"}}
{"date": "2024-02-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-29 00:00:00", "acceptedDate": "2024-02-29 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924005915/0001415889-24-005915-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588924005915/xslF345X05/form4-02292024_050201.xml"}}
{"date": "2024-02-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-27 00:00:00", "acceptedDate": "2024-02-27 17:10:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/0001415889-24-005544-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924005544/xslF345X05/form4-02272024_050202.xml"}}
{"date": "2024-02-26", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-26 00:00:00", "acceptedDate": "2024-02-26 17:08:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924027585/0001104659-24-027585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924027585/tm246405d5_ex1-1.htm"}}
{"date": "2024-02-26", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-26 00:00:00", "acceptedDate": "2024-02-26 06:12:03", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924027205/0001104659-24-027205-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924027205/tm246405-2_424b5.htm"}}
{"date": "2024-02-23", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-23 00:00:00", "acceptedDate": "2024-02-23 17:00:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924005065/0001415889-24-005065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924005065/xslF345X05/form4-02232024_050201.xml"}}
{"date": "2024-02-23", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-23 00:00:00", "acceptedDate": "2024-02-22 21:14:47", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924026710/0001104659-24-026710-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924026710/tm246405d4_fwp.htm"}}
{"date": "2024-02-23", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-23 00:00:00", "acceptedDate": "2024-02-22 17:50:55", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924026638/0001104659-24-026638-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924026638/tm246827d1_s8.htm"}}
{"date": "2024-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 08:39:47", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924025826/0001104659-24-025826-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924025826/tm246405-1_424b5.htm"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:23:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004426/0001415889-24-004426-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004426/xslF345X05/form4-02202024_050201.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:20:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/0001415889-24-004428-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004428/xslF345X05/form4-02202024_100233.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:17:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004423/0001415889-24-004423-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004423/xslF345X05/form4-02202024_100216.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004422/0001415889-24-004422-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004422/xslF345X05/form4-02202024_050245.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004421/0001415889-24-004421-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004421/xslF345X05/form4-02202024_050235.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/0001415889-24-004420-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004420/xslF345X05/form4-02202024_050232.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004419/0001415889-24-004419-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004419/xslF345X05/form4-02202024_050224.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/0001415889-24-004418-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004418/xslF345X05/form4-02202024_050219.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/0001415889-24-004417-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/xslF345X05/form4-02202024_050210.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004415/0001415889-24-004415-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588924004415/xslF345X05/form4-02202024_050201.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:15:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004416/0001415889-24-004416-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924004416/xslF345X05/form4-02202024_050205.xml"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 12:45:17", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/abbv-20231231.htm"}}
{"date": "2024-02-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 09:00:41", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/0001104659-24-025262-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm"}}
{"date": "2024-02-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 07:49:24", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924013692/0001104659-24-013692-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924013692/tm245657d1_99-1.htm"}}
{"date": "2024-02-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-06 00:00:00", "acceptedDate": "2024-02-06 17:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924002828/0001415889-24-002828-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924002828/xslF345X05/form4-02062024_050202.xml"}}
{"date": "2024-02-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 07:51:16", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000007/0001551152-24-000007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000007/abbv-20231231xexhibit991.htm"}}
{"date": "2024-01-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-01-25 00:00:00", "acceptedDate": "2024-01-25 16:59:27", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000108636424003786/0001086364-24-003786-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1364742/000108636424003786/us00287y1091_012524.txt"}}
{"date": "2024-01-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-01-05 00:00:00", "acceptedDate": "2024-01-05 16:03:27", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000002/0001551152-24-000002-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000002/abbv-20231231nonxgaapxex991.htm"}}
{"date": "2024-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-01-03 00:00:00", "acceptedDate": "2024-01-03 17:17:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924000345/0001415889-24-000345-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924000345/xslF345X05/form4-01032024_100158.xml"}}
{"date": "2024-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-01-03 00:00:00", "acceptedDate": "2024-01-03 17:08:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924000335/0001415889-24-000335-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588924000335/xslF345X05/form4-01032024_100107.xml"}}
{"date": "2024-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2024-01-03 00:00:00", "acceptedDate": "2024-01-03 17:00:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588924000327/0001415889-24-000327-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588924000327/xslF345X05/form4-01032024_050102.xml"}}
{"date": "2023-12-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-12-28 00:00:00", "acceptedDate": "2023-12-28 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923016990/0001415889-23-016990-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923016990/xslF345X05/form4-12282023_051202.xml"}}
{"date": "2023-12-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-12-22 00:00:00", "acceptedDate": "2023-12-22 16:13:55", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923016896/0001415889-23-016896-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923016896/xslF345X02/form3-12222023_091246.xml"}}
{"date": "2023-12-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-12-06 00:00:00", "acceptedDate": "2023-12-06 17:28:36", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923124047/0001104659-23-124047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923124047/tm2332303d1_ex99-1.htm"}}
{"date": "2023-11-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-11-30 00:00:00", "acceptedDate": "2023-11-30 08:47:57", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923122241/0001104659-23-122241-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923122241/tm2331814d1_ex99-1.htm"}}
{"date": "2023-11-15", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-11-15 00:00:00", "acceptedDate": "2023-11-15 13:32:15", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000087666123000860/0000876661-23-000860-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/876661/000087666123000860/xslF25X02/primary_doc.xml"}}
{"date": "2023-11-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-11-06 00:00:00", "acceptedDate": "2023-11-06 13:01:04", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/abbv-20230930.htm"}}
{"date": "2023-10-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-27 00:00:00", "acceptedDate": "2023-10-27 07:49:53", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000040/0001551152-23-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000040/abbv-20230930xexhibit991.htm"}}
{"date": "2023-10-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-19 00:00:00", "acceptedDate": "2023-10-19 17:06:08", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923014447/0001415889-23-014447-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923014447/xslF345X02/form3-10192023_091003.xml"}}
{"date": "2023-10-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-19 00:00:00", "acceptedDate": "2023-10-19 17:04:29", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923014446/0001415889-23-014446-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923014446/xslF345X02/form3-10192023_091022.xml"}}
{"date": "2023-10-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-12 00:00:00", "acceptedDate": "2023-10-12 17:17:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/0001104659-23-108864-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/0001104659-23-108864.txt"}}
{"date": "2023-10-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-04 00:00:00", "acceptedDate": "2023-10-04 16:11:14", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000036/0001551152-23-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000036/abbv-20230930nonxgaapxex991.htm"}}
{"date": "2023-10-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 17:00:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923013895/0001415889-23-013895-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588923013895/xslF345X05/form4-10032023_051001.xml"}}
{"date": "2023-10-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 17:00:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923013896/0001415889-23-013896-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588923013896/xslF345X05/form4-10032023_051004.xml"}}
{"date": "2023-09-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-09-27 00:00:00", "acceptedDate": "2023-09-27 17:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923013605/0001415889-23-013605-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588923013605/xslF345X05/form4-09272023_050901.xml"}}
{"date": "2023-09-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-09-11 00:00:00", "acceptedDate": "2023-09-11 17:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923013148/0001415889-23-013148-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588923013148/xslF345X05/form4-09112023_050901.xml"}}
{"date": "2023-08-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-08-07 00:00:00", "acceptedDate": "2023-08-07 13:10:46", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/abbv-20230630.htm"}}
{"date": "2023-08-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-08-02 00:00:00", "acceptedDate": "2023-08-02 17:07:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923011768/0001415889-23-011768-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588923011768/xslF345X05/form4-08022023_090805.xml"}}
{"date": "2023-07-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-07-27 00:00:00", "acceptedDate": "2023-07-27 07:45:22", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000028/0001551152-23-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000028/abbv-20230630xexhibit991.htm"}}
{"date": "2023-07-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-07-10 00:00:00", "acceptedDate": "2023-07-10 17:04:36", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923010986/0001415889-23-010986-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923010986/xslF345X02/form3-07102023_090731.xml"}}
{"date": "2023-07-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-07-06 00:00:00", "acceptedDate": "2023-07-06 16:18:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000026/0001551152-23-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000026/abbv-20230630nonxgaapxex991.htm"}}
{"date": "2023-07-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-07-05 00:00:00", "acceptedDate": "2023-07-05 17:00:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923010774/0001415889-23-010774-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588923010774/xslF345X04/form4-07052023_050703.xml"}}
{"date": "2023-07-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-07-05 00:00:00", "acceptedDate": "2023-07-05 17:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923010773/0001415889-23-010773-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588923010773/xslF345X04/form4-07052023_050701.xml"}}
{"date": "2023-06-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-06-29 00:00:00", "acceptedDate": "2023-06-29 17:00:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923076373/0001104659-23-076373-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923076373/0001104659-23-076373.txt"}}
{"date": "2023-06-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-06-28 00:00:00", "acceptedDate": "2023-06-28 17:00:25", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923075870/0001104659-23-075870-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923075870/tm2319683d1_11k.htm"}}
{"date": "2023-06-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-06-09 00:00:00", "acceptedDate": "2023-06-09 16:02:15", "formType": "S-8 POS", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923069890/0001104659-23-069890-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923069890/tm2318314d1_s8pos.htm"}}
{"date": "2023-05-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-31 00:00:00", "acceptedDate": "2023-05-31 16:59:36", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923066671/0001104659-23-066671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923066671/tm2317364d1_sd.htm"}}
{"date": "2023-05-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-12 00:00:00", "acceptedDate": "2023-05-12 17:00:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007908/0001415889-23-007908-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007908/xslF345X04/form4-05122023_050501.xml"}}
{"date": "2023-05-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-10 00:00:00", "acceptedDate": "2023-05-10 17:10:23", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923058520/0001104659-23-058520-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923058520/0001104659-23-058520.txt"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:05:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007678/0001415889-23-007678-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1223690/000141588923007678/xslF345X04/form4-05092023_050504.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:05:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007677/0001415889-23-007677-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1194624/000141588923007677/xslF345X04/form4-05092023_050501.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:04:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007675/0001415889-23-007675-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1355580/000141588923007675/xslF345X04/form4-05092023_090541.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:03:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007674/0001415889-23-007674-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588923007674/xslF345X04/form4-05092023_090547.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:03:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007673/0001415889-23-007673-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007673/xslF345X04/form4-05092023_090514.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:02:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007671/0001415889-23-007671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1466338/000141588923007671/xslF345X04/form4-05092023_090521.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:02:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007669/0001415889-23-007669-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1061632/000141588923007669/xslF345X04/form4-05092023_090558.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:01:19", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007667/0001415889-23-007667-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1061632/000141588923007667/xslF345X04/form4a-05092023_090506.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:00:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007665/0001415889-23-007665-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007665/xslF345X04/form4-05092023_050504.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:00:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007666/0001415889-23-007666-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239126/000141588923007666/xslF345X04/form4-05092023_050507.xml"}}
{"date": "2023-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-09 00:00:00", "acceptedDate": "2023-05-09 17:00:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007664/0001415889-23-007664-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588923007664/xslF345X04/form4-05092023_050502.xml"}}
{"date": "2023-05-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 12:54:58", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/abbv-20230331.htm"}}
{"date": "2023-05-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 08:08:57", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923006474/0001214659-23-006474-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1394096/000121465923006474/g52230px14a6g.htm"}}
{"date": "2023-05-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:17:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923007107/0001415889-23-007107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1194624/000141588923007107/xslF345X04/form4-05022023_090519.xml"}}
{"date": "2023-04-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-27 00:00:00", "acceptedDate": "2023-04-27 17:00:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006965/0001415889-23-006965-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006965/xslF345X04/form4-04272023_050402.xml"}}
{"date": "2023-04-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-27 00:00:00", "acceptedDate": "2023-04-27 07:36:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000019/0001551152-23-000019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000019/abbv-20230331xexhibit991.htm"}}
{"date": "2023-04-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-20 00:00:00", "acceptedDate": "2023-04-20 15:39:32", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923005702/0001214659-23-005702-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923005702/o420230px14a6g.htm"}}
{"date": "2023-04-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 17:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006720/0001415889-23-006720-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006720/xslF345X04/form4-04192023_050401.xml"}}
{"date": "2023-04-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-11 00:00:00", "acceptedDate": "2023-04-11 12:34:40", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923005193/0001214659-23-005193-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1086462/000121465923005193/r410232px14a6g.htm"}}
{"date": "2023-04-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-05 00:00:00", "acceptedDate": "2023-04-05 17:00:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006301/0001415889-23-006301-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006301/xslF345X04/form4-04052023_050407.xml"}}
{"date": "2023-04-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-05 00:00:00", "acceptedDate": "2023-04-05 17:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006300/0001415889-23-006300-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006300/xslF345X04/form4-04052023_050401.xml"}}
{"date": "2023-04-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-05 00:00:00", "acceptedDate": "2023-04-05 16:33:31", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000015/0001551152-23-000015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000015/abbv-20230331nonxgaapxex991.htm"}}
{"date": "2023-04-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-04 00:00:00", "acceptedDate": "2023-04-04 17:00:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006074/0001415889-23-006074-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588923006074/xslF345X04/form4-04042023_050406.xml"}}
{"date": "2023-04-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-04-04 00:00:00", "acceptedDate": "2023-04-04 17:00:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923006073/0001415889-23-006073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588923006073/xslF345X04/form4-04042023_050401.xml"}}
{"date": "2023-03-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-28 00:00:00", "acceptedDate": "2023-03-28 16:37:56", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923037749/0001104659-23-037749-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923037749/tm2310687d1_ex10-1.htm"}}
{"date": "2023-03-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-28 00:00:00", "acceptedDate": "2023-03-28 15:52:09", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923037696/0001104659-23-037696-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923037696/tm2310745d1_defa14a.htm"}}
{"date": "2023-03-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-28 00:00:00", "acceptedDate": "2023-03-28 11:57:38", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923004287/0001214659-23-004287-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923004287/b328230px14a6g.htm"}}
{"date": "2023-03-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-28 00:00:00", "acceptedDate": "2023-03-27 18:10:54", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923004251/0001214659-23-004251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465923004251/r327233px14a6g.htm"}}
{"date": "2023-03-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-21 00:00:00", "acceptedDate": "2023-03-21 17:21:21", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923035160/0001104659-23-035160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923035160/tm234090d3_ars.pdf"}}
{"date": "2023-03-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-21 00:00:00", "acceptedDate": "2023-03-21 17:19:16", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923035159/0001104659-23-035159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923035159/tm233485d3_defa14a.htm"}}
{"date": "2023-03-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-20 00:00:00", "acceptedDate": "2023-03-20 17:02:10", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837023004206/0001558370-23-004206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837023004206/tmb-20230320xdefa14a.htm"}}
{"date": "2023-03-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-20 00:00:00", "acceptedDate": "2023-03-20 17:00:42", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837023004204/0001558370-23-004204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837023004204/abbv-20230505xdef14a.htm"}}
{"date": "2023-03-15", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-15 00:00:00", "acceptedDate": "2023-03-15 17:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004956/0001415889-23-004956-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004956/xslF345X03/form4-03152023_050301.xml"}}
{"date": "2023-03-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-10 00:00:00", "acceptedDate": "2023-03-10 17:06:41", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004679/0001415889-23-004679-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004679/xslF345X02/form3-03102023_100331.xml"}}
{"date": "2023-03-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-07 00:00:00", "acceptedDate": "2023-03-07 17:00:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004429/0001415889-23-004429-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588923004429/xslF345X03/form4-03072023_050306.xml"}}
{"date": "2023-03-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-07 00:00:00", "acceptedDate": "2023-03-07 17:00:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004428/0001415889-23-004428-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923004428/xslF345X03/form4-03072023_050303.xml"}}
{"date": "2023-03-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-06 00:00:00", "acceptedDate": "2023-03-06 17:00:58", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837023002939/0001558370-23-002939-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837023002939/abbv-20230505xpre14a.htm"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:08:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003857/0001415889-23-003857-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003857/xslF345X03/form4-03022023_100349.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:07:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003856/0001415889-23-003856-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003856/xslF345X03/form4-03022023_100350.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:06:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003855/0001415889-23-003855-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003855/xslF345X03/form4-03022023_100358.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:04:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003854/0001415889-23-003854-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003854/xslF345X03/form4-03022023_100328.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:03:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003853/0001415889-23-003853-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003853/xslF345X03/form4-03022023_100331.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:02:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003852/0001415889-23-003852-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003852/xslF345X03/form4-03022023_100330.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 17:01:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003851/0001415889-23-003851-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003851/xslF345X03/form4-03022023_100335.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:35:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003844/0001415889-23-003844-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003844/xslF345X03/form4-03022023_040301.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:30:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003820/0001415889-23-003820-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003820/xslF345X03/form4-03022023_040302.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:30:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003822/0001415889-23-003822-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588923003822/xslF345X03/form4-03022023_040314.xml"}}
{"date": "2023-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:30:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003821/0001415889-23-003821-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003821/xslF345X03/form4-03022023_040309.xml"}}
{"date": "2023-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 17:00:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003007/0001415889-23-003007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923003007/xslF345X03/form4-02222023_050201.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:16:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002947/0001415889-23-002947-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1061632/000141588923002947/xslF345X03/form4-02212023_110231.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:14:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002946/0001415889-23-002946-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002946/xslF345X03/form4-02212023_110208.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:13:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002945/0001415889-23-002945-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002945/xslF345X03/form4-02212023_110202.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:12:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002944/0001415889-23-002944-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002944/xslF345X03/form4-02212023_110252.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:11:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/0001415889-23-002943-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002943/xslF345X03/form4-02212023_110239.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:10:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002942/0001415889-23-002942-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002942/xslF345X03/form4-02212023_110227.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:08:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002941/0001415889-23-002941-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002941/xslF345X03/form4-02212023_110237.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:07:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/0001415889-23-002940-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002940/xslF345X03/form4-02212023_110258.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:06:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002939/0001415889-23-002939-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1239127/000141588923002939/xslF345X03/form4-02212023_110253.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:02:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/0001415889-23-002937-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/xslF345X03/form4-02212023_110234.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 18:00:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/0001415889-23-002936-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002936/xslF345X03/form4-02212023_110223.xml"}}
{"date": "2023-02-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 17:59:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002935/0001415889-23-002935-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923002935/xslF345X03/form4-02212023_100213.xml"}}
{"date": "2023-02-17", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-17 00:00:00", "acceptedDate": "2023-02-17 12:54:29", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/abbv-20221231.htm"}}
{"date": "2023-02-16", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-16 00:00:00", "acceptedDate": "2023-02-15 17:45:08", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000130655023008705/0001306550-23-008705-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1364742/000130655023008705/us00287y1091_021523.txt"}}
{"date": "2023-02-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-09 00:00:00", "acceptedDate": "2023-02-09 10:54:46", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923015040/0001104659-23-015040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465923015040/tv0002-abbvieinc.htm"}}
{"date": "2023-02-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-02-09 00:00:00", "acceptedDate": "2023-02-09 07:55:01", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000006/0001551152-23-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000006/abbv-20221231xexhibit991.htm"}}
{"date": "2023-01-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-01-10 00:00:00", "acceptedDate": "2023-01-10 08:15:36", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923002452/0001104659-23-002452-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923002452/tm232769d1_ex99-1.htm"}}
{"date": "2023-01-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-01-06 00:00:00", "acceptedDate": "2023-01-06 16:15:27", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000004/0001551152-23-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000004/abbv-20221231nonxgaapxex991.htm"}}
{"date": "2023-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 17:06:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923000087/0001415889-23-000087-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588923000087/xslF345X03/form4-01032023_100102.xml"}}
{"date": "2023-01-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 17:05:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588923000086/0001415889-23-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588923000086/xslF345X03/form4-01032023_100105.xml"}}
{"date": "2022-12-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-12-14 00:00:00", "acceptedDate": "2022-12-14 17:06:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922012547/0001415889-22-012547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922012547/xslF345X03/form4-12142022_101246.xml"}}
{"date": "2022-11-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-11-29 00:00:00", "acceptedDate": "2022-11-29 09:01:21", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661.txt"}}
{"date": "2022-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-11-04 00:00:00", "acceptedDate": "2022-11-04 17:45:59", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922114984/0001104659-22-114984-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922114984/tm2229665d1_s8.htm"}}
{"date": "2022-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-11-04 00:00:00", "acceptedDate": "2022-11-04 13:07:23", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/0001551152-22-000045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000045/abbv-20220930.htm"}}
{"date": "2022-10-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-28 00:00:00", "acceptedDate": "2022-10-28 07:48:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000038/0001551152-22-000038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000038/abbv-20220930xexhibit991.htm"}}
{"date": "2022-10-27", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-27 00:00:00", "acceptedDate": "2022-10-27 17:01:31", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922010845/0001415889-22-010845-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922010845/xslF345X02/form3-10272022_021015.xml"}}
{"date": "2022-10-17", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-17 00:00:00", "acceptedDate": "2022-10-17 09:05:36", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922109061/0001104659-22-109061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922109061/tm2228315d1_8k.htm"}}
{"date": "2022-10-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-14 00:00:00", "acceptedDate": "2022-10-14 17:02:17", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922108910/0001104659-22-108910-index.htm", "finalLink": ""}}
{"date": "2022-10-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-05 00:00:00", "acceptedDate": "2022-10-05 16:14:22", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000034/0001551152-22-000034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000034/abbv-20221005.htm"}}
{"date": "2022-10-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-04 00:00:00", "acceptedDate": "2022-10-04 17:08:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922010247/0001415889-22-010247-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1171780/000141588922010247/xslF345X03/form4-10042022_021024.xml"}}
{"date": "2022-10-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-10-04 00:00:00", "acceptedDate": "2022-10-04 17:02:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922010242/0001415889-22-010242-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1448074/000141588922010242/xslF345X03/form4-10042022_021018.xml"}}
{"date": "2022-08-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-08-04 00:00:00", "acceptedDate": "2022-08-04 15:57:33", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/0001551152-22-000030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000030/abbv-20220630.htm"}}
{"date": "2022-07-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-07-29 00:00:00", "acceptedDate": "2022-07-29 07:49:25", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000026/0001551152-22-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000026/abbv-20220729.htm"}}
{"date": "2022-07-08", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-07-08 00:00:00", "acceptedDate": "2022-07-08 13:11:13", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922007553/0001415889-22-007553-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922007553/xslF345X02/form3-07082022_100701.xml"}}
{"date": "2022-07-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-07-06 00:00:00", "acceptedDate": "2022-07-06 16:17:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000023/0001551152-22-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000023/abbv-20220706.htm"}}
{"date": "2022-07-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-07-05 00:00:00", "acceptedDate": "2022-07-05 17:25:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922007380/0001415889-22-007380-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922007380/xslF345X03/form4-07052022_020740.xml"}}
{"date": "2022-07-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-07-05 00:00:00", "acceptedDate": "2022-07-05 17:23:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922007379/0001415889-22-007379-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000141588922007379/xslF345X03/form4-07052022_020714.xml"}}
{"date": "2022-06-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-06-29 00:00:00", "acceptedDate": "2022-06-29 08:30:25", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922075519/0001104659-22-075519-index.htm", "finalLink": ""}}
{"date": "2022-06-28", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-06-28 00:00:00", "acceptedDate": "2022-06-28 09:16:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm", "finalLink": ""}}
{"date": "2022-06-23", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-06-23 00:00:00", "acceptedDate": "2022-06-23 17:07:28", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922073948/0001104659-22-073948-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922073948/tm2219211d2_11k.htm"}}
{"date": "2022-06-23", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-06-23 00:00:00", "acceptedDate": "2022-06-23 17:06:21", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922073946/0001104659-22-073946-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922073946/tm2219211d1_11k.htm"}}
{"date": "2022-05-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-31 00:00:00", "acceptedDate": "2022-05-31 17:01:34", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922066635/0001104659-22-066635-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922066635/tm2216942d1_sd.htm"}}
{"date": "2022-05-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-25 00:00:00", "acceptedDate": "2022-05-25 16:58:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/0001179110-22-003137-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003137/xslF345X03/edgar.xml"}}
{"date": "2022-05-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-20 00:00:00", "acceptedDate": "2022-05-20 17:03:56", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003108/0001179110-22-003108-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003108/xslF345X03/edgar.xml"}}
{"date": "2022-05-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-20 00:00:00", "acceptedDate": "2022-05-20 17:00:54", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003107/0001179110-22-003107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003107/xslF345X03/edgar.xml"}}
{"date": "2022-05-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 17:12:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/0001179110-22-003077-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003077/xslF345X03/edgar.xml"}}
{"date": "2022-05-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 17:12:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003076/0001179110-22-003076-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003076/xslF345X03/edgar.xml"}}
{"date": "2022-05-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-13 00:00:00", "acceptedDate": "2022-05-13 17:46:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003023/0001179110-22-003023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022003023/xslF345X03/edgar.xml"}}
{"date": "2022-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-11 00:00:00", "acceptedDate": "2022-05-11 17:06:45", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922058862/0001104659-22-058862-index.htm", "finalLink": ""}}
{"date": "2022-05-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-10 00:00:00", "acceptedDate": "2022-05-10 17:05:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/0001179110-22-002947-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002947/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:15:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002934/0001179110-22-002934-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002934/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:14:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002933/0001179110-22-002933-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002933/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:14:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002932/0001179110-22-002932-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002932/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:13:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002931/0001179110-22-002931-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002931/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:13:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002930/0001179110-22-002930-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002930/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:13:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002929/0001179110-22-002929-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002929/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:12:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002928/0001179110-22-002928-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002928/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:11:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002927/0001179110-22-002927-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002927/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:10:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002926/0001179110-22-002926-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002926/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:10:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002925/0001179110-22-002925-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002925/xslF345X03/edgar.xml"}}
{"date": "2022-05-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:09:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002924/0001179110-22-002924-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002924/xslF345X03/edgar.xml"}}
{"date": "2022-05-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-05-06 00:00:00", "acceptedDate": "2022-05-06 12:51:05", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/abbv-20220331.htm"}}
{"date": "2022-04-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-29 00:00:00", "acceptedDate": "2022-04-29 09:00:02", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000012/0001551152-22-000012-index.htm", "finalLink": ""}}
{"date": "2022-04-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-29 00:00:00", "acceptedDate": "2022-04-29 07:45:08", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000010/0001551152-22-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000010/abbv-20220429.htm"}}
{"date": "2022-04-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-21 00:00:00", "acceptedDate": "2022-04-21 17:12:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922048450/0001104659-22-048450-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922048450/tm2213254d1_8k.htm"}}
{"date": "2022-04-13", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-13 00:00:00", "acceptedDate": "2022-04-13 09:15:31", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922045308/0001104659-22-045308-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922045308/tm2212581d1_8k.htm"}}
{"date": "2022-04-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-11 00:00:00", "acceptedDate": "2022-04-11 16:35:11", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922005064/0001214659-22-005064-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922005064/b48224px14a6g.htm"}}
{"date": "2022-04-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 17:16:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002546/0001179110-22-002546-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002546/xslF345X03/edgar.xml"}}
{"date": "2022-04-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 17:15:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002545/0001179110-22-002545-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002545/xslF345X03/edgar.xml"}}
{"date": "2022-04-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 17:14:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002544/0001179110-22-002544-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002544/xslF345X03/edgar.xml"}}
{"date": "2022-04-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 08:36:26", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922004737/0001214659-22-004737-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922004737/g41222px14a6g.htm"}}
{"date": "2022-03-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-30 00:00:00", "acceptedDate": "2022-03-30 16:39:41", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922004517/0001214659-22-004517-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1086462/000121465922004517/o329220px14a6g.htm"}}
{"date": "2022-03-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-25 00:00:00", "acceptedDate": "2022-03-25 17:09:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002416/0001179110-22-002416-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002416/xslF345X03/edgar.xml"}}
{"date": "2022-03-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-25 00:00:00", "acceptedDate": "2022-03-25 14:54:47", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922004367/0001214659-22-004367-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465922004367/g325221px14a6g.htm"}}
{"date": "2022-03-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-21 00:00:00", "acceptedDate": "2022-03-21 17:02:03", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837022004013/0001558370-22-004013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837022004013/tmb-20220321xdefa14a.htm"}}
{"date": "2022-03-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-21 00:00:00", "acceptedDate": "2022-03-21 17:00:50", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837022004011/0001558370-22-004011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837022004011/tmb-20220506xdef14a.htm"}}
{"date": "2022-03-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-11 00:00:00", "acceptedDate": "2022-03-11 17:05:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002147/0001179110-22-002147-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002147/xslF345X03/edgar.xml"}}
{"date": "2022-03-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-07 00:00:00", "acceptedDate": "2022-03-07 17:01:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002018/0001179110-22-002018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022002018/xslF345X03/edgar.xml"}}
{"date": "2022-03-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-07 00:00:00", "acceptedDate": "2022-03-07 16:56:53", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837022002961/0001558370-22-002961-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837022002961/tmb-20220506xpre14a.htm"}}
{"date": "2022-03-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-04 00:00:00", "acceptedDate": "2022-03-04 16:16:21", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922030613/0001104659-22-030613-index.htm", "finalLink": ""}}
{"date": "2022-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-02 00:00:00", "acceptedDate": "2022-03-02 17:04:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001925/0001179110-22-001925-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001925/xslF345X03/edgar.xml"}}
{"date": "2022-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-02 00:00:00", "acceptedDate": "2022-03-02 17:03:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001923/0001179110-22-001923-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001923/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:15:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001842/0001179110-22-001842-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001842/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:14:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001841/0001179110-22-001841-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001841/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:11:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001839/0001179110-22-001839-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001839/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:11:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001837/0001179110-22-001837-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001837/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:09:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001835/0001179110-22-001835-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001835/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:09:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001834/0001179110-22-001834-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001834/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:08:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001832/0001179110-22-001832-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001832/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:08:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001830/0001179110-22-001830-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001830/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:08:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001829/0001179110-22-001829-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001829/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:07:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001828/0001179110-22-001828-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001828/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:06:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001826/0001179110-22-001826-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001826/xslF345X03/edgar.xml"}}
{"date": "2022-03-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-03-01 00:00:00", "acceptedDate": "2022-03-01 18:06:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001825/0001179110-22-001825-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001825/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:42:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001520/0001179110-22-001520-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001520/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:42:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/0001179110-22-001519-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:42:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001518/0001179110-22-001518-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001518/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:40:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001517/0001179110-22-001517-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001517/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:40:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/0001179110-22-001516-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001516/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:39:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001515/0001179110-22-001515-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001515/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:39:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001513/0001179110-22-001513-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001513/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:34:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001510/0001179110-22-001510-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001510/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:33:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/0001179110-22-001509-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001509/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:33:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001508/0001179110-22-001508-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001508/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:32:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/0001179110-22-001507-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001507/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:32:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001506/0001179110-22-001506-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022001506/xslF345X03/edgar.xml"}}
{"date": "2022-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-22 00:00:00", "acceptedDate": "2022-02-22 17:02:39", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922025712/0001104659-22-025712-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922025712/tm227095-1_s3asr.htm"}}
{"date": "2022-02-18", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-18 00:00:00", "acceptedDate": "2022-02-18 12:41:31", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm"}}
{"date": "2022-02-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-09 00:00:00", "acceptedDate": "2022-02-09 15:15:58", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922016352/0001104659-22-016352-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465922016352/tv0138-abbvieinc.htm"}}
{"date": "2022-02-08", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-08 00:00:00", "acceptedDate": "2022-02-08 17:13:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000922/0001179110-22-000922-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000922/xslF345X03/edgar.xml"}}
{"date": "2022-02-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:29:37", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000083423722006222/0000834237-22-006222-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1364742/000083423722006222/us00287y1091_020322.txt"}}
{"date": "2022-02-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-02-02 00:00:00", "acceptedDate": "2022-02-02 07:48:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000003/0001551152-22-000003-index.htm", "finalLink": ""}}
{"date": "2022-01-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-01-05 00:00:00", "acceptedDate": "2022-01-05 17:27:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000262/0001179110-22-000262-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000262/xslF345X03/edgar.xml"}}
{"date": "2022-01-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 17:03:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000120/0001179110-22-000120-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000120/xslF345X03/edgar.xml"}}
{"date": "2022-01-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 17:02:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000119/0001179110-22-000119-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000119/xslF345X03/edgar.xml"}}
{"date": "2022-01-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2022-01-04 00:00:00", "acceptedDate": "2022-01-04 17:02:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000118/0001179110-22-000118-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911022000118/xslF345X03/edgar.xml"}}
{"date": "2021-12-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-30 00:00:00", "acceptedDate": "2021-12-30 17:01:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011274/0001179110-21-011274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011274/xslF345X03/edgar.xml"}}
{"date": "2021-12-23", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-23 00:00:00", "acceptedDate": "2021-12-23 17:01:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011230/0001179110-21-011230-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011230/xslF345X03/edgar.xml"}}
{"date": "2021-12-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-21 00:00:00", "acceptedDate": "2021-12-21 17:29:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011176/0001179110-21-011176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011176/xslF345X03/edgar.xml"}}
{"date": "2021-12-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-21 00:00:00", "acceptedDate": "2021-12-21 17:21:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011172/0001179110-21-011172-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011172/xslF345X03/edgar.xml"}}
{"date": "2021-12-17", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-17 00:00:00", "acceptedDate": "2021-12-17 17:02:30", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921151213/0001104659-21-151213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921151213/tm2135667d2_8k.htm"}}
{"date": "2021-12-17", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-17 00:00:00", "acceptedDate": "2021-12-17 17:01:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011109/0001179110-21-011109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021011109/xslF345X03/edgar.xml"}}
{"date": "2021-12-16", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-16 00:00:00", "acceptedDate": "2021-12-16 17:02:49", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921150570/0001104659-21-150570-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921150570/tm2135667d1_8k.htm"}}
{"date": "2021-12-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-14 00:00:00", "acceptedDate": "2021-12-14 17:01:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010958/0001179110-21-010958-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010958/xslF345X03/edgar.xml"}}
{"date": "2021-12-14", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-14 00:00:00", "acceptedDate": "2021-12-14 17:00:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010956/0001179110-21-010956-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010956/xslF345X03/edgar.xml"}}
{"date": "2021-12-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-10 00:00:00", "acceptedDate": "2021-12-10 17:02:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010830/0001179110-21-010830-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010830/xslF345X03/edgar.xml"}}
{"date": "2021-12-08", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-12-08 00:00:00", "acceptedDate": "2021-12-08 17:01:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010695/0001179110-21-010695-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021010695/xslF345X03/edgar.xml"}}
{"date": "2021-11-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-11-04 00:00:00", "acceptedDate": "2021-11-04 17:35:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009885/0001179110-21-009885-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009885/xslF345X03/edgar.xml"}}
{"date": "2021-11-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-11-02 00:00:00", "acceptedDate": "2021-11-02 12:52:31", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/0001551152-21-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000031/abbv-20210930.htm"}}
{"date": "2021-10-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-10-29 00:00:00", "acceptedDate": "2021-10-29 07:42:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000028/0001551152-21-000028-index.htm", "finalLink": ""}}
{"date": "2021-10-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-10-04 00:00:00", "acceptedDate": "2021-10-04 17:04:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009162/0001179110-21-009162-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009162/xslF345X03/edgar.xml"}}
{"date": "2021-10-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-10-04 00:00:00", "acceptedDate": "2021-10-04 17:04:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009161/0001179110-21-009161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009161/xslF345X03/edgar.xml"}}
{"date": "2021-10-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-10-04 00:00:00", "acceptedDate": "2021-10-04 17:04:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009160/0001179110-21-009160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021009160/xslF345X03/edgar.xml"}}
{"date": "2021-09-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-09-10 00:00:00", "acceptedDate": "2021-09-10 17:02:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008721/0001179110-21-008721-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008721/xslF345X03/edgar.xml"}}
{"date": "2021-09-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-09-10 00:00:00", "acceptedDate": "2021-09-10 17:01:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008720/0001179110-21-008720-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008720/xslF345X03/edgar.xml"}}
{"date": "2021-08-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-08-25 00:00:00", "acceptedDate": "2021-08-25 18:08:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008422/0001179110-21-008422-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008422/xslF345X03/edgar.xml"}}
{"date": "2021-08-25", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-08-25 00:00:00", "acceptedDate": "2021-08-25 18:08:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008421/0001179110-21-008421-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021008421/xslF345X03/edgar.xml"}}
{"date": "2021-08-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-08-19 00:00:00", "acceptedDate": "2021-08-19 13:05:59", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921107639/0001104659-21-107639-index.htm", "finalLink": ""}}
{"date": "2021-08-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-08-02 00:00:00", "acceptedDate": "2021-08-02 13:28:20", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/0001551152-21-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000025/abbv-20210630.htm"}}
{"date": "2021-07-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-07-30 00:00:00", "acceptedDate": "2021-07-30 07:52:10", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000021/0001551152-21-000021-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000021/abbv-20210730.htm"}}
{"date": "2021-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:09:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021007284/0001179110-21-007284-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021007284/xslF345X03/edgar.xml"}}
{"date": "2021-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:09:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021007283/0001179110-21-007283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021007283/xslF345X03/edgar.xml"}}
{"date": "2021-07-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 09:08:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021007282/0001179110-21-007282-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021007282/xslF345X03/edgar.xml"}}
{"date": "2021-06-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-06-21 00:00:00", "acceptedDate": "2021-06-21 16:02:36", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921083465/0001104659-21-083465-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921083465/tm2119960d2_11k.htm"}}
{"date": "2021-06-21", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-06-21 00:00:00", "acceptedDate": "2021-06-21 16:01:36", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921083459/0001104659-21-083459-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921083459/tm2119960d1_11k.htm"}}
{"date": "2021-06-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-06-01 00:00:00", "acceptedDate": "2021-06-01 17:01:17", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921075111/0001104659-21-075111-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921075111/a21-18100_1sd.htm"}}
{"date": "2021-05-26", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-26 00:00:00", "acceptedDate": "2021-05-26 17:20:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005980/0001179110-21-005980-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005980/xslF345X03/edgar.xml"}}
{"date": "2021-05-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-12 00:00:00", "acceptedDate": "2021-05-12 17:12:16", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921065216/0001104659-21-065216-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921065216/tm2115585d1_s8.htm"}}
{"date": "2021-05-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-12 00:00:00", "acceptedDate": "2021-05-12 17:04:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005245/0001179110-21-005245-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005245/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:07:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005209/0001179110-21-005209-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005209/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:07:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005208/0001179110-21-005208-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005208/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:07:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005207/0001179110-21-005207-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005207/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:06:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005206/0001179110-21-005206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005206/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:06:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005205/0001179110-21-005205-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005205/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:06:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005204/0001179110-21-005204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005204/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:06:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005202/0001179110-21-005202-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005202/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:05:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005201/0001179110-21-005201-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005201/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:05:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005200/0001179110-21-005200-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005200/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:05:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005199/0001179110-21-005199-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005199/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:05:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005197/0001179110-21-005197-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005197/xslF345X03/edgar.xml"}}
{"date": "2021-05-11", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-11 00:00:00", "acceptedDate": "2021-05-11 17:05:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005196/0001179110-21-005196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021005196/xslF345X03/edgar.xml"}}
{"date": "2021-05-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-10 00:00:00", "acceptedDate": "2021-05-10 17:00:41", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921063958/0001104659-21-063958-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921063958/tm2115632d1_8k.htm"}}
{"date": "2021-05-07", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-07 00:00:00", "acceptedDate": "2021-05-07 10:14:00", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/0001551152-21-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000016/abbv-20210331.htm"}}
{"date": "2021-05-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-05 00:00:00", "acceptedDate": "2021-05-05 16:23:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021004898/0001179110-21-004898-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021004898/xslF345X03/edgar.xml"}}
{"date": "2021-05-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 15:39:51", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000087666121000631/0000876661-21-000631-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/876661/000087666121000631/xslF25X02/primary_doc.xml"}}
{"date": "2021-05-04", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 14:30:11", "formType": "UPLOAD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000000000021005685/0000000000-21-005685-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000000000021005685/filename1.pdf"}}
{"date": "2021-04-30", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-04-30 00:00:00", "acceptedDate": "2021-04-30 07:44:56", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000013/0001551152-21-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000013/abbv-20210430.htm"}}
{"date": "2021-04-20", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-04-20 00:00:00", "acceptedDate": "2021-04-20 08:30:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921052229/0001104659-21-052229-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921052229/tm2113328d1_ex99-1.htm"}}
{"date": "2021-04-15", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-04-15 00:00:00", "acceptedDate": "2021-04-15 13:10:18", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465921004206/0001214659-21-004206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1394096/000121465921004206/p415211px14a6g.htm"}}
{"date": "2021-04-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-04-01 00:00:00", "acceptedDate": "2021-04-01 16:43:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003957/0001179110-21-003957-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003957/xslF345X03/edgar.xml"}}
{"date": "2021-04-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-04-01 00:00:00", "acceptedDate": "2021-04-01 16:43:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003956/0001179110-21-003956-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003956/xslF345X03/edgar.xml"}}
{"date": "2021-04-01", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-04-01 00:00:00", "acceptedDate": "2021-04-01 16:43:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003954/0001179110-21-003954-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003954/xslF345X03/edgar.xml"}}
{"date": "2021-03-31", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-31 00:00:00", "acceptedDate": "2021-03-31 14:18:44", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465921003675/0001214659-21-003675-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465921003675/j331212px14a6g.htm"}}
{"date": "2021-03-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-29 00:00:00", "acceptedDate": "2021-03-29 10:56:08", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000121465921003519/0001214659-21-003519-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000121465921003519/j329210px14a6g.htm"}}
{"date": "2021-03-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-22 00:00:00", "acceptedDate": "2021-03-22 17:03:36", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837021003321/0001558370-21-003321-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837021003321/tmb-20210322xdefa14a.htm"}}
{"date": "2021-03-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-22 00:00:00", "acceptedDate": "2021-03-22 17:00:54", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837021003318/0001558370-21-003318-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837021003318/tmb-20210507xdef14a.htm"}}
{"date": "2021-03-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-19 00:00:00", "acceptedDate": "2021-03-19 17:00:28", "formType": "CORRESP", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921039166/0001104659-21-039166-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921039166/filename1.htm"}}
{"date": "2021-03-16", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-16 00:00:00", "acceptedDate": "2021-03-16 12:30:05", "formType": "UPLOAD", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000000000021003131/0000000000-21-003131-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000000000021003131/filename1.pdf"}}
{"date": "2021-03-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-12 00:00:00", "acceptedDate": "2021-03-12 17:02:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921035654/0001104659-21-035654-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921035654/tm219217d1_ex99-1.htm"}}
{"date": "2021-03-09", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-09 00:00:00", "acceptedDate": "2021-03-09 17:26:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003128/0001179110-21-003128-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021003128/xslF345X03/edgar.xml"}}
{"date": "2021-03-08", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-08 00:00:00", "acceptedDate": "2021-03-08 17:27:52", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155837021002580/0001558370-21-002580-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155837021002580/tmb-20210507xpre14a.htm"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:34:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002611/0001179110-21-002611-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002611/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:32:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002608/0001179110-21-002608-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002608/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:31:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002607/0001179110-21-002607-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002607/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:31:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002605/0001179110-21-002605-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002605/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:30:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002603/0001179110-21-002603-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002603/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:29:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002601/0001179110-21-002601-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002601/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:29:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002599/0001179110-21-002599-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002599/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:27:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002596/0001179110-21-002596-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002596/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:26:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002594/0001179110-21-002594-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002594/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:26:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002592/0001179110-21-002592-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002592/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:25:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002589/0001179110-21-002589-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002589/xslF345X03/edgar.xml"}}
{"date": "2021-03-02", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-03-02 00:00:00", "acceptedDate": "2021-03-02 20:25:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002588/0001179110-21-002588-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002588/xslF345X03/edgar.xml"}}
{"date": "2021-02-24", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-24 00:00:00", "acceptedDate": "2021-02-24 18:28:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002251/0001179110-21-002251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002251/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:25:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002053/0001179110-21-002053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002053/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:25:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002052/0001179110-21-002052-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002052/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:23:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/0001179110-21-002051-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002051/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:23:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002050/0001179110-21-002050-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002050/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:23:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/0001179110-21-002049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002049/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:19:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/0001179110-21-002048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:19:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002047/0001179110-21-002047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002047/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:18:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002046/0001179110-21-002046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002046/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:17:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/0001179110-21-002045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002045/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:17:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002044/0001179110-21-002044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002044/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:16:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002043/0001179110-21-002043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002043/xslF345X03/edgar.xml"}}
{"date": "2021-02-22", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 18:15:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002042/0001179110-21-002042-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021002042/xslF345X03/edgar.xml"}}
{"date": "2021-02-19", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-19 00:00:00", "acceptedDate": "2021-02-19 14:05:43", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/abbv-20201231.htm"}}
{"date": "2021-02-16", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-16 00:00:00", "acceptedDate": "2021-02-16 15:46:32", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000142284821000091/0001422848-21-000091-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1422848/000142284821000091/SEC13G_Filing.htm"}}
{"date": "2021-02-10", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 10:30:26", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921017320/0001104659-21-017320-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465921017320/tv0110-abbvieinc.htm"}}
{"date": "2021-02-03", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 07:41:10", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000003/0001551152-21-000003-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000003/abbv-20210203.htm"}}
{"date": "2021-01-29", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-29 00:00:00", "acceptedDate": "2021-01-28 18:11:13", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000083423721003108/0000834237-21-003108-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1364742/000083423721003108/us00287y1091_012821.txt"}}
{"date": "2021-01-15", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-15 00:00:00", "acceptedDate": "2021-01-15 16:00:37", "formType": "CORRESP", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921004698/0001104659-21-004698-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921004698/filename1.htm"}}
{"date": "2021-01-12", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-12 00:00:00", "acceptedDate": "2021-01-12 16:30:55", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921003462/0001104659-21-003462-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921003462/tm212802d1_ex99-1.htm"}}
{"date": "2021-01-06", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-06 00:00:00", "acceptedDate": "2021-01-06 17:00:20", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921001570/0001104659-21-001570-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921001570/tm211488d1_8k.htm"}}
{"date": "2021-01-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 17:02:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000196/0001179110-21-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000196/xslF345X03/edgar.xml"}}
{"date": "2021-01-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 17:01:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000195/0001179110-21-000195-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000195/xslF345X03/edgar.xml"}}
{"date": "2021-01-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 17:01:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000194/0001179110-21-000194-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000194/xslF345X03/edgar.xml"}}
{"date": "2021-01-05", "symbol": "ABBV", "type": "sec_filings", "result": {"symbol": "ABBV", "cik": "0001551152", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 17:00:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000193/0001179110-21-000193-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/1551152/000117911021000193/xslF345X03/edgar.xml"}}
{"date": "2025-12-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-22 05:56:49", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Bought by Sara Bay Financial", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-bought-by-sara-bay-financial-20251222.jpg", "site": "defenseworld.net", "text": "Sara Bay Financial grew its stake in AbbVie Inc. (NYSE: ABBV) by 21.2% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,179 shares of the company's stock after purchasing an additional 3,002 shares during the period. AbbVie comprises", "url": "https://www.defenseworld.net/2025/12/22/abbvie-inc-abbv-shares-bought-by-sara-bay-financial.html"}}
{"date": "2025-12-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-22 05:56:47", "publisher": "Defense World", "title": "Foster Victor Wealth Advisors LLC Raises Stock Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/foster-victor-wealth-advisors-llc-raises-stock-position-in-20251222.jpg", "site": "defenseworld.net", "text": "Foster Victor Wealth Advisors LLC increased its position in shares of AbbVie Inc. (NYSE: ABBV) by 4.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 79,462 shares of the company's stock after acquiring an additional 3,209 shares during the period. AbbVie makes", "url": "https://www.defenseworld.net/2025/12/22/foster-victor-wealth-advisors-llc-raises-stock-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-22 05:12:52", "publisher": "Defense World", "title": "Charles Schwab Trust Co Acquires 15,502 Shares of AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/charles-schwab-trust-co-acquires-15502-shares-of-abbvie-20251222.jpg", "site": "defenseworld.net", "text": "Charles Schwab Trust Co raised its holdings in AbbVie Inc. (NYSE: ABBV) by 93.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 32,105 shares of the company's stock after buying an additional 15,502 shares during the period. Charles Schwab Trust Co's holdings", "url": "https://www.defenseworld.net/2025/12/22/charles-schwab-trust-co-acquires-15502-shares-of-abbvie-inc-abbv.html"}}
{"date": "2025-12-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-22 05:12:52", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV is CHICAGO TRUST Co NAs 8th Largest Position", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-is-chicago-trust-co-nas-8th-20251222.jpg", "site": "defenseworld.net", "text": "CHICAGO TRUST Co NA trimmed its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 10.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 59,632 shares of the company's stock after selling 7,129 shares during the period. AbbVie makes", "url": "https://www.defenseworld.net/2025/12/22/abbvie-inc-abbv-is-chicago-trust-co-nas-8th-largest-position.html"}}
{"date": "2025-12-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-22 04:44:00", "publisher": "The Motley Fool", "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever", "image": "https://images.financialmodelingprep.com/news/want-decades-of-passive-income-3-stocks-to-buy-20251222.jpg", "site": "fool.com", "text": "AbbVie is a Dividend King that successfully navigated a challenging patent cliff. Coca-Cola is a household name that has survived and thrived for 139 years.", "url": "https://www.fool.com/investing/2025/12/22/want-decades-of-passive-income-3-stocks-to-buy-now/"}}
{"date": "2025-12-21", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-21 09:23:12", "publisher": "MarketBeat", "title": "3 Dividend Growth Stocks Analysts Are Upgrading for 2026", "image": "https://images.financialmodelingprep.com/news/3-dividend-growth-stocks-analysts-are-upgrading-for-2026-20251221.jpg", "site": "marketbeat.com", "text": "A single analyst's rating and price target, the consensus rating and price target, for that matter, have little value to investors without the proper context. The context is the sentiment strength and trend, which for stocks like PepsiCo NASDAQ: PEP, AbbVie NYSE: ABBV, and United Parcel Service NYSE: UPS, is strong and bullish.", "url": "https://www.marketbeat.com/stock-ideas/3-dividend-growth-stocks-analysts-are-upgrading-for-2026/"}}
{"date": "2025-12-21", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-21 03:54:42", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Sold by BDF Gestion", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-sold-by-bdf-gestion-20251221.jpg", "site": "defenseworld.net", "text": "BDF Gestion lessened its position in AbbVie Inc. (NYSE: ABBV) by 17.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,522 shares of the company's stock after selling 7,178 shares during the quarter. AbbVie makes up 0.9% of BDF Gestion's investment portfolio,", "url": "https://www.defenseworld.net/2025/12/21/abbvie-inc-abbv-shares-sold-by-bdf-gestion.html"}}
{"date": "2025-12-20", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-20 01:38:01", "publisher": "Benzinga", "title": "Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal", "image": "https://images.financialmodelingprep.com/news/trump-secures-drug-price-cuts-from-9-major-pharma-20251220.jpeg", "site": "feeds.benzinga.com", "text": "Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.", "url": "https://www.benzinga.com/news/health-care/25/12/49525415/trump-secures-drug-price-cuts-from-9-major-pharma-firms-including-bristol-myers-gilead-merck-in-"}}
{"date": "2025-12-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-19 16:01:00", "publisher": "GuruFocus", "title": "Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc", "image": "https://images.financialmodelingprep.com/news/vanguard-health-care-funds-strategic-moves-spotlight-on-abbvie-20251219.png", "site": "gurufocus.com", "text": "Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2", "url": "https://www.gurufocus.com/news/4078525/vanguard-health-care-funds-strategic-moves-spotlight-on-abbvie-inc"}}
{"date": "2025-12-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-19 10:45:00", "publisher": "Market Watch", "title": "Trump to announce new drug-pricing deals later today", "image": "https://images.financialmodelingprep.com/news/trump-to-announce-new-drugpricing-deals-later-today-20251219.jpg", "site": "marketwatch.com", "text": "The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.", "url": "https://www.marketwatch.com/story/trump-to-announce-new-drug-pricing-deals-later-today-8261bdfe"}}
{"date": "2025-12-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-18 16:30:00", "publisher": "The Motley Fool", "title": "Is AbbVie a Millionaire Maker?", "image": "https://images.financialmodelingprep.com/news/is-abbvie-a-millionaire-maker-20251218.jpg", "site": "fool.com", "text": "AbbVie is a pharmaceutical company with a focus on immunology, oncology, neuroscience, and aesthetics. The company's third-quarter earnings were down materially year over year, but it raised its full-year guidance.", "url": "https://www.fool.com/investing/2025/12/18/is-abbvie-a-millionaire-maker/"}}
{"date": "2025-12-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-18 13:45:00", "publisher": "The Motley Fool", "title": "Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.", "image": "https://images.financialmodelingprep.com/news/worried-about-the-stock-market-in-2026-these-3-20251218.jpg", "site": "fool.com", "text": "Invest in stocks with good fundamentals, solid growth prospects, and steady dividends. These blue chip stocks have strong businesses that generate consistently strong results.", "url": "https://www.fool.com/investing/2025/12/18/worried-about-the-market-in-2026-these-3-stocks/"}}
{"date": "2025-12-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-18 09:03:18", "publisher": "247 Wallst", "title": "Retirees Banking on Quarterly Income Choose HDV Over Growth Funds for Its Defensive Holdings", "image": "https://images.financialmodelingprep.com/news/retirees-banking-on-quarterly-income-choose-hdv-over-growth-20251218.webp", "site": "247wallst.com", "text": "When income matters more than growth, retirees turn to funds that deliver quarterly checks without volatility. The iShares Core High Dividend ETF (NYSEARCA:HDV) yields 3.3%, triple the S&P 500's 1.03%. That difference translates to predictable cash flow for investors who need their portfolio to pay bills. Built for Income, Not Speculation HDV tracks 75 U.S.... Retirees Banking on Quarterly Income Choose HDV Over Growth Funds for Its Defensive Holdings.", "url": "https://247wallst.com/investing/2025/12/18/retirees-banking-on-quarterly-income-choose-hdv-over-growth-funds-for-its-defensive-holdings/"}}
{"date": "2025-12-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-18 05:58:48", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Sold by Carolina Wealth Advisors LLC", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-sold-by-carolina-wealth-advisors-20251218.jpg", "site": "defenseworld.net", "text": "Carolina Wealth Advisors LLC lessened its stake in shares of AbbVie Inc. (NYSE: ABBV) by 98.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 620 shares of the company's stock after selling 38,267 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/18/abbvie-inc-abbv-shares-sold-by-carolina-wealth-advisors-llc.html"}}
{"date": "2025-12-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-18 04:56:41", "publisher": "Defense World", "title": "Grant Private Wealth Management Inc Sells 8,979 Shares of AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/grant-private-wealth-management-inc-sells-8979-shares-of-20251218.jpg", "site": "defenseworld.net", "text": "Grant Private Wealth Management Inc cut its position in AbbVie Inc. (NYSE: ABBV) by 75.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,915 shares of the company's stock after selling 8,979 shares during the quarter. Grant Private Wealth Management Inc's", "url": "https://www.defenseworld.net/2025/12/18/grant-private-wealth-management-inc-sells-8979-shares-of-abbvie-inc-abbv.html"}}
{"date": "2025-12-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-18 03:52:55", "publisher": "Defense World", "title": "Acropolis Investment Management LLC Has $1.62 Million Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/acropolis-investment-management-llc-has-162-million-position-in-20251218.jpg", "site": "defenseworld.net", "text": "Acropolis Investment Management LLC raised its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 115.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,978 shares of the company's stock after purchasing an additional 3,746 shares during the quarter. Acropolis", "url": "https://www.defenseworld.net/2025/12/18/acropolis-investment-management-llc-has-1-62-million-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-17", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-17 16:11:16", "publisher": "Reuters", "title": "AbbVie, several other pharma companies near MFN deal with Trump, sources say", "image": "https://images.financialmodelingprep.com/news/abbvie-several-other-pharma-companies-near-mfn-deal-with-20251217.jpg", "site": "reuters.com", "text": "AbbVie and several other drugmakers are expected to announce on Friday agreements with the U.S. government to lower certain prescription drug prices and meet other demands made by President Donald Trump, according to sources familiar with the situation.", "url": "https://www.reuters.com/legal/litigation/abbvie-several-other-pharma-companies-near-mfn-deal-with-trump-sources-say-2025-12-17/"}}
{"date": "2025-12-17", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-17 14:17:18", "publisher": "CNBC Television", "title": "Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc", "image": "https://images.financialmodelingprep.com/news/final-trades-abbvie-inc-microsoft-netflix-and-twilio-inc-20251217.jpg", "site": "youtube.com", "text": "Market movers: The Investment Committee's top stocks to watch right now.", "url": "https://www.youtube.com/watch?v=rL7clOGYDZQ"}}
{"date": "2025-12-17", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-17 10:01:07", "publisher": "Zacks Investment Research", "title": "Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?", "image": "https://images.financialmodelingprep.com/news/is-trending-stock-abbvie-inc-abbv-a-buy-now-20251217.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2805471/is-trending-stock-abbvie-inc-abbv-a-buy-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2805471"}}
{"date": "2025-12-16", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-16 10:02:08", "publisher": "Zacks Investment Research", "title": "How AbbVie's Pipeline Is Lining Up Key Product Launches", "image": "https://images.financialmodelingprep.com/news/how-abbvies-pipeline-is-lining-up-key-product-launches-20251216.jpg", "site": "zacks.com", "text": "ABBV is lining up multiple late-stage launches, from Rinvoq label expansions to Parkinson???s and oncology assets nearing FDA decisions.", "url": "https://www.zacks.com/stock/news/2804834/how-abbvie-s-pipeline-is-lining-up-key-product-launches?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2804834"}}
{"date": "2025-12-16", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-16 06:16:43", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Purchased by GAMMA Investing LLC", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-purchased-by-gamma-investing-llc-20251216.jpg", "site": "defenseworld.net", "text": "GAMMA Investing LLC grew its stake in shares of AbbVie Inc. (NYSE: ABBV) by 8.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 57,159 shares of the company's stock after acquiring an additional 4,633 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/16/abbvie-inc-abbv-shares-purchased-by-gamma-investing-llc.html"}}
{"date": "2025-12-16", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-16 05:32:59", "publisher": "Defense World", "title": "Gilbert Capital Group Inc. Takes Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/gilbert-capital-group-inc-takes-position-in-abbvie-inc-20251216.jpg", "site": "defenseworld.net", "text": "Gilbert Capital Group Inc. purchased a new position in AbbVie Inc. (NYSE: ABBV) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,824 shares of the company's stock, valued at approximately $710,000. A number of other large investors also recently bought and sold", "url": "https://www.defenseworld.net/2025/12/16/gilbert-capital-group-inc-takes-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-15", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-15 05:38:43", "publisher": "Defense World", "title": "Rep. Julie Johnson Sells Off Shares of AbbVie Inc. (NYSE:ABBV)", "image": "https://images.financialmodelingprep.com/news/rep-julie-johnson-sells-off-shares-of-abbvie-inc-20251215.jpg", "site": "defenseworld.net", "text": "Representative Julie Johnson (D-Texas) recently sold shares of AbbVie Inc. (NYSE: ABBV). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in AbbVie stock on November 13th. The trade occurred in the Representative's \"CHASE BROKERAGE ACCOUNT (3935)\" account. Representative Julie Johnson also recently made the following trade(s):", "url": "https://www.defenseworld.net/2025/12/15/rep-julie-johnson-sells-off-shares-of-abbvie-inc-nyseabbv.html"}}
{"date": "2025-12-15", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-15 03:52:52", "publisher": "Defense World", "title": "Caldwell Trust Co Takes Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/caldwell-trust-co-takes-position-in-abbvie-inc-abbv-20251215.jpg", "site": "defenseworld.net", "text": "Caldwell Trust Co bought a new stake in shares of AbbVie Inc. (NYSE: ABBV) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 25,110 shares of the company's stock, valued at approximately $4,661,000. Several other hedge funds have also added", "url": "https://www.defenseworld.net/2025/12/15/caldwell-trust-co-takes-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-14", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-14 23:30:00", "publisher": "Seeking Alpha", "title": "AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings", "image": "https://images.financialmodelingprep.com/news/amg-frontier-small-cap-growth-fund-q3-sees-strong-20251214.jpg", "site": "seekingalpha.com", "text": "Our portfolios underperformed during the quarter and trail year to date. Health care was the primary hindrance as a result of our underweight in biotech and negative stock selection. We have materially decreased our position as we evaluate this specific risk.", "url": "https://seekingalpha.com/article/4853262-amg-frontier-small-cap-growth-fund-q3-sees-strong-outperformance-across-semiconductor-holdings"}}
{"date": "2025-12-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-13 14:37:00", "publisher": "The Motley Fool", "title": "My Top 3 Healthcare Stocks to Buy in 2026", "image": "https://images.financialmodelingprep.com/news/my-top-3-healthcare-stocks-to-buy-in-2026-20251213.jpg", "site": "fool.com", "text": "With its diverse product line, AbbVie is a terrific dividend stock with a solid underlying business. Eli Lilly is growing its top line incredibly rapidly and expanding into other therapeutic areas.", "url": "https://www.fool.com/investing/2025/12/13/my-top-3-healthcare-stocks-to-buy-in-2026/"}}
{"date": "2025-12-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-13 12:26:47", "publisher": "24/7 Wall Street", "title": "5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine", "image": "https://images.financialmodelingprep.com/news/5-dividend-powerhouses-that-could-transform-your-portfolio-into-20251213.jpg", "site": "247wallst.com", "text": "Building wealth through dividends requires more than chasing high yields. The path to getting rich combines meaningful current income with consistent dividend growth, backed by sustainable business fundamentals.", "url": "https://247wallst.com/investing/2025/12/13/5-dividend-powerhouses-that-could-transform-your-portfolio-into-a-wealth-building-machine/"}}
{"date": "2025-12-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-13 10:10:04", "publisher": "247 Wallst", "title": "Why Ditching Schwab U.S. Dividend Equity ETF In the AI Era Is a Mistake", "image": "https://images.financialmodelingprep.com/news/why-ditching-schwab-us-dividend-equity-etf-in-the-20251213.jpg", "site": "247wallst.com", "text": "The rapid rise of artificial intelligence (AI) has transformed the stock market in recent years, powering massive gains in technology giants and growth-oriented investments. At the same time, dividend-focused funds like the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) have faced scrutiny for lagging behind broader indices dominated by AI-driven companies. Schwab U.S. Dividend Equity ETF... Why Ditching Schwab U.S. Dividend Equity ETF In the AI Era Is a Mistake.", "url": "https://247wallst.com/investing/2025/12/13/why-ditching-schwab-u-s-dividend-equity-etf-in-the-ai-era-is-a-mistake/"}}
{"date": "2025-12-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-13 04:32:48", "publisher": "Defense World", "title": "Adage Capital Partners GP L.L.C. Lowers Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/adage-capital-partners-gp-llc-lowers-position-in-abbvie-20251213.jpg", "site": "defenseworld.net", "text": "Adage Capital Partners GP L.L.C. decreased its stake in AbbVie Inc. (NYSE: ABBV) by 10.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,618,841 shares of the company's stock after selling 179,892 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/13/adage-capital-partners-gp-l-l-c-lowers-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-13 03:58:54", "publisher": "Defense World", "title": "Ameriprise Financial Inc. Sells 3,127,890 Shares of AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/ameriprise-financial-inc-sells-3127890-shares-of-abbvie-inc-20251213.jpg", "site": "defenseworld.net", "text": "Ameriprise Financial Inc. decreased its stake in AbbVie Inc. (NYSE: ABBV) by 25.2% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,267,451 shares of the company's stock after selling 3,127,890 shares during the quarter. Ameriprise Financial Inc.", "url": "https://www.defenseworld.net/2025/12/13/ameriprise-financial-inc-sells-3127890-shares-of-abbvie-inc-abbv.html"}}
{"date": "2025-12-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-12 12:23:00", "publisher": "The Motley Fool", "title": "Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026", "image": "https://images.financialmodelingprep.com/news/here-are-2-affordable-healthcare-stocks-to-buy-heading-20251212.jpeg", "site": "fool.com", "text": "One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.", "url": "https://www.fool.com/investing/2025/12/12/2-affordable-healthcare-stocks-to-buy-into-2026/"}}
{"date": "2025-12-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-12 08:46:13", "publisher": "Zacks Investment Research", "title": "AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock", "image": "https://images.financialmodelingprep.com/news/abbvie-slipped-below-50day-sma-last-week-how-to-20251212.jpg", "site": "zacks.com", "text": "AbbVie dips below its 50-day SMA, but strong immunology momentum and a resilient long-term trend keep the story compelling.", "url": "https://www.zacks.com/stock/news/2803475/abbvie-slipped-below-50-day-sma-last-week-how-to-play-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2803475"}}
{"date": "2025-12-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-12 07:22:40", "publisher": "24/7 Wall Street", "title": "Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks", "image": "https://images.financialmodelingprep.com/news/proven-income-generators-ranking-the-most-reliable-dividend-growth-20251212.jpg", "site": "247wallst.com", "text": "Dividend investing rewards patience. The best dividend stocks don't just pay consistentlythey raise payouts year after year, compounding income for shareholders who stay the course.", "url": "https://247wallst.com/investing/2025/12/12/proven-income-generators-ranking-the-most-reliable-dividend-growth-stocks/"}}
{"date": "2025-12-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-12 07:07:57", "publisher": "MarketBeat", "title": "Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul", "image": "https://images.financialmodelingprep.com/news/dividend-powerhouses-3-bluechip-stocks-built-for-the-long-20251212.jpg", "site": "marketbeat.com", "text": "The wall of worry continues to grow as investors race into 2026. Concentration risk is one that may not get talked about enough.", "url": "https://www.marketbeat.com/stock-ideas/dividend-powerhouses-3-blue-chip-stocks-built-for-the-long-haul/"}}
{"date": "2025-12-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-12 04:00:00", "publisher": "The Motley Fool", "title": "The Smartest Dividend Stocks to Buy With $5,000 Right Now", "image": "https://images.financialmodelingprep.com/news/the-smartest-dividend-stocks-to-buy-with-5000-right-20251212.jpg", "site": "fool.com", "text": "Bank of America's low payout ratio means this is a dividend you can count on. AbbVie's raking in money with immunology drugs Skyrizi and Rinvoq.", "url": "https://www.fool.com/investing/2025/12/12/the-smartest-dividend-stocks-to-buy-with-5000-righ/"}}
{"date": "2025-12-11", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-11 11:06:00", "publisher": "The Motley Fool", "title": "Is AbbVie Stock Too Cheap to Ignore at Today's Price?", "image": "https://images.financialmodelingprep.com/news/is-abbvie-stock-too-cheap-to-ignore-at-todays-20251211.jpg", "site": "fool.com", "text": "Some valuation metrics suggest that AbbVie is a cheap stock. The company's growth prospects through 2030 look attractive.", "url": "https://www.fool.com/investing/2025/12/11/is-abbvie-stock-too-cheap-to-ignore-at-todays-pric/"}}
{"date": "2025-12-11", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-11 08:51:04", "publisher": "Zacks Investment Research", "title": "Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth", "image": "https://images.financialmodelingprep.com/news/heres-how-abbvies-oncology-drugs-are-aiding-topline-growth-20251211.jpg", "site": "zacks.com", "text": "ABBV's expanding oncology lineup, spanning new solid tumor drugs and rising Venclexta sales, is helping drive steady top-line growth.", "url": "https://www.zacks.com/stock/news/2802731/here-s-how-abbvie-s-oncology-drugs-are-aiding-top-line-growth?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2802731"}}
{"date": "2025-12-10", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-10 20:01:55", "publisher": "Seeking Alpha", "title": "AbbVie: Unique Mix Of Growth And Value", "image": "https://images.financialmodelingprep.com/news/abbvie-unique-mix-of-growth-and-value-20251210.jpg", "site": "seekingalpha.com", "text": "AbbVie earns a Strong Buy rating, driven by exceptional execution post-Humira patent cliff and robust 2025 share price outperformance. Skyrizi and Rinvoq are rapidly replacing Humira, delivering 47% and 35% YoY growth in Q3 2025, with patent protection into the 2030s. ABBV's business mix is diversified, with immunology and neuroscience segments together driving double-digit revenue growth and supporting strong EPS prospects.", "url": "https://seekingalpha.com/article/4852308-abbvie-stock-unique-mix-of-growth-value"}}
{"date": "2025-12-10", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-10 12:19:49", "publisher": "24/7 Wall Street", "title": "This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence", "image": "https://images.financialmodelingprep.com/news/this-dividend-pharma-giant-yielding-29-just-got-a-20251210.jpg", "site": "247wallst.com", "text": "Healthcare stocks have lagged the broader market for the past three years, weighed down by post-COVID earnings volatility, policy uncertainties around drug pricing, and a surge in tech-driven gains from the AI boom.", "url": "https://247wallst.com/investing/2025/12/10/this-dividend-pharma-giant-yielding-2-9-just-got-a-big-vote-of-confidence/"}}
{"date": "2025-12-10", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-10 08:09:21", "publisher": "247 Wallst", "title": "Here Are Wednesdays Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More", "image": "https://images.financialmodelingprep.com/news/here-are-wednesdays-top-wall-street-analyst-research-calls-20251210.jpg", "site": "247wallst.com", "text": "Pre-Market Stock Futures: Futures are trading modestly lower as the big day has finally arrived: the Federal Reserve will wrap up its last meeting of 2025, and the odds still heavily favor a 25-basis-point rate hike. The worry hanging over traders is that many fear a \"hawkish rate cut.\" Where they do cut 25 basis... Here Are Wednesday's Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More.", "url": "https://247wallst.com/investing/2025/12/10/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-amazon-com-biogen-echostar-ferrari-ge-vernova-pepsico-take-two-interactive-and-more/"}}
{"date": "2025-12-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-09 10:55:17", "publisher": "The Motley Fool", "title": "1 Major Factor Behind the Healthcare Sector's Recent Surge", "image": "https://images.financialmodelingprep.com/news/1-major-factor-behind-the-healthcare-sectors-recent-surge-20251209.jpg", "site": "fool.com", "text": "Eli Lilly's GLP-1 drug became the world's best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other companies are soaring on new drugs or the growth of existing ones.", "url": "https://www.fool.com/investing/2025/12/09/major-factor-behind-healthcare-sector-surge/"}}
{"date": "2025-12-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-09 04:44:00", "publisher": "The Motley Fool", "title": "3 Top Dividend Stocks to Buy in December", "image": "https://images.financialmodelingprep.com/news/3-top-dividend-stocks-to-buy-in-december-20251209.jpg", "site": "fool.com", "text": "AbbVie is a Dividend King that has proven its resilience. Ares Capital offers an ultra-high yield, with solid near-term and long-term growth prospects.", "url": "https://www.fool.com/investing/2025/12/09/3-top-dividend-stocks-to-buy-in-december/"}}
{"date": "2025-12-08", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-08 18:46:20", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-falls-more-steeply-than-broader-market-what-20251208.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) concluded the recent trading session at $223.12, signifying a -1.31% move from its prior day's close.", "url": "https://www.zacks.com/stock/news/2801259/abbvie-abbv-falls-more-steeply-than-broader-market-what-investors-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2801259"}}
{"date": "2025-12-08", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-08 01:30:00", "publisher": "GlobeNewsWire", "title": "OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development", "image": "https://images.financialmodelingprep.com/news/ose-immunotherapeutics-announces-strategic-amendment-to-abbvies-partnership-on-20251208.jpg", "site": "globenewswire.com", "text": "OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development Strategic Amendment Enhances OSE Immunotherapeutics' Role in ABBV-230 Development While Preserving AbbVie's Long-Term Commitment NANTES, France, December 8 th , 2025  7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced an amendment to its partnership agreement with AbbVie regarding ABBV-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently in the pre-clinical development stage. Under the revised agreement, OSE Immunotherapeutics regains control of the early-stage development of the ABBV-230, while AbbVie maintains its rights to control future development and commercialization following successful completion of Phase 1.", "url": "https://www.globenewswire.com/news-release/2025/12/08/3201201/0/en/OSE-Immunotherapeutics-Announces-Strategic-Amendment-to-AbbVie-s-Partnership-on-ABBV-230-Development.html"}}
{"date": "2025-12-07", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-07 07:30:00", "publisher": "Seeking Alpha", "title": "The Generational Shift I See Now - And My 33 Stocks For What's Coming", "image": "https://images.financialmodelingprep.com/news/the-generational-shift-i-see-now-and-my-33-20251207.jpg", "site": "seekingalpha.com", "text": "I see a generational opportunity in quality stocks, defined by high ROE, stable earnings growth, and low debt. Quality stocks have underperformed AI-driven leaders, creating rare relative value and attractive risk/reward for diversified, income-focused investors. My screen highlights 33 U.S. large caps with 25% ROE and 2% yield, many trading at compelling valuations.", "url": "https://seekingalpha.com/article/4850802-the-generational-shift-i-see-now-and-my-33-stocks-for-whats-coming"}}
{"date": "2025-12-07", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-07 04:09:01", "publisher": "Defense World", "title": "Cerity Partners LLC Has $210.15 Million Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/cerity-partners-llc-has-21015-million-holdings-in-abbvie-20251207.jpg", "site": "defenseworld.net", "text": "Cerity Partners LLC increased its position in AbbVie Inc. (NYSE: ABBV) by 15.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,132,136 shares of the company's stock after acquiring an additional 153,108 shares during the quarter. Cerity Partners LLC owned about", "url": "https://www.defenseworld.net/2025/12/07/cerity-partners-llc-has-210-15-million-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-06", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-06 08:45:00", "publisher": "The Motley Fool", "title": "The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.", "image": "https://images.financialmodelingprep.com/news/the-pharmaceutical-sector-is-surging-heres-1-stock-every-20251206.jpg", "site": "fool.com", "text": "AbbVie's third-quarter results exceeded Wall Street's expectations. Sales from the pharmaceutical company's three top drugs are soaring.", "url": "https://www.fool.com/investing/2025/12/06/the-pharmaceutical-sector-is-surging-heres-1-stock/"}}
{"date": "2025-12-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-04 09:15:00", "publisher": "The Motley Fool", "title": "Could Buying AbbVie Today Set You Up for Life?", "image": "https://images.financialmodelingprep.com/news/could-buying-abbvie-today-set-you-up-for-life-20251204.jpg", "site": "fool.com", "text": "AbbVie has performed exceedingly well over the past 12 years. The company still has many of the traits that led to that result.", "url": "https://www.fool.com/investing/2025/12/04/could-buying-abbvie-today-set-you-up-for-life/"}}
{"date": "2025-12-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-04 08:40:19", "publisher": "Zacks Investment Research", "title": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?", "image": "https://images.financialmodelingprep.com/news/how-strong-is-abbvies-immunology-franchise-after-humiras-loe-20251204.jpg", "site": "zacks.com", "text": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.", "url": "https://www.zacks.com/stock/news/2799340/how-strong-is-abbvie-s-immunology-franchise-after-humira-s-loe?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2799340"}}
{"date": "2025-12-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-04 06:16:43", "publisher": "Defense World", "title": "Groupe la Francaise Purchases 6,466 Shares of AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/groupe-la-francaise-purchases-6466-shares-of-abbvie-inc-20251204.jpg", "site": "defenseworld.net", "text": "Groupe la Francaise lifted its position in shares of AbbVie Inc. (NYSE: ABBV) by 34.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,376 shares of the company's stock after acquiring an additional 6,466 shares during the period.", "url": "https://www.defenseworld.net/2025/12/04/groupe-la-francaise-purchases-6466-shares-of-abbvie-inc-abbv.html"}}
{"date": "2025-12-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-03 16:53:28", "publisher": "Seeking Alpha", "title": "AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-presents-at-piper-sandler-37th-annual-20251203.jpg", "site": "seekingalpha.com", "text": "AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript", "url": "https://seekingalpha.com/article/4850007-abbvie-inc-abbv-presents-at-piper-sandler-37th-annual-healthcare-conference-transcript"}}
{"date": "2025-12-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-03 10:01:07", "publisher": "Zacks Investment Research", "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-is-attracting-investor-attention-here-is-20251203.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "url": "https://www.zacks.com/stock/news/2798751/abbvie-inc-abbv-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2798751"}}
{"date": "2025-12-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-03 02:16:42", "publisher": "Defense World", "title": "AbbVie Inc. (NYSE:ABBV) Receives Average Rating of Moderate Buy from Analysts", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-nyseabbv-receives-average-rating-of-moderate-buy-20251203.jpg", "site": "defenseworld.net", "text": "AbbVie Inc. (NYSE: ABBV - Get Free Report) has earned an average recommendation of \"Moderate Buy\" from the twenty-five research firms that are covering the stock, MarketBeat reports. Ten investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating on the company.", "url": "https://www.defenseworld.net/2025/12/03/abbvie-inc-nyseabbv-receives-average-rating-of-moderate-buy-from-analysts.html"}}
{"date": "2025-12-02", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-02 08:15:00", "publisher": "PRNewsWire", "title": "AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers", "image": "https://images.financialmodelingprep.com/news/abbvie-to-feature-new-data-at-ash-2025-showcasing-20251202.jpg", "site": "prnewswire.com", "text": "Data being presented showcases AbbVie's breadth and depth of research across a range of therapeutic modalities such as T-Cell Engagers, BCL-2 Inhibitors and Antibody-Drug Conjugates for a spectrum of difficult-to-treat blood cancers NORTH CHICAGO, Ill. , Dec. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including  multiple myeloma (MM), follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), acute myeloid leukemia (AML) and amyloidosis (AL).", "url": "https://www.prnewswire.com/news-releases/abbvie-to-feature-new-data-at-ash-2025-showcasing-continued-advances-across-novel-treatment-modalities-in-multiple-blood-cancers-302630296.html"}}
{"date": "2025-12-02", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-02 03:23:00", "publisher": "PRNewsWire", "title": " l'occasion du 19e Congrs europen sur les cphales, AbbVie va prsenter les donnes de la phase 3 d'ECLIPSE dmontrant la supriorit de l'atogpant (AQUIPTA) par rapport au placebo dans le soulagement complet de la douleur pour le traitement aigu de la migraine", "image": "https://images.financialmodelingprep.com/news/-loccasion-du-19e-congrs-europen-sur-les-cphales-20251202.jpg", "site": "prnewswire.com", "text": "/PRNewswire/ -- AbbVie (NYSE: ABBV) a annonc aujourd'hui les premiers rsultats de l'tude pivot de phase 3 ECLIPSE, qui value l'innocuit, l'efficacit et", "url": "https://www.prnewswire.com/news-releases/a-loccasion-du-19e-congres-europeen-sur-les-cephalees-abbvie-va-presenter-les-donnees-de-la-phase-3-declipse-demontrant-la-superiorite-de-latogepant-aquipta-par-rapport-au-placebo-dans-le-soulagement-complet-de-la-douleur-p-302630129.html"}}
{"date": "2025-12-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-01 23:59:00", "publisher": "PRNewsWire", "title": "AbbVie prsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die berlegenheit von Atogepant (AQUIPTA) gegenber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migrne belegen", "image": "https://images.financialmodelingprep.com/news/abbvie-prsentiert-auf-dem-19-european-headache-congress-phase3daten-20251201.jpg", "site": "prnewswire.com", "text": "/PRNewswire/ -- AbbVie (NYSE: ABBV) hat heute die vorlufigen Ergebnisse der zulassungsrelevanten Phase-3-Studie ECLIPSE bekannt gegeben, in der die", "url": "https://www.prnewswire.com/news-releases/abbvie-prasentiert-auf-dem-19-european-headache-congress-phase-3-daten-aus-der-eclipse-studie-die-die-uberlegenheit-von-atogepant-aquipta-gegenuber-placebo-bei-der-schmerzlinderung-in-der-akutbehandlung-von-migrane-belegen-302629890.html"}}
{"date": "2025-12-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-01 12:16:00", "publisher": "PRNewsWire", "title": "AbbVie presentar datos de fase 3 de ECLIPSE en el 19 Congreso Europeo de Cefaleas", "image": "https://images.financialmodelingprep.com/news/abbvie-presentar-datos-de-fase-3-de-eclipse-en-20251201.jpg", "site": "prnewswire.com", "text": "- AbbVie presentar datos de fase 3 de ECLIPSE que demuestran la superioridad de Atogepant (AQUIPTA) sobre placebo para lograr la eliminacin del dolor en el", "url": "https://www.prnewswire.com/news-releases/abbvie-presentara-datos-de-fase-3-de-eclipse-en-el-19-congreso-europeo-de-cefaleas-302629315.html"}}
{"date": "2025-12-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-01 05:55:05", "publisher": "Seeking Alpha", "title": "AbbVie: Increased Outlook For 2025 And Expansions Merit Continued \"Strong Buy\" Rating", "image": "https://images.financialmodelingprep.com/news/abbvie-increased-outlook-for-2025-and-expansions-merit-continued-20251201.jpg", "site": "seekingalpha.com", "text": "AbbVie (ABBV) remains a \"Strong Buy\" due to robust growth in immunology and neuroscience portfolios, offsetting Humira's decline. ABBV's oncology segment is poised for expansion with trispecific antibody ISB 2001 for relapsed/refractory multiple myeloma and Epkinly's third FDA approval. Epkinly's rapid sales growth and multiple ongoing phase 3 studies signal further upside potential in ABBV's oncology pipeline.", "url": "https://seekingalpha.com/article/4848894-abbvie-increased-outlook-for-2025-and-expansions-merit-continued-strong-buy-rating"}}
{"date": "2025-12-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-01 04:00:00", "publisher": "PRNewsWire", "title": "AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress", "image": "https://images.financialmodelingprep.com/news/abbvie-to-present-phase-3-eclipse-data-demonstrating-atogepant-20251201.jpg", "site": "prnewswire.com", "text": "/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced primary results from the pivotal Phase 3 ECLIPSE study, evaluating the safety, efficacy and tolerability of", "url": "https://www.prnewswire.com/news-releases/abbvie-to-present-phase-3-eclipse-data-demonstrating-atogepant-aquipta-superiority-over-placebo-in-achieving-pain-freedom-for-the-acute-treatment-of-migraine-at-the-19th-european-headache-congress-302628656.html"}}
{"date": "2025-12-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-01 03:30:54", "publisher": "Defense World", "title": "BLI Banque de Luxembourg Investments Has $1.82 Million Stock Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/bli-banque-de-luxembourg-investments-has-182-million-stock-20251201.jpg", "site": "defenseworld.net", "text": "BLI Banque de Luxembourg Investments trimmed its position in AbbVie Inc. (NYSE: ABBV) by 15.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,999 shares of the company's stock after selling 1,800 shares during the quarter. BLI Banque de Luxembourg", "url": "https://www.defenseworld.net/2025/12/01/bli-banque-de-luxembourg-investments-has-1-82-million-stock-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-12-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-12-01 03:30:49", "publisher": "Defense World", "title": "Boston Family Office LLC Has $13.36 Million Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/boston-family-office-llc-has-1336-million-holdings-in-20251201.jpg", "site": "defenseworld.net", "text": "Boston Family Office LLC lessened its position in AbbVie Inc. (NYSE: ABBV) by 0.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 72,035 shares of the company's stock after selling 581 shares during the quarter. Boston Family Office LLC's holdings in", "url": "https://www.defenseworld.net/2025/12/01/boston-family-office-llc-has-13-36-million-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-29 15:30:00", "publisher": "The Motley Fool", "title": "3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years", "image": "https://images.financialmodelingprep.com/news/3-highyielding-dividend-growth-stocks-that-can-generate-passive-20251129.jpg", "site": "fool.com", "text": "The stocks listed below yield between 2.7% and 3.5%. They are in different sectors of the economy and can help diversify your portfolio while also generating plenty of recurring cash flow.", "url": "https://www.fool.com/investing/2025/11/29/high-yield-dividend-growth-stocks-passive-income/"}}
{"date": "2025-11-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-29 08:02:04", "publisher": "Seeking Alpha", "title": "Best Dividend Aristocrats For December 2025", "image": "https://images.financialmodelingprep.com/news/best-dividend-aristocrats-for-december-2025-20251129.jpg", "site": "seekingalpha.com", "text": "The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among Aristocrats averages 5.46% for 2025, with most constituents announcing increases, though growth is slightly below 2024 levels.", "url": "https://seekingalpha.com/article/4848726-best-dividend-aristocrats-for-december-2025"}}
{"date": "2025-11-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-29 03:27:02", "publisher": "Defense World", "title": "Berry Wealth Group LP Has $3.12 Million Stock Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/berry-wealth-group-lp-has-312-million-stock-holdings-20251129.jpg", "site": "defenseworld.net", "text": "Berry Wealth Group LP increased its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 479.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,804 shares of the company's stock after buying an additional 13,903 shares during the quarter.", "url": "https://www.defenseworld.net/2025/11/29/berry-wealth-group-lp-has-3-12-million-stock-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-29 03:26:57", "publisher": "Defense World", "title": "Balanced Wealth Group LLC Raises Stock Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/balanced-wealth-group-llc-raises-stock-holdings-in-abbvie-20251129.jpg", "site": "defenseworld.net", "text": "Balanced Wealth Group LLC lifted its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 23.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,609 shares of the company's stock after buying an additional 691 shares during", "url": "https://www.defenseworld.net/2025/11/29/balanced-wealth-group-llc-raises-stock-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-28 07:01:00", "publisher": "Globe News Wire", "title": "LAgence des mdicaments du Canada met une recommandation positive pour le remboursement de SKYRIZI (risankizumab) pour le traitement de la colite ulcreuse, et AbbVie conclut une lettre dintention avec lAlliance pharmaceutique pancanadienne", "image": "https://images.financialmodelingprep.com/news/lagence-des-mdicaments-du-canada-met-une-recommandation-positive-20251128.jpeg", "site": "globenewswire.com", "text": "SKYRIZI, un inhibiteur de l'interleukine 23 (IL-23), a fait l'objet de deux recommandations conscutives de l'Agence des mdicaments du Canada (AMC) visant son remboursement pour le traitement des maladies inflammatoires de l'intestin, initialement pour la maladie de Crohn et maintenant pour la colite ulcreuse.", "url": "https://www.globenewswire.com/news-release/2025/11/28/3196206/0/fr/L-Agence-des-m%C3%A9dicaments-du-Canada-%C3%A9met-une-recommandation-positive-pour-le-remboursement-de-SKYRIZI-risankizumab-pour-le-traitement-de-la-colite-ulc%C3%A9reuse-et-AbbVie-conclut-une-le.html"}}
{"date": "2025-11-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-28 07:01:00", "publisher": "GlobeNewsWire", "title": "SKYRIZI (risankizumab) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance", "image": "https://images.financialmodelingprep.com/news/skyrizi-risankizumab-receives-positive-reimbursement-recommendation-by-canadas-drug-20251128.jpg", "site": "globenewswire.com", "text": "MONTREAL, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV) has announced two positive updates for Canadians living with ulcerative colitis (UC).", "url": "https://www.globenewswire.com/news-release/2025/11/28/3196206/0/en/SKYRIZI-risankizumab-Receives-Positive-Reimbursement-Recommendation-by-Canada-s-Drug-Agency-for-Ulcerative-Colitis-and-AbbVie-Concludes-Letter-of-Intent-with-the-pan-Canadian-Pharm.html"}}
{"date": "2025-11-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-28 05:30:00", "publisher": "The Motley Fool", "title": "8 Dividend Stocks Every Investor Should Consider", "image": "https://images.financialmodelingprep.com/news/8-dividend-stocks-every-investor-should-consider-20251128.jpg", "site": "fool.com", "text": "Dividend investing isn't just about yield -- payout ratio and growth potential matter too. Several of these companies have increased dividends for decades without interruption.", "url": "https://www.fool.com/investing/2025/11/28/8-dividend-stocks-every-investor-should-consider/"}}
{"date": "2025-11-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-26 11:45:58", "publisher": "Zacks Investment Research", "title": "AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights", "image": "https://images.financialmodelingprep.com/news/abbvie-and-pfizer-a-closer-look-at-two-pharma-20251126.jpg", "site": "zacks.com", "text": "ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.", "url": "https://www.zacks.com/stock/news/2796033/abbvie-and-pfizer-a-closer-look-at-two-pharma-heavyweights?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2796033"}}
{"date": "2025-11-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-25 09:30:00", "publisher": "GlobeNewsWire", "title": "AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec", "image": "https://images.financialmodelingprep.com/news/abbvie-and-admare-bioinnovations-foster-life-sciences-innovation-with-20251125.jpg", "site": "globenewswire.com", "text": "MONTREAL, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV), jointly with the adMare BioInnovations, announced the launch of the AbbVie Biotech Innovators Award, a prize to help foster innovation and support growth in Quebec's life sciences sector.", "url": "https://www.globenewswire.com/news-release/2025/11/25/3194446/0/en/AbbVie-and-adMare-BioInnovations-Foster-Life-Sciences-Innovation-with-the-Launch-of-the-AbbVie-Biotech-Innovators-Award-in-Quebec.html"}}
{"date": "2025-11-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-25 04:44:43", "publisher": "Defense World", "title": "Advisors Asset Management Inc. Has $13.75 Million Stock Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/advisors-asset-management-inc-has-1375-million-stock-position-20251125.jpg", "site": "defenseworld.net", "text": "Advisors Asset Management Inc. cut its stake in shares of AbbVie Inc. (NYSE: ABBV) by 3.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,091 shares of the company's stock after selling 2,840 shares during the period. Advisors Asset Management Inc.'s holdings in", "url": "https://www.defenseworld.net/2025/11/25/advisors-asset-management-inc-has-13-75-million-stock-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-25 04:05:02", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Bought by Aviso Financial Inc.", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-bought-by-aviso-financial-inc-20251125.jpg", "site": "defenseworld.net", "text": "Aviso Financial Inc. increased its stake in shares of AbbVie Inc. (NYSE: ABBV) by 4.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,764 shares of the company's stock after purchasing an additional 494 shares during the quarter. Aviso", "url": "https://www.defenseworld.net/2025/11/25/abbvie-inc-abbv-shares-bought-by-aviso-financial-inc.html"}}
{"date": "2025-11-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-25 03:30:57", "publisher": "Defense World", "title": "Associated Banc Corp Has $6.43 Million Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/associated-banc-corp-has-643-million-holdings-in-abbvie-20251125.jpg", "site": "defenseworld.net", "text": "Associated Banc Corp raised its holdings in AbbVie Inc. (NYSE: ABBV) by 1.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 34,643 shares of the company's stock after buying an additional 600 shares during the quarter. Associated Banc Corp's holdings in AbbVie", "url": "https://www.defenseworld.net/2025/11/25/associated-banc-corp-has-6-43-million-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-24", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-24 08:00:00", "publisher": "PRNewsWire", "title": "AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/abbvie-to-present-at-the-piper-sandler-37th-annual-20251124.jpg", "site": "prnewswire.com", "text": "NORTH CHICAGO, Ill. , Nov. 24, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025.", "url": "https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-piper-sandler-37th-annual-healthcare-conference-302623535.html"}}
{"date": "2025-11-24", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-24 07:25:00", "publisher": "The Motley Fool", "title": "5 Dividend Stocks to Hold for the Next 10 Years", "image": "https://images.financialmodelingprep.com/news/5-dividend-stocks-to-hold-for-the-next-10-20251124.jpg", "site": "fool.com", "text": "These dividend stocks represent the communications services, energy, financial services, healthcare, and real estate sectors. All of them have attractive dividend yields.", "url": "https://www.fool.com/investing/2025/11/24/5-dividend-stocks-to-hold-for-the-next-10-years/"}}
{"date": "2025-11-24", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-24 06:11:05", "publisher": "Zacks Investment Research", "title": "The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc", "image": "https://images.financialmodelingprep.com/news/the-zacks-analyst-blog-jpmorgan-netflix-abbvie-and-ohio-20251124.jpg", "site": "zacks.com", "text": "JPM shows solid operational strength as analysts highlight its NII outlook, fee pressures and expense trajectory through 2027.", "url": "https://www.zacks.com/stock/news/2794500/the-zacks-analyst-blog-jpmorgan-netflix-abbvie-and-ohio-valley-banc?cid=CS-STOCKNEWSAPI-FT-press_releases-2794500"}}
{"date": "2025-11-23", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-23 04:24:45", "publisher": "Defense World", "title": "American Century Companies Inc. Boosts Stock Position in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/american-century-companies-inc-boosts-stock-position-in-abbvie-20251123.jpg", "site": "defenseworld.net", "text": "American Century Companies Inc. increased its stake in shares of AbbVie Inc. (NYSE: ABBV) by 11.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,428,814 shares of the company's stock after buying an additional 349,973 shares during the period. AbbVie comprises about 0.3%", "url": "https://www.defenseworld.net/2025/11/23/american-century-companies-inc-boosts-stock-position-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-22 07:32:43", "publisher": "Defense World", "title": "Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/bank-julius-baer-co-ltd-zurich-lowers-stock-holdings-20251122.jpg", "site": "defenseworld.net", "text": "Bank Julius Baer and Co. Ltd Zurich cut its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 3.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,690 shares of the company's stock after selling 1,538 shares during the", "url": "https://www.defenseworld.net/2025/11/22/bank-julius-baer-co-ltd-zurich-lowers-stock-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-22 07:32:43", "publisher": "Defense World", "title": "AXQ Capital LP Increases Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/axq-capital-lp-increases-holdings-in-abbvie-inc-abbv-20251122.jpg", "site": "defenseworld.net", "text": "AXQ Capital LP raised its stake in AbbVie Inc. (NYSE: ABBV) by 21.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,978 shares of the company's stock after purchasing an additional 1,762 shares during the quarter. AbbVie comprises about", "url": "https://www.defenseworld.net/2025/11/22/axq-capital-lp-increases-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-22 04:18:53", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Bought by AlphaCore Capital LLC", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-bought-by-alphacore-capital-llc-20251122.jpg", "site": "defenseworld.net", "text": "AlphaCore Capital LLC increased its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 17.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,029 shares of the company's stock after purchasing an additional 4,182 shares during", "url": "https://www.defenseworld.net/2025/11/22/abbvie-inc-abbv-shares-bought-by-alphacore-capital-llc.html"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 18:00:00", "publisher": "GuruFocus", "title": "Jeff Auxier's Strategic Moves: Fiserv Inc. Takes Center Stage with 0.24% Portfolio Impact", "image": "https://images.financialmodelingprep.com/news/jeff-auxiers-strategic-moves-fiserv-inc-takes-center-stage-20251119.png", "site": "gurufocus.com", "text": "Insightful Analysis of Jeff Auxier (Trades, Portfolio)'s Third Quarter 2025 13F Filing Jeff Auxier (Trades, Portfolio) recently submitted the 13F filing for th", "url": "https://www.gurufocus.com/news/3217361/jeff-auxiers-strategic-moves-fiserv-inc-takes-center-stage-with-024-portfolio-impact"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 12:23:33", "publisher": "24/7 Wall Street", "title": "2 Dividend Stocks to Hold Through Any Market Cycle", "image": "https://images.financialmodelingprep.com/news/2-dividend-stocks-to-hold-through-any-market-cycle-20251119.jpg", "site": "247wallst.com", "text": "Trying to build a portfolio that can survive recessions, inflation, and market volatility is one of the biggest challenges any investor can face.", "url": "https://247wallst.com/investing/2025/11/19/2-dividend-stocks-to-hold-through-any-market-cycle/"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 10:10:52", "publisher": "Zacks Investment Research", "title": "AbbVie Stock Rebounds After Q3 Dip: Time to Buy, Hold or Sell?", "image": "https://images.financialmodelingprep.com/news/abbvie-stock-rebounds-after-q3-dip-time-to-buy-20251119.jpg", "site": "zacks.com", "text": "ABBV rebounds after its Q3 dip as strong immunology and neuroscience growth offset Humira erosion and aesthetics weakness.", "url": "https://www.zacks.com/stock/news/2792944/abbvie-stock-rebounds-after-q3-dip-time-to-buy-hold-or-sell?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2792944"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 10:01:47", "publisher": "Zacks Investment Research", "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-is-a-trending-stock-facts-to-20251119.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "url": "https://www.zacks.com/stock/news/2792934/abbvie-inc-abbv-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2792934"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 08:25:00", "publisher": "MarketBeat", "title": "Healthcare Rotation Underway: 3 Stocks Leading the Charge", "image": "https://images.financialmodelingprep.com/news/healthcare-rotation-underway-3-stocks-leading-the-charge-20251119.jpg", "site": "marketbeat.com", "text": "Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, the industry is starting to feel the weight of expectations, and many of the tech sector's biggest winners have been struggling amidst a volatile market.", "url": "https://www.marketbeat.com/originals/healthcare-rotation-underway-3-stocks-leading-the-charge/"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 04:34:43", "publisher": "Defense World", "title": "Aspen Investment Management Inc Has $895,000 Holdings in AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/aspen-investment-management-inc-has-895000-holdings-in-abbvie-inc-20251119.jpg", "site": "defenseworld.net", "text": "Aspen Investment Management Inc grew its position in AbbVie Inc. (NYSE: ABBV) by 6.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,823 shares of the company's stock after buying an additional 290 shares during the", "url": "https://www.defenseworld.net/2025/11/19/aspen-investment-management-inc-has-895000-holdings-in-abbvie-inc-abbv.html"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 03:56:48", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Shares Bought by ARS Investment Partners LLC", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-shares-bought-by-ars-investment-partners-llc-20251119.jpg", "site": "defenseworld.net", "text": "ARS Investment Partners LLC increased its position in AbbVie Inc. (NYSE: ABBV) by 1.3% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 29,389 shares of the company's stock after buying an additional 383 shares during the quarter.", "url": "https://www.defenseworld.net/2025/11/19/abbvie-inc-abbv-shares-bought-by-ars-investment-partners-llc.html"}}
{"date": "2025-11-19", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-19 03:09:02", "publisher": "Defense World", "title": "AbbVie Inc. $ABBV Stock Position Lowered by Alteri Wealth LLC", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-stock-position-lowered-by-alteri-wealth-llc-20251119.jpg", "site": "defenseworld.net", "text": "Alteri Wealth LLC trimmed its position in shares of AbbVie Inc. (NYSE: ABBV) by 21.7% during the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,526 shares of the company's stock after selling 1,528 shares during the period. Alteri Wealth LLC's holdings in", "url": "https://www.defenseworld.net/2025/11/19/abbvie-inc-abbv-stock-position-lowered-by-alteri-wealth-llc.html"}}
{"date": "2025-11-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-18 12:47:00", "publisher": "PRNewsWire", "title": "AbbVie Announces U.S. FDA Approval of EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma", "image": "https://images.financialmodelingprep.com/news/abbvie-announces-us-fda-approval-of-epkinly-epcoritamabbysp-in-20251118.jpg", "site": "prnewswire.com", "text": "- EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available for patients with relapsed or refractory follicular lymphoma after at least one line of systemic therapy - In the Phase 3 EPCORE FL-1 trial, EPKINLY + R2 demonstrated significantly superior progression-free survival and overall response rates compared to standard of care R2 with approximately 3 out of 4 patients achieving a complete response - Approval marks third indication for EPKINLY and first-ever FDA approval for a bispecific combination therapy in lymphoma NORTH CHICAGO, Ill. , Nov. 18, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that EPKINLY (epcoritamab-bysp), a T-cell engaging bispecific antibody administered subcutaneously, in combination with rituximab and lenalidomide (EPKINLY + R2) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL).", "url": "https://www.prnewswire.com/news-releases/abbvie-announces-us-fda-approval-of-epkinly-epcoritamab-bysp-in-combination-with-rituximab-and-lenalidomide-for-relapsed-or-refractory-follicular-lymphoma-302618968.html"}}
{"date": "2025-11-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-18 10:41:57", "publisher": "Zacks Investment Research", "title": "Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3", "image": "https://images.financialmodelingprep.com/news/heres-how-neuroscience-drugs-aided-abbvies-topline-growth-in-20251118.jpg", "site": "zacks.com", "text": "ABBV's neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD treatments fueling growth.", "url": "https://www.zacks.com/stock/news/2792456/here-s-how-neuroscience-drugs-aided-abbvie-s-top-line-growth-in-q3?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2792456"}}
{"date": "2025-11-18", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-18 09:00:00", "publisher": "Seeking Alpha", "title": "It's Best Time In 10 Years To Lock In Income: Our Picks", "image": "https://images.financialmodelingprep.com/news/its-best-time-in-10-years-to-lock-in-20251118.jpg", "site": "seekingalpha.com", "text": "Investors can now access 47% from top-quality REITs, 3.5%+ from dividend ETFs, and 6%+ from midstream infrastructure  without taking on excessive risk. While the S&P 500 is up ~110% since 2020, 7080% of returns come from the Mag7, leaving broad-market returns near inflation levels. US inflation sits at 3%, and Western Europe reports 3.54%, emphasizing the need for income-producing assets to preserve purchasing power for retirees.", "url": "https://seekingalpha.com/article/4844515-its-best-time-in-10-years-to-lock-in-income-our-picks"}}
{"date": "2025-11-15", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-15 07:25:00", "publisher": "The Motley Fool", "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.", "image": "https://images.financialmodelingprep.com/news/want-decades-of-passive-income-3-stocks-to-buy-20251115.jpg", "site": "fool.com", "text": "AbbVie is a Dividend King with a bright future. Enbridge offers an especially dependable dividend.", "url": "https://www.fool.com/investing/2025/11/15/want-decades-of-passive-income-3-stocks-to-buy-now/"}}
{"date": "2025-11-14", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-14 16:31:33", "publisher": "Seeking Alpha", "title": "AbbVie Inc. (ABBV) Presents at 7th Annual Healthcare Symposium Transcript", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-presents-at-7th-annual-healthcare-symposium-20251114.jpg", "site": "seekingalpha.com", "text": "AbbVie Inc. ( ABBV ) 7th Annual Healthcare Symposium November 14, 2025 11:55 AM EST Company Participants Michael Paas Conference Call Participants Elena Meng Michelle Kehily Stephen Morse Magdalena Sobieszczyk Presentation Operator Okay, everyone, if we can wrap up our conversations so that we can get started and come to the main room. So our final panel today is about vaccines.", "url": "https://seekingalpha.com/article/4843997-abbvie-inc-abbv-presents-at-7th-annual-healthcare-symposium-transcript"}}
{"date": "2025-11-14", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-14 15:19:12", "publisher": "CNBC Television", "title": "Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman", "image": "https://images.financialmodelingprep.com/news/biopharma-companies-have-confidence-in-their-ability-to-do-20251114.jpg", "site": "youtube.com", "text": "Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.", "url": "https://www.youtube.com/watch?v=X24CQW_cpss"}}
{"date": "2025-11-14", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-14 04:12:52", "publisher": "Defense World", "title": "Arvest Bank Trust Division Sells 323 Shares of AbbVie Inc. $ABBV", "image": "https://images.financialmodelingprep.com/news/arvest-bank-trust-division-sells-323-shares-of-abbvie-inc-20251114.jpg", "site": "defenseworld.net", "text": "Arvest Bank Trust Division decreased its stake in shares of AbbVie Inc. (NYSE: ABBV) by 0.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 94,971 shares of the company's stock after selling 323 shares during the quarter. AbbVie comprises about", "url": "https://www.defenseworld.net/2025/11/14/arvest-bank-trust-division-sells-323-shares-of-abbvie-inc-abbv.html"}}
{"date": "2025-11-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-13 16:02:00", "publisher": "GuruFocus", "title": "Robert Bruce's Strategic Moves: AT&T Inc. Sees a -1.41% Portfolio Impact", "image": "https://images.financialmodelingprep.com/news/robert-bruces-strategic-moves-att-inc-sees-a-141-portfolio-20251113.png", "site": "gurufocus.com", "text": "Insightful Analysis of Robert Bruce (Trades, Portfolio)'s Third Quarter 2025 13F Filing Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for", "url": "https://www.gurufocus.com/news/3207779/robert-bruces-strategic-moves-att-inc-sees-a-141-portfolio-impact"}}
{"date": "2025-11-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-13 08:30:00", "publisher": "PRNewsWire", "title": "AbbVie Announces 20 Recipients of Migraine Career Catalyst Award", "image": "https://images.financialmodelingprep.com/news/abbvie-announces-20-recipients-of-migraine-career-catalyst-award-20251113.jpg", "site": "prnewswire.com", "text": "As a leader in migraine treatment, AbbVie is committed to addressing the impact of migraine in the workplace. 2025 honorees represent a diverse group of achieversfrom teachers and authors to small business owners and aspiring yoga and meditation instructorseach redefining success while living with migraine.", "url": "https://www.prnewswire.com/news-releases/abbvie-announces-20-recipients-of-migraine-career-catalyst-award-302613759.html"}}
{"date": "2025-11-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-13 08:10:11", "publisher": "24/7 Wall Street", "title": "Here Are Thursday's Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More", "image": "https://images.financialmodelingprep.com/news/here-are-thursdays-top-wall-street-analyst-research-calls-20251113.jpg", "site": "247wallst.com", "text": "The stock futures are trading lower on Thursday, following another incredible day for the Dow Jones Industrials, while the rotation out of the NASDAQ and into technology is still gaining traction.", "url": "https://247wallst.com/investing/2025/11/13/here-are-thursdays-top-wall-street-analyst-research-calls-abbvie-applovin-autozone-booking-holdings-coreweave-doordash-and-more/"}}
{"date": "2025-11-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-12 15:06:26", "publisher": "Benzinga", "title": "AbbVie Shares Rise To Intraday High After Key Trading Signal", "image": "https://images.financialmodelingprep.com/news/abbvie-shares-rise-to-intraday-high-after-key-trading-20251112.jpg", "site": "benzinga.com", "text": "AbbVie Inc (NYSE:ABBV) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:04 AM EST on November 12, ABBV triggered a Power Inflow signal at a price of $228.47. In the hour leading up to the Power Inflow signal, ABBV's stock price had some slight pullback following the initial price rise that occurred earlier in the day.", "url": "https://www.benzinga.com/Opinion/25/11/48816772/abbvie-shares-rise-to-intraday-high-after-key-trading-signal"}}
{"date": "2025-11-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-12 12:56:11", "publisher": "Zacks Investment Research", "title": "How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?", "image": "https://images.financialmodelingprep.com/news/how-much-did-skyrizi-and-rinvoq-drive-abbvies-q3-performance-20251112.jpg", "site": "zacks.com", "text": "ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.", "url": "https://www.zacks.com/stock/news/2790121/how-much-did-skyrizi-and-rinvoq-drive-abbvie-s-q3-performance?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2790121"}}
{"date": "2025-11-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-12 08:30:00", "publisher": "PRNewsWire", "title": "Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence", "image": "https://images.financialmodelingprep.com/news/allergan-aesthetics-unveils-new-data-at-2025-american-society-20251112.jpg", "site": "prnewswire.com", "text": "-A total of 17 abstracts, including three accepted for presentation in the Cosmetic \"Top Ten\" Session, underscore Allergan Aesthetics' global industry leadership across multiple aesthetic categories -Oral abstract presentations include Phase 3 clinical study results for first-in-class botulinum neurotoxin serotype E(trenibotulinumtoxinE) and results from a Phase 4 study evaluating natural outcomes and patient satisfaction in a diverse population following use of 64 units of BOTOXCosmetic (onabotulinumtoxinA) for treatment of upper facial lines - Expert panel discussion explores new Hyaluronic Acid Injectable Fillers Report, along with current use, facts, and real-world satisfaction data IRVINE, Calif. , Nov. 12, 2025 /PRNewswire/ --Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of Dermatologic Surgery (ASDS) Annual Meeting, November 13-16, 2025, in Chicago, Illinois.", "url": "https://www.prnewswire.com/news-releases/allergan-aesthetics-unveils-new-data-at-2025-american-society-for-dermatologic-surgery-annual-meeting-showcasing-transformative-innovation-and-portfolio-excellence-302611934.html"}}
{"date": "2025-11-12", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-12 08:30:00", "publisher": "GlobeNewsWire", "title": "Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders", "image": "https://images.financialmodelingprep.com/news/chiesi-group-enters-into-an-exclusive-license-agreement-with-20251112.jpg", "site": "globenewswire.com", "text": "PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain barrier (BBB)-crossing platform technology in lysosomal storage disorders (LSD) to address challenging disease areas with high unmet need.", "url": "https://www.globenewswire.com/news-release/2025/11/12/3186250/0/en/Chiesi-Group-Enters-into-an-Exclusive-License-Agreement-with-Aliada-Therapeutics-a-Wholly-Owned-Subsidiary-of-AbbVie-to-Advance-Blood-Brain-Barrier-Crossing-Platform-Technology-in-.html"}}
{"date": "2025-11-11", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-11 22:40:33", "publisher": "Seeking Alpha", "title": "AbbVie Has Many Bullish Attributes (Technical Analysis)", "image": "https://images.financialmodelingprep.com/news/abbvie-has-many-bullish-attributes-technical-analysis-20251111.jpg", "site": "seekingalpha.com", "text": "AbbVie presents a bullish outlook supported by positive earnings, a strong dividend, and robust technical indicators. ABBV beat Q3 earnings and revenue expectations, raised full-year EPS guidance, and boasts a promising drug pipeline with strong Skyrizi and Rinvoq sales. Technically, ABBV trades above its 30-week EMA, shows bullish momentum, increasing institutional volume, and has outperformed the S&P 500 this year.", "url": "https://seekingalpha.com/article/4842247-abbvie-has-many-bullish-attributes-technical-analysis"}}
{"date": "2025-11-11", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-11 10:50:08", "publisher": "The Motley Fool", "title": "Three Healthcare Buys That Wall Street Loves", "image": "https://images.financialmodelingprep.com/news/three-healthcare-buys-that-wall-street-loves-20251111.jpg", "site": "fool.com", "text": "New technologies and an aging population are lifting the healthcare sector. Immunotherapy and anti-obesity drugs are leading the way.", "url": "https://www.fool.com/investing/2025/11/11/three-healthcare-buys-that-wall-street-loves/"}}
{"date": "2025-11-11", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-11 08:49:00", "publisher": "The Motley Fool", "title": "5 Top Stocks to Buy in November", "image": "https://images.financialmodelingprep.com/news/5-top-stocks-to-buy-in-november-20251111.jpg", "site": "fool.com", "text": "As we wind down 2025, the markets are looking shaky and I want my portfolio to be well diversified in the case of a recession or market correction. As such, in today's video I am going to take all this into consideration and dive into five top stocks I believe could be great additions to your portfolio moving forward.", "url": "https://www.fool.com/investing/2025/11/11/5-top-stocks-to-buy-in-november/"}}
{"date": "2025-11-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-09 11:05:00", "publisher": "The Motley Fool", "title": "What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.", "image": "https://images.financialmodelingprep.com/news/what-is-considered-a-good-stock-dividend-3-healthcare-stocks-20251109.jpg", "site": "fool.com", "text": "Skyrizi and Rinvoq sales are pushing AbbVie's sales higher. UnitedHealth Group raised its full-year guidance and is rebounding from a disastrous 2025.", "url": "https://www.fool.com/investing/2025/11/09/what-is-considered-a-good-stock-dividend-3-healthc/"}}
{"date": "2025-11-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-09 04:21:00", "publisher": "The Motley Fool", "title": "Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now", "image": "https://images.financialmodelingprep.com/news/got-5000-these-are-3-of-the-cheapest-growth-20251109.jpg", "site": "fool.com", "text": "The stocks listed here trade at forward price-to-earnings multiples of less than 20. They have underrated growth prospects, which could set them up for better-than-expected gains in the long run.", "url": "https://www.fool.com/investing/2025/11/09/got-5000-these-are-3-of-the-cheapest-growth-stocks/"}}
{"date": "2025-11-08", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-08 06:38:43", "publisher": "Seeking Alpha", "title": "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer", "image": "https://images.financialmodelingprep.com/news/healthcare-q3-dividend-roundup-i-prefer-abbvie-over-pfizer-20251108.jpg", "site": "seekingalpha.com", "text": "AbbVie's and Pfizer's Q3 earnings and dividend updates prompt a rating upgrade to Hold for ABBV and reiteration of Sell for PFE. PFE's higher yield (almost 7%) and single-digit P/E (FY1 P/E is ~8x only) can be attractive for deep value investors. The high yield and cheap valuation are for good reasons.", "url": "https://seekingalpha.com/article/4840843-healthcare-q3-dividend-roundup-i-prefer-abbvie-over-pfizer"}}
{"date": "2025-11-05", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-05 10:01:09", "publisher": "Zacks Investment Research", "title": "Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know", "image": "https://images.financialmodelingprep.com/news/investors-heavily-search-abbvie-inc-abbv-here-is-what-20251105.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2785517/investors-heavily-search-abbvie-inc-abbv-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2785517"}}
{"date": "2025-11-05", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-05 02:42:53", "publisher": "Defense World", "title": "AbbVie (NYSE:ABBV) Stock Price Up 1.9% After Analyst Upgrade", "image": "https://images.financialmodelingprep.com/news/abbvie-nyseabbv-stock-price-up-19-after-analyst-upgrade-20251105.jpg", "site": "defenseworld.net", "text": "AbbVie Inc. (NYSE: ABBV - Get Free Report)'s stock price was up 1.9% during mid-day trading on Tuesday after JPMorgan Chase and Co. raised their price target on the stock from $250.00 to $260.00. JPMorgan Chase and Co. currently has an overweight rating on the stock. AbbVie traded as high as $217.08 and last traded at", "url": "https://www.defenseworld.net/2025/11/05/abbvie-nyseabbv-stock-price-up-1-9-after-analyst-upgrade.html"}}
{"date": "2025-11-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-04 08:11:43", "publisher": "24/7 Wall Street", "title": "Here Are Tuesday's Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More", "image": "https://images.financialmodelingprep.com/news/here-are-tuesdays-top-wall-street-analyst-research-calls-20251104.jpg", "site": "247wallst.com", "text": "The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir's 6.9% decline despite beating earnings expectations and giving strong forward guidance.", "url": "https://247wallst.com/investing/2025/11/04/here-are-tuesdays-top-wall-street-analyst-research-calls-apple-abbvie-broadcom-cyberark-palantir-technologies-and-more/"}}
{"date": "2025-11-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-04 05:15:00", "publisher": "The Motley Fool", "title": "2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon", "image": "https://images.financialmodelingprep.com/news/2-healthcare-stocks-for-individual-investors-with-a-10year-20251104.jpg", "site": "fool.com", "text": "Long-term investors shouldn't overlook this top pharma stock and top medical device maker. AbbVie is seeing impressive growth from both its immunology portfolio and neuroscience products.", "url": "https://www.fool.com/investing/2025/11/04/2-healthcare-stocks-for-individual-investors-with/"}}
{"date": "2025-11-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-04 03:05:04", "publisher": "Defense World", "title": "Best Medical Stocks To Watch Today  November 2nd", "image": "https://images.financialmodelingprep.com/news/best-medical-stocks-to-watch-today-november-2nd-20251104.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Pfizer, UnitedHealth Group, AbbVie, and Johnson and Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. \"Medical stocks\" are shares of publicly traded companies that operate in the healthcare sector, including pharmaceutical and biotechnology firms, medical device makers, hospitals, diagnostic labs, and health services providers.", "url": "https://www.defenseworld.net/2025/11/04/best-medical-stocks-to-watch-today-november-2nd.html"}}
{"date": "2025-11-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-04 03:05:01", "publisher": "Defense World", "title": "Top Pharmaceutical Stocks To Follow Now  November 2nd", "image": "https://images.financialmodelingprep.com/news/top-pharmaceutical-stocks-to-follow-now-november-2nd-20251104.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Pfizer, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and commercialize prescription drugs, vaccines, and related therapies. For investors, they offer exposure to significant R&D and regulatory risk-stock performance is heavily", "url": "https://www.defenseworld.net/2025/11/04/top-pharmaceutical-stocks-to-follow-now-november-2nd.html"}}
{"date": "2025-11-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-03 07:30:00", "publisher": "The Motley Fool", "title": "My Favorite Dividend King to Buy in November", "image": "https://images.financialmodelingprep.com/news/my-favorite-dividend-king-to-buy-in-november-20251103.jpg", "site": "fool.com", "text": "AbbVie has increased its dividend for 53 consecutive years and more than quadrupled its dividend since 2013. The drugmaker has a clear growth runway thanks to rising stars in its lineup and a promising pipeline.", "url": "https://www.fool.com/investing/2025/11/03/my-favorite-dividend-king-to-buy-in-november/"}}
{"date": "2025-11-02", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-02 09:15:00", "publisher": "The Motley Fool", "title": "2 Magnificent Dividend Stocks to Buy and Hold Forever", "image": "https://images.financialmodelingprep.com/news/2-magnificent-dividend-stocks-to-buy-and-hold-forever-20251102.jpg", "site": "fool.com", "text": "Investing in strong dividend stocks is a great way to earn better-than-average long-term returns. AbbVie has a reliable, non-cyclical business and a long and impressive track record of dividend growth.", "url": "https://www.fool.com/investing/2025/11/02/2-magnificent-dividend-stocks-to-buy-hold-forever/"}}
{"date": "2025-11-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-01 23:15:00", "publisher": "Seeking Alpha", "title": "ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November", "image": "https://images.financialmodelingprep.com/news/adp-snapon-lead-14-companies-to-announce-annual-increases-in-20251101.jpg", "site": "seekingalpha.com", "text": "This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. The pattern of modest dividend increases continues, with only three of 19 companies announcing double-digit percentage boosts in October. November brings a larger chance of 10%+ increases from several companies, including industrials Roper Technologies and Snap-on, and healthcare companies Becton, Dickinson and Cencora.", "url": "https://seekingalpha.com/article/4836708-adp-snap-on-lead-14-companies-to-announce-annual-increases-first-half-november"}}
{"date": "2025-11-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-01 12:36:08", "publisher": "MarketBeat", "title": "ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat", "image": "https://images.financialmodelingprep.com/news/abbv-stock-250-may-be-the-new-floor-after-20251101.jpg", "site": "marketbeat.com", "text": "AbbVie Inc. NYSE: ABBV delivered a strong third-quarter earnings report with a beat on the top and bottom lines and an increase in its forward guidance. The results clear the way for ABBV stock to make $250 the new floor for the stock.", "url": "https://www.marketbeat.com/originals/abbv-stock-250-may-be-the-new-floor-after-beat-and-raise-quarter/"}}
{"date": "2025-11-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-01 10:25:22", "publisher": "Seeking Alpha", "title": "Best Dividend Aristocrats For November 2025", "image": "https://images.financialmodelingprep.com/news/best-dividend-aristocrats-for-november-2025-20251101.jpg", "site": "seekingalpha.com", "text": "The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW, and IBM have delivered strong double-digit returns this year. Dividend growth for the Aristocrats in 2025 averages 5.27%, with most constituents raising payouts, though growth may not exceed 2024's rate.", "url": "https://seekingalpha.com/article/4836679-best-dividend-aristocrats-for-november-2025"}}
{"date": "2025-11-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-11-01 06:15:00", "publisher": "The Motley Fool", "title": "Why AbbVie Stock Flopped on Friday", "image": "https://images.financialmodelingprep.com/news/why-abbvie-stock-flopped-on-friday-20251101.jpg", "site": "fool.com", "text": "Despite the pharmaceutical giant's beat-and-raise third quarter, investors were expecting better. Profitability guidance, even though it was raised, came in under analyst estimates.", "url": "https://www.fool.com/investing/2025/11/01/why-abbvie-stock-flopped-on-friday/"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 15:56:23", "publisher": "Seeking Alpha", "title": "AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-q3-2025-earnings-call-transcript-20251031.jpg", "site": "seekingalpha.com", "text": "AbbVie Inc. ( ABBV ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Elizabeth Shea - Senior Vice President of Investor Relations Robert Michael - CEO & Chairman of the Board Jeffrey Stewart - Executive VP & Chief Commercial Officer Roopal Thakkar - Executive VP of Research and Development & Chief Scientific Officer Scott Reents - Executive VP & CFO Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Vamil Divan - Guggenheim Securities, LLC, Research Division Matthew Phipps - William Blair & Company L.L.C., Research Division David Amsellem - Piper Sandler & Co., Research Division David Risinger - Leerink Partners LLC, Research Division Steve Scala - TD Cowen, Research Division Simon Baker - Rothschild & Co Redburn, Research Division Luisa Hector - Joh.", "url": "https://seekingalpha.com/article/4836381-abbvie-inc-abbv-q3-2025-earnings-call-transcript"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 15:21:14", "publisher": "Zacks Investment Research", "title": "AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised", "image": "https://images.financialmodelingprep.com/news/abbvie-q3-earnings-sales-beat-2025-eps-outlook-raised-20251031.jpg", "site": "zacks.com", "text": "ABBV tops Q3 earnings and revenue estimates, driven by Rinvoq and Skyrizi gains, and lifts its 2025 EPS outlook.", "url": "https://www.zacks.com/stock/news/2782920/abbvie-q3-earnings-sales-beat-2025-eps-outlook-raised?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2782920"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 12:20:50", "publisher": "Zacks Investment Research", "title": "Demographic Megatrend: Stocks Poised to Benefit From Global Aging", "image": "https://images.financialmodelingprep.com/news/demographic-megatrend-stocks-poised-to-benefit-from-global-aging-20251031.jpg", "site": "zacks.com", "text": "Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.", "url": "https://www.zacks.com/stock/news/2782782/demographic-megatrend-stocks-poised-to-benefit-from-global-aging?cid=CS-STOCKNEWSAPI-FT-seniors_&_aging-2782782"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 12:20:41", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-q3-earnings-how-key-metrics-compare-to-20251031.jpg", "site": "zacks.com", "text": "While the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.", "url": "https://www.zacks.com/stock/news/2782812/abbvie-abbv-q3-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2782812"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 11:47:20", "publisher": "Benzinga", "title": "AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend", "image": "https://images.financialmodelingprep.com/news/abbvie-raises-2025-outlook-helped-by-strong-immunology-growth-20251031.jpg", "site": "benzinga.com", "text": "AbbVie Inc. (NYSE:ABBV) reported third-quarter 2025 sales of $15.78 billion on Friday, beating the consensus of$15.59 billion.", "url": "https://www.benzinga.com/markets/earnings/25/10/48564942/abbvie-raises-2025-outlook-helped-by-strong-immunology-growth-boost-dividend"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 10:39:51", "publisher": "Seeking Alpha", "title": "AbbVie: Why Q3 Confirms Its Immunology Dominance", "image": "https://images.financialmodelingprep.com/news/abbvie-why-q3-confirms-its-immunology-dominance-20251031.jpg", "site": "seekingalpha.com", "text": "AbbVie Inc., 2 hours ago, published monstrous results for Q3, once again strengthening my confidence that it is a \"powerhouse\" in the autoimmune disease drugs market. Net revenues from AbbVie's immunology portfolio totaled $7.89 billion this quarter, compared to $7.05 billion in Q3 2024. Sales of Elahere, an ADC used to treat ovarian cancer, reached $170 million in Q3 2025, up 22.3% year-on-year and 6.9% quarter-on-quarter.", "url": "https://seekingalpha.com/article/4836301-abbvie-why-q3-confirms-its-immunology-dominance"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 10:00:59", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Q3 Earnings and Revenues Surpass Estimates", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-q3-earnings-and-revenues-surpass-estimates-20251031.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $3 per share a year ago.", "url": "https://www.zacks.com/stock/news/2782486/abbvie-abbv-q3-earnings-and-revenues-surpass-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2782486"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 09:02:38", "publisher": "24/7 Wall Street", "title": "5 Dividend ETFs That Could Pay You for Life", "image": "https://images.financialmodelingprep.com/news/5-dividend-etfs-that-could-pay-you-for-life-20251031.jpg", "site": "247wallst.com", "text": "Whether you're just beginning to invest or sailing into retirement, you can benefit from a lifetime stream of passive income.", "url": "https://247wallst.com/investing/2025/10/31/5-dividend-etfs-that-could-pay-you-for-life/"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 08:42:00", "publisher": "WSJ", "title": "AbbVie Lifts Profit Outlook as Sales Rise", "image": "https://images.financialmodelingprep.com/news/abbvie-lifts-profit-outlook-as-sales-rise-20251031.jpg", "site": "wsj.com", "text": "AbbVie raised its full-year adjusted earnings outlook, even though profit was pressured by increased expenses during the third quarter.", "url": "https://www.wsj.com/business/earnings/abbvie-lifts-profit-outlook-as-sales-rise-2db042c4"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 08:20:00", "publisher": "Barrons", "title": "AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings.", "image": "https://images.financialmodelingprep.com/news/abbvie-beats-thirdquarter-estimates-theres-more-to-the-drugmakers-20251031.jpg", "site": "barrons.com", "text": "Revenue attributed to AbbVie's oncology and aesthetics portfolio declined in the quarter.", "url": "https://www.barrons.com/articles/abbvie-earnings-stock-price-15008c13"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 07:54:43", "publisher": "Reuters", "title": "AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs", "image": "https://images.financialmodelingprep.com/news/abbvie-lifts-annual-profit-forecast-on-resilient-demand-for-20251031.jpg", "site": "reuters.com", "text": "AbbVie raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq helped boost third-quarter results above Wall Street estimates.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-lifts-annual-profit-forecast-resilient-demand-newer-immunology-drugs-2025-10-31/"}}
{"date": "2025-10-31", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-31 07:49:00", "publisher": "PRNewsWire", "title": "AbbVie Reports Third-Quarter 2025 Financial Results", "image": "https://images.financialmodelingprep.com/news/abbvie-reports-thirdquarter-2025-financial-results-20251031.jpg", "site": "prnewswire.com", "text": "Reports Third-Quarter Diluted EPS of $0.10 on a GAAP Basis, a Decrease of 88.6 Percent; Adjusted Diluted EPS of $1.86, a Decrease of 38.0 Percent; These Results Include an Unfavorable Impact of $1.50 Per Share Related to Acquired IPR&D and Milestones Expense  Delivers Third-Quarter Net Revenues of $15.776 Billion, an Increase of 9.1 Percent on a Reported Basis or 8.4 Percent on an Operational Basis  Third -Quarter Global Net Revenues from the Immunology Portfolio Were $7.885 Billion, an Increase of 11.9 Percent on a Reported Basis, or 11.2 Percent on an Operational Basis; Global Skyrizi Net Revenues Were $4.708 Billion; Global Rinvoq Net Revenues Were $2.184 Billion; Global Humira Net Revenues Were $993 Million  Third -Quarter Global Net Revenues from the Neuroscience Portfolio Were $2.841 Billion, an Increase of 20.2 Percent on a Reported Basis, or 19.6 Percent on an Operational Basis; Global Vraylar Net Revenues Were $934 Million; Global Botox Therapeutic Net Revenues Were $985 Million; Combined Global Ubrelvy and Qulipta Net Revenues Were $642 Million  Third -Quarter Global Net Revenues from the Oncology Portfolio Were $1.682 Billion, a Decrease of 0.3 Percent on a Reported Basis, or 1.3 Percent on an Operational Basis; Global Imbruvica Net Revenues Were $706 Million; Global Venclexta Net Revenues Were $726 Million; Global Elahere Net Revenues Were $170 Million  Third -Quarter Global Net Revenues from the Aesthetics Portfolio Were $1.193 Billion, a Decrease of 3.7 Percent on a Reported Basis, or 4.2 Percent on an Operational Basis; Global Botox Cosmetic Net Revenues Were $637 Million; Global Juvederm Net Revenues Were $253 Million  Raises 2025 Adjusted Diluted EPS Guidance Range from $10.38 - $10.58 to $10.61 - $10.65, which Includes an Unfavorable Impact of $2.05 Per Share Related to Acquired IPR&D and Milestones Expense Incurred Year-To-Date Through the Third Quarter 2025  Announces 2026 Dividend Increase of 5.5 Percent, Beginning with Dividend Payable in February 2026 NORTH CHICAGO, Ill. , Oct. 31, 2025 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2025.", "url": "https://www.prnewswire.com/news-releases/abbvie-reports-third-quarter-2025-financial-results-302600511.html"}}
{"date": "2025-10-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-29 17:00:00", "publisher": "PRNewsWire", "title": "The One & Only BOTOX Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year", "image": "https://images.financialmodelingprep.com/news/the-one-only-botox-cosmetic-onabotulinumtoxina-day-returns-november-19-20251029.jpeg", "site": "prnewswire.com", "text": "Allergan Aesthetics gives patients exciting BOTOX Cosmetic offers only in the All app Buy one $50 gift card, get one free, plus, register, book a consultation, and get treated for a chance to win $25,000*  IRVINE, Calif. , Oct. 29, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the seventh annual BOTOX Cosmetic Daywill take place on Wednesday, November 19, 2025.", "url": "https://www.prnewswire.com/news-releases/the-one--only-botox-cosmetic-onabotulinumtoxina-day-returns-november-19-with-the-biggest-celebration-of-the-year-302598960.html"}}
{"date": "2025-10-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-29 08:11:00", "publisher": "PRNewsWire", "title": "AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ) in Adults and Adolescents with Vitiligo", "image": "https://images.financialmodelingprep.com/news/abbvie-announces-positive-topline-results-from-phase-3-pivotal-20251029.jpg", "site": "prnewswire.com", "text": "In two replicate Phase 3 studies, upadacitinib (RINVOQ  ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial Vitiligo Area Scoring Index (F-VASI 75) from baseline at week 481 Both studies met key ranked secondary endpoints1 NORTH CHICAGO, Ill. , Oct. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announcedpositive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib (RINVOQ;15 mg, once daily in adult and adolescent patients living with non-segmental vitiligo (NSV).1 NSV, the most common form of vitiligo (occurring in over 90% of patients), is characterized by symmetrical and bilateral white patches on both sides of the body.2-4 \"Vitiligo is more than a skin condition  it's a chronic autoimmune disease that can deeply affect a person's confidence, identity and daily life,\"said Kori Wallace, M.D.", "url": "https://www.prnewswire.com/news-releases/abbvie-announces-positive-topline-results-from-phase-3-pivotal-studies-evaluating-upadacitinib-rinvoq-in-adults-and-adolescents-with-vitiligo-302597634.html"}}
{"date": "2025-10-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-28 11:28:40", "publisher": "Seeking Alpha", "title": "AbbVie: Deep Discount Before Earnings", "image": "https://images.financialmodelingprep.com/news/abbvie-deep-discount-before-earnings-20251028.jpg", "site": "seekingalpha.com", "text": "AbbVie Inc. is reiterated as a Strong Buy ahead of Q3 earnings, with revenue growth expected to outpace the sector median. ABBV consistently delivers double beats, maintains robust FCF margins, and is investing aggressively in R&D for future growth. The DDM model suggests ABBV is significantly undervalued, with a fair value estimate indicating 27% upside potential over the next year.", "url": "https://seekingalpha.com/article/4834058-abbvie-deep-discount-before-earnings"}}
{"date": "2025-10-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-28 10:40:55", "publisher": "CNBC", "title": "Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings", "image": "https://images.financialmodelingprep.com/news/healthy-returns-what-to-expect-from-eli-lilly-merck-20251028.jpg", "site": "cnbc.com", "text": "Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.", "url": "https://www.cnbc.com/2025/10/28/healthy-returns-eli-lilly-merck-gilead-and-abbvie-earnings-preview.html"}}
{"date": "2025-10-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-28 09:50:41", "publisher": "Zacks Investment Research", "title": "Should You Buy AbbVie Stock Ahead of Q3 Earnings Report?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-abbvie-stock-ahead-of-q3-earnings-20251028.jpg", "site": "zacks.com", "text": "ABBV's Q3 results are likely to hinge on Skyrizi and Rinvoq growth, as Humira erosion and hefty IPR&D charges are expected to pressure near-term earnings.", "url": "https://www.zacks.com/stock/news/2778719/should-you-buy-abbvie-stock-ahead-of-q3-earnings-report?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2778719"}}
{"date": "2025-10-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-28 06:26:00", "publisher": "The Motley Fool", "title": "Billionaire Israel \"Izzy\" Englander Has Loaded Up on This Dividend King. Should You?", "image": "https://images.financialmodelingprep.com/news/billionaire-israel-izzy-englander-has-loaded-up-on-this-20251028.jpg", "site": "fool.com", "text": "Englander more than quintupled his hedge fund's position in AbbVie in Q2. AbbVie offers an impressive dividend record and a solid dividend yield.", "url": "https://www.fool.com/investing/2025/10/28/billionaire-israel-izzy-englander-has-loaded-up-on/"}}
{"date": "2025-10-27", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-27 12:06:06", "publisher": "Zacks Investment Research", "title": "What's in Store for These 5 Pharma Bigwigs This Earnings Season?", "image": "https://images.financialmodelingprep.com/news/whats-in-store-for-these-5-pharma-bigwigs-this-earnings-20251027.jpg", "site": "zacks.com", "text": "As earnings season accelerates, pharma heavyweights LLY, MRK, ABBV, BMY and GILD prepare to reveal their Q3 results amid a strong sector start.", "url": "https://www.zacks.com/stock/news/2777998/what-s-in-store-for-these-5-pharma-bigwigs-this-earnings-season?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_preview_esp-2777998"}}
{"date": "2025-10-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-26 11:21:00", "publisher": "The Motley Fool", "title": "Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade", "image": "https://images.financialmodelingprep.com/news/prediction-these-dividend-stocks-could-outperform-growth-stocks-in-20251026.jpg", "site": "fool.com", "text": "AbbVie put a major patent cliff behind it, and won't face another one anytime soon. Apple is building up its services business while looking for ways to get around the threat of tariffs.", "url": "https://www.fool.com/investing/2025/10/26/prediction-these-dividend-stocks-could-outperform/"}}
{"date": "2025-10-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-26 07:01:35", "publisher": "Seeking Alpha", "title": "Wall Street Week Ahead", "image": "https://images.financialmodelingprep.com/news/wall-street-week-ahead-20251026.jpg", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.", "url": "https://seekingalpha.com/article/4833469-wall-street-week-ahead"}}
{"date": "2025-10-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-26 02:40:50", "publisher": "Defense World", "title": "Pharmaceutical Stocks To Watch Now  October 24th", "image": "https://images.financialmodelingprep.com/news/pharmaceutical-stocks-to-watch-now-october-24th-20251026.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Wellgistics Health, Pfizer, AbbVie, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies engaged in the research, development, manufacturing, and sale of prescription drugs, biologics, and vaccines. For investors, these stocks are typically driven by factors like", "url": "https://www.defenseworld.net/2025/10/26/pharmaceutical-stocks-to-watch-now-october-24th.html"}}
{"date": "2025-10-24", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-24 11:01:21", "publisher": "Zacks Investment Research", "title": "Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for", "image": "https://images.financialmodelingprep.com/news/analysts-estimate-abbvie-abbv-to-report-a-decline-in-20251024.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/2776444/analysts-estimate-abbvie-abbv-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2776444"}}
{"date": "2025-10-24", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-24 10:31:20", "publisher": "Zacks Investment Research", "title": "Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?", "image": "https://images.financialmodelingprep.com/news/wall-street-analysts-think-abbvie-abbv-is-a-good-20251024.jpg", "site": "zacks.com", "text": "The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.", "url": "https://www.zacks.com/stock/news/2776296/wall-street-analysts-think-abbvie-abbv-is-a-good-investment-is-it?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2776296"}}
{"date": "2025-10-23", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-23 13:07:54", "publisher": "The Motley Fool", "title": "AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth", "image": "https://images.financialmodelingprep.com/news/abbvie-draws-growing-institutional-confidence-as-investors-seek-steady-20251023.jpg", "site": "fool.com", "text": "Added 304,281 shares in AbbVie; estimated transaction value of $61.96 million Trade value was 0.23% of the fund's reportable U.S. equity assets under management Post-trade stake: 2,324,286 shares valued at $538.17 million as of September 30, 2025 The position now accounts for 2.01% of 13F assets, placing it outside the fund's top five holdings", "url": "https://www.fool.com/coverage/filings/2025/10/23/los-angeles-capital-loads-up-abbv-with-304k-shares/"}}
{"date": "2025-10-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-22 19:00:00", "publisher": "The Motley Fool", "title": "AbbVie: Navigating Challenges and Seizing Opportunities in the Pharma Sector", "image": "https://images.financialmodelingprep.com/news/abbvie-navigating-challenges-and-seizing-opportunities-in-the-pharma-20251022.jpg", "site": "fool.com", "text": "Explore the exciting world of AbbVie (ABBV 1.17%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!", "url": "https://www.fool.com/investing/2025/10/22/abbvie-navigating-challenges-and-seizing-opportuni/"}}
{"date": "2025-10-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-22 18:45:50", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-sees-a-more-significant-dip-than-broader-20251022.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) concluded the recent trading session at $228.68, signifying a -1.17% move from its prior day's close.", "url": "https://www.zacks.com/stock/news/2774600/abbvie-abbv-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2774600"}}
{"date": "2025-10-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-22 11:30:39", "publisher": "Zacks Investment Research", "title": "AbbVie Up More Than 30% in 6 Months: How to Play the Stock", "image": "https://images.financialmodelingprep.com/news/abbvie-up-more-than-30-in-6-months-how-20251022.jpg", "site": "zacks.com", "text": "AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.", "url": "https://www.zacks.com/stock/news/2774259/abbvie-up-more-than-30-in-6-months-how-to-play-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2774259"}}
{"date": "2025-10-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-22 10:00:20", "publisher": "Zacks Investment Research", "title": "Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock", "image": "https://images.financialmodelingprep.com/news/here-is-what-to-know-beyond-why-abbvie-inc-20251022.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2773877/here-is-what-to-know-beyond-why-abbvie-inc-abbv-is-a-trending-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2773877"}}
{"date": "2025-10-21", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-21 21:01:12", "publisher": "Zacks Investment Research", "title": "This 3 Stocks Portfolio Provides Monthly Income", "image": "https://images.financialmodelingprep.com/news/this-3-stocks-portfolio-provides-monthly-income-20251021.webp", "site": "zacks.com", "text": "Who doesn't like payday? Investors can structure a portfolio that provides monthly income with this combination of three stocks.", "url": "https://www.zacks.com/stock/news/2773645/this-3-stocks-portfolio-provides-monthly-income?cid=CS-STOCKNEWSAPI-FT-stocks_in_the_news-2773645"}}
{"date": "2025-10-21", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-21 14:27:27", "publisher": "CNBC Television", "title": "Final Trades: Abbvie, Qualcomm, Aptiv, and Palo Alto Networks", "image": "https://images.financialmodelingprep.com/news/final-trades-abbvie-qualcomm-aptiv-and-palo-alto-networks-20251021.jpg", "site": "youtube.com", "text": "The Investment Committee give you their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=P4SFPbDCTN8"}}
{"date": "2025-10-21", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-21 08:00:00", "publisher": "PRNewsWire", "title": "The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients", "image": "https://images.financialmodelingprep.com/news/the-confidence-project-by-botox-cosmetic-onabotulinumtoxina-unveils-this-20251021.jpeg", "site": "prnewswire.com", "text": "Each winner will be awarded a $20,000 grant to fuel their businesses. Since the program's inception, BOTOX Cosmetic has awarded more than $1 million in grants to The Confidence Project entrepreneurs.", "url": "https://www.prnewswire.com/news-releases/the-confidence-project-by-botox-cosmetic-onabotulinumtoxina-unveils-this-years-grant-recipients-302589714.html"}}
{"date": "2025-10-20", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-20 11:11:14", "publisher": "Zacks Investment Research", "title": "Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings", "image": "https://images.financialmodelingprep.com/news/heres-what-to-expect-from-abbvies-oncology-segment-in-q3-20251020.jpg", "site": "zacks.com", "text": "ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's decline.", "url": "https://www.zacks.com/stock/news/2772367/here-s-what-to-expect-from-abbvie-s-oncology-segment-in-q3-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2772367"}}
{"date": "2025-10-20", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-20 08:12:53", "publisher": "Reuters", "title": "AbbVie's Rinvoq shows superiority over Humira in head-to-head study", "image": "https://images.financialmodelingprep.com/news/abbvies-rinvoq-shows-superiority-over-humira-in-headtohead-study-20251020.jpg", "site": "reuters.com", "text": "AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira, meeting the main goal of a head-to-head trial.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-rinvoq-shows-superiority-over-humira-head-to-head-study-2025-10-20/"}}
{"date": "2025-10-20", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-20 08:00:00", "publisher": "PRNewsWire", "title": "RINVOQ (upadacitinib) Demonstrated Superiority Versus HUMIRA (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor", "image": "https://images.financialmodelingprep.com/news/rinvoq-upadacitinib-demonstrated-superiority-versus-humira-adalimumab-for-primary-20251020.jpg", "site": "prnewswire.com", "text": "Upadacitinib demonstrated superiority versus adalimumab for primary endpoint of achieving low disease activity (DAS28-CRP3.2) and ranked secondary endpoint of remission(DAS28-CRP", "url": "https://www.prnewswire.com/news-releases/rinvoq-upadacitinib-demonstrated-superiority-versus-humira-adalimumab-for-primary-endpoint-in-a-head-to-head-study-in-rheumatoid-arthritis-patients-who-have-failed-first-tnf-inhibitor-302588110.html"}}
{"date": "2025-10-17", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-17 16:34:32", "publisher": "Seeking Alpha", "title": "AbbVie: \"Strong Buy\" On Rinvoq Expansions And Immunology Pipeline Addition", "image": "https://images.financialmodelingprep.com/news/abbvie-strong-buy-on-rinvoq-expansions-and-immunology-pipeline-addition-20251017.jpg", "site": "seekingalpha.com", "text": "AbbVie earns a Strong Buy rating in my book, driven by Rinvoq's label expansions and robust immunology pipeline growth. ABBV achieved FDA approval for Rinvoq in giant cell arteritis and reported strong phase 3 results for severe alopecia areata, supporting long-term revenue growth. The acquisition of Capstan Therapeutics brings CPTX2309, a first-in-class tLNP CAR-T candidate, potentially transforming B-cell autoimmune disorder treatment landscape.", "url": "https://seekingalpha.com/article/4830869-abbvie-strong-buy-on-rinvoq-expansions-and-immunology-pipeline-addition"}}
{"date": "2025-10-17", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-17 09:00:00", "publisher": "PRNewsWire", "title": "AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin", "image": "https://images.financialmodelingprep.com/news/abbvie-completes-acquisition-of-gilgamesh-pharmaceuticals-bretisilocin-20251017.jpg", "site": "prnewswire.com", "text": "Acquisition expandsAbbVie's psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). NORTH CHICAGO, Ill.", "url": "https://www.prnewswire.com/news-releases/abbvie-completes-acquisition-of-gilgamesh-pharmaceuticals-bretisilocin-302587587.html"}}
{"date": "2025-10-16", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-16 06:45:00", "publisher": "The Motley Fool", "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.", "image": "https://images.financialmodelingprep.com/news/want-decades-of-passive-income-3-stocks-to-buy-now-20251016.jpg", "site": "fool.com", "text": "The idea of steady money flowing in, year after year, should appeal to nearly everyone. This isn't an unrealistic dream; investing in stocks that pay reliable dividends can make it a reality.", "url": "https://www.fool.com/investing/2025/10/16/want-decades-of-passive-income-3-stocks-to-buy-now/"}}
{"date": "2025-10-15", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-15 18:46:09", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-stock-falls-amid-market-uptick-what-investors-20251015.jpg", "site": "zacks.com", "text": "The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.", "url": "https://www.zacks.com/stock/news/2769637/abbvie-abbv-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2769637"}}
{"date": "2025-10-15", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-15 08:00:00", "publisher": "Business Wire", "title": "Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal", "image": "https://images.financialmodelingprep.com/news/enveric-biosciences-hires-ip-powerhouse-to-defend-its-us-20251015.jpg", "site": "businesswire.com", "text": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals (Gilgamesh) against Enveric's issued U.S. Patent No. 12,138,276 (the'276 patent,) entitled,.", "url": "https://www.businesswire.com/news/home/20251015624378/en/Enveric-Biosciences-Hires-IP-Powerhouse-to-Defend-Its-U.S.-Patent-with-Claims-Relevant-to-Bretisilocin-Recently-Acquired-by-AbbVie-in-1.2-Billion-Deal/"}}
{"date": "2025-10-14", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-14 12:11:06", "publisher": "Zacks Investment Research", "title": "Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?", "image": "https://images.financialmodelingprep.com/news/can-rinvoq-and-skyrizi-sales-drive-another-strong-quarter-20251014.jpg", "site": "zacks.com", "text": "ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.", "url": "https://www.zacks.com/stock/news/2768457/can-rinvoq-and-skyrizi-sales-drive-another-strong-quarter-for-abbvie?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2768457"}}
{"date": "2025-10-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-13 13:28:00", "publisher": "CNBC Television", "title": "Final Trades: Abbvie, Amazon, Datadog and Sixth Street Specialty Lending", "image": "https://images.financialmodelingprep.com/news/final-trades-abbvie-amazon-datadog-and-sixth-street-specialty-20251013.jpg", "site": "youtube.com", "text": "The Investment Committee give you their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=M4V_gplcadI"}}
{"date": "2025-10-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-13 10:57:00", "publisher": "PRNewsWire", "title": "U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ (upadacitinib) for the Treatment of Inflammatory Bowel Disease", "image": "https://images.financialmodelingprep.com/news/us-food-and-drug-administration-fda-approves-updated-indication-20251013.jpg", "site": "prnewswire.com", "text": "-    Updated indication allows the use of RINVOQ (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically inadvisable and who have received at least one approved systemic therapy NORTH CHICAGO, Ill. , Oct. 13, 2025 /PRNewswire/ --AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn's disease (CD).", "url": "https://www.prnewswire.com/news-releases/us-food-and-drug-administration-fda-approves-updated-indication-statement-for-rinvoq-upadacitinib-for-the-treatment-of-inflammatory-bowel-disease-302582159.html"}}
{"date": "2025-10-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-13 09:53:00", "publisher": "The Motley Fool", "title": "2 Dividend Stocks to Double Up on Right Now", "image": "https://images.financialmodelingprep.com/news/2-dividend-stocks-to-double-up-on-right-now-20251013.jpg", "site": "fool.com", "text": "Dividend stocks never go out of style, but they might be even more worthy of consideration right now because some evidence suggests that troubles lie ahead. The government shutdown and remaining uncertainty regarding tariffs could rock the economy or equity markets (or both).", "url": "https://www.fool.com/investing/2025/10/13/2-dividend-stocks-to-double-up-on-right-now/"}}
{"date": "2025-10-13", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-13 07:15:00", "publisher": "PRNewsWire", "title": "AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors", "image": "https://images.financialmodelingprep.com/news/abbvie-to-present-new-data-at-esmo-2025-reinforcing-leadership-20251013.jpg", "site": "prnewswire.com", "text": "New data fromtelisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC portfolio designed to target difficult-to-treat cancers. NORTH CHICAGO, Ill.", "url": "https://www.prnewswire.com/news-releases/abbvie-to-present-new-data-at-esmo-2025-reinforcing-leadership-in-advancing-targeted-therapies-for-solid-tumors-302581936.html"}}
{"date": "2025-10-10", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-10 10:01:08", "publisher": "Zacks Investment Research", "title": "Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?", "image": "https://images.financialmodelingprep.com/news/is-trending-stock-abbvie-inc-abbv-a-buy-now-20251010.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2766090/is-trending-stock-abbvie-inc-abbv-a-buy-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2766090"}}
{"date": "2025-10-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-09 11:19:09", "publisher": "The Motley Fool", "title": "Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing", "image": "https://images.financialmodelingprep.com/news/carolina-wealth-trims-its-abbvie-stake-to-nearly-nothing-20251009.png", "site": "fool.com", "text": "Carolina Wealth Advisors, LLC disclosed in an Oct. 7, 2025, U.S. Securities and Exchange Commission filing that it sold 38,267 AbbVie shares for the quarter ended Sept. 30, 2025, an estimated $7.79 million trade based on quarterly average pricing.", "url": "https://www.fool.com/coverage/filings/2025/10/09/carolina-wealth-dumps-38k-abbv-shares-worth-78-million/"}}
{"date": "2025-10-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-09 11:16:07", "publisher": "Zacks Investment Research", "title": "AbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025?", "image": "https://images.financialmodelingprep.com/news/abbvie-vs-eli-lilly-which-large-drugmaker-has-the-20251009.jpg", "site": "zacks.com", "text": "Lilly's explosive GLP-1 growth and AbbVie's post-Humira rebound set up a fierce 2025 showdown between two pharma powerhouses.", "url": "https://www.zacks.com/stock/news/2765491/abbvie-vs-eli-lilly-which-large-drugmaker-has-the-edge-in-2025?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2765491"}}
{"date": "2025-10-09", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-09 08:00:00", "publisher": "PRNewsWire", "title": "SkinMedica Debuts Reimagined Packaging and Unveils New HA5 Hydra Collagen Water Burst Moisturizer", "image": "https://images.financialmodelingprep.com/news/skinmedica-debuts-reimagined-packaging-and-unveils-new-ha5-hydra-20251009.jpg", "site": "prnewswire.com", "text": "By the makers of BOTOX Cosmetic (onabotulinumtoxinA), SkinMedica's new packaging features a refreshed logo, modernized look, and luxe copper color palette. The brand's new HA5 moisturizer is designed to support the skin barrier and microbiome for bouncy, dewy, and soft skin.", "url": "https://www.prnewswire.com/news-releases/skinmedica-debuts-reimagined-packaging-and-unveils-new-ha5-hydra-collagen-water-burst-moisturizer-302579065.html"}}
{"date": "2025-10-08", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-08 07:17:01", "publisher": "MarketBeat", "title": "Why AbbVie and Johnson & Johnson Could Outperform Pfizer", "image": "https://images.financialmodelingprep.com/news/why-abbvie-and-johnson-johnson-could-outperform-pfizer-20251008.jpg", "site": "marketbeat.com", "text": "Pfizer Inc. NYSE: PFE made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of around $23.61 on Sept.", "url": "https://www.marketbeat.com/stock-ideas/why-abbvie-and-johnson-and-johnson-could-outperform-pfizer/"}}
{"date": "2025-10-08", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-08 03:41:35", "publisher": "The Motley Fool", "title": "Why AbbVie Stock Soared in September", "image": "https://images.financialmodelingprep.com/news/why-abbvie-stock-soared-in-september-20251008.jpg", "site": "fool.com", "text": "Any pharmaceutical company as large and sprawling as AbbVie (ABBV 1.41%) never stops being busy, from pushing investigational drugs along the development pipeline to shipping blockbuster medications to pharmacies.", "url": "https://www.fool.com/investing/2025/10/08/why-abbvie-stock-soared-in-september/"}}
{"date": "2025-10-07", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-07 04:44:00", "publisher": "The Motley Fool", "title": "3 Dividend Stocks to Double Up On Right Now", "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-to-double-up-on-right-now-20251007.jpg", "site": "fool.com", "text": "If x is good, isn't 2x even better? Usually. Granted, there can be too much of a good thing.", "url": "https://www.fool.com/investing/2025/10/07/3-dividend-stocks-to-double-up-on-right-now/"}}
{"date": "2025-10-06", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-06 17:25:00", "publisher": "MarketBeat", "title": "3 Exceptional Stocks to Build Long-Term Wealth", "image": "https://images.financialmodelingprep.com/news/3-exceptional-stocks-to-build-longterm-wealth-20251006.jpg", "site": "marketbeat.com", "text": "Blue-chip stocks come to mind. The companies behind these stocks are mature that generate significant profits that they return to shareholders in the form of buybacks and dividends.", "url": "https://www.marketbeat.com/stock-ideas/3-exceptional-stocks-to-build-long-term-wealth/"}}
{"date": "2025-10-06", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-06 13:29:00", "publisher": "Seeking Alpha", "title": "My Top 5 Biotech Stocks Big Pharma Could Buy Next", "image": "https://images.financialmodelingprep.com/news/my-top-5-biotech-stocks-big-pharma-could-buy-20251006.jpg", "site": "seekingalpha.com", "text": "While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of Mr. Market's interest zone. Since the exclusivity of key blockbusters of 'giants', including Merck andPfizer, expires in the next 4 years, there is an urgent need to continue rejuvenating their portfolios of drugs.", "url": "https://seekingalpha.com/article/4828107-my-top-5-biotech-stocks-big-pharma-could-buy-next"}}
{"date": "2025-10-06", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-06 11:16:06", "publisher": "Zacks Investment Research", "title": "AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week?", "image": "https://images.financialmodelingprep.com/news/abbvie-stock-on-the-move-what-sparked-the-6-20251006.jpg", "site": "zacks.com", "text": "ABBV shares rose 6% last week as optimism swept the pharma sector after Pfizer's landmark drug-pricing deal with the Trump administration.", "url": "https://www.zacks.com/stock/news/2762791/abbvie-stock-on-the-move-what-sparked-the-6-jump-in-the-past-week?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2762791"}}
{"date": "2025-10-06", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-06 09:00:00", "publisher": "PRNewsWire", "title": "AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX) for the Treatment of Upper Limb Essential Tremor", "image": "https://images.financialmodelingprep.com/news/abbvie-announces-positive-topline-results-from-phase-2-elate-20251006.jpg", "site": "prnewswire.com", "text": "OnabotulinumtoxinA (BOTOX) met the primary endpoint in the Phase 2 trial, demonstrating a statistically significant improvement from baseline in the Tremor Disability Scale-Revised (TREDS-R) total unilateral score compared to placebo.1 The trial also met all six secondary endpoints.2 Results from safety analyses were generally consistent with the well-established safety profile of onabotulinumtoxinA.1 NORTH CHICAGO, Ill. , Oct. 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX) compared to placebo for the treatment of upper limb essential tremor.", "url": "https://www.prnewswire.com/news-releases/abbvie-announces-positive-topline-results-from-phase-2-elate-trial-evaluating-onabotulinumtoxina-botox-for-the-treatment-of-upper-limb-essential-tremor-302575398.html"}}
{"date": "2025-10-04", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-04 10:01:11", "publisher": "24/7 Wall Street", "title": "Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)", "image": "https://images.financialmodelingprep.com/news/top-dividend-stocks-poised-for-explosive-growth-in-2026-20251004.jpg", "site": "247wallst.com", "text": "Geopolitical events, judicial rulings, new law legislation, and policy changes are all circumstances occurring on domestic and international stages that are triggering big stock moves in various industrial sectors.", "url": "https://247wallst.com/investing/2025/10/04/top-dividend-stocks-poised-for-explosive-growth-in-2026-abbv-gd-rgr/"}}
{"date": "2025-10-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-03 16:16:57", "publisher": "Reuters", "title": "AbbVie expects $2.7 billion R&D charge in third quarter", "image": "https://images.financialmodelingprep.com/news/abbvie-expects-27-billion-rd-charge-in-third-quarter-20251003.jpg", "site": "reuters.com", "text": "Drugmaker AbbVie in a regulatory filing on Friday said it expects third-quarter earnings to include a $2.7 billion charge related to in-process research and development (IPR&D) expenses.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-expects-27-billion-rd-charge-third-quarter-2025-10-03/"}}
{"date": "2025-10-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-03 14:50:36", "publisher": "The Motley Fool", "title": "St Louis Financial Loads Up on AbbVie (ABBV) With 14,600 Shares Buy", "image": "https://images.financialmodelingprep.com/news/st-louis-financial-loads-up-on-abbvie-abbv-with-14600-20251003.png", "site": "fool.com", "text": "St. Louis Financial Planners Asset Management, LLC initiated a new stake in AbbVie (ABBV -0.78%), acquiring 14,630 shares for an estimated $3.39 million in Q3 2025.", "url": "https://www.fool.com/coverage/filings/2025/10/03/st-louis-financial-loads-up-abbv-with-14600-shares-buy/"}}
{"date": "2025-10-03", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-03 11:05:33", "publisher": "Seeking Alpha", "title": "AbbVie: Wins Accumulating While We Wait For Next BD Steps", "image": "https://images.financialmodelingprep.com/news/abbvie-wins-accumulating-while-we-wait-for-next-bd-20251003.jpg", "site": "seekingalpha.com", "text": "AbbVie is outperforming expectations with strong commercial results, pipeline progress, and the legal win that secured Rinvoq's long-term market exclusivity. ABBV has raised the full-year revenue guidance by $1.5 billion since the start of the year, and I am raising my estimate range again to reflect the better-than-expected performance. The pipeline is delivering late-stage wins, notably with Rinvoq, Epkinly, and Qulipta.", "url": "https://seekingalpha.com/article/4827703-abbvie-wins-accumulating-while-we-wait-for-next-bd-steps"}}
{"date": "2025-10-02", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-02 18:45:53", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-stock-sinks-as-market-gains-heres-why-20251002.jpg", "site": "zacks.com", "text": "In the closing of the recent trading day, AbbVie (ABBV) stood at $236.56, denoting a -3.2% move from the preceding trading day.", "url": "https://www.zacks.com/stock/news/2761042/abbvie-abbv-stock-sinks-as-market-gains-here-s-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2761042"}}
{"date": "2025-10-02", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-02 08:20:03", "publisher": "Forbes", "title": "ABBV Stock vs. Eli Lilly & Merck", "image": "https://images.financialmodelingprep.com/news/abbv-stock-vs-eli-lilly-merck-20251002.jpg", "site": "forbes.com", "text": "AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision to grant a three-year exemption from 100% import tariffs. Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/02/abbv-stock-vs-eli-lilly--merck/"}}
{"date": "2025-10-02", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-02 08:00:00", "publisher": "PRNewsWire", "title": "AbbVie to Host Third-Quarter 2025 Earnings Conference Call", "image": "https://images.financialmodelingprep.com/news/abbvie-to-host-thirdquarter-2025-earnings-conference-call-20251002.jpg", "site": "prnewswire.com", "text": "NORTH CHICAGO, Ill. , Oct. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2025 financial results on Friday, October 31, 2025, before the market opens.", "url": "https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2025-earnings-conference-call-302571622.html"}}
{"date": "2025-10-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-01 08:00:00", "publisher": "PRNewsWire", "title": "Natrelle Awarded Supplier Agreement from Vizient", "image": "https://images.financialmodelingprep.com/news/natrelle-awarded-supplier-agreement-from-vizient-20251001.jpg", "site": "prnewswire.com", "text": "This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market. IRVINE, Calif.", "url": "https://www.prnewswire.com/news-releases/natrelle-awarded-supplier-agreement-from-vizient-302568579.html"}}
{"date": "2025-10-01", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-10-01 05:25:00", "publisher": "The Motley Fool", "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever", "image": "https://images.financialmodelingprep.com/news/want-decades-of-passive-income-3-stocks-to-buy-20251001.jpg", "site": "fool.com", "text": "Stocks in the S&P 500 (^GSPC 0.41%) offer a miserly yield of 1.2% (on average) today. You can do way better than that and still invest in very attractive businesses.", "url": "https://www.fool.com/investing/2025/10/01/passive-income-stocks-buy-now-hold-forever/"}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-30 15:00:00", "publisher": "PRNewsWire", "title": "AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.", "image": "https://images.financialmodelingprep.com/news/abbvie-begins-construction-on-70-million-expansion-to-further-20250930.jpg", "site": "prnewswire.com", "text": "Expansion increases biologics manufacturing for immunology and oncology medicines Milestone marks progress on AbbVie's long-term commitment to U.S. manufacturing Furthers longstanding commitment to AbbVie's Massachusetts sites and workforce NORTH CHICAGO, Ill. , Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass.", "url": "https://www.prnewswire.com/news-releases/abbvie-begins-construction-on-70-million-expansion-to-further-increase-biologics-manufacturing-and-rd-presence-in-the-us-302571294.html"}}
{"date": "2025-09-30", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-30 08:00:00", "publisher": "PRNewsWire", "title": "AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment Options", "image": "https://images.financialmodelingprep.com/news/abbvie-submits-biologics-license-application-bla-to-us-fda-20250930.jpg", "site": "prnewswire.com", "text": " BLA based on data from the global Phase 1/2 CADENZA trial NORTH CHICAGO, Ill. , Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of investigational Pivekimab sunirine (PVEK) for treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).", "url": "https://www.prnewswire.com/news-releases/abbvie-submits-biologics-license-application-bla-to-us-fda-for-pivekimab-sunirine-pvek---an-investigational-antibody-drug-conjugate-adc-to-treat-rare-cancer-with-limited-treatment-options-302570103.html"}}
{"date": "2025-09-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-29 19:30:00", "publisher": "GlobeNewsWire", "title": "Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases", "image": "https://images.financialmodelingprep.com/news/nxera-pharma-to-receive-us10-million-milestone-payment-from-20250929.png", "site": "globenewswire.com", "text": "Tokyo, Japan and Cambridge and London, UK, 30 September 2025  Nxera Pharma Co., Ltd. (Nxera or the Company; TSE 4565) announces that it has reached a second important R&D milestone under its multi-target discovery collaboration with AbbVie focused on neurological diseases, resulting in a payment of US$10 million to Nxera.", "url": "https://www.globenewswire.com/news-release/2025/09/29/3158227/0/en/Nxera-Pharma-to-Receive-US-10-Million-Milestone-Payment-from-AbbVie-under-Collaboration-Targeting-Neurological-Diseases.html"}}
{"date": "2025-09-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-29 15:41:08", "publisher": "Zacks Investment Research", "title": "AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease", "image": "https://images.financialmodelingprep.com/news/abbvie-seeks-fda-nod-for-tavapadon-to-treat-parkinsons-20250929.jpg", "site": "zacks.com", "text": "ABBV files for FDA approval of tavapadon, a once-daily oral Parkinson's drug backed by late-stage TEMPO studies.", "url": "https://www.zacks.com/stock/news/2759201/abbvie-seeks-fda-nod-for-tavapadon-to-treat-parkinson-s-disease?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2759201"}}
{"date": "2025-09-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-29 12:00:00", "publisher": "PRNewsWire", "title": "AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility", "image": "https://images.financialmodelingprep.com/news/abbvie-breaks-ground-on-new-north-chicago-active-pharmaceutical-20250929.jpg", "site": "prnewswire.com", "text": "New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines Facility expected to be fully operational and serving patients by 2027 Milestone marks progress on AbbVie's long-term commitment to U.S. manufacturing NORTH CHICAGO, Ill. , Sept. 29, 2025 /PRNewswire/ --AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois.", "url": "https://www.prnewswire.com/news-releases/abbvie-breaks-ground-on-new-north-chicago-active-pharmaceutical-ingredient-manufacturing-facility-302569711.html"}}
{"date": "2025-09-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-29 10:01:09", "publisher": "Zacks Investment Research", "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know", "image": "https://images.financialmodelingprep.com/news/abbvie-inc-abbv-is-attracting-investor-attention-here-is-20250929.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2758700/abbvie-inc-abbv-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2758700"}}
{"date": "2025-09-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-29 09:11:21", "publisher": "Reuters", "title": "AbbVie to launch ovarian cancer drug in UK at the same list price as US", "image": "https://images.financialmodelingprep.com/news/abbvie-to-launch-ovarian-cancer-drug-in-uk-at-20250929.jpg", "site": "reuters.com", "text": "AbbVie said on Monday it would launch its ovarian cancer drug Elahere in the U.K. at a list price equal to that in the U.S.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-launch-ovarian-cancer-drug-uk-same-list-price-us-2025-09-29/"}}
{"date": "2025-09-29", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-29 09:00:00", "publisher": "PRNewsWire", "title": "AbbVie Announces UK Pricing Strategy for ELAHERE (mirvetuximab soravtansine-gynx)", "image": "https://images.financialmodelingprep.com/news/abbvie-announces-uk-pricing-strategy-for-elahere-mirvetuximab-soravtansinegynx-20250929.jpg", "site": "prnewswire.com", "text": "The list price will be consistent with the United States to reflect the value of the innovation AbbVie is committed to ensuring that developed nations fully recognize the value of our medicines in improving patient outcomes, consistent with the level of recognition in the United States NORTH CHICAGO, Ill. , Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced plans to launch ELAHERE(mirvetuximab soravtansine-gynx) in the U.K. at a list price equal to the U.S., reflecting the advanced innovation and value of the treatment for adult patients with folate receptor-alpha (FR) positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens.1 ELAHERE is the first-and-only approved FR-directed antibody drug conjugate (ADC) medicine.", "url": "https://www.prnewswire.com/news-releases/abbvie-announces-uk-pricing-strategy-for-elahere-mirvetuximab-soravtansine-gynx-302569509.html"}}
{"date": "2025-09-28", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-28 10:00:00", "publisher": "The Motley Fool", "title": "5 Dividend Powerhouses to Buy and Never Sell", "image": "https://images.financialmodelingprep.com/news/5-dividend-powerhouses-to-buy-and-never-sell-20250928.jpg", "site": "fool.com", "text": "Here's a statistic that should reshape how you think about investing: Companies that consistently raise dividends have crushed the S&P 500 by 2.5 percentage points annually since 1972. Not tech highfliers.", "url": "https://www.fool.com/investing/2025/09/28/5-dividend-powerhouses-to-buy-and-never-sell/"}}
{"date": "2025-09-27", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-27 07:00:53", "publisher": "Seeking Alpha", "title": "AbbVie For Healthy Dividend Growth", "image": "https://images.financialmodelingprep.com/news/abbvie-for-healthy-dividend-growth-20250927.jpg", "site": "seekingalpha.com", "text": "AbbVie is rated a strong buy for its strong dividend growth, robust fundamentals, and proven track record as a Dividend King. ABBV offers a compelling mix of a 3% yield and nearly 7% annual historical dividend growth, supported by a conservative payout ratio and strong earnings. Growth drivers include immunology drugs Skyrizi and Rinvoq, with management projecting solid EPS growth and a likely 6% dividend hike in October.", "url": "https://seekingalpha.com/article/4826365-abbvie-for-healthy-dividend-growth"}}
{"date": "2025-09-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-26 16:50:24", "publisher": "CNBC Television", "title": "Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham", "image": "https://images.financialmodelingprep.com/news/many-pharma-companies-already-made-us-investment-promises-says-20250926.jpg", "site": "youtube.com", "text": "CNBC's Closing Bell Overtime team discusses President Trump's plan to impose a 100% tariff on all any branded or patented Pharmaceutical Product entering the U.S. with Geoff Meacham of Citi Research.", "url": "https://www.youtube.com/watch?v=Y8KXHmkqiCg"}}
{"date": "2025-09-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-26 12:46:30", "publisher": "Zacks Investment Research", "title": "Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?", "image": "https://images.financialmodelingprep.com/news/has-abbvie-successfully-navigated-topline-growth-post-humira-loe-20250926.jpg", "site": "zacks.com", "text": "ABBV eyes a 2025 rebound as Skyrizi and Rinvoq drive growth beyond Humira, with oncology and neuroscience adding momentum.", "url": "https://www.zacks.com/stock/news/2757868/has-abbvie-successfully-navigated-top-line-growth-post-humira-loe?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2757868"}}
{"date": "2025-09-26", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-26 08:45:00", "publisher": "PRNewsWire", "title": "AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease", "image": "https://images.financialmodelingprep.com/news/abbvie-submits-new-drug-application-to-us-fda-for-20250926.jpg", "site": "prnewswire.com", "text": "Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel selective dopamine D1/D5 receptor partialagonist, in Parkinson's disease If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option NORTH CHICAGO, Ill. , Sept. 26, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tavapadon, a novel selective dopamine D1/D5 receptor partialagonist that was studied as a once daily oral treatment for Parkinson's disease.", "url": "https://www.prnewswire.com/news-releases/abbvie-submits-new-drug-application-to-us-fda-for-tavapadon-for-the-treatment-of-parkinsons-disease-302567585.html"}}
{"date": "2025-09-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-25 11:53:00", "publisher": "GlobeNewsWire", "title": "AbbVie's Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists", "image": "https://images.financialmodelingprep.com/news/abbvies-rinvoq-gains-early-traction-in-giant-cell-arteritis-market-20250925.jpeg", "site": "globenewswire.com", "text": "Spherix Global Insights finds majority of specialists expect Rinvoq's uptake to accelerate, with potential implications branching to the polymyalgia rheumatica landscape. Spherix Global Insights finds majority of specialists expect Rinvoq's uptake to accelerate, with potential implications branching to the polymyalgia rheumatica landscape.", "url": "https://www.globenewswire.com/news-release/2025/09/25/3156509/0/en/AbbVie-s-Rinvoq-Gains-Early-Traction-in-Giant-Cell-Arteritis-Market-Expanding-Options-for-Rheumatologists.html"}}
{"date": "2025-09-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-25 05:00:00", "publisher": "The Motley Fool", "title": "3 Top Dividend Stocks to Buy and Hold Forever", "image": "https://images.financialmodelingprep.com/news/3-top-dividend-stocks-to-buy-and-hold-forever-20250925.jpg", "site": "fool.com", "text": "Dividends have quietly driven the bulk of stock market returns for over a century. While share prices grab headlines, reinvested dividends account for the majority of total returns in global equity markets since 1900.", "url": "https://www.fool.com/investing/2025/09/25/3-top-dividend-stocks-to-buy-and-hold-forever/"}}
{"date": "2025-09-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-25 05:00:00", "publisher": "PRNewsWire", "title": "Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai", "image": "https://images.financialmodelingprep.com/news/allergan-aesthetics-to-showcase-multimodal-treatment-approach-and-continued-commitment-20250925.jpg", "site": "prnewswire.com", "text": "New AA (Allergan Aesthetics) Signature multimodal treatment approach to be presented at AMWC Dubai following successful launch in 25 countries so far this year. Experts to explore the paradigm shift in medical aesthetics and decode new AA Signature approach at Allergan Medical Institute (AMI) symposium.", "url": "https://www.prnewswire.com/news-releases/allergan-aesthetics-to-showcase-multimodal-treatment-approach-and-continued-commitment-to-skin-quality-at-amwc-dubai-302565990.html"}}
{"date": "2025-09-25", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-25 04:44:00", "publisher": "The Motley Fool", "title": "Where Will AbbVie Be in 5 Years?", "image": "https://images.financialmodelingprep.com/news/where-will-abbvie-be-in-5-years-20250925.jpg", "site": "fool.com", "text": "AbbVie (ABBV -1.13%) ranks as the third-largest pharmaceutical company in the world, with a market capitalization hovering around $390 billion. It markets around a dozen blockbuster drugs, plus many others that generate millions of dollars in sales each year.", "url": "https://www.fool.com/investing/2025/09/25/where-will-abbvie-be-in-5-years/"}}
{"date": "2025-09-24", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-24 18:45:29", "publisher": "Zacks Investment Research", "title": "AbbVie (ABBV) Declines More Than Market: Some Information for Investors", "image": "https://images.financialmodelingprep.com/news/abbvie-abbv-declines-more-than-market-some-information-for-20250924.jpg", "site": "zacks.com", "text": "AbbVie (ABBV) concluded the recent trading session at $219.99, signifying a -1.18% move from its prior day's close.", "url": "https://www.zacks.com/stock/news/2756684/abbvie-abbv-declines-more-than-market-some-information-for-investors?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2756684"}}
{"date": "2025-09-23", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-23 05:00:00", "publisher": "PRNewsWire", "title": "Allergan Aesthetics Announces Expansion of SKINVIVE by JUVDERM into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality", "image": "https://images.financialmodelingprep.com/news/allergan-aesthetics-announces-expansion-of-skinvive-by-juvderm-into-35-20250923.jpg", "site": "prnewswire.com", "text": "SKINVIVE  to launch in 35 additional markets worldwide from September taking the total to 57 international launches in 2025. Research highlights 94% of people want to improve facial skin quality1*, with deep hydration valued across all ages worldwide2.", "url": "https://www.prnewswire.com/news-releases/allergan-aesthetics-announces-expansion-of-skinvive-by-juvederm-into-35-new-markets-reinforcing-its-commitment-to-advancing-global-skin-quality-302563617.html"}}
{"date": "2025-09-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-22 21:20:00", "publisher": "The Motley Fool", "title": "1 Top Dividend Stock to Buy and Hold Forever", "image": "https://images.financialmodelingprep.com/news/1-top-dividend-stock-to-buy-and-hold-forever-20250922.jpg", "site": "fool.com", "text": "Strong dividend payers can be a stabilizing force in a well-diversified portfolio. That's because corporations that can consistently pay and raise their payouts over a long period are often relatively low-risk, well-established companies with robust underlying operations.", "url": "https://www.fool.com/investing/2025/09/22/1-top-dividend-stock-to-buy-and-hold-forever/"}}
{"date": "2025-09-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-22 11:13:08", "publisher": "The Motley Fool", "title": "What Is One of the Best Pharmaceutical Stocks to Buy Right Now?", "image": "https://images.financialmodelingprep.com/news/what-is-one-of-the-best-pharmaceutical-stocks-to-20250922.jpg", "site": "fool.com", "text": "It isn't easy to find a pharmaceutical company that has a strong product lineup and a robust pipeline, but also cranks out a generous dividend every quarter. I've been an AbbVie (ABBV 1.02%) bull for years, and especially these days, I think it's a bargain stock that can produce outsized returns for a long time to come.", "url": "https://www.fool.com/investing/2025/09/22/best-pharmaceutical-stocks-to-buy-now/"}}
{"date": "2025-09-22", "symbol": "ABBV", "type": "stock_news", "result": {"symbol": "ABBV", "publishedDate": "2025-09-22 04:46:00", "publisher": "The Motley Fool", "title": "Forever Dividend Stocks: 3 Income Stocks I Never Plan to Sell", "image": "https://images.financialmodelingprep.com/news/forever-dividend-stocks-3-income-stocks-i-never-plan-to-20250922.jpg", "site": "fool.com", "text": "Warren Buffett was onto something when he said that his \"favorite holding period is forever.\" Like Buffett, I prefer to buy stocks that I hope to be able to own for a long time.", "url": "https://www.fool.com/investing/2025/09/22/forever-dividend-stocks-3-income-stocks-i-never-pl/"}}
